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Abstract 
Using administrative data to measure the quality and safety of hospital care offers many 
opportunities. However, progress has been limited to few countries and predominantly to a small 
subset of broad measures, such as Hospital Standardised Mortality Rates. In this thesis, I investigate 
the potential advantages and feasibility – in terms of validity and applicability – of specialty-specific 
indicators.  
In the first part of my PhD work, I examine the case for specialty-specific indicators. I also present 
potential applications which overcome some of the existing shortcomings of previous uses of 
indicators based on administrative data.  
In the next stage of the project I focus on assessing feasibility by focusing on two specialties – stroke 
and obstetric care – conducting systematic reviews and consulting with experts to develop two 
indicator sets. As part of this, I identified the shortcomings in current use of indicators in these 
specialties.  To investigate the limitations of these indicators, I applied the indicator definitions to 
English hospital administrative data (Hospital Episode Statistics, HES) and evaluated whether they 
can be used to discriminate between hospitals based on their performance and, importantly, to 
understand the effect of differences in coding practice.  
The final aspect of the research was to investigate alternative applications for the indicators which 
can overcome some of the shortcomings highlighted in both the prior analyses and existing 
literature. In doing so, I raise serious, robust shortcomings on the quality and safety of weekend 
care.  
Novel aspects of this research 
New indicator sets:  First collation of obstetric and stroke indicators based on administrative data 
New application:  First application of some of these indicators to English data 
 Applying indicator bundles to improve validity 
New methods: Present innovative methods to investigate bias from coding practice  
New insights: Reveal previously unknown issues on variation of care in England 
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Jumbo (1861 – 1885) was an African elephant of enormous proportions. The giant mammal was 
famed in Paris and London zoos. Despite 100,000 school children writing to Queen Victoria not to 
sell him, Jumbo was bought by the owner of “The Greatest Show on Earth”.  The picture has been 
included here to introduce an idiom, the elephant in the room, and a fable, the blind men and the 
elephant, from which you can draw analogies to measuring healthcare quality and safety. However, 
this thesis perhaps offers a more promising story than that of Jumbo. Unfortunately, the 4 metre tall 
Jumbo died – reportedly saving a young circus elephant – when crushed by a locomotive. Further, 
the stuffed Jumbo was destroyed in a fire in 1975.  
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Part One:  
Introduction and 
concepts 
  
It was six men of Indostan 
To learning much inclined, 
Who went to see the Elephant 
(Though all of them were blind), 
That each by observation 
Might satisfy his mind. 
(The Blind Men and the Elephant, John Godfrey Saxe 1816-87) 
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Overview 
"Declare the past, diagnose the present, foretell the future; practice these acts.  
As to diseases, make a habit of two things-to help, or at least to do no harm"  
(Epidemics, Book 1, Section XI, Hippocrates, 460-370BC) 
 
Context 
This chapter sets out the quality and safety landscape outlining the impact of, and interest in, 
shortcomings in healthcare. In particular, I highlight the importance of measuring the quality and 
safety of hospital care. Thereafter, I present the previous techniques used to meet this 
measurement demand, and provide a short critique of these. The chapter closes by setting out the 
case for further development of measures of quality and safety.  
Methods 
A narrative review of the literature 
Findings 
The quality and safety of healthcare remains a global concern. The literature reveals: significant 
shortcomings in quality and safety; high impact of these adverse events; potential preventability; 
and widespread interest. There is scope to develop further healthcare indicators and apply them 
in a broader array of countries than currently adopts them. 
Related papers 
Tsang C, Palmer W, Bottle A, Majeed A, Aylin P. A review of patient safety measures based on 
routinely collected hospital data. Am J Med Qual 2011;27(2):154-69. 
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1.1. Introduction to quality and safety in 
healthcare 
1.1.1. Improving healthcare 
There has been considerable progress in health care across the world. From 2000 to 2009, 
total expenditure on health has increased by a seventh (from 8.2% to 9.4% of total global 
GDP) and now represents a more significant part of governments accounts, with general 
government expenditure on health increasing from 13.3% to 14.3% of total government 
expenditure.1 People’s health is also improving. The World Health Organisation (WHO) 
estimated that the reduction in the rate of child mortality between 1978 and 2006 is 
equivalent to over 18 000 children’s lives being saved every day.2 Global life expectancy has 
also increased by four years, to 68, between 1990 and 2009.1 
1.1.2. Patient safety 
A seminal report by the Institute of Medicine (IoM), published in 1999, outlined the patient 
safety issue.3 Despite these improvements, there is a longstanding acknowledgment of the 
existence of persistent risks to patients’ safety. ‘The longstanding cornerstone of medicine 
"do no harm" exists because of the fragility of life and health during medical care 
encounters’(p1).4 While health services are treating more patients, due to the ever increasing 
size and complexity of healthcare, upholding this maxim is proving more and more difficult.5 
Such harm manifests as patient safety events, defined by one organisation as “any 
unintended or unexpected incident which could have or did lead to harm for one or more 
patients receiving… care”.6 Patient safety events come under many labels, including: 
iatrogenic harm, medical errors, nosocomial infections, substandard care, adverse events, 
critical incidents, preventable or avoidable complications, and sentinel events.  
The number of labels reflects the various types of adverse events – such as diagnostic errors, 
equipment failure, infections, blood transfusion-related injuries, and misinterpretation of 
other medical orders 7 – and belies the common belief that medical errors usually involve 
incorrect drug use or wrong-site surgery. Whilst the context within which healthcare services 
are operating is making the risks more pronounced, the problem of patient safety events is 
not new, with studies on such incidents being produced throughout the 1950s and an 
emerging body of evidence by the 1990s.8 However, despite these early reports, in terms of 
research, patient safety is still a new and fast growing area.9 
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1.1.3. Quality in healthcare 
As a result of developments of the health services and increased scrutiny, expectations have 
changed. Healthcare is expected to be not just safe but of high quality which can be defined 
as “the degree to which health services for individuals and populations increase the 
likelihood of desired health outcomes and are consistent with current professional 
knowledge.”10 This can include new technologies and procedures. The proliferation of health 
research and resultant guidelines to instruct the provision of care has helped to codify 
differences in quality, in terms of processes as well as outcomes. Again ‘quality’ is a broad 
term and can include not only evaluation of clinical contact but of patient satisfaction and 
access. 
1.1.4. Continuum of quality and safety 
1.1.4.1. Difficulty in disaggregating quality and safety 
The changes in perceptions over what is expected from healthcare services redefine the line 
between quality and patient safety. To demonstrate this problem, consider the thought 
experiment on misdiagnosis:  
Patient A has a rare condition that has ambiguous symptoms. Patient B has a typical case of 
a common disease that has high diagnosis rates within the population. Both conditions are 
easily treatable but, on presentation to the health service, both are misdiagnosed and the 
prescribed treatment makes no effect on Patient A’s state but makes Patient B less well. 
Given Patient B might have reasonable expectations of being correctly diagnosed and the 
failure to do so caused harm, most definitions would categorise this as a patient safety 
event. Whereas, the lower expectations of correct diagnosis and lack of harm would, under 
most definitions, classify Patient A as quality, but not patient safety, incident. However, the 
question of what likelihood of correct diagnosis and level of harm (or failure to improve) 
does the line between quality and safety fall remains subjective. Indeed, this lack of 
distinction has been highlighted in academic literature.11,12  
1.1.4.2. Defining quality and safety in this project 
Despite difficulties in disaggregating between these two aspects of healthcare delivery, 
some parts of the remainder of this chapter (particular on estimating prevalence and costs) 
will focus predominantly on commonly evoked patient safety events and measurement since 
this is sufficient to describe the importance of measurement, and benefits from being easier 
to conceptualise given the more dichotomous nature of patient safety events. I did not 
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attempt to create a potentially burdensome and redundant framework for codifying events 
along the continuum since both quality and safety have intrinsic interest to all stakeholders, 
as detailed in section 1.3, p27. For brevity, I use the term ‘adverse event’ to cover both 
quality and patient safety incidents.  
1.2. Causes, counts and costs 
1.2.1. Conceptual models 
Many frameworks have been used to describe the causes of patient safety events or 
shortcomings in quality, although most have focused on the former, such as: Donabedian’s 
interconnected outcome, process and structure;13 the widely-used14 categorisation proposed 
by James Reason with errors as slips, lapse or mistakes;15 or the long list of causes presented 
by the World Alliance for Patient Safety including poor training, misdiagnosis and latent 
failures.16 Given the different dimensions that can compound to result in an adverse event, 
any categorisation will struggle to be both mutually exclusive and comprehensively 
exhaustive. There is, therefore, no agreement on the best scheme for classifying adverse 
events14 and many existing categorisations have omissions. For example, Reason’s popular 
scheme fails to capture some commonly cited adverse events, such as equipment failures. 
1.2.2. Prevalence and preventability 
1.2.2.1. National estimates 
The Harvard study in 1984 was the first major investigation into the extent of the patient 
safety issue and estimated that adverse events, defined in this instance as “injuries caused 
by medical management, and of the subgroup of such injuries that resulted from negligent 
or substandard care” (p370), occurred in 3.7% of admissions.17 A similar, subsequent study 
undertaken in Australia, using a broader definition of adverse events, estimated an incidence 
rate of 16.6% of admissions.18 Although these two studies represent the most exhaustive 
evaluation of the number of patient safety events in their respective countries, they are still 
thought to underestimate the actual prevalence.19 A number of further studies have 
estimated the prevalence of such events, as outlined in Table 1 below. 
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Table 1: National estimates on the prevalence of patient safety events 
Country Study Number of 
hospital 
admissions † 
Number of 
adverse 
events † 
Adverse event 
rate (% patients) 
† 
Adverse event rate 
(% admissions) 
Australia Quality in Australian 
Health Care Study, 
QAHCS (1992) 
14 179 2 353  
(1 499) ‡ 
- 16.6  
(10.6) ‡ 
France (Pilot study)  - - - 14.5 
New Zealand^ (1998) 6 579 849 12.9 11.2 
United Kingdom (1999-2000) 1 014 119 11.7 10.8 
Denmark (1998) 1 097 176 9.0 9.0 
Canada (2001) 3 720 279 7.5 7.5 
United States ~ California Insurance 
Feasibility Study 
- - - 4.7  
United States Harvard Medical 
Practice Study (1984) 
30 195 1 133 3.8 3.7 
United States Utah-Colorado Study, 
UTCOS (1992) 
14 565 475 
(787) ‡ 
3.2 
(5.4) ‡ 
2.9 
Notes: ^ Included all acute care; † Additional information from WHO (2004)
8
; ‡ UTCOS and QAHCS were revised 
using the same methodology. These comparable results are given in brackets; ~  Study measured ‘potentially 
compensable events’. 
Source: Adapted from Vincent (2006), p42.
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1.2.2.2. Amenable to healthcare 
Further analysis has suggested that most patient safety events identified in the studies of 
national prevalence were preventable, although “some adverse events are not preventable 
and they reflect the risk associated with treatment, such as a life-threatening allergic 
reaction to a drug when the patient had no known allergies to it.” 21 In the Harvard case, 
later analysis estimated that 70% of adverse events were potentially preventable 22 and in 
the Australian study the equivalent figure was 51%.18 In a preliminary study in 2001 using a 
similar method in England, of the adverse events identified (which occurred in 10.8% of 
admissions) almost half (48%) were judged preventable.23 
1.2.3. Cost of adverse events 
1.2.3.1. Increased use of hospital resources 
Patients who are harmed as a result of an adverse event can, and often do, have longer 
admissions and require additional procedures. For example, in the Harvard and Utah studies, 
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adverse drug events were associated with an increase of 2.2 and 1.9 days, respectively, in 
comparison to data from matched controls.19 When considering only preventable events, 
the figure for the Harvard study was 4.6 days. Analysis focusing on paediatric care showed 
that some patient safety events were associated with considerable increases in average 
length of stay, with an increase of 18 days for decubitus ulcers, 26 days for postoperative 
sepsis and 30 days for infection as a result of medical care.24 In addition to the acute care 
costs, there are also potentially other costs incurred as a result of adverse events, such as in 
primary care and attendances at accident and emergency when the harm, as can be the case 
for hospital acquired infection, presents itself after discharge. 
1.2.3.2. Increased mortality 
As well as harm to patients, adverse events can result in death. Analysing the effects on 
mortality over a range of patient safety events, Miller and Zhan (2004) found an increased 
rate of in-hospital deaths.24 The varying effects identified by the study ranged from those for 
the patient safety event of birth trauma, with an increased rate of mortality with odds ratio 
1.3 compared with infants who did not have trauma at birth, to iatrogenic pneumothorax 
(odds ratio of 7.5) and postoperative respiratory failure (odds ratio of 76.6). The authors of 
this analysis, as with that presented in the previous paragraph, are not able to control for 
potential bias, such as in the scenario where an unmeasured case-mix factor is associated 
with an increased likelihood both of an adverse event being identified (due to more obvious 
poorer outcome in those with complex comorbidities) and death. In another study 
investigating the proportion of active-care patient deaths that were preventable, almost a 
quarter (23%) were rated by a clinician panel as at least possibly preventable by optimal 
care, with 6% deemed to be probably or definitely preventable.25 
1.2.3.3. Financial costs 
Adverse events are also an important issue due to their financial cost. An event may 
introduce additional costs through, for example: the hospital being reimbursed for 
additional bed days and procedures; legal fees; a burden on the workforce to support the 
additional care required; emotional cost to any practitioner involved; and any physical or 
mental harm on the patient. To date, few studies have looked at the societal and personal 
costs with focus remaining on hospital charges. Drawing again on the findings of the Harvard 
and Utah studies, adverse drug events have been associated with an increased average cost 
per admission of $2 262 and $2 595 ($4 685 when considering only preventable adverse 
drug events).19 These figures are dwarfed by a US study on paediatric care which found, 
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across a range of patient safety events, excess charges per discharge ranged from $30 000 to 
$140 000 depending on the type of patient safety events.26 
1.2.3.4. National estimates of costs 
Further to estimating the effects on patient safety events at patient and hospital levels, 
efforts have been made to extrapolate the burden on a national scale. Many of these 
estimates are based on the studies, outlined in Table 1 (p25), that evaluated the prevalence 
of adverse events. An IoM report estimated that between 44 000 and 98 000 deaths per year 
were due to medical errors in US hospitals,27 whereas a news report stated that medical 
mistakes killed 180 000 people a year.28 However, McDonald and colleagues (2000) argued 
that these estimates are likely to be overestimates; in particular, since there is a lack of 
consideration of the expected risk of in-hospital death in the absence of a medical error.29 
Further questions are cast over the validity of these estimates by the fact that the 
extrapolation are made by people not involved in the original reports and so the original 
notions of preventability are missed.25 Specifically, there are problems associated with the 
extrapolation of results from small studies to a national level and comparisons between 
countries are affected by the variations in definitions used in the original studies. A more 
sophisticated approach, which is relevant to the discussion at the end of the thesis 
(paragraph 11.6.3.6, p268), might be to assess quality-adjusted life years (QALYs) lost. 
As well as the estimates based on the effects on mortality rates, a number of efforts have 
been made to estimate the cost of patient safety events on a national level. In the US, solely 
within paediatric care, excess charges were estimated to be in the region of $1 billion.30 One 
report suggests that the national annual cost of patient safety events is approximately $37.6 
billion. Of this about half of the costs ($17 billion) are associated with preventable errors, 
and half of this expenditure (on preventable medical errors) is accounted for through direct 
health care costs.27 In Australia, a study based on 2003-04 data estimated that the burden 
was in the region of Aus$2 billion (equivalent to around US $1.5 billion).18,31  
1.3. Interest of quality and patient safety 
There has been an increased focus on quality and safety from all stakeholders. This 
increased interest is a results of a multitude of factors, including: changing risks;32 dramatic 
reforms in healthcare systems and organisational structures;33 the introduction of legislation 
governing quality and safety 34 and policies such as linking adverse events to healthcare 
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providers’ remuneration;33 and increased awareness - both in terms of certain types of 
events such as hospital acquired infections35 and due to high-profile adverse events.36  
1.3.1. Policy focus 
1.3.1.1. Government priority 
Perhaps as a result of these startling figures on the national effects of poor quality and 
patient safety events, many governments have begun to increase the priority they place on 
reducing such events.37 Some governments have demonstrated their intensions by 
introducing incentives to reduce adverse events. One indication of this change is the number 
of new agencies and legislation designed to improve patient safety, such as the National 
Patient Safety Agency (NPSA) which was established in England in 2001 (although the 
function transferred to the newly formed independent national body, the NHS 
Commissioning Board – now NHS England – in the reforms in June 2012).34  
The social insurance program administered by the government in the USA, have introduced 
an initiative designed to improve patient safety whereby hospitals are not fully reimbursed if 
the patient is affected by certain patient safety events.38 In England, in 2010 the government 
announced a policy to levy financial penalties on hospitals for care that results in an 
emergency readmission. As the subject of these policies, this highlights the importance of 
adverse events to hospitals. This rise in national action may also have been driven by the 
increased public and media attention, which is discussed below. This is coupled with the 
increased focus on the health services in general due to, for example, the problems 
associated with aging populations, rising costs, lack of accountability and inequalities. 32  
1.3.1.2. Intra-governmental priority 
Another possible driver for the raised priority is interest taken by international 
organisations. For example, in 2004 the WHO, following pressure that the Organisation and 
its member states paid closer attention to patient safety, set up the World Alliance for 
Patient Safety.  
1.3.2. Hospital focus 
1.3.2.1. Importance to hospitals 
The additional length of stay and procedures outlined above have an operational cost to 
hospitals due to the burden on their resources, both in terms of capacity and workforce. For 
example, a 2007 study conducted in Japanese hospitals estimated there were 6,240 person-
hours dedicated to patient safety practices per 100-beds each year, including about 1,141 
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person-hours for infection control alone.39 The study included incident reporting, external 
audit, management of medication and maintenance of medical equipment. It did, however, 
not include the staff hours associated with the additional lengths of stay and procedures. 
Moreover, the increasingly common policy of patient choice, whereby the person is able to 
select who provides their healthcare, means any hospital with a reported poor record on 
adverse events is likely to miss out on possible treatment opportunities and the funding 
attached to them. 
1.3.2.2. Importance of acute care 
Acute care is an important part of any healthcare service. Around a third of personal health 
care expenditure in the USA is committed towards hospital care, with this proportion having 
increased recently.40 In England, in 2012-13, half of local health spend was on “general and 
acute”, “accident and emergency” and “maternity” (£47 billion out of £91 billion), which is 
more than double that spent on primary care (£21 billion on GP Services, community 
prescribing costs, dental services).41  Moreover, the estimates given earlier on the 
prevalence of patient safety events are predominantly based on the hospital setting and, as 
such, it’s a known area of importance. 
In particular, the acuity means the likelihood of a perceptible change following an adverse 
event is important as it aids outcome measurement whilst also reiterating the high impact 
(and therefore the need to address it). 
1.3.3. Patient and media focus 
1.3.3.1. High profile cases 
A number of high-profile patient safety events have raised the public’s awareness of medical 
errors. In England, the death of a child at Bristol Royal Infirmary following surgery - which 
was undertaken against the advice of anaesthetists, some surgeons and the Department of 
Health (DH) - was widely reported in the media and led to an external inquiry. A subsequent 
investigation into the cases of 53 children treated at the hospital, led to three doctors being 
found guilty of serious professional misconduct. Other countries have had similar cases 
capture the media and public’s attention. For example, the case of Willie King in Florida, who 
had the ‘wrong leg’ removed, and that of Libby Zion, who died following the reaction of a 
drug administered by an overworked, unsupervised junior doctor, highlighted patient safety 
issues in the US.36 
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1.3.3.2. Emerging areas of focus 
The interest of patients and the media has been further intensified by the emergence of 
healthcare associated infections as an issue in health service delivery. Studies into the 
prevalence of infections, combined with high-profile outbreaks, have focused this interest. 
Both Methicillin-resistant Staphylococcus aureus (MRSA) and Clostridium difficle (C-diff) 
have emerged as serious issues in healthcare provision42 and are increasingly seen as 
amenable to better healthcare.35  
1.3.3.3. Increased awareness 
Further to the media coverage of high-profile incidents, the prevalence means that many 
people have personal experience of adverse events. A survey conducted in the US found that 
around 42% of people reported a medical error having affected themselves, a friend or 
relative.43 As a result, there is heightened concern about such errors, with respondents to 
the survey reporting the health care system as ‘moderately safety’. Another survey, 
conducted by the American Society of Health-System Pharmacists, found that over half of 
Americans are ‘very concerned’ about either being given the wrong medicine (61%) or 
complications from a medical procedure (56%).44 
1.4. Need for indicators 
Given the scale of the issues as outlined above, there is a clear need for measurement 
efforts to help understand prevalence, causes and preventability. In particular the demand 
comes from a range of sources, as outlined below.  
1.4.1. Indicators 
1.4.1.1. History of measurement 
While the focus on measurement has intensified, it is not new; such studies can be dated to 
the first anaesthetic death in 1848,14,45,46 or perhaps even earlier with Florence Nightingale 
reporting in the mid-1800s that patients in London had a greater risk of dying if hospitalised 
than if cared for at home.47 The increased focus on quality and safety was not 
instantaneously matched by additional measurement efforts. As expressed by Mainz (2003), 
there is a need for measurement efforts to catch up with the interest in quality and safety: 
“Much of the interest in quality of care has developed in response to recent dramatic 
transformations of health care systems, accompanied by new organisational 
structures and reimbursement strategies that may affect the quality of care. 
However, only of late has systematic evidence about quality of care begun to be 
collected in most health care systems.” (p523)33  
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1.4.1.2. Definition of indicator 
Indicators of the quality and safety of healthcare have been defined in several ways.33 For 
the purpose of this project, I use the definition based on that proffered by Joint Commission 
on Accreditation of Healthcare Organizations (JCAHO),48 as set out below. The requirements 
of a good indicator are discussed later (paragraph3.2.3, p66). 
‘Indicator’ refers to a quantified measure that can be used to monitor and evaluate the 
quality or safety of important governance, management, clinical, and support functions that 
affect patient outcomes. 
1.4.1.3. Types of indicators 
These indicators can take many different forms in terms of the format of their numerical 
output and the subject they evaluate. They can measure sentinel events or rate-based 
incidents and can be related to structure, process or outcome of healthcare (Table 2). I have 
also added ‘proxy outcome’ which is often ignored in the literature as a possible indicator. 
Each of the types of indicators has advantages and disadvantages. For example, while 
outcome measures can evaluate actual health improvements they are susceptible to 
influence from factors other than the standard of healthcare, such as environmental aspects. 
Table 2: Examples of different indicators 
Type of indicator Detail Example 
Sentinel events Count of never events Number of patient who die during 
surgery 
Rate-based 
indicator 
Proportion of admissions 
with preferred treatment or 
outcome 
The proportion of patients in hospital 
during a study period which acquire 
a healthcare associated infection 
Structural Pertaining to organisational 
resources 
Evidence that hospital uses specialist 
wards 
Process Access to specific treatments Proportion of trauma patients 
receiving urgent scans 
Outcome Relating to patient’s health 
following intervention 
Mortality or emergency readmission 
rates 
Proxy outcome Treatment suggesting a 
certain outcome 
Patients receiving blood transfusions 
following treatment (suggesting 
post-operative haemorrhage) 
Intermediate 
outcome 
Biological indicator 
associated with higher risk of 
poor outcome  
Proportion of patients with high 
blood pressure 
Source: adapted from Table 2 and 3 in Mainz 2003 33 
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1.4.1.1. Indicator bundles 
While inherently interesting, outcome measures have been criticised for their reliance on 
appropriate risk-adjustment models to account for case-mix, with suggestions that – for the 
purpose of monitoring hospital performance – non-mortality outcomes or process measures 
should be developed.49 As far back at 1992, there was a recognition that most efforts had 
concentrated primarily on mortality rates.50 
Of course these types of measures can be, and have been, used in conjunction with one 
another with, for instance, one US hospital using a: “framework to monitoring patient safety, 
combining a valid rate-based measures to evaluate outcomes and processes of case, and 
non-rate-based measures to evaluate structure and context of care.” (p659)51 Indeed, in a 
review of methods for measuring errors and adverse event endorsed a comprehensive 
monitoring system using a combination of methods.52 The advantages of applying a range of 
measures is discussed later (paragraph 2.5.2, p52). 
1.4.2. Demand for indicators 
1.4.2.1. Under-reporting 
McIntyre and Popper noted in 1983 that “errors need to be recorded and analysed if we are 
to discover why they occurred and how they could be prevented” (p1919) 535353524949; however, 
emerging evidence suggests that there is considerable underreporting from the current 
systems. For instance, a study found that in England, only 7% of patient safety incidents 
identified using a case note review were included in the routine reporting system, with an 
even lower positive predictive value (5%) for incidents resulting in harm.54 Whilst not at such 
a high level, a review of underreporting by Douglas and Pronovost presented findings from 
studies from across the USA and UK that showed a majority of errors go unreported, with 
evidence that more serious errors are often not reported. The authors conclude that this 
underreporting has serious consequences: plaguing the knowledge of the issues; skewing 
interest toward those events that are reported; and leading to an inability to generalise 
findings.55   
1.4.2.2. Increasing demand for measures 
As a result of this increased focus, all these stakeholders – from the public to governments 
and international organisations – have demanded the tools to help analyse the problem and 
to facilitate improvements. There has been a simultaneous increase in importance to 
healthcare providers, commissioners, regulators, and patients of assessing the quality of 
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care.33,56  The increased focus on quality improvements – related to, for instance, the aging 
populations, higher prevalence of chronic diseases, the introduction of new medical 
technologies, and increased public expectation57,58 – has been coupled with an increased 
demand for measures of quality and safety.  
1.4.2.3. Measurement efforts remain short 
Yet the research to date has failed to satisfy the need; “the literature [on measuring adverse 
events] consists mostly of descriptive studies. Articles on many of the topics of interest are 
rare, and the studies are of variable quality” (p 10).59 Whilst studies have given an indication 
of the scale of the problem, without better measurement some aspects will inevitably be 
ignored and go unaddressed with quality and patient safety failings remaining the elephant 
in the room. 
1.4.2.4. Government and intra-governmental demand for measures 
Such measures are also needed as the foundation of some governmental policies. The 
requirement is particularly conspicuous in the healthcare systems which have implemented 
a patient choice agenda, such as the NHS in England. Further to fitting in with current 
strategies, Governments also require this information to set future priorities: 
“Greater priority should be given to clinical areas where there is evidence that the 
quality of care is either variable or substandard, so that areas with a substantial 
potential for quality improvement are chosen.” (pi6)60  
And the move towards measuring quality of care has not only been a function of 
Governments’ requirements, rather the lead has been taken by international organisations, 
such as the WHO and Organisation for Economic Cooperation and Development (OECD).32 
1.4.2.5. Increase in guidelines 
Many indicators – especially process measures – are based on clinical guidelines. Where 
there is sufficient clinical evidence, these guidelines are based on a review of these existing 
findings or elsewhere the standards are based on a formal process to gain appropriate 
clinical consensus.33  
There has been a proliferation in clinical guidelines. For instance, in England, the National 
Institute for Health and Clinical Excellence (NICE) which was only formed in 1999 had, by 
2013, 165 clinical guidelines (coupled with guidance for 381 interventional procedures, 275 
technology appraisals and 42 public health areas).61 
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1.4.2.6. Demand for new approaches 
As well as new measures (paragraph 1.4.2.2, p32) a more general demand has been 
articulated for new approaches to addressing adverse events. The implication from a 
number of authors is that measures have to be further developed: "Efforts to improve 
patient safety have fallen short of IoM's ambitious goal" (p850)62 and "the overall approach to 
patient safety…and definitional issues… remains debated"(p1868).63 Indeed the message that 
the current approach is inadequate has also been echoed in the UK.64 In particular, there has 
been a demand for more systematic and on-going methods:   
“Adverse events are systematically and frequently reported in European countries 
and analyses are made in order to learn from incidents and improve safety. This is 
resource consuming work, which creates a major need to measure dimensions of 
safety on an ongoing systematic basis, implement learning organisations, 
demonstrate ongoing safety improvement, determine when lapses in patient safety 
occur, and document positive effect of the efforts made.” (p4) 65 
1.4.3. Strengths and weaknesses of methods for 
identifying and analysing adverse events 
A number of different techniques have been used for measuring adverse events, including: 
review of medical records; interviews with healthcare providers; direct observation; active 
clinical surveillance; morbidity and mortality conferences; incident reporting system; 
external audit and confidential enquiry; studies on claims and complaints; autopsy reports; 
IT and electronic medical records; and administrative data analysis.  
The advantages and disadvantages of the different methods are summarised in Table 3. In 
2003, two reviews were published on the relatively advantages and disadvantages of 
methods for assessing patient safety. 52,59 With other, more recent, comparisons of strengths 
and weaknesses having been published,66,67 I do not restate these in depth here. 
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Table 3: The strengths and weaknesses of methods for measuring quality and safety  
Category Method Strengths Weaknesses 
A
d
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c 
st
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d
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s 
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e
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io
lo
gy
 d
es
ig
n
s 
an
d
 
sy
st
e
m
at
ic
 d
at
a 
co
lle
ct
io
n
s 
Review of medical 
records (case note 
review) 
Uses readily available data 
Commonly used 
High reliability of extracted data 
Judgments about adverse events not 
reliable 
Medical records are incomplete 
Hindsight bias 
Format not readily usable for research 
Interviews with 
healthcare providers 
Potentially provides additional data on root 
causes 
Hindsight bias* 
Reporting bias* 
Direct observation Potentially accurate and precise 
Provides data otherwise unavailable 
Detects more active errors than other 
methods 
Time consuming and expensive 
Difficult to train reliable observers 
Potential concerns about confidentiality 
Possible to be overwhelmed with 
information 
Active clinical 
surveillance 
Potentially accurate and precise for adverse 
events 
Time consuming and expensive 
M
et
h
o
d
s 
b
as
ed
 o
n
 r
ep
o
rt
in
g 
Morbidity and 
mortality 
conferences 
Can suggest contributory factors 
Familiar to healthcare providers 
Hindsight bias 
Reporting bias 
Focused on diagnostic errors 
Infrequently used 
Incident reporting 
system 
Provide multiple perspectives over time 
Can be a part of routine operations 
Reporting bias 
Hindsight bias 
Data often unavailable for research 
External audit and 
confidential enquiry 
Provides mechanism for identifying root 
causes  
Integrates multiple data sources 
Validity of the data untested 
Cost for using data uncertain 
 
A
n
al
ys
is
 o
f 
ro
u
ti
n
el
y 
co
lle
ct
ed
 d
at
a 
Studies on claims 
and complaints 
Provides multiple perspectives (patients, 
providers, lawyers) 
Hindsight bias 
Reporting bias 
Non-standard source of data 
Autopsy reports Provides data otherwise unavailable (e.g. on 
missed-diagnoses) 
High reliability of data 
Biased data as not systematically 
undertaken 
IT and electronic 
medical records 
Inexpensive after initial investment 
Monitors in real time 
Integrates multiple data sources 
Susceptible to programming and/or data 
entry errors 
Expensive to implement 
Administrative data 
analysis 
Use readily available data 
Commonly used 
Judgements about adverse events not 
reliable 
Medical records are incomplete 
Hindsight bias 
Note: * assessed by author 
Source: Thomas et al (2003),
52
 Vincent (2006),
20
 Michel (2003),
59
 Zhan et al (2003).
68
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1.4.4. No consensus on a preferred technique 
There is no consensus over which is the best method for measuring adverse events and 
neither is this surprising, since the utility value of each method depends on the purpose, 
whether that be identifying rates of incidents, ascertaining causes or acting as a warning 
system.20 
Despite the range of methods available for identifying and analysing adverse events, quality 
and safety shortcomings remain a significant issue and there is little consensus over how 
best to address it. A study commissioned by the WHO, completed in 2003, identified 262 
articles relating to methods for identifying and analysing adverse events.59 The report 
evaluated the effectiveness of each of the methods against criteria defined by the WHO 69 
which highlighted a lack of a preferred method. This conclusion was echoed in a further 
study published that year.52 That is not to say that the WHO think that having no preferred 
method means the pursuit of measuring adverse events is futile; conversely it has called for 
improved efforts, so “making them visible”(p4).70  
1.5. Implications for scope 
This chapter has set out the case for addressing the shortcomings in quality and safety and 
provided the rationale for investigating new approaches, especially those with potential to 
be active, on-going surveillance tools. The chapter also explained that the study incorporates 
measures of what would be typically classified as quality measures alongside patient safety 
indicators due to this difficulty to disaggregate between the two types and since they both 
have intrinsic interest. The estimates on prevalence point to a lack of consensus on the scale. 
This suggests value in both further national efforts and exploratory work on their 
preventability, scale and causes. 
The next chapter sets out the case for using indicators based on administrative data which 
were scored promisingly in the above-mentioned WHO-commissioned review of methods59 
to meet this demand for an on-going measurement tool. In particular, the chapter focuses 
on the potential benefits of applying such indicators to specific specialties.  
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Chapter 2. 
Specialty-specific 
indicators 
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Overview 
"You can't manage what you can't measure"  
quoted on p1, Weingart (2003)
71
 
Context 
The previous chapter presented the argument for measuring quality and safety in healthcare and the 
importance within that of acute care. In this chapter the existing literature is reviewed to identify 
potential tools for addressing this unmet need. 
 
Methods:  
A narrative literature review 
 
Findings 
There is a strong rationale for using administrative data, including that it has the potential to meet the 
demand for active surveillance tools for quality and safety. Furthermore, specialty-level development and 
application of quality and safety indicators – rather than the organisation-wide measures which dominate 
the current debate – can overcome some of the known limitations of such indicators. 
 
What this chapter adds  
Introduces the concept of specialty-specific indicators 
First explicit rationale for using specialty-specific indicators based on administrative data 
 
Related papers 
Tsang C, Palmer W, Bottle A, Majeed A, Aylin P. A review of patient safety measures based on routinely 
collected hospital data. Am J Med Qual 2011;27(2):154-69. 
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2.1. Use of administrative data 
2.1.1. Introduction to administrative data 
2.1.1.1. Definition of administrative data 
Administrative data potentially encompass a large array of collection methods and output and the 
term remains ill-defined. These differences in administrative hospital datasets include variation in 
the fields and specific codes for diagnoses, procedures, and timings. 
‘Administrative data’ are, for the purpose of this project, defined using the following inclusion 
criteria:  
- routinely collected data covering more than one hospital; 
- used for administrative purposes (e.g. for reimbursement); and 
- can be replicated using the internationally-recognised ICD9 or ICD10 diagnoses coding framework 
2.1.1.2. Common datasets 
The most widely used administrative data in research include those of the Agency for Healthcare 
Research and Quality’s (AHRQ) Healthcare Costs and Utilization Project (HCUP), in particular: 
- the State Inpatient Databases (HCUP SID). Currently, 44 States participate in the HCUP SID, 
encompassing 95% of all USA’s community hospital discharges, with data available from 
1990; 
- the Nationwide Inpatient Sample (HCUP NIS). The largest all-payer inpatient care database in 
the USA, containing approximately 8 million hospital stays from around 1,000 hospitals, 
equating to a 20% stratified sample of USA’s community hospitals, with data available from 
1988.72 
Within the recent history of research on quality and safety, there has been a rise in the use of 
administrative data. To demonstrate the use of some key datasets, I conducted a general search of 
the literature. i  The results give an indication of the rise in use of such datasets and, while the 
                                                          
i
 I performed a search of title, abstract and key words fields within Medline (Ovid MEDLINE(R) In-Process & 
Other Non-Indexed Citations and Ovid MEDLINE(R) 1946 to Present), limited to the names (and common 
abbreviations or alternate spellings) of key datasets in the USA and, for England, Hospital Episode Statistics.  
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limitations of the search strategy render the results imprecise, the conclusion that there has been an 
increase in the publications based on administrative data is unquestionable (Figure 1).   
Figure 1. Trend in publications based on administrative datasets   
 
Notes: USA total is a sum of counts for the three non-HES datasets 
2.1.2. Use of data 
2.1.2.1. Background in non-healthcare settings 
The use of administrative data to assess quality has been pioneered by the aviation, petrochemical 
and nuclear energy industries with their so-called High Reliability Organisations (HROs).73 Whilst the 
use of administrative data to measure healthcare outcomes is not new; the heightened attention 
being paid to quality and safety in healthcare is increasing the demand for data.27  Such data were 
used first, in the 1970s, to show variations in care, and its use developed to outcomes 
measurements in the 1980s before moving on to quality and patient safety since the 1990s.68 
2.1.2.2. Growth in indicators 
Coinciding with a growth in quality indicators, there has been a rise in the use of administrative data. 
To exemplify this I searched Medline (Ovid MEDLINE(R) In-Process & Other Non-Indexed Citations 
and Ovid MEDLINE(R) 1946 to Present) to give an indication of growth in the use of quality indicators 
and administrative data. I limited the search to the (MESH) indexing term “quality indicator, 
healthcare” and search term “administrative data” on the title, abstract and key word fields.  
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Figure 2. Trends in publication of quality indicators and use of administrative data 
 
Administrative data are collected in many countries and there is scope to expand the use of these 
data to flag issues in the quality and safety of hospital care, both in terms of wider and better 
coverage of the indicators applied and a broader range of health services subjected to evaluation.  
2.1.3. The development of indicators 
2.1.3.1. Historical overview of indicator development 
Since the development of the original quality indicators in the early 1990s, many medical providers, 
healthcare organisations and researchers have contributed to their advancement and understanding 
of their efficacy. A paper in 200174 suggested that the number of quality indicators had risen to over 
200, and by 2009 one initiative, the International Quality Improvement Programme,75 had identified 
nearly 700. However, these numbers should be interpreted with caution as a small variation on an 
existing algorithm for a measure could be classified as a new indicator thus inflating overall counts. 
2.1.3.2. Key indicator sets 
A key set of indicators was proposed by the Complications Screening Program (CSP) for screening for 
variations in quality in 1992.50 Since then, the Agency for Healthcare Research and Quality (AHRQ) 
has been at the forefront of indicator development. Examples of key indicator sets are given in Table 
4.  
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Table 4. Examples of key quality and patient safety indicator sets 
 Abbreviation Reference Example of 
indicators/groups 
Key associated 
studies 
Complication 
Screening 
Program 
CSP indicators Iezzoni et al 
(1992)
50
  
27 indicators, e.g.: 
Septicemia, wound 
infection, cellulitis or 
decubitus ulcer. 
Iezzoni et al (1997)
76
 
Lawthers et al 
(2000)
77
 
HCUP Quality 
Indicators (1994) 
HCUP QIs Ball et al (1998) 
78
 
33 indicators, e.g.: 
Hysterectomy, low birth 
weight, mortality after 
knee replacement 
Johantgen et al 
(1998)
79
 
Refined HCUP 
Quality 
Indicators 
HCUP II QIs Davies et al 
(2001)
80
 
25 provider-level, e.g.: 
stroke mortality, VBAC 
rates, CE volume 
 
HCUP Patient 
Safety Indicators 
HCUP PSIs Miller et al 
(2001) 
81
 
12 groups, e.g.: 
transfusion reaction, 
postoperative infection, 
obstetric misadventure 
 
AHRQ Patient 
Safety Indicators 
AHRQ PSIs McDonald et al 
(2002) 
82
 
20 hospital-level 
indicators, e.g.: decubitus 
ulcer and birth trauma 
Romano et al (2003)
83
 
Zhan et al (2003) 
84
 
Indicators for 
Patient Safety, 
OECD 
OECD HCQI Millar et al 
(2004) 
85
 
21 indicators, e.g.: Wrong 
blood type; ventilator 
pneumonia; birth trauma 
McLoughlin et al 
(2006)
86
 
Safety 
Improvement for 
Patients in 
Europe 
SimPatIE Kristensen et al 
(2007) 
65
 
42 indicators with 24 
recommended, e.g.: 
wrong site surgery; 
complications of 
anaesthesia; decubitus 
ulcer 
 
Notes: VBAC - Vaginal Birth After Caesarean; CE – Carotid Endarterectomy 
2.1.3.3. Development of indicators 
In the editorial introduction to the first major set of quality indicators – CSP, Iezzoni et al (1992) – 
the commentator states that they “believe the algorithms will prove difficult to improve 
upon.”(p361)50 However, there have been a number of improvements in the indicators to address the 
limitations of the previous iterations. For example, in 2001 AHRQ published a new set of indicators 
to address some of the shortcomings of some of the original Healthcare Cost and Utilization Project 
(HCUP) Quality Indicators, such as their lack of: severity or risk adjustment; measures covering non-
surgical medical care; and reliability.87 Despite these developments, even by 2008, this “valuable 
source of information on patient activity remain[ed] under-utilised.”(p2)88 
2.2. Advantages of using administrative data 
In a review of available methods for measuring adverse events, Michel highlights that: (1) rapid 
assessment methods are needed; (2) the relevance of the method depends on the patient safety 
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measurement goal; and (3) the relevance of a method depends on the availability of the data.59 The 
first and third of these points are covered in the advantages set out below, while the second is 
integral to the discussion about the purpose of the reporting, raised in Chapter 11.  There are many 
advantages offered by using administrative data to evaluate quality and safety, include those listed 
below. Advantages are, of course, contextual but those set out here can be viewed in the light of 
surveillance (a purpose whose rationale is set out above). 
2.2.1. Longitudinal 
Administrative data are typically continuous.68,89 This property permits two additional routes of 
investigation over snapshot cross-sectional studies: tracking the performance of providers over time 
(multiple cross-sectional studies) or tracking patients over time (cohort studies) by linking of 
patients’ records from different admissions. This longitudinal nature is particularly useful for 
identifying, by looking at specific readmissions, an adverse event for which the symptoms do not 
present until after discharge.  
While this project focuses on acute care, it is worth noting that this longitudinal property of the data 
allows the researcher to make inferences about what happens outside of hospitals, which has been 
an area of increasing academic interest. As Weingart and colleagues 90 pointed out, little is known 
outside hospitals, but administrative data have the potential to record, through emergency 
admissions and readmissions, an adverse event which may occur outside the non-acute setting. 
Already, patient safety projects are looking to extend the focus of their research to beyond purely 
inpatient admissions.56  
2.2.2. Ease and cost-effectiveness of use 
2.2.2.1. Accessibility of data 
Administrative data are generally collected to support monitoring or reimbursement activities 33 and, 
therefore, need to be readily accessible. This advantage has been pointed out in the literature 71 68 
and, more directly, one paper concluded that such information represented “the most readily 
available set of data systems for tracking patient safety”(p9).34 
2.2.2.2. Computer readable 
The monitoring and reimbursement purposes of administrative datasets involve analysis of the 
information they contain. This property of being in computer-readable and analysis-ready format 
makes the use of the data for studying adverse events easier.91  
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2.2.2.3. Cost-effective 
Similar to the advantages of being accessible and computer readable, an additional benefit stems 
from the administrative data having already been collected and so can usually be accessed at little or 
no cost.24,33,68,71,73,92 "Administrative datasets provide a substantially cheaper… way of monitoring 
rates of adverse events"(p24).93 International examples have shown that the costs of running 
nationwide programmes for disseminating information from these indicators are also relatively low. 
For example, the Danish National Indicator Project (NIP), which monitors clinical indicators (both 
quality and patient safety indicators) across six diseases, costs approximately US$750 000 
nationwide per year. The project team estimate that the marginal cost for adding additional disease 
areas to the project would be in the region of US$75 000 56. In England, the HES database costs an 
estimated £1 per record to collect compared with around £10 - £60 per record for clinical registers.89 
2.2.3. Timely 
Since the monitoring and reimbursement needs to be done in a timely way, the administrative data 
are provided regularly and with limited time lag.89 For example, in the NHS in England, the 
underlying data that are the basis for the Hospital Episode Statistics (HES) administrative dataset are 
usually updated every month. As such "administrative datasets provide a… more timely way of 
monitoring rates of adverse event"(p24).93  
2.2.4. Coverage  
2.2.4.1. Large populations 
Another attraction of administrative data are that they covers large populations71,89,91 with, in many 
cases, the information covering every inpatient procedure offered in hospitals. Again taking England 
as an example, HES include not only care given by NHS hospitals but also care provided to NHS 
patients by the independent sector and care given to private patients in NHS hospitals. In 2007-08, 
the HES dataset included more than 15 million episodes of inpatient care and over 54 million 
outpatient attendances.94 
2.2.4.2. Increasingly large proportions of healthcare 
Historically, administrative datasets focused predominantly on subsets of inpatient care. However, in 
response to the demands for increased data to support initiatives such as pay-for-performance 
within hospitals, there is increasing coverage of services included in administrative data. For 
example, in the NHS, national data on outpatient episodes and A&E attendances are also recorded, 
accounting for approximately 12 million and 40 million respectively each year.  
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2.2.5. Standardised definitions and rules 
Administrative data are based on standardised definitions and rules which have been improved 
through a number of iterations. The first international classification edition was adopted in 1893. 
The role of updating the framework was passed to the WHO at its creation in 1948, and regulations 
adopted in 1967 stipulate that Member States use the updated classifications. The 10th revision of 
International Classification of Diseases (ICD-10) was introduced in 1990 and is used in over 100 
countries.95 However, there are some notable exceptions, with the USA predominantly using an 
updated ICD-9 framework. These have been developed over a number of years with many iterations 
and now offer a relatively comprehensive list of codes and associated guidance. 
2.2.6. Basis for Pay for Performance schemes 
2.2.6.1. Resulting in improved coding 
Administrative data are increasingly used for more rigorous performance monitoring and as the 
basis for reimbursement schemes. Although this does increase the incentive for gaming, it is also a 
motivation for increased depth of coding, for example coding more secondary diagnoses. Further, 
the use of administrative data for reimbursement schemes is often associated with an augmented 
data audit regime, as was the case in the NHS where the Audit Commission have assumed more 
work in researching coding accuracy.ii The expectation is, therefore, that the accuracy and depth of 
coding is improving.34  
A systematic review, published in 2012, on discharge coding accuracy of routinely collected data in 
Great Britain found that primary diagnosis accuracy has improved from 73.8% to 96.0% (p=0.02) 
since the introduction of Payment by Results in 2002. The authors concluded that such data are 
sufficiently robust for use in research and managerial decision making.96 
2.2.6.2. Some adverse events can be costed 
This reimbursement aspect has other advantages. Given that healthcare systems are resource 
constrained, a full understanding of cost implications is important for policy makers to choose 
priorities. The use of administrative data to reimburse hospitals means that, when a possible 
adverse event is identified, the cost associated with that admission can be readily estimated. As a 
result, the economic impact of adverse events can be approximated,59 and hospitals and 
governments can make more informed decisions on resources or service redesign.  
                                                          
ii
 In 2014, legislation to abolish the Audit Commission was passed as law, with a planned closure date of 1 April 
2015. However, the organisations involved in setting the Payment by Results framework (Monitor, NHS 
England and Department of Health) will all have an invested interest in ensuring good quality data. 
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2.2.7. Independent reporting 
The individuals who code the medical records are independent from the team involved in the 
healthcare procedures. This arrangement has some limitations, such as the lack of knowledge of the 
care provided increasing the chance of miscoding, which are discussed below. However, whilst this 
does not mean that the reporting is entirely independent since the clinicians are still involved in 
recording the procedures on the medical record, indicators based on such data at least offer some 
level of independence, thus meeting one of the WHO’s criterion for good indicators.97  
2.3. Limitation of PSIs 
“The sensual eye is just like the palm of the hand.  
The palm has not the means of veering the whole of the beast.” 
 (The Elephant in the dark, Rumi, 1207-1273) 
Whilst indicators of quality and safety based on administrative data offer a number of intrinsic 
advantages as already discussed, some limitations have been raised. These concerns are often linked 
to the information not being specifically designed to analyse patient safety. The most prominently 
cited limitations, which constrain the possible applications rather than making administrative data 
redundant with respect to analysing patient safety, are outlined below. 
2.3.1. Attribution of sequence and causation  
2.3.1.1. Difficulty to attribute 
While administrative data are longitudinal and include dates for procedures, the datasets offer 
limited information on the timing of events.81,93,98 For instance, it is difficult to accurately deduce the 
sequence of events, including when a diagnosis was made,68 and therefore doubt can remain over 
whether harm was related to quality of care, an adverse event or a pre-existing morbidity.34,40 The 
HES dataset in England, for example, does not explicitly distinguish whether a safety incident 
(flagged by a diagnosis or procedural code) was due to medical error rather than an existing 
complication which was present on admission to the hospital. 
2.3.1.2. Importance of attribution 
Reviewing the existing literature reveals conflicting findings on whether this issue on attribution is 
important. One study investigating the issue of present-on-admission based on 14 selected AHRQ 
PSIs found that for five indicators the rate would be lower if ‘present on admission’ was accounted 
for by the administrative data.99 A study, in the USA, evaluating the sensitivity and specificity of 
some complication codes at flagging patient safety incidents found, by retrospectively reviewing the 
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case notes, that the flagged condition was present on admission in 13% of surgical cases and 58% of 
medical cases.100 Another study suggested one-third of discharges were flagged by PSIs because of a 
diagnosis already present at admission.101 However, some of the adverse events that are dismissed 
as present on admission could be the result of a patient being harmed during a previous admission 
or the failure of the primary or tertiary care sectors, and therefore still of interest. In response to this 
problem a number of studies have altered the coding structure so that pre-existing conditions are 
flagged.102 
2.3.2. Judgements of responsibility and preventability 
As well as lacking detailed information on the sequences and causation of an adverse event, neither 
does administrative data contain any consistent approach for recording whether the harm was 
preventable or rather a complication of care.71,93 Although some of the diagnosis codes do explicitly 
imply preventability and certain adverse events lend themselves to detection through appropriate 
algorithms, many indicators rely on judgements about whether a sequence of procedures and 
diagnoses is likely to identify an event which was preventable. This is particularly relevant to 
indicators of hospital acquired infections, since it may not be clear that the appearance of an 
infection-related diagnosis code during the admission is the result of a delayed diagnosis of an 
existing infection or one that has actually been hospital-acquired.  
2.3.3. Problems in coding details 
The administrative data are based on the coding of case notes using a consistent framework. Further 
to imperfect information about preventability there are also limitations since the coding frameworks 
were not developed to specifically analyse quality and patient safety issues and are not 
comprehensive.68,81 As a result, the resultant indicators do not represent a comprehensively 
exhaustive list of measures as analysing administrative data cannot pick up all possible adverse 
events.24 As such, the method would be inappropriate for trying to estimate prevalence.99 It should 
be noted that ICD-10 has a generally more detailed coding framework than the predecessor ICD-9 – 
e.g. viral hepatitis expanded from ICD-9 code ‘070’ to ICD-10 codes ‘B15’-‘B19’, and from one to five 
3-digit categories103 so such criticisms raised on the former framework – such as by the Agency for 
Healthcare Research and Quality 40 – cannot necessarily be generalised to the more comprehensive 
ICD-10 framework.  
2.3.4. Case-mix adjustment 
There are also limitations to the extent in which administrative data permit you to adjust for case 
mix.81,98 For example, there are a heterogeneity in severity within many of the diagnosis codes,34 
which is a particular issue within medical or psychiatric specialties.4 Similarly, it is also a problem 
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where patients often have complex comorbidities.98,99 In some instances there is no effort made to 
adjust for case mix, for example the SimPatIE project catalogues ‘death in low mortality DRG 
[disease resource group]’ as not requiring any risk-adjustment.104 Risk adjustment is clearly 
important and, without it, some of the indicators may be redundant:  
“the level of the PSIs which monitor harm (e.g. rates of mortality and infections) is usually 
sensitive to bias caused by the severity of the disease, comorbidities and lifestyle factors. 
Validity of these indicators is therefore depend on simultaneous collection of patient-related 
data appropriate for risk adjustment. Empirical evidence suggests that administrative data 
are not satisfactory in this respect especially when used at clinical (hospital) level”(p14).65 
This assessment by Kristensen and colleagues paints a particularly negative picture and is not 
backed up with any empirical evidence on the effect of such bias.  
2.3.5. Accuracy of coding 
2.3.5.1. Errors and gaming 
Administrative data are collected through the coding of medical records which are the notes made 
by clinicians on the care given to patients. Therefore the accuracy of the dataset depends on the 
standard of documentation and accuracy of coding. Also, the primary uses of the administrative data 
for monitoring and reimbursement might provide a potential incentives for ‘gaming’34 and make it 
“unreliable because of coding problems”(pi9).105 The issues on coding was raised as far back at 1994 
by Romano and Mark106 and has been reiterated often since.83,99 
2.3.5.2. Hospital variation 
Further to general issues of coding, there is evidence of significant differences in the standard of 
coding within and across hospitals.40,81,107 The same study that identified the factors influencing 
coding standards found that HRG errors – i.e. the degree to which the correct payment was made – 
ranged across NHS hospital trusts from 0.3 to 52%.108 Factors that might affect the standard of 
coding in different hospitals include the depth of coding used (there is considerable variation by 
hospital in the mean number of codes used per record),93 level of clinicians involvement, and 
standards of validation.108 
2.3.6. Some have not been applied to ICD-10 
As the older ICD-9 coding framework is replaced with the revised ICD-10 system, likewise the 
algorithms used to flag quality and safety events need to be updated. A group of researchers and 
users of health administrative data from Canada, the United States, Switzerland, Australia, China and 
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the United Kingdom came together in June 2005, and identified the translation of indicators to ICD-
10 as one of the high-priority methodological research areas.109 
2.3.7. Limited evidence on effectiveness 
There is limited evidence on whether application of such indicators is effective.67 This may be a 
combination of lack of time lag to evaluate this relatively recent development, and difficulties to 
account for bias created by changing data recording practices over time. However, some of the 
positive findings to date are drawn out in the discussion (Chapter 11). 
2.4. Review of validity of indicators 
2.4.1. Defining validity of indicators 
Validity is a measure of the effectiveness of indicators. In the project to refine the original AHRQ 
indicators (HCUP II QI), the following criteria were used to judge the validity of the indicators (Figure 
3).74 These aspects of validity are not comprehensive with, for instance, no assessment of content 
validity which refers to the extent to which a measure represents all facets of quality or safety being 
assessed. Moreover, these dimensions of validity do not necessarily carry equal weight, with this 
being a function of the method being applied. For instance, “reliability is important when using an 
indicator to make comparisons among groups or within groups over time” (p524).33 A more detailed 
assessment of validity is given in the following Chapter.  
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Figure 3. Dimensions of validity used by AHRQ 
 
2.4.2. Previous literature on validity  
2.4.2.1. Examples of validation results 
Findings from specific studies on validity are not necessarily generalisable due to, for instance: most 
assessments covering only a subset of the dimensions of validity; differences in data accuracy and 
completeness between different datasets. Most evaluation have focused on patient safety 
measures, presumably as the events being investigated are, possibly more significant by nature, 
often more identifiable than quality differences so making validation easier. A review of literature 
found that validation of existing indicators had been largely restricted to the USA and the validity of 
many individual indicators remains unresolved.88 Of these publications on aspects of validity, the 
results are mixed in terms of techniques used and the resultant findings, for example:  
- by comparing two reporting systems and conducting a case note review, one study found 
that one of the AHRQ PSIs (PSI-7, selected infections) performed poorly;110  
- another study compared an indicator based on administrative data to case note review and 
found that the former identified 23.3 decubitus ulcers per 1000 patients, to a true rate of 
6.14, a 74% variance;111 and 
- in the UK, out of 2,150 medical records that were flagged as having an adverse event by a 
PSIs, 72.5% were found to match the (translated) AHRQ PSI specification.112 
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2.4.2.2. Difficulty in generalising 
Different indicators are susceptible to different bias or errors and their validities will vary 
considerably. The possible exception is face validity, which is less dependent on the actual dataset 
being employed and, in this case, Rosen and colleagues found that several studies had demonstrated 
that such indicators have reasonable face validity.113 Despite this difficulty in generalising findings, 
some academics inadvisably made sweeping conclusions. A symptom of the issue is the 
contradictory nature of some conclusions, with some stating that indicators have demonstrated 
good reliability, based on the consistent results found across studies 113,114 and across years 73,115 
whereas, for instance, Naessens and colleagues concluded that “in general, many patient safety 
indicators do not reliably identify adverse hospital events” (p781).101 
2.5. Potential applications of indicators 
Whilst there are certainly some limitations to the current array of QIs and PSIs, these failings do not 
rule such indicators either irrelevant or unusable. Rather the floors just limit the extent to which the 
indicators can be appropriately used. Rivard, Rosen et al noted that “to address the question of how 
best to use patient safety indicators, one needs to assess both what the indicators can validly be 
used for as well as what purpose people may want to derive from them”(p1644).73 
2.5.1. Types of reporting 
2.5.1.1. Framework for describing reporting 
In general, performance indicators can be used for four different functions: facilitating 
accountability; monitoring performance; as a learning tool; and forming policy initiatives.58 In 
exploring the purpose of indicators in comparing performance of NHS hospital trusts, one paper 
categorised utilisations of indicators through the type of information they can provide: either ‘hard’ 
(formal and quantitative) or ‘soft’ (informal and subjective) information.116 This is covered in more 
detail at the end of the thesis.  
2.5.1.2. Recommended reporting type 
The WHO has recommended that reporting systems should be blame-free, concluding that 
successful systems are: non-punitive; confidential; independent; analysed by experts; credible; 
timely; systems-orientated; and responsive.97 This conclusion was echoed, in part, by the team 
constructing a national set of indicators in Denmark which called for reporting systems to be: 
confidential, sanction-free, learning oriented.117 
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2.5.1.3. Previously recommended applications 
As well as setting conceptual frameworks on the use of such indicators, the literature also contains 
many examples of specific suggestions for these indicators (Figure 4). For example, one paper 
suggested that “their simplicity and reliability make them valuable as a higher-level safety 
performance measure. They offer one means for coordination and integration of patient safety data 
and activity within and across organizations” (p1633).73 
Figure 4. Suggested indicator applications 
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2.5.2. Applying sets of indicators 
The case for bundles of indicators was introduced earlier (paragraph 1.4.1.1, p32) with specific 
advantages set out below. An explanation of the domains of validity is given in paragraph 3.2.1.2, 
p64. 
2.5.2.1. Improving content validity 
To draw on the analogy of the blind men and the elephant, the story – in some of its interpretations 
– tells of a number of blind men, each grasping at an elephant but all touching different limbs. The 
result being that the man holding one of the elephant’s legs makes an entirely different inference of 
what the object is to his peer grasping its trunk. Whilst none of the men are able to deduce alone 
the full nature of the elephant, with enough hands and communication between them a correct 
identification can be made. This holds true with these indicators which cannot alone give a whole 
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picture of patient safety, however, a range of indicators used in conjunction with other 
measurement methods could give a useful depiction. 
2.5.2.2. Allowing additional validation techniques 
Using a set of indicators also provides the opportunity to undertake additional validation. 
Specifically, the validation is based on the hypotheses that: 
- Two similar measures of the same construct should yield similar results (construct validity) 
- Process and outcome measures evaluating the same aspect of care should be correlation 
(convergent validity); 
- An indicator should be associated with “better” measures of performance (criterion validity)  
2.5.2.3. The Donabedian model revisited 
As explained earlier (paragraph 1.2.1, p24), the commonly cited model by Donabedian regarding 
patient safety incidents describes the interplay between structure, process and outcomes. By using 
appropriately focused set of indicators, these various factors can all be investigated, to some extent, 
to help epidemiological study design. 
2.5.3. Primarily organisational-wide indicators to date 
2.5.3.1. Legacy of broad indicators 
To date the focus of performance monitoring using administrative data has been organisation-wide, 
cross-specialty indicators, in particular hospital standardised mortality rates (HSMRs). This 
phenomenon was cited in the rationale for developing the first major set of quality indicators (CSP, 
Iezzoni et al 1992 50) however recent publications have concluded that this limited focus remains the 
same.49 A key example of the prominence of these broad measures are the well-publicised HSMRs 
based on routinely collected hospital episode statistics (HES) for the major acute hospitals in 
England, which have been published since January 2001 and, indeed, the monitoring of 
organisational-wide indicators has coincided with some improved results, such as decreases in 
recorded hospital-standardised mortality rates.125  
2.5.3.2. Limitations 
However, there are substantial limitations to such broad indicators. Given the widely held belief that 
it is important to report performance indicators to clinicians (as discussed in more detail at the end 
of this thesis, paragraph 11.5.1, p260) it is surprising that researchers and regulators have persisted 
in relying predominantly on organisation-wide indicators of performance which have only limited 
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relevance to an individual clinician. This situation is epitomised by a recent, comprehensive review of 
PSIs which purposefully excluded studies “primarily on specific disease, diagnoses or 
treatments”(p14).88 
2.5.3.3. Application of indicators to specific cohorts  
There has been some development of indicators for particular cohorts of patients, such as the long-
standing AHRQ Paediatric Quality Indicators which have been available in January, 2006, contains 
indicators that apply to the special characteristics of the paediatric population. Similarly the first 
AHRQ HCUP indicator set reported mortality for different groups.78 Similarly, indicator sets not 
exclusively based on administrative data – such as the Danish NIP – have commonly included some 
specialty-specific indicators.33 
2.6. Advantages of reporting specialty-specific 
indicators 
The following section draws on both the limitations of administrative data (described in this Chapter) 
and those generic limitations in existing measurement (described in the previous Chapter) to show 
that specialty-specific indicators offer the potential to overcome these key challenges to some 
extent. Specialty-specific measurement is topical: as suggested in 2012, “after recent UK policy 
developments, considerable attention has been focused upon how clinical specialities measure and 
report on the quality of care delivered to patients”.126 
2.6.1. Introduction to concept of specialty 
2.6.1.1. Definition of specialty 
‘Specialty’ refers to a branch of medical science, such as urology or paediatrics. For the purpose of 
this project, formulating strict criteria of the term specialty is not necessary since the findings on 
feasibility are generalisable to either broader or narrower groupings. The specialties investigated are 
defined in more detail in the relevant sections. 
In reality, the case put forward and empirical findings on the benefits of specialty indicators hold for 
those indicators pitched at a lower-then-hospital and higher-than-clinician level. 
2.6.1.2. Differentiating categories of specialties 
Specialties can be classified according to whether they are:  
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- surgical (i.e. an important part of diagnosis of treatment is achieved through major surgical 
techniques) or medical (related to internal medicine; i.e. important part of diagnosis is never 
achieved through surgery);  
- the characteristics of patients treated (e.g. paediatricians treat children);  
- diagnostic (e.g. radiology) or therapeutic (e.g. geriatrics);  
- organ-based (e.g. cardiology) or technique-based (e.g. anaesthetics).127 
2.6.2. Introduction to specialty-specific indicators 
2.6.2.1. Demand for specialty-specific initiatives 
Although few in number, there are specialty-specific systems for addressing patient safety and, 
where these have been evaluated, some have shown promise. For instance, Wu and colleagues were 
able to use a specialty-specific system to analyse patient safety issues and, as a result, implement a 
number of safety initiatives.128  “They suggest that, in time, specialty systems such as their own must 
be integrated with other reporting systems, such as risk management, State or national systems, to 
minimise duplication of effort and reduce the burden on the staff”(p69).20 In fact, the author of the 
1999 IoM report that was integral to increasing the priority of patient safety has suggested that 
specialty-based, focused reporting programs should be developed by other specialties.129 
2.6.2.2. Previous specialty-specific initiatives 
Previous papers on quality and safety indicators have disaggregated the indicators by specialty or 
diagnosis. In 2006, Mattke and colleagues recommended the use of 12 mental health, 17 cardiac 
care and 9 diabetes indicators,130 whilst another paper recommended the use of indicators 
categorised by diagnosis: stroke, heart failure, schizophrenia, acute gastrointestinal surgery, heart 
failure, and lung cancer.56 In the AHRQ HCUP II indicator set, the following areas of healthcare were 
given specific, separate consideration: cardiovascular, cerebrovascular, other vascular, geriatric, 
obstetric, paediatric, chronic conditions, diabetes.80 Similarly, the SimPatIE indicator set included the 
AHRQ obstetrics indicators and five single indicators for specific diagnoses.65  
2.6.3. Difference between specialties 
The following section highlights some key variations in specialties which suggest that cross-specialty 
indicators have specific limitations and, as a result, disaggregating performance measurement tools 
into individual specialties carries advantages.  
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2.6.3.1. Different cultures 
Some specialties have more developed safety cultures. This variation can, in part, be traced 
historically. The British Ministry of Health set up a committee to examine morbidity and mortality 
during child birth in the 1930s. Consequently, a local programme was established, involving 
antenatal clinics, meetings between midwives and family doctors, a new specialist ward and senior 
hospital clinician post, which reduced the rate of mortality in that area from 9 to 1.7 per 1000 
deliveries within 5 years.20 This area of medicine has continued to pioneer, in relative terms, patient 
safety.20 And the importance of this patient safety culture is highlighted elsewhere.131 
2.6.3.2. Different prevalence 
There is no reason to assume that patient safety is an equally important issue, with similar 
prevalence, across different aspects on healthcare. For example, the effects and causes of adverse 
events in elective surgical admissions are, by their nature, more easily identified. Evidence suggests 
that there are significant variations between specialties in the number of adverse events occurring. 
For example, in the specialty of mental health, analysis of existing PSIs suggests that people with 
schizophrenia have higher chances of suffering from post-operative respiratory failure, deep vein 
thrombosis and sepsis. The same study concluded that there is scope for further work to fill in the 
gaps in knowledge about adverse events within the specialty of mental health.132  
As a result, indicators are likely to identify more events in some specialties. Analysis using the AHRQ 
PSI algorithms suggested that 31% of adverse events identified occurred in obstetric hospitalisation 
although this will be biased to some extent by the selection of indicators.98 
2.6.3.3. Different impact 
Similarly, there is no reason to assume that PSIs are likely to result in equivalent levels of harm 
between specialties: anaesthetists’ mistakes, for example, may be more serious than those of 
doctors in other specialties;14 and in critical care, due to the high number of patients with complex 
and severe illnesses, the effects of any adverse event are more pronounced 133. As a result of these 
variations, it would be preferable to prioritise some specialties and disaggregate between those 
specialties with different levels of impact from patient safety events. 
2.6.3.4. Applicability of coding framework 
The framework used for coding medical records to create the administrative dataset on which PSIs 
are based is not comprehensive (as discussed earlier in §2.3.3). As a result, the framework will be 
naturally better suited to accurately identify adverse events in some specialties. For instance, a study 
that conducted a case note review to check the validity of results from applying the AHRQ PSIs to 
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NHS data found that the highest levels of agreement were found with the indicators relating to 
obstetric care.112  Consequently, previous work on developing indicators has focused on certain 
specialties. For example, a project covering hospitals in Queensland, Australia chose to focus on 
mental health, stroke, emergency departments, COPD and medication.134 
2.6.3.5. Maturity of existing tools for monitoring 
Further to the example of Wu et al, some specialties already have established tools for monitoring 
adverse events. “These systems are designed to provide information on specific clinical issues, which 
can be shared within the professional group” (p68).20 In particular, anaesthesia, neonatal and adult 
intensive care units have established specific systems.20,128,129  
2.6.4. Nature of specialties 
This section discusses the properties of specialties, in particular as groups of clinicians, that make 
specialty-specific measures, in theory, appropriate. 
2.6.4.1. Group learning  
The patient safety literature has underlined the importance of group learning as well as 
organisational and individual learning.73 McIntyre and Popper highlighted that “experiences need to 
be pooled so that doctors may also learn from the errors of others”(p1919).53 Specialties offer such a 
group which already have existing channels, such as through morbidity and mortality conferences, to 
be analysing these initiatives.  
2.6.4.2. Specialty cultures 
One of the keys to improving patient safety is to ensure that the health workforce develops the will 
to address the issues.135 This was shown empirically by Kline and colleagues who found that a more 
positive culture of patient safety within hospital units was related to lower incident severity.136 A 
review of patient safety culture literature performed in 2007 also found that clinicians are a key 
factor in the patient safety culture.137 Reporting to clinicians can, itself, be seen as an initiative for 
improving the patient safety culture. Further to the importance of clinicians in improving the patient 
safety culture, the same reviewers suggested that groups of people, termed as “sub cultures”, such 
as specialty teams, are also important.  
2.6.4.3. Understanding epidemiology and proposing changes in practice 
Once a patient safety issue has been identified, a suitable response needs to be developed. Some 
mistakes in healthcare are as a result of complex processes and structures, such as in medication 
which involves numerous stages.138 Given these complexities, specialty teams, and clinicians within 
them, are the appropriate recipients of the information as they can analyse any issue in the 
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appropriate context. Certainly, there is recognition that addressing patient safety requires in-depth 
involvement of clinicians. Leggat and colleagues, for instance, point out the importance of the skill 
and capacity of healthcare workers in delivering safer patient care.135 Involving clinicians has been 
shown to be effective; for example, involving clinical teams in the monitoring of VTE resulted in a 
number of practical changes to working practices being made.139  
2.6.4.4. Narrowed focus 
There are currently gaps in our knowledge about the epidemiology and effects of adverse events. 
However, it is clear that to improve patient safety these gaps in our understanding need to be 
addressed. Mayers-Oakes, in a paper which outlined research in breast cancer, diabetes mellitus, 
upper gastrointestinal and lower intestinal, concluded that this need could be met by narrowing the 
focus of indicators.140 The implication from this conclusion is that concentrating indicators on 
specialties rather than, say, pan-hospital issues would be beneficial. Certainly, initiatives with less 
focus have not always been successful. For instance, Weiner and colleagues suggested that hospital-
wide initiatives have not always improved patient safety.141 This narrowed focus can also help 
improve interpretability and increase validity by selecting either homogenous patients or areas 
where less case-mix adjustment is needed.65  
2.6.4.5. Developing new and existing indicators 
The increased demand for indicators (1.4.2) that has precipitated from the raised profile of patient 
safety should be met, at least in part, by developing and validating more indicators.73,130 Clinicians 
and specialty teams are well placed to help address this need due to their knowledge and 
experience. Further to meeting the need for additional information, developing additional indicators 
would also:  
- reduce the focus on particular diagnoses and whether they are coded. This would reduce 
any ability and incentive to ‘game’ by not coding accurately or comprehensively; and 
- “create the opportunity to test correlations and identify factors from among indicators. This 
in turn would enable the indicators to depict patient safety on a number of distinct 
dimensions”(p1647-8).73 
2.6.5. Disadvantages of specialty-specific 
Many indicators will be specific to that specialty and therefore not applicable to other specialties. 
One implication is therefore that it is difficult to compare results between specialties and create, for 
example, control groups for evaluations.142 One solution is to create other counterfactuals by 
comparing between patient groups, hospitals or time-periods.  
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By being more focused, the indicators may be less likely to measure aspects of the treatment and 
outcomes that are not anticipated; conversely, broader measures have a higher propensity to detect 
unexpected issues.143 However, increasing the breadth of indicators will usually make controlling for 
bias more difficult. 
2.7. Research objectives 
2.7.1. Hypotheses 
The use of hospital-level cross-specialty indicators is relatively well established. However, there is 
scope to expand the use of administrative data, in terms of: using more focused indicators; applying 
and validating the measures in novel ways; and introducing them to new healthcare services. As 
such, the project was designed to test the following hypotheses: 
1. A specialty-specific approach to developing indicators can result in a more useful and valid 
bundle of indicators to identify quality and safety issues; 
2. Hospital-level comparisons could be improved through better validation techniques (coding 
practice, indicator comparison and organisational factors); and 
3. The temporal nature of administrative data can be used to overcome some of the limitations 
of such indicators and highlight important quality and safety issues. 
2.7.2. Thesis outline 
To test these hypotheses, a range of qualitative and quantitative methods were applied (Table 5). 
Table 5. Methods table 
Hypothesis Chapter (Key method) 
1. A specialty-specific approach to developing indicators can result in a more 
useful and valid bundle of indicators to identify quality and safety issues 
Chapters 4 and 8  
(Systematic reviews) 
2. Hospital-level comparisons could be improved through more robust 
validation techniques (coding practice, indicator comparison and 
organisational factors) 
Chapters 5 and 9  
(Logistic and multi-level 
regression modelling) 
3. The temporal nature of administrative data can be used to overcome 
some of the limitations of such indicators and highlight important quality 
and safety issues. 
Chapters 6, 7 and 10 
(Logistic and multi-level 
linear modelling) 
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Overview 
Context 
The previous two chapters have set out the case for further work in evaluating the feasibility of using 
specialty-specific indicators based on administrative data. This chapter presents the analytical approach 
taken. The design of the individual studies on the two specialties is also driven by the specific literature 
reviews (Chapters 4 and 7) and the implications on the methods are described in these later specialty-
related sections. 
Methods 
Review of existing analytical approaches to developing and utilising indicators based on administrative 
data. 
Findings 
Hospital stroke care and obstetrics are appropriate specialties to use as case studies – due to their 
importance, evidence of scope to improve, and relative differences – for demonstrating feasibility of 
applying specialty-specific indicators. A range of methods have been used to identify, develop and present 
indicators. 
 
What this chapter adds  
Set out the analytical opportunity for this new concept of specialty-specific indicators 
Present a new hybrid approach to evaluating indicators 
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3.1. Introduction to study design 
3.1.1. Introduction to feasibility 
Now that the case for specialty-specific indicators based on administrative data has been made, the 
next step is to ensure that they can be applied in a robust fashion. “It is imperative that clinical 
indicators are meaningful, scientifically sound, generalisable, and interpretable. To achieve this, 
clinical indicators must be developed, tested, and implemented with scientific rigour”(pi5).144 This 
project investigates the feasibility of using specialty-specific indicators based on administrative data 
to meet this need. 
‘Feasibility’ is defined, for this project, in broad terms including not only the various dimensions of 
validity but also the ability to apply these indicators. It is tested here using a reactive approach, 
namely applying analytical tests to address the gaps in current knowledge (such as assessing the 
strength of correlations between indicators as a marker of validity) while drawing on previous 
literature where this is generalisable (such as comparing findings from the indicators to similar 
research). 
3.1.2. Addressing limitation in indicator use 
The previous chapter covered the literature on how indicators based on administrative data have 
been recommended for use, which is covered again in the final chapter. If one accepts the premises 
that (a) administrative data hold the potential to improve the measurement of quality and safety 
and (b) the misapplication of administrative data would be a retrograde step, then an implication is 
that it would be worthwhile to focus the application on mitigating the extant limitations. As such, 
the studies contained in this monograph are designed to show how to best overcome or evaluate 
the key limitations from the existing literature, as outlined in Table 6.  
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Table 6. Recommended study design to mitigate limitations 
Para. Issue Detail Recommendation on study design 
2.3.1 Causation Difficulty in attribution 
of sequence and 
causation 
Range of indicator types: Complement outcome 
measures with process indicators that inherently 
are more amenable to hospital performance. 
Regression analysis between outcomes, activity 
and structural factors: Investigate associations 
between hospital performance and other hospital 
factors. 
2.3.2 Judging 
preventability 
Difficulty to assess 
responsibility and 
preventability 
Using comparative analysis: Evaluate differences 
between provider performance and longitudinal 
trends, complemented with statistical analyses, to 
estimate achievable performance.  
2.3.3 Coding detail Problems in coding 
framework not 
identifying key events 
Systematic review of existing measures: 
Comprehensive evaluation of what indicators 
exist and which aspects of care can be evaluated. 
2.3.4 Risk model Need for case-mix 
adjustment 
Case-mix adjustment: Include detail on the risk 
model 
Specialty-level: Limit to less heterogeneous 
groups of patients 
2.3.5 Coding errors Variation in coding 
practice and accuracy 
Sensitivity analyses: Re-run analysis to evaluate 
potential effect of differences in coding practice 
and accuracy 
2.4.2 USA-bias Most of the studies 
originated from the 
USA using ICD-9 
Apply to ICD-10 dataset: Use a non-USA dataset 
based on the current ICD-10 coding framework 
 
In summary, the recommendations above are that the individual studies’ elements: focus on 
specialties; apply a bundle of indicators including outcomes and processes; investigate correlations 
between performance and organisational factors; compare performance between hospitals and over 
time; outline the case-mix adjustment explicitly; and conduct sensitivity analyses to understand 
effect of variation in coding practice and accuracy. The specific analytical framework used – which 
encompasses the addressing of existing shortcomings – is described below. 
3.2. Analytical framework 
3.2.1. Introduction 
3.2.1.1. Issues with validation 
It is not possible to have a perfectly validated indicator; even if an indicator’s performance was 
compared to an absolute gold standard then this would be snapshot and not necessarily provide 
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assurance to all time periods. Some domains of validity “are easier to tap than others; unfortunately, 
the most challenging domains to tap are often the most useful for health care providers who wish to 
understand the meaning of the data.”(p4)145 In particular, lack of a gold standard means that 
‘criterion validity’ is not possible. The domains of validity described here are not ordered in a 
hierarchical fashion; indeed, it is not possible to rank the relative importance of the criteria. Across 
the domains there are inherent ambiguities and little consensus on their meaning.142 
Concepts of validity are poorly described in literature on patient outcomes, this is not due to a lack 
of theoretical discussions but a lack of consistency.142 I have therefore formulated an analytical 
framework to evaluate validity and other aspects of feasibility using literature on psychometric 
testing and patient-based outcome measures and present an interpretation below.  
The framework does not represent a comprehensively exhaustive test and, indeed, it would be 
inefficient to apply every method suggested for taking assurance on validity. In the editorial 
introduction to the first set of indicators – CSP, Iezzoni et al (1992) – the consensual approach 
involving a panel of physicians to provide face validity and precision, was questioned as not being 
replicable. In particular, the physicians did not agree on their interpretation of the presence or not of 
an adverse event within the medical note abstracts when trying to validate measure results on CSP.50 
3.2.1.2. Aspects of validation 
As discussed at the start of this chapter (paragraph 3.1.1), a key aspect of feasibility is to ensure the 
indicators are valid (the other aspects of feasibility – and how they are considered – are given later 
in this chapter). Validity has a number of domains, although these are neither comprehensively 
exhaustive nor mutually exclusive (Table 7). To organise the plethora of concepts, I have grouped the 
methods for demonstrating validity (individual ‘components’) within four global domains (construct, 
content, face, and criterion). 
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Table 7. Domains of validity 
Validation domain 
(‘global definition’) 
Requirement Validation methods (‘component definition’) 
Construct  validity Two measures of the same construct 
should yield similar results 
Convergent validity: compare process and 
outcome measures 
Discriminant validity: compare to supposedly 
unrelated measures 
Comparison to structural factors, e.g. skill mix 
Content (logical) 
validity 
Indicator should represent all facets of 
the subject of evaluation 
Consensual validity: near consensus of an 
expert panel (for content) or multi-disciplinary 
panel (for face validity). These domains are 
relatively less setting/purpose-specific, so 
previous evaluations can often be generalised. 
Face validity Indicator should "look like" it is going to 
measure what it is supposed to measure 
Criterion 
(concrete) validity  
Indicator should be associated with 
“better” measures of performance 
Concurrent validity: comparison to previously 
validated measure 
Predictive validity: (similar to concurrent) 
comparison of predicted score and eventual 
results from validated measure  
Source: adapted from concepts described in Romano et al (2007)
145
 and Brewer (2000)
146
 
3.2.1.3. Study validation 
In addition to the aspects of indicator validity, there are domains of study validity. Key domains are: 
ecological validity (that the study design approximates the real-world); internal validity (the extent 
to which a causal conclusion is correct, involving minimising of systematic error); and external 
validity of study, which relates to how generalisable the results are.146 
3.2.2. Previous indicator validation 
Evaluations on how ‘good’ an indicator performs usually involves the notions of ‘validity’ and 
‘reliability’; however, these terms are used in many ways in the literature.147,148 Some of this 
variation in the evaluation of indicators might be appropriate since how ‘good’ an indicator is 
depends on the context of both the subject and purpose of the measurement. To mitigate this issue 
of differing contexts, the framework used to evaluate the indicators in this project is based on three 
previously endorsed frameworks used to evaluate (albeit non-specialty) quality and safety indicators 
based on administrative data, alongside the domains of validity taken from wider literature:  
1. the Danish NIP, where ideal indicators were characterised as being: based on agreed 
definitions, and described exhaustively and exclusively; highly or optimally specific and 
sensitive; valid and reliable; discriminatory; relates clearly identifiable events for the user; 
useful for comparisons; evidence-based.33  
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2. the refinement the HCUP QIs, whereby indicators were required to have: face validity, 
precision, minimum bias, construct validity, ability to foster quality improvement, should or 
could be used effectively.80 
3. OECD HCQI indicator project used: importance (impact on health, policy importance, 
amenability); scientific soundness (face validity, content validity) and feasibility (data 
availability, reporting burden).85 
3.2.3. The analytical framework 
3.2.3.1. Methods for evaluation 
I synthesised these frameworks into a single hybrid set of criteria that were used to define the 
project protocol, as listed in the final column (Table 8, with further details on how the specific 
methods are designed to address this framework given in paragraph 3.6, p77). This is a pragmatic 
approach built on making efficient use of the data and tools available, since previous efforts – 
including those of Romano (2007) showed that even a comprehensive assessment can be 
inconclusive with, for instance, an indicator for obstetric trauma having mixed validity: “Recent 
evidence on construct validity of this indicator is inconclusive, but the evidence on criterion validity 
is quite supportive”(p18).145 
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Table 8. Analytical framework 
  Domain Indicator requirement Study design 
Im
p
o
rt
a
n
c
e
 
1. Impact Addresses clear gap, with policy 
importance 
Systematic reviews to find potentially important 
applications. Identifying key variations in indicators 
performance.  
2. Amenable Relates to an outcome that can be 
influenced by healthcare 
performance 
Comparison between key results and 
organisational factors. 
S
c
ie
n
ti
fi
c
 s
o
u
n
d
n
e
s
s
 o
f 
in
d
ic
a
to
rs
 
3. Face and content 
validity 
Sound clinical or empirical rationale 
for its use, and represent all facets of 
the subject of evaluations 
Literature review to identify indicators with pre-
evaluated face/content validity. 
Consultation with experts on new measures 
(consensual validity). 
4. Precision  Relatively large variation among 
providers that is not due to random 
variation or patient characteristics. 
Includes responsiveness, 
discriminative (cross-sectional) and 
evaluative (longitudinal) validity. 
Hospital results displayed on funnel plots to 
identify outliers while accounting for random 
chance. 
5. Construct validity Supported by evidence of 
relationship with quality, and related 
to other similar indicators 
Statistical analysis of correlations between the set 
of indicators, including outcome v. process 
indicators (convergent validity). 
6. Minimum bias Unaffected by systematic differences 
in case-mix  
Not incentivise gaming of the 
indicator 
Detailed risk-adjustment model applied to 
indicators and stratification of key results.  
Sensitivity analyses of influence of coding error 
and practice. 
A
p
p
li
c
a
b
il
it
y
 
7. Data availability Applicable to administrative data Application of indicators to show ICD-10 based 
data is sufficient. 
8. Reporting burden Minimal reporting burden Application of indicators to show that results can 
be derived without significant burden. 
9.  External and 
ecological validity 
Generalisability of findings Explicit statement of assumptions used. 
Sources: Adapted concepts presented in Davies et al (2001);
80
 Mainz (2003);
33
 Millar et al (2004);
85
 Romano et al (2007);
145
 
and Brewer (2000).
146
 
Iezzoni and colleagues concluded that indicators “needed to be validated if they were to be used; 
however, what was not obvious was what constitutes validity in this context”(p366).50 Some aspects 
of validity and applicability not covered in the evaluations framework – such as the ability of the 
indicators to be effective and “work well” in a portfolio of quality and safety metrics – are, instead, 
accounted for in the overall discussion (Chapter 11) since they relate to the reporting system. In 
particular, “internal validity” (correct causation) is partially proven through tests on convergent 
validity which may show, for instance, that providers offering more of a certain treatment or with a 
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different skill mix have better performance but the causation is also appropriate for assessment by 
clinicians and, therefore, relates to the reporting system. 
3.2.3.2. Limitations to evaluation protocol 
The key limitation of this validation process stems from no “gold standard” against which the results 
can be compared (criterion validity). On the precision element, given the inability to know absolutely 
whether a quality or safety event has occurred, calculating indicator-level false positive and false 
negative levels  - as suggested in some validation frameworks, such as Mainz 200333 and Rosen 
2007149 - is not possible. However, I have mitigated against this by accounting for hospital-level false 
positive rates using statistical controls and, where available, drawing on previous research, such as 
the work by Bottle et al (2008) which found, for instance, that from the 2,150 records audited, 72.5% 
were found to match the PSI specification.112 
3.3. Specialty selection 
3.3.1. Selection framework 
Given the aforementioned case to develop and apply specialty-specific indicators, the first stage of 
the study was to select specialties. Within the NHS, specialties are not mutually exclusive and there 
is no single agreed list of recognised specialties. However, given the nature of the research 
presented here, there was no need for precision in the labelling of specialties. By comparing 
previous lists of specialties (curriculum list, Royal Colleges of Physicians, Surgery, Paediatricians and 
Child Health, Obstetrics & Gynaecology, Psychiatrists, Anaesthetists, Radiology, Ophthalmology and 
the Faculty of Occupational Medicine and College of Emergency Medicine), I created a list of 51 
recognised specialties within the NHS, excluding general practice and public health which are not 
hospital-based specialties.  
I took a pragmatic approach to selecting which specialties should be evaluated, starting with the 
domains of ‘Impact’ and ‘Amenable’ from the evaluation framework (Table 7, p65). These criteria 
focusing on importance – or ensuring that there is scope for improvement - have been expressed 
elsewhere.144 Given the number of specialties, I took a range of additional considerations in selecting 
the specialties. To increase the generalisability of the findings on applying such indicators, I 
purposefully chose specialties with differences, particularly in: 
1. culture and current initiatives to improve quality and safety, in particular referring to  the 
NPSA which then had research programmes into four specialties: anaesthesia, neonatal, 
obstetrics and gynaecology, oncology;150  
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2. the range of treatments and outcomes; 
3. extent to which the policy of choice of provider is potentially applicable; 
4. the extent to which administrative data has previously been applied, including the 
availability of suitable indicators was considered, although the research plan did allow for 
the development of new indicators. 
I excluded specialties with only rare events since these are less likely to have a sufficient evidence-
base to have robust guidelines and, as such, there would be difficulty in knowing which processes 
might be improved by monitoring.144 The decision was made in consultation with a public health 
doctor. 
3.3.2.  Selected specialties 
Based on the framework, I chose to proceed with stroke and obstetrics specialties. This is not the 
only pair of specialties that comply with the criteria but uniqueness was not a pre-requisite and 
proceeding with these two are sufficient to meet the goals of the project with any wider assessment 
would be outside the scope for a doctoral thesis. The differences - and combined coverage of 
different facets of healthcare - that led to this decision are summarised in Table 9.  
Table 9. Differences in selected specialties 
Criteria Stroke Obstetrics 
Overall burden of disease 
(incidents/year in England) 
110,000 stroke
151
 700,000 births 
152
 
Type Medical Surgical/Medical 
Status of specialty New Longstanding 
Characterisation of 
measurement 
New and predominantly audit 
based 
Longstanding with varied tools 
Indicators in CSP (1992) No No 
Indicators in HCUP QIs No Yes 
Indicators in AHRQ PSIs No Yes 
Indicators in Danish NIP
144
 Yes No 
Specific NPSA initiative No Yes 
Prevalent Unknown Yes 
Evidence of scope for 
improvement 
Yes Yes 
Specific patients No Yes 
Patient type Unwell patients Predominantly well patients 
Choice of provider Rarely Potentially 
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3.4. Developing an indicator set 
3.4.1. Framework for developing indicators 
Jan Mainz, from the Danish NIP, presented a conference paper in 200160 – later published in 2003 as 
a companion piece to an article defining and characterising the NIP measures 144 – outlining a 
method for developing evidence-based clinical indicators. Whilst this framework gives only the 
shortest consideration of the testing of the indicators by application to the data, it provides a useful 
guide for the initial stage of the project, and the way in which this project complies with the 
proposed method is summarised in Table 10.  
The OECD indicator set which was published at a similar time used a far less comprehensive method 
for developing an indicator set, involving an expert panel with each member asked to identify 20 
measures they felt had the greatest prospects of being selected. Through a series of conference calls 
and email discussions, the Patient Safety Panel converged on a final list of 21 indicators.85  
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Table 10. Development of indicator sets 
Phase Steps Sub-steps Method applied in this study Chapters 
P
la
n
n
in
g 
1. Choose the 
clinical area to 
evaluate 
Establish importance (high 
volume, cost, variation) 
Systematic reviews (secondary 
purpose) 
4, 8 
Identify opportunities for 
clinical intervention 
Systematic reviews (secondary 
purpose) 
4, 8 
2. Organise the 
measurement 
team 
Select group participants Various consultations/ 
collaborations with clinical 
specialists, statisticians, and 
clinical coders 
 
Organise and divide tasks  
D
e
ve
lo
p
m
e
n
t 
p
h
as
e
 
3. Provide an 
overview of 
existing evidence 
and practice 
Present documentation and 
knowledge from the 
scientific literature for 
potential indicators 
Systematic reviews (primary 
purpose) 
4, 8 
Establish consensus about 
existing knowledge and 
practice 
Systematic reviews (primary 
purpose) 
4, 8 
4. Select clinical 
indicators and 
standards 
Select process indicators Predetermined criteria for 
selecting indicators, including that 
both process and outcome 
measures are used 
5, 9 
Select outcome indicators 5, 9 
Identify prognostic factors 
(risk adjustment) 
Systematic reviews (primary 
purpose) 
4, 8 
Establish consensus and 
rating procedures 
Stroke: online consultation 
Obstetrics: use of previously 
endorsed indicators 
5, 9 
5. Design 
measure 
specification 
Define indicators and 
standards 
Described in application of 
indicators for comparing 
performance. Standards, cohort 
and risk-model developed 
through systematic reviews 
(primary purpose) and testing. 
5, 9 
Identify target population 5, 9 
Determine inclusion and 
exclusion criteria 
5, 9 
Devise risk adjustment 
strategy 
5, 9 
Identify data sources Use of English administrative data 3, 5, 9 
Describe data collection 
procedures 
Process for collecting English data 
outlined below 
3 
Develop a plan The analytical plan and 
techniques are described below 
3 
6. Perform pilot 
testing 
 Application of indicators 
according to analytical framework 
(Table 8, p67) 
3, 5, 6, 7, 
9, 10 
Source: Mainz 2003144 
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3.4.2. Literature review type 
3.4.2.1. Meeting requirements of previous indicator development 
frameworks 
The literature review was designed to meet the following development steps set out by Mainz (and 
as described in Table 10, p71) to: present documentation and knowledge from the scientific 
literature for potential indicators; establish consensus about existing knowledge and practice; and 
identify prognostic factors (risk adjustment). To meet these objectives the review would need to be 
comprehensive and I employed the approach of a systematic review, which are used to collate “all 
evidence relating to the objectives and to reduce any bias in answering the literature review 
questions”.153 The literature review was also designed to meet the development steps to establish 
importance and scope for improvement, although these were not a core objective as they do not 
require such a robust approach. 
3.4.2.2. Gaps in specialty literature 
As set out above (Table 8, p67, Domain 1) a key component to addressing the feasibility of using 
specialty-specific indicators is to evaluate the current literature within that specialty and understand 
what the gaps are. Whilst some of the generic issues with quality and safety indicators are presented 
in the previous chapter, that discussion also highlighted the variation between specialties which will 
result in unique advantages and disadvantages for applying administrative data to monitor care. 
3.4.2.3. Literature review type 
These literature reviews were atypical in that they were not designed to answer a single question – 
such as the effectiveness of a specific treatment – but rather to understand which, and how, 
indicators have been applied to date. It was also hoped that the approach would reveal the current 
shortcomings in the development and utilisation of indicators. Despite the likely heterogeneity of 
the studies prohibiting formal, quantified meta-analyses, the literature reviews shared the features 
of a systematic, rather than narrative, review (Table 11). As such, these collations and appraisals of 
the literature are termed as systematic reviews in this monograph. 
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Table 11. Key distinctions between narrative and systematic reviews 
Core Feature Narrative Review Systematic Review Review protocol 
Study question  Often broad in scope. Often a focused clinical 
question. 
Multiple, specific, non-
clinical objectives 
Data sources and 
search strategy 
Which databases were 
searched and search 
strategy are not 
typically provided. 
Comprehensive search of 
many databases as well as 
the so called grey 
literature. Explicit search 
strategy provided. 
Comprehensive, 
reproducible search 
strategy. 
Selection of 
articles for study 
Not usually specified, 
potentially biased. 
Criterion-based selection, 
uniformly applied. 
Predetermined criteria 
applied. 
Article review or 
appraisal  
Variable, depending on 
who is conducting the 
review. 
Rigorous critical appraisal, 
typically using a data 
extraction form. 
Extraction form used. 
Study quality If assessed, may not 
use formal quality 
assessment. 
 
Some assessment of 
quality is almost always 
included as part of the 
data extraction process. 
 
Assess quality of both 
study (e.g. reporting of 
assumptions) and 
indicators (e.g. case-mix 
model). 
Synthesis Often a qualitative 
summary. 
Quantitative summary 
(meta-analysis) if the data 
can be appropriately 
pooled; qualitative 
otherwise. 
Likely qualitative 
synthesis due to 
heterogeneity of study 
designs and 
administrative data used. 
Inferences Sometimes evidence-
based. 
Usually evidence-based. Inferences all based on 
extracted information. 
Source: Adapted from West et al (2002)
154
, Cook et al (1997)
155
, Green et al (2008)
156
 
3.4.3. Previous systematic reviews 
To ensure that the work is not redundant, it is good practice to check whether there are existing or 
on-going similar reviews.157 I reviewed existing and on-going reviews by searching the Cochrane 
Database of Systematic Reviews (CDSR)c, key websites and making enquiries at key organisations 
involved in the development, application and validation of indicators. The additional purpose of this 
process was to both: 
- inform the design of the specialty-specific systematic reviews by having a comprehensive 
understanding of what sources, search terms, inclusion criteria have been used to answer 
meet similar objectives; and 
- use the descriptive results (such as number of indicators collated, dates of studies and 
countries of origin) from these previous reviews as benchmarks to compare to the results of 
                                                          
c
 Other sites searched included: National Institute for Health and Clinical Excellence (NICE); NIHR Health 
Technology Assessment (NIHR HTA) programme websites; Campbell Collaboration website; Evidence for Policy 
and Practice Information (EPPI) Centre website and it’s database of systematic and non-systematic reviews  
of public health interventions (DoPHER).  
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the specialty-specific systematic reviews and, therefore, allow normative conclusions on the 
effectiveness of identifying indicators. 
Details from key previous literature reviews of quality and safety indicators were collated (Appendix 
B, p297) with a summary of these previous reviews given in Table 12. 
Table 12. Selected details from sample of previous review of indicators 
Review Date of 
publication 
Search terms Resources Results 
International  Quality 
Improvement 
Programme (IQIP) 
Since 1985 Not stated Not stated Nearly 700 indicators 
covering four care settings  
HCUP QIs 1994/1998 Not stated Not stated Final list of 33 quality 
measures 
National Indicators of 
Safety and Quality 
Project (Australia) 
ACSQHC 
established in 
2000 
Not stated Not stated 152 papers on health 
AHRQ QIs 2001 MeSH terms “hospital, 
statistics, and methods” and 
“quality indicators” 
Embase, Medline, 
hand search, author 
search 
181 articles on potential 
indicators, with 27 explicitly 
defining novel indicator 
Millar et al (OECD HCQI 
project) 
2004 n/a (reviewed 7 preview 
indicator sets) 
Based on previous 
indicator searches 
21 indicators selected 
SimPatIE 2007 Patient safety, indicator, risk, 
harm and test*, Usage/Use, 
Apply, Valid 
Pubmed and google 
scholar 
42 potential indicators with 
24 recommended for all or 
part of Europe 
CPSSQ (Imperial 
College, London) 
2008 Two dimensional search string 
pertaining to [patient safety 
indicators] and [adverse 
events] 
Included: Medline, 
Embase, grey 
literature, 
government 
websites 
91 articles on patient safety 
indicators 
Joint Commission’s 
NHQM 
2009 (v2.6b) 
based on work 
from 1999 
Not stated Not stated ORYX initiative has over 8,000 
measures.  CMS chose 21 
measures from shortlist of 39 
Notes: NHQM: National Hospital Quality Measures; ACQHC: Australian Council for Safety and Quality in Health Care 
3.4.4. Literature search resources 
3.4.4.1. Electronic databases 
Electronic databases were searched to identify both peer-reviewed journal articles and other 
research such as conference proceedings and unpublished work. There were two main processes 
regarding the use of electronic databases: 
- An extensive systematic search of Institute of Scientific Information (ISI) Web of Science, 
Medical Literature Analysis and Retrieval System Online (Medline) and Excerpta Medica 
Database (Embase) databases – the latter two through the OVID interface – from inception 
to the date of the search.  
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- Searching databases of previously compiled indicators such as: AHRQ’s Clearinghouse (which 
included measures used by, for instance, the Canadian Institute for Health Information, 
Australian Council on Healthcare Standards, British Medical Association);158 OECD’s Health 
Care Quality Indicators (HCQI) project;130 the EU sponsored SIMPATIE project and EUPHORIC 
measures;159 HCUP refined indicators;80 and Queensland Health: Clinical Practice 
Improvement Centre measures.160  
3.4.4.2. Other data sources 
To complement the searches of electronic databases, I also used the following methods: 
- An online search, including a selection of government and patient safety organisation 
websites (Appendix C), to identify grey literature, in the form of research and technical 
papers and reports, conference abstracts, government reports and committee working 
documents were obtained from this search.   
- Searching bibliographies of key articles to identify additional papers which met the eligibility 
criteria. 
The Physiotherapy Evidence Database was not searched as previous research found it did not 
include new citations relating to these indicators.161 
3.5. Selecting indicators 
3.5.1. Considerations on indicator selection 
3.5.1.1. Previous indicator selection 
AHRQ had a criteria that “in order to be retained as a potential PSI, at least one of the first three 
studies needed to demonstrate a positive predictive value of at least 75%, meaning that 3 out of 4 
patients identified by the measure did indeed have the complication of interest”.40 However the lack 
of similar studies in the UK on PSIs let alone other specialty-specific indicators meant that such a 
strong criterion was not possible. As a looser criterion, AHRQ also stated that indicators should have 
been used effectively in the past, and/or have high potential for working well with other indicators 
currently in use. In the updating of the initial indicators, the HCUP II QI project has a criterion that at 
least 1% of hospitalised patients and/or 20% of providers are captured.74 
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3.5.1.2. Project protocol for indicator selection 
The intentional differences in the chosen specialties dictated a different set of criteria for selecting 
the indicators and any specific criteria are presented in the relevant chapters. However, generic 
criteria based on the findings from previous literature discussed earlier are that indicators should:  
a. constitute a bundle, defined here as at least 6 indicators; 
b. include process and outcome indicators; 
c. focus on an area with known variation in performance; 
d. cover adverse events affecting at least 1% of hospitalised patients and/or 20% of providers. 
Alongside the author, an expert in administrative data, a public health doctor and a senior doctor in 
the relevant specialty fed into the development of the indicator set. I acknowledge that the resulting 
set of indicators would not necessarily be unique; however, this does not affect the ability to 
determine the feasibility of applying such indicators. I have demonstrated how these are also aligned 
with the analytical framework in (Table 13), although the final three domains on applicability (‘Data 
availability’, ‘Reporting burden’, ‘External and ecological validity’) are not included despite these 
inherently being partially addressed by the characteristics of indicator bundles offering a wider 
range of information and yet being based on the same data source. 
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 Table 13. Use of multiple measures and mix of process and outcome measures to address 
analytical framework 
  Domain a. Multiple 
measures 
b. Process and 
outcomes 
c. Known variation d. Prevalent 
Im
p
o
rt
a
n
c
e
 
1. Impact More 
comprehensive 
understanding of 
impact 
Understanding of 
both impact on 
hospitals (process) 
and patients 
(outcome) 
- Evidence of high 
impact 
2. Amenable - Associations 
between processes 
and outcomes 
suggest amenability 
Suggests possibility 
to improve to peer 
performance 
- 
S
c
ie
n
ti
fi
c
 s
o
u
n
d
n
e
s
s
 o
f 
in
d
ic
a
to
rs
 
3. Face and content 
validity 
Cover more facets 
of subject of 
evaluation 
- - - 
4. Construct validity Can test for 
associations 
between 
measures 
Can test for 
associations 
between process 
and outcome 
measures 
- - 
5. Precision - - Ability to identify 
differences 
- 
6. Minimum bias - Process measures 
less likely to be 
affected by case 
mix 
- Higher numbers 
reduce effect of 
random variation 
Notes: Sources and Notes in Table 8, p67.  
3.5.2. Defining indicators 
An established requirement is that the indicator is based on agreed definitions, and described 
exhaustively and exclusively.33 The indicators used in this study are, therefore, set out in detail with 
key assumptions explained. 
3.6. Applying indicators 
In this section I describe the statistical methods common to the application of indicators to both 
specialties. The alignment of these statistical tests with the analytical framework is set out in Table 
14, although again the final three domains on applicability (‘Data availability’, ‘Reporting burden’, 
‘External and ecological validity’) are not included since these are addressed through the application 
itself rather than the results.  
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Table 14. Statistical tests to address the analytical framework 
  Domain Statistical technique Output 
Im
p
o
rt
a
n
c
e
 1. Impact Descriptive analysis National rates of adverse events 
2. Amenable Regression (performance v. 
structural factors) 
Effect size and significance of 
correlation 
S
c
ie
n
ti
fi
c
 s
o
u
n
d
n
e
s
s
 o
f 
in
d
ic
a
to
rs
 
3. Face and content 
validity 
n/a n/a 
4. Precision Descriptive analysis Range of scores, by group 
Mean number of cases, per unit 
  Statistical testing Presentation on funnel plots 
5. Construct validity Regression Spearman rank correlation, rho, 
and significance 
6. Minimum bias Multi-level regression Risk-adjusted rates, r
2
 (variation 
explained by model) and c-
statistic (discriminatory power 
at admission level)
162
 
  Comparison of risk-adjusted and 
crude rates 
Spearman rank correlation, rho, 
and significance; 
% change in outlier 
performance
163
  
  Descriptive analysis Stratification of key results 
  Regression analysis including 
hospital-level coding variables 
Coding- and risk-adjusted rates 
Spearman rank correlation, rho; 
and significance 
% change in outlier performance 
Notes: Sources and Notes in Table 8, p67.  
3.6.1. Descriptive statistics 
For most of the analyses, the first step is to produce crude statistics, including bivariate associations. 
The methods used are summarised in Table 15. 
Table 15. Simple statistical tests  
Test Data type 
Pearson chi-squared, Χ2 Categorical 
Mann Whitney U test non-normally distributed ordinal 
t-tests (ANOVA) normally distributed continuous  
Pearson correlation, r non-normally distributed continuous 
Spearman rank correlation, r non-normally distributed ordinal 
 
Chapter 3: Project design and methods 
79 
3.6.2. Regression models 
Regression analyses were used to calculate odds ratios (ORs) for both unadjusted and case-mix 
adjusted indicators. The indicators in this project are dichotomous in nature (with each admission 
either having or not having the complication in question) and, as such modelling is based on the 
binomial distribution. Each relevant hospital admission is flagged with a “0” or “1”, referring to the 
absence or not of the quality or safety events. The binomial distribution has mean n.p and standard 
deviation √(n.p.[1-p]), where p is the proportion of cases and n the sample size. 
The logistic regression can be used to predict the odds at an admission-level (Formula 1) and odds 
ratio (OR), which is defined as the odds from one group of admissions divided the odds from another 
group (Formula 2). Odds and ORs have a floor of 0 and no ceiling. 
       
                                    
                                             
   Formula 1 
      (
∑         
∑         
)         Formula 2 
Where: 
i = admission within a wider set, say, A;  j,k = groups of admissions within set A;  
Regression analyses are used to predict the presence of an event based on predictor variables, which 
can be either continuous or categorical data. The expected value of the response variable is fit to 
these predictor variables, e.g. the probability of death is estimated for different patient age groups. 
Using natural logarithm transformation (and inverted back using the exponential function), a logistic 
regression can predict probability of an event as a continuous variable even though the observed 
events are categorical (binary). The PROC LOGISTIC function is used within the SAS software.   
3.6.3. Generalised linear models 
When there is evidence that the outcome is affected at different levels – in this case, both patient-
level and provider-level, a multi-level model is required. Where this was the case, I fitted generalised 
linear mixed models using SAS’s PROC GLIMMIX function. The clustering of patients may affect 
results; however, where I report provider-level variation with no hospital level explanatory factor I 
do not adjust for clustering (in the reported model) since the effects were found to be small. 
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3.6.4. Unadjusted indicator rates 
In the first instance, crude rates (at national and provider levels) were calculated for each indicator. 
These simple proportion or crude rates (CR) are given by Formula 3 with the 100(1-α)% confidence 
interval limits given by Formulae 4a and 4b.164  
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    Formula 4b 
Where: 
i = hospital 1,…;   ni = total number of admissions at hospital i 
z = 1 – α/2 percentile of a standard normal distribution 
Oi = observed number of admission at hospital i meeting the numerator criteria (e.g. receiving scan) 
3.6.5. Risk adjustment 
Previously cited risk factors were collated in the systematic reviews. A priori variables were retained 
unless they threatened model convergence. This allowed consistency in the case-mix adjustment 
across the different measures. In other words, all candidate variables were retained, even if not 
statistically significant, as the goal was confounder control.162  
3.6.6. Goodness of fit 
A common measure of goodness of fit is that described by Hosmer and Lemeshow; however, recent 
analyses have suggested this test is likely to produce significant results with large data sets and it is 
unclear how important the imperfect calibration is for a typical hospital in practice.165 I inspected 
standard errors for non-convergence, co-linearity, and over-fitting, including only main effects. As 
reported in the analytical framework above, I reported the c- and r2-statistics for each model:  
 the c-statistic measures how well models discriminate between cases with an adverse event 
to those without (0.5 indicating no ability to discriminate and 1 for perfect discrimination);  
 the r2-statistic is a measure of how much of the variation is explained by the model (0 
indicating none of the variation being explained and 1 indicating all explained).166  
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Model fit was also assessed graphically in plots of the residuals by the predicted values. 
3.6.7. Standardisation of indicator results 
A standardised ratio is the observed number of events relative to the number of events that would 
be expected if predictive chance of events was applied to the particular observed population 
characteristics. A common example is the standardised mortality ratio (SMR). The indirectly 
standardised ratio (ISR) is given in Formula 5, with confidence intervals given in Formulae 6a and 
6b.167 From these standardised rates, an indirectly adjusted rate (IAR) can be calculated by applying 
the ISR to the population crude rate (Formula 7) 
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  Formula 6b 
 
IAR = ISR .CRpopulation       Formula 7 
where: 
Op is the observed number of events in the subject population in group p; 
Ep is the expected number of events in the subject population in group p given the standard rates; 
np is the number of individuals in the subject population in group p; 
 p is the group-specific rate estimated rate for group p.  
Oupper and Olower are defined above in Formulae 4a and 4b. 
This method assumes both: (1) a homogeneity within each patient group; and (2) that, overall, the 
expected number of events is that of the observed level. The group-specific rates  i can be 
calculated either directly (subject population rates applied to a standard population) or indirectly 
(applying standard or calculated rates to the structure of the subject population). This project uses 
the latter, due to the advantage of being more robust when there small number of events of interest 
164 and due to a lack of standard/reference population making the former unfeasible.  
3.6.8. Funnel plots 
I used funnel plots, with 95% and 99.8% confidence levels.168 The main advantage of this graphical 
representation is that it can reflect the fact the confidence intervals for different sizes of providers. 
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3.7. Setting 
England was chosen to evaluate the feasibility of applying specialty-specific indicators, which 
complied with the inclusion criteria that the setting was outside the USA and based on 
administrative data which used the ICD-10 diagnosis coding framework. As well introducing the 
setting, I show below that this choice also complies with the analytical framework criteria of high 
impact and being amenable. 
3.7.1. Structure of English NHS 
In England, 60 years after its creation, the National Health Service (NHS) provides 64 million 
outpatient and A&E attendances and, in general practice, 290 million consultations per year.5 This 
care is provided by the 1.35 million staff who work for the range of providers including NHS hospitals 
(NHS trusts or NHS foundation trusts), GPs, dentists, and private sector and voluntary sector 
organisations. Following the reforms of 2012, the policy direction is set by the Department of Health 
(DH), with leadership for the commissioning system assumed through the independent organisation 
NHS England.169  
3.7.2. Quality and safety in England 
3.7.2.1. Prevalence of quality and safety in England 
Recognition of the patient safety issue in England came with the publication of a seminal report in 
2000.64 Five years later, a study by the National Audit Office reported that the cost to the NHS of 
patient safety events included: £2 billion a year in extra bed days; an additional £1 billion to this 
expenditure due to hospital acquired infections; and £423 million in settled clinical negligence claims 
(National Audit Office 2005). 
3.7.2.2. Quality and safety regulation regime in England 
In England, the Care Quality Commission (CQC) has acted as the independent quality regulator for all 
health and social care services in England since 2009. Previously, this role was conducted by the 
Healthcare Commission, the Commission for Social Care Inspection and the Mental Health Act 
Commission.170  
A system for reporting patient safety incident reports – the National Reporting and Learning System 
(NRLS)d – was established in 2003, with the intention that the information is used to develop tools 
and guidance to help local improvements in safety. More than four million incident reports have 
                                                          
d
 The NRLS also cover NHS trusts in Wales 
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now been submitted by healthcare staff. In 2010, it became mandatory for hospital trust to report 
serious incidents to the Care Quality Commission.171 
3.7.2.3. Quality and safety monitoring in England 
The monitoring of quality and safety in England is developing; however, few projects have used 
administrative data. The Government introduced the NHS Outcomes Framework in 2012 (with full 
role from 2013) to provide an overview of performance and act as a catalyst for driving quality 
improvement and outcome measurement.172 The Framework replaced the old regimes such as ‘vital 
signs’ and ‘national indicators’. The NHS Executive introduced a set of clinical indicators based on 
administrative data in 1999.173 Yet a systematic review of published articles on patient safety 
indicators published in 2008 identified only two studies23,174 describing adverse event measurement 
and monitoring in British hospitals.88 
3.7.3. Focus on acute care 
3.7.3.1. Definition of acute setting 
‘Primary care’ services are typically the first contract point within the NHS and provided by, for 
example, GPs, NHS-walk-in-centres, dentists, and pharmacists. Secondary, or ‘acute’ care, is 
provided by hospitals.  
3.7.3.2. Framework for identifying the setting 
Administrative data systems exist in many healthcare settings, such as family (general) practice and 
hospitals, and can be used to analyse the quality and safety of the setting that provides the data or 
other settings. For instance, hospital administrative data can evidently be used to measure hospital 
performance, but by analysing emergency admission rates, for example, inferences about the quality 
of community care could be made. The following paragraphs set out why the project focuses on 
hospital data and hospital performance; although I do not argue that other data resources and 
settings are less important. To show the value in this scope, I again recall the criteria above on 
‘importance’ regarding the room for improvement and being amenable.  
3.7.3.3. Importance for hospitals 
As discussed above (paragraph 1.3.2, p28), the importance of quality and safety for hospitals is well 
established. 
3.7.3.4. Amenable to indicator-use 
The use of quality and safety indicators based on administrative data is relatively recent, especially 
outside the USA, and so little work has gone into evaluating whether they are an effective tool to 
PART I: Introduction 
84 
improve care. 59 However, there have been some promising examples, such as one hospital that 
detected poor performance on the HCUP indicators and were able to amend their procedures to 
improve appropriate utilisation.40 There is also evidence that similar improvement programmes – 
such as using other computerised clinical information – can be well-received by hospital providers, 
improve error detection and could reduce the incidence of adverse events in hospitals.59,175-177 
3.7.3.5. Scope to improve use of indicators in this setting 
Importantly, there also remains scope to improve the use of indicators based on administrative data 
in this setting. A systematic review of patient safety indicators in 2008 identified 165 publications 
relating to patient safety in hospitals, of which only 51 were original research.88 Only one cross-
sectional study (a survey for determining hospital staff’s attitude to safety culture)178 and on case 
control study (using administrative data to identify potential quality problems)90 investigated 
validation. 
3.7.3.6. Findings on quality and safety in English hospitals 
The existence of significant variations in quality and safety of care in English hospitals has been well 
established.151,152 In particular, annual reports by Dr Foster Intelligence – a joint venture with the 
Department of Health – have suggested wide-spread variation over a range of conditions and 
measures.179   
3.8. Data 
3.8.1. Introduction to Hospital Episode Statistics 
The Hospital Episode Statistics captured almost 18 million episodes of admitted patient care in 2012-
13,180 with each record covering the continuous period during which the patient is under the care of 
one consultant (Finished Consultant Episode, FCE). These FCEs are linked together into hospital 
spells which can be further linked to any spells resulting from the transfer of a patient to another 
NHS hospital to form ‘superspells’ (referred to here as admissions). Diagnoses are recorded using the 
International Statistical Classification of Diseases and Related Health Problems, tenth version (ICD-
10) and procedures are coded using the Office of Population Censuses and Survey’s Classification of 
Surgical Operations and Procedures, fourth version (OPCS-4).  
This data constitutes Hospital Episode Statistics (HES) which were conceived in 1987, to replace a 
system based on collecting data from around 10% of patients. The data are cleaned according to 
published rules.181 
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3.8.2. Ethical considerations 
The Dr Foster Unit at Imperial has permission to hold HES data under Section 251 (formerly Section 
60) granted by the National Information Governance Board for Health and Social Care (NIGB, 
formerly the Patient Information Advisory Group). The Unit also have approval for using these data 
for research from the South East Research Ethics Committee. 
3.8.3. Software 
The following software programmes were in the project: Endnote X3, X5 and X6 (Endnote Carlsbad, 
CA); Microsoft Office Word and Excel 2007 and 2010; and SAS Version 9.2 TS Level 2MO.  
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Overview 
Context 
The previous part of the monograph outlined the rationale and analytical approaches for using routinely-
collected administrative data, focused at the specialty-level, to evaluate the quality and safety of hospital 
care. To understand the feasibility of meaningfully applying the indicators to a particular specialty (acute 
stroke care), a consolidated understanding of previous measurement efforts is required. This objective 
was met following the systematic review methodology described in this chapter. 
Methods 
A systematic review of original studies that applied, evaluated or validated stroke-specific indicators 
based on administrative data. Indicator and study details were collated. 
Findings 
The initial search identified 1,999 unique citations and I identified 99 studies, and 20 broad groups of 
indicators. Most measures had been applied in the USA (n=64) and Canada (n=11) with few studies 
describing any substantial validation of the indicators, and the application of the indicators – in terms of 
definitions of stroke and risk-adjustment models – inconsistent. The use of stroke-specific indicators is 
patchy, in terms of the countries that have applied them and the indicators used. There is potential to 
make more meaningful inferences about the quality and safety of acute stroke care by applying a more 
comprehensive set of indicators and being more explicit about the assumptions used.  
The literature review followed a similar process to a review of all patient safety measure based on 
routinely-collected hospital data which identified only a similar magnitude of studies (n = 124) despite its 
far broader scope. 
What this chapter adds  
The first comprehensive review of stroke-specific indicators based on administrative data. 
The first review of how the stroke indicators have been applied, including strategies for case 
ascertainment, risk-adjustment and validation. 
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4.1. Background on stroke care 
4.1.1. About stroke 
Strokes are caused by an interruption of the blood supply to the brain, either through a clot 
(ischaemic) or bleed (haemorrhagic). The subsequent lack of oxygen and nutrients can cause 
damage to the brain tissue, commonly resulting in sudden weakness or numbness of the face, arm 
or leg. The outcome from stroke will, along with patient characteristics, depend on the area of the 
brain affected and the severity of the interruption.182 An indicative stroke care pathway is included 
as Figure 5.  
4.1.2. Importance 
4.1.2.1. Burden of stroke 
Stroke is the second leading cause of death worldwide, accounting for an estimated 5.7 million 
fatalities annually, equivalent to 1 in 10 deaths.182  
4.1.2.2. Treatment of stroke 
Specialist training for stroke care is a recent phenomenon.183 The development of the area as a 
specialty has coincided with dramatic changes in the management of stroke care due to burgeoning 
evidence of effectiveness of certain treatments. For instance, a systematic review in 1997 indicated 
that organisation of inpatient care in designated wards (stroke units), compared to conventional 
care, reduced mortality and disability despite no routinely employed medical or surgical 
interventions at that point.184,185 However, in the subsequent years such interventions were 
developed and, for instance,  by 2007 the use of thrombolysis “clot busting” treatment for certain 
stroke types (ischaemic) had been approved in England.186 This, in turn, changed the importance of 
stroke patients receiving urgent scans so that their stroke type could be determined within the time 
window for administering thrombolysis.151  
4.1.2.3. Amenable to healthcare 
Previous research has suggested that stroke outcomes can be improved through the delivery of 
improved healthcare. Perhaps as a result of the developing nature of stroke care with lag time in 
some organisations and settings, unacceptable variations in the organisation and delivery of care 
exists.187 For instance, a national (English) report also recently highlighted both the enduring 
variations in hospital care and that some levels of care remain unacceptably low.151 This 
phenomenon is not restricted to England.188  
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Figure 5. Indicative recommended stroke care pathway 
 
Source: Adapted from National Audit Office (2010)
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4.2. Introduction 
4.2.1. Stroke as a specialty 
As a specialty, ‘Stroke’ is a subset of internal medicine dealing with the treatment of strokes. Stroke 
is a new specialty with attending physicians previously – and often still – being geriatric or neurology 
specialists. 
4.2.2. Stroke measurement 
4.2.2.1. Demand for indicators 
There has been widespread demand for better measurement of the burden of stroke and the quality 
of care administered. The WHO have actively supported countries to understand their stroke 
mortality rates whilst also highlighting a general lack of quality and safety indicators, particularly in 
developing countries.182,189 At a national-level, taking the example of England, the DH have 
introduced stroke-specific measures of discharge home,190 survival rates and emergency 
readmissions to hospitals within 28 days of discharge for stroke.191 The Department also reiterated 
that, compared with other countries, there were relatively poor outcomes in England across some 
measures of stroke and, as such, the area was earmarked as a priority.192 Academics have also called 
for indicators to measure stroke care performance.193,194  
4.2.2.2. Existing measures 
To date, the most comprehensive and high-profile study to benchmark stroke care have been based 
on specific stroke registers and prospective studies. National stroke audits are being used across the 
world, such as in England, Argentina, and Canada 195 More detail on measurement in the former of 
these nations (England), is given in the following chapter (paragraph 5.1.1.2, p117). In late 2009, a 
small indicator set was introduced for hospitals to monitor and review which included in-hospital 
stroke mortality.196 
Previous research has suggested that the use of quality indicators in stroke care could improve 
performance. For instance, improvements have been attributed to the introduction of a registry in 
the USA with 10 performance measures,197 another USA-based registry,198 and the NSSA.199 Despite 
the promising outcomes from these performance measurement activities, little use has been made 
of the vast amounts of detailed, patient-level, administrative data that is routinely collected in many 
nations to measure the quality and safety of individual specialities such as stroke care. As such, there 
would be value in documenting what stroke-specific indicators have been used to date and how 
these have been applied. 
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4.3. Objectives 
To produce a comprehensive list of indicators of the quality and safety of hospital stroke care that 
can be based on administrative hospital data, and provide a critical assessment of how these have 
been applied previously. This latter objective is designed to inform the quantitative analyses 
presented in the following three chapters. 
4.4. Methods 
4.4.1. Search resources 
An outline of the systematic methodology was given in a previous chapter (paragraphs 3.4.2- 3.4.3, 
p72-). In summary, the approach used in this review is developed from the methodology of Tsang 
and colleagues on reviewing patient safety measures based on routinely collected hospital data.67 
The method used to search for peer-reviewed journal articles and other research is described earlier 
(paragraph 3.4.4, p74). An initial search of the databases – designed to identify peer-reviewed 
journal articles – was performed between May and July 2010 and also later in the review process in 
May 2011. 
4.4.2. Validation of search results 
As a further check of completeness, I also reviewed the extracted indicators against measures in an 
American list of approved stroke and stroke rehab measures, even though they were not designed 
specifically for administrative data.200 Where a study was based on a database similar to 
administrative data – such as a Cleveland-based study 201 which included five measures that could all 
be applied to administrative data – these measures were cross-referenced against the compiled list 
of potential indicators to ensure they were already included.  
4.4.3. Definitions  
4.4.3.1. Definition for administrative data 
Recall from paragraph 2.1.1.1 that ‘administrative data’ is defined, for the purpose of this review and 
to meet the ambition of the study, using the inclusion criteria: routinely collected data covering 
more than one hospital; used for administrative purposes (e.g. for reimbursement); and can be 
replicated using the internationally-recognised ICD-9 or ICD-10 diagnoses coding framework. 
As a principle, where a study was based on administrative data linked to another supplementary 
source, the individual measures described in the paper were reviewed to assess whether they could 
be replicated with administrative data alone. This ensured that no potentially important indicator 
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was excluded and that validation studies, where results from administrative data are compared to 
an augmented or different dataset, were included. 
4.4.3.2. Definition of quality and safety  
As discussed earlier (paragraph 1.1.4), providing an exact definition of quality and safety is difficult 
and its application for the purpose of this review on stroke care is possibly best defined by the 
treatment of contentious indicators: 
 Length of stay is included as, while in some instances this is considered a measure of hospital 
efficiency rather than treatment effectiveness, some variations – such as a dichotomous 
indicator of long length of stay – are more likely to be considered a proxy for aspects of 
quality. One study, which described length of stay as an economic measure, in fact found 
that it was positively correlated with quality measures.202 
 Hospital charges are not considered as a quality indicator since this is a compound measure 
of patient characteristics, length of stay, and treatments provided – which can be picked up 
as separate indicators and risk adjustments – and is a more direct measure of hospital 
efficiency. 
 Clinically associated complications of stroke that are not amenable to healthcare – such as a 
study on fractures following stroke – are not included.203 
4.4.4. Search strategy 
4.4.4.1. Electronic databases 
The following three electronic databases were interrogated: Ovid MEDLINE(R) In-Process & Other 
Non-Indexed Citations and Ovid MEDLINE(R) 1946 to Present; Ovid Embase Classic+Embase 1947 to 
2011 May 15; and Web of Science (to present). 
4.4.4.2. Search terms 
The search terms used were informed by previous stroke literature reviews.204,205 The databases 
were interrogated using a two-dimensional search string using the ‘AND’ conjunction to identify 
papers relating to stroke which mention either a quality indicator or routine data (Figure 6). Medline 
and Embase were interrogated using both indexing terms (MESH and EMTREE, as shown in the 
Figure) and also using a two-dimensional search string akin to that used for Web of Science to check 
if the use of the index terms were systematically omitting results.  
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Terms for TIAs were also included to accommodate studies which were focused on these ‘minor 
strokes’ but may include stroke-specific indicators. As with similar reviews, only English language 
articles were included, and non-human studies were removed. 67,161  
Figure 6. Search terms 
Web of Science 
Indicator* OR "administrative data" OR "routine data" OR "routinely collected data" OR "hospital 
episode statistics" OR "hospital episodes statistics" OR "claims data" OR "International 
Classification of Diseases" OR "International Statistical Classification of Diseases" OR ICD NOT 
"implantable cardioverter" 
AND 
Stroke OR Cerebro*vascular OR CVA OR Apoplexy OR (brain AND vascular) OR (transient isch*mic 
attack). 
 
Embase  
‘health care quality’ OR ‘clinical indicator’ OR ‘performance measurement system’ OR 
‘international classification of diseases’)  
AND  
‘stroke’ OR ‘transient ischemic attack’.  
 
Medline  
‘quality indicators, health care’ or ‘international classification of disease’ 
AND  
‘stroke’ OR ‘ischemic attack, transient’. 
4.4.4.1. Duplicates 
Duplicate citations were identified using Endnote reference management software by identifying 
entries with identical authors, date, journal, and title.  
4.5. Review process 
4.5.1. First stage review criteria 
4.5.1.1. Inclusion and criteria for review of indicator use 
Recall that literature on quality and safety measures were retained if (1) based on routinely collected 
hospital administrative data; and (2) applied, evaluated or validated a potential or actual indicator of 
the quality or safety of hospital stroke care. To meet this latter criterion, an included study had to 
provide numerical results on performance against the indicator. 
Specifically, as a first stage, abstracts were reviewed and candidate papers were excluded if:  
 None of the described indicators related to an acute stroke so, for instance, excluding 
measures relating to surgical procedures for prevention of stroke; 
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 None of the described indicators explicitly relate to the quality and safety of health care 
provided, such as measures of cost (and also stroke incidence given this is a wider measure 
of public health). As a result, readmission for stroke is included206 but neither stroke 
incidence nor those complications of stroke not associated with quality (such as Generalised 
Convulsive Status Epilepticus, GCSE) are included 207; and 
 The study was not based on routinely-collected hospital administrative data (as defined 
above). 
Where there was insufficient detail in the abstracts to ascertain whether the criteria above were 
met, the study was included in the second stage (full text) review. 
4.5.1.1. Inclusion of additional papers describing indicators 
Secondly, I separately collated studies which described indicators that could be applied to 
administrative data but no actual database was used (and so failing the first stage criteria to provide 
numerical results) to ensure a well-defined comprehensive list of indicators.  
4.5.2. Second stage review criteria 
For the second stage, the remaining articles had the same exclusion criteria applied to the full texts. 
This stage provided a form of quality assurance by double-reviewing many of the studies whilst also 
giving the opportunity to collate a range of additional information from the papers. As well as the 
details of the publication (such as author, title, year of publication) a standard template was used to 
extract information relating to the studies (Table 16). Information on validation techniques applied 
and any key limitations were also recorded where available. The heterogeneity of the studies being 
considered meant that no meta-analysis would be possible so the results were not systematically 
recorded.  
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Table 16. Information extracted 
Study section Data field 
Design Country 
 Details of cohort 
 Longitudinal 
 Key Limitation(s) 
Data Database(s) 
 Year(s) of data 
 Diagnosis coding framework 
Variables Quality and safety indicator(s) 
 Key covariate(s) 
Case ascertainment Diagnosis field(s) 
 Diagnosis codes 
Statistical methods Risk adjustment 
 Validation technique(s) 
4.5.3. Data extraction and review 
4.5.3.1. Analytical tools 
I catalogued and reviewed the extracted details using Endnote versions X3 and X4 (EndNote 
Carlsbad, CA) reference management software. A standard form was used to collate the information 
for the second stage (review of full texts).  Similarly, a standard template was used to record the 
different categories of measures used. Statistical analyses of study details, such as trends in number 
of publications, were performed using Microsoft Office Excel 2010 (Microsoft Corp., USA). 
4.5.3.2. Comparative analyses 
In discussing the descriptive statistics on the literature, I use comparisons to previous literature 
reviews on patient safety indicators, predominantly that of Tsang et al, 66,67 to provide a benchmark 
to judge whether the specialty-specific nature of the review, and the specialty in question (stroke), 
have revealed atypical results. A comparison to the obstetrics literature review (Chapter 7) is 
included in the discussion (Chapter 11).  
The information from the studies was compared as a whole and in subsets since certain purposes, 
for instance, would require specific risk-adjustment models and strategies for identifying stroke 
episodes. For example, where the purpose of the study is to validate the identification of safety 
issues against medical notes, it is unlikely that you would want to adjust for case-mix, whereas for 
comparisons between providers such a risk-adjustment would be important.  
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4.6. Results 
4.6.1. Identification of studies 
The initial search identified 1,999 articles of which 206 duplicates were removed. Of the remaining 
1,793 articles screened, the full text was retrieved for 169 studies with the most common reason for 
exclusion being: non-relevant (n=1243); the study describes an indicator not applied to routinely-
collected administrative data (n=140); evaluated only the prevalence of stroke (n=78); and 
investigated only the accuracy of diagnosis coding of stroke (n = 33).  
During the second review stage, a further 88 studies were excluded, although 18 were added from 
the search of grey literature and review of the bibliographies of key articles, resulting in 99 articles 
(Figure 7). The information extracted from the articles are summarised in Table 17. 
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Figure 7. Inclusion and exclusion of articles in the literature review 
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Table 17. Characteristics of literature 
 Number of 
studies 
Proportion 
of all studies 
Examples 
Data years ^    
Pre-1995 10 10.1% Ostbye (1997)
208
, Shapiro (1994)
209
 
1995-1999 24 24.2% Mosimaneotsile (2000)
210
, Polanczyk 
(2002)
211
 
2000-2004 41 41.4% Kuwubara (2006)
212
, Lee (2010)
213
 
Post-2004 19 19.2% Kleindorfer (2009)
214
, Lichtman (2011)
215
 
Not described 5 5.1% Tirschwell (1999)
216
 
Country of study    
USA 64 64.6% Mitchell (1996)
217
, Borzecki (2010)
218
  
Canada 11 11.1% Field (2004)
219
, Johansen (2006)
220
 
England 4 4.0% Laudicella (2008)
221
, Lazzarino (2011)
222
 
Taiwan 3 3.0% Lee (2010)
213
 
Australia 3 3.0% Scott (2004)
223
 
Multi-national 3 3.0% Mattke (2006)
130
 
Other single-nation 
studies 
11 11.1% e.g. Netherlands, Slobbe (2008)
224
 
Number of primary indicators  
1 62 62.6% Tonarelli (2010)
225
 Tseng (2009)
226
 
2 – 3 30 30.3% Votruba (2006)
227
, Williams (2004)
228
 
4 – 5 7 7.1% Smith (2006)
229
 Tu (2003)
230
 
> 5 0 0.0% - 
Trend analysis    
Longitudinal 30 30.3% Zhu (2009)
231
, Volpp (2006)
232
 
Non-longitudinal 69 69.7% Zhu (2008)
233
, Votruba (2006)
227
 
Diagnosis coding    
ICD-9 73 73.7% Adeoye (2011)
234
, Andaluz (2008)
235
 
ICD-10 11 11.1% Cho (2009)
236
, Gattellari (2009)
237
 
Other † 15 15.2% e.g. both ICD-9 and ICD-10, Westert 
(2002)
238
 
Stroke diagnosis field    
Primary only 57 57.6% Gregory (2009)
239
, Lee (2010)
213
 
Primary and some 
secondary 
1 1.0% Meyer (2009)
240
 
Primary and all 
secondary codes 
6 6.1% Lanska (1994)
241
 
DRG-level 3 3.0% Cleves (1997)
242
 
Not described 32 32.3% Censullo (2008)
243
, Crowley (2009)
244
 
TOTAL 99 -  
Notes:  ^ Where studies covered multiple years of data, the study is categorised according to the most recent year 
 † Includes studies where coding framework not described and where both ICD-9 and ICD-10 used. 
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4.6.2. Details from studies 
4.6.2.1. Country 
Three-in-five published studies were based on data from the USA, with the next most prolific 
country being Canada (n=11). No other nation had more than 4 studies based on administrative data 
evaluating this specialty.  
4.6.2.2. Year of study 
None of the studies were published before 1987; however, this is likely to be an artefact of the 
commonly used administrative databases not being established before 1988 (paragraph 2.1.1.2, 
p39). The number of studies has increased over time and around two-thirds (64%) of the studies 
incorporated data from 2000 or later. Due to time lags in accessing, analysing and publishing studies 
based on administrative data one might expect a time lag in publishing data and, therefore, the 
trend was considered before 2007. Using a linear regression of year (of latest data used in each 
study) against number of studies shows that there has been a substantial and significant increase 
over time (β = +0.45, p-value < 0.001) (Figure 8). 
Figure 8. Number of publications compared to latest year of data 
 
 Note: Year represents the latest date of data used within studies 
4.6.3. Study designs 
4.6.3.1. Cross-sectional regional analysis 
The studies were predominantly cross-sectional in design, with study populations ranging from 
admissions at a single hospital to multiple national populations and 2 studies presenting the analyses 
at multiple geographical levels.214,245 At the most aggregated geographical level, there were 3 cross-
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sectional descriptive studies comparing performance across countries.130,238,246 Other studies used 
the regional geographical unit either with the purpose of directly comparing performance 206,218,247,248 
or investigating particular regional-level covariates such as variations in: competition;232,249 use of 
comprehensive regional stroke networks;250 Health Maintenance Organisation (HMO) penetration;251 
and level of rehabilitation provided by local health authorities within a region.252  
4.6.3.2. Cross-sectional provider-level analysis 
At the provider-level, only two studies were directly focused on highlighting variation between 
hospitals.243,245 Rather, these provider-level studies predominantly focused on investigating the 
effect of particular hospital characteristics. The most prominent hospital characteristics being 
studied were:  
- teaching status, measured either dichotomously 211,217,235,253-258 or using the resident-to-bed 
ratio as a proxy to differentiate between major teaching, minor teaching, and nonteaching 
hospitals 257; and  
- size, measured through either number of beds 235,258,259 or throughput 227,247,260-263; 
- type, including municipal vs voluntary,209 HMO vs Fee For Service,264 Veterans Association 
(VA) vs non-VA,218 and non-profit vs for profit vs public ownership;258 and 
- level of stroke specialism, which incorporates studies looking at the association in 
performance with level of stroke accreditation or existence of a specialist stroke unit. 
215,217,231,237,255,265,266 
Further hospital characteristics evaluated were: staffing levels;236,257 exposure to competition;249,258 
and treatment intensity (cost and treatments).267  
At a sub-provider level, some studies focused on clinician experience in terms of volume of stroke 
patients they see 268 and clinician specialty.217,229,269-271 Other studies used a more investigatory 
approach, with multiple hypotheses about associations between performance against the indicators 
and a range of hospital factors,213 or even a range of patient and hospital factors.226,261,272-276 
4.6.3.3. Cross-sectional patient characteristic level 
Similarly, some investigatory studies looked at how different patient groups performed against the 
indicators and, for some research, looked across a range of patient factors.222,277 Other studies 
investigated associations between performance and specific patient characteristics, such as 
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ethnicity;278,279 220,232,280-284 age;239,280 gender;280,285 socio-economic status;239,286 distance to 
hospital;227 and insurance status.287 
Away from patient characteristics, other studies looked at the association between exposure of 
patients to different treatments,259 288 with a number of studies looking at the influence of day of 
admission on outcomes.253 268 289 244,290 
4.6.3.4. Temporal design 
Under a third of studies (30/99) used longitudinal analysis, with a small selection using quasi-
experimental design: 
- regions, e.g. the effect of reimbursement changes for uncompensated care; 249 
- hospitals,  e.g. the association between quality and whether a hospital had been 
merged/acquired; 291 and 
- a single hospital, e.g. how introducing a more specialist service affected performance. 231,266 
4.6.4. Details from datasets 
4.6.4.1. Data source 
The studies reviewed used a range of different administrative databases, with the most frequent 
including the: 
- AHRQ-sponsored HCUP NIS and HCUP SIDs (see paragraph 2.1.1.2); 
- National Patient Care Database's Patient Treatment File, which includes records of all 
hospital admissions from Veteran Association patients; and 
- Medicare Provider Analysis and Review (MEDPAR) file, which includes data from claims for 
services provided to USA beneficiaries admitted to Medicare facilities, available since 
1999.292   
Some studies used multiple administrative databases – for example, international studies for which 
there are no cross-national administrative databases18,33,34 – or, more commonly, administrative 
hospital data were supplemented with another source, such as mortality records to account for 
deaths outside the hospital setting. The administrative datasets were found to be heterogeneous 
with, for instance, many variations in the coding framework for operations/treatments received.  
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4.6.4.2. Case ascertainment 
Almost three-quarters of studies used the ICD-9 framework for coding diagnoses, with only 11 being 
based on ICD-10. A third of studies did not describe which fields were used to identify strokes, 
although most that did used only the primary/principle diagnosis (57/66).  
Limiting the description to those studies that used the ICD-10 framework, the most commonly used 
codes were: I61 (intracerebral haemorrhage); I63 (cerebral infarction); I64 (stroke, no specified as 
haemorrhage or infarction) and, to a lesser extent, I60 (subarachnoid haemorrhage) and I62 (other 
non-traumatic intracranial haemorrhage). However, there were numerous variations (Table 18). For 
instance, one study – described as evaluating all strokes – only used I63.237 In some instances, the 
studies set out prognostic differences between the stroke types as a rationale for making 
exclusions217,260 while in others the study was explicitly focused on a specific stroke type although no 
reason for this restriction was given.206,235 
Table 18. Variations in use of ICD-10 diagnosis codes for identifying stroke 
ICD-10 
code 
Description Examples of study 
Example of additional codes used  
H34.1 Central retinal artery occlusion Zhu (2009)213 ; Field (2004)249 
G45  TIAs and related syndromes  Zhu (2009)231 
G45, not 
G45.4  
TIA excluding transient global amnesia Field (2004)219 
I69  Sequelae of cerebrovascular disease Katzenellenbogen (2010)293 
all other 
I6x codes 
See note* Reklaitiene (2008) 251; Slobbe (2008)224; Tu 
(2009)
253
 
Examples of codes excluded  
I61 Intracerebral haemorrhage Saposnik (2007)202; Saposnik (2008) 204 
I63.6 Cerebral infarction due to cerebral 
venous thrombosis, non-pyogenic 
Pajunen (2005)
294
 
I60 Subarachnoid haemorrhage Scott (2004)223; Mattke (2006)116; NHS 
Information Centre (2011)
 180
  
I62 Other non-traumatic intracranial 
haemorrhage 
Zhu (2009)
231
; Lazzarino (2011) 228; Field 
(2004)
219
 
I64 Stroke, no specified as haemorrhage or 
infarction 
Cho and Yun (2009)
236
 
Notes: I60 – I64 and I69 described elsewhere, I65-6 (Occlusion and stenosis of precerebral and cerebral arteries, not  
resulting in cerebral infarction), I67 (Other cerebrovascular diseases), I68 (Cerebrovascular disorders in diseases classified 
elsewhere). 
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4.6.4.3. Extract validation 
Few studies explicitly validated the accuracy of the underlying data or appropriateness of the 
assumptions used to extract details of stroke patients. Within the studies reviewed, the only coding 
items for which the validity was evaluated were the coding of stroke diagnoses 163 and recording of 
thrombolysis 295,296 including using comparison with non-administrative datasets.225,234,297 One study 
excluded hospitals for which the data was deemed of inappropriate accuracy.263  
4.6.5. Risk models 
4.6.5.1. Case mix adjustment 
The studies used various adjustments to mitigate the effects of differing case-mix. At its most 
rudimentary, some studies presented unadjusted rates when making comparisons219,221,266 and 
others stratified their findings by age,130,235 or age and gender.240,248,294  Some studies used modelling 
techniques to adjust for these latter two patient demographics.208,218,220,224,245,298,299 The most 
common set of variables used in the risk adjustment were age, gender and a measure of 
comorbidities 251,253 230,231,233,242,265 however there were many additional variables considered in the 
studies (Table 19). 
Table 19. Factors included in risk models 
Factor Covariate 
Patient 
characteristics 
Social deprivation/socio-economic status 
253,287,288
  
Ethnicity 
300
 
232,283
 
284
  
Resident of country 
237
  
Marital status 
163,237,252
 
Distance to hospital 
227
 
Insurance (payer, including Medicaid status)
229,236,237,239,244,247,262-264,272,281,284,289-291
 
Medical history Place of admission 
258
 
163,227,288
 
First vs recurrent stroke 
301
 
Previous admissions: overall 
206,220,271
 
CVD-specific 
217
 
Stroke-specific 
263,301
 
TIA-specific 
163,301
 
Stroke/treatment 
details 
Stroke type 
163,213,239,252,263,279,286,302
, including stratified
215,246
  
Temporal: year of treatment 
247
 
216,264,274,283
; season 
290
;  and proportion of patients admitted at 
weekends
271
 
Measures of severity: Use of mechanical ventilation 
272,273,281
 
163
 
213
 
229,237,264,273
; Signs of cognitive 
functions and awareness 
237
; gastronomy tube 
229,264,272,273,281
; certain surgical operations 
213
 
264
; 
hemiplegia or  hemiparesis 
213
 
264,279
; and residual neurologic deficits 
213
 
264
.  Craniotomy 
277
; Other 
conditions (e.g. pneumonia, atrial fibrillation, urinary incontinence) 
237
; Severity (late effects of 
stroke, which includes cognitive deficits. Speech and language deficits an, and paralysis, 
dysphagia, incontinence, and delirium) 
271
; Gastronomy, tracheotomy, interventional intracranial 
thrombolysis, interventional angioplasty, endarterectomy, operative angioplasty, extracranial-
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intracrancial arterial bypass 
212
 
Treatment details 
(e.g. hospital 
characteristics) 
Hospital location 
239,260-263,268,277,287,288,290
 
Hospital size  as volume 
269,291
 
211,276,286-288,290
 and beds 
211,259,271,287
 
Hospital teaching status 
227,260,263,268,275,276
 and hospital ownership 
211
 
268
 
Clustering within hospitals 
232,249,257
 
Physician specialty 
261,263,276
 
To account for the regionalisation on services, studies have also adjusted for whether a patient 
was transferred between hospitals
217
; regional resources 
268
; and competition 
268
 
Stroke outcome Discharge destination 
275
 
ICU 
277
 
261,275
 
Length of stay 
272
 
238,273,277,281
 (particularly for time bound indicators, such as mortality within 28 
days) 
4.6.5.2. Participant exclusions 
To account for potential bias from different stroke, patient and hospital characteristics, studies used 
a range of exclusion criteria to define their participants. The most common criterion was age of 
patient, although sometimes this was necessitated by the underlying administrative databases being 
age-specific. Cut-offs for the exclusion of young people included 18,276 20,286,299 35,224 and 40.238 
Conversely, other publications excluded older patient , such as those over 105 years old,286 with one 
study excluding those over 75 because of the possibility of increasing unreliability of the clinical 
diagnoses of stroke with advancing age.303  
Other exclusions related to removing patients with atypical prognosis, such as: lengths of stay over 
one year;220 previous admission admitted for CVD in five years before admission;220,286 patients 
admitted from long-term care;257 208 non-residents;208 transfers;208,287 admissions not through 
emergency department;269,286 patients discharged within 1 day of admission or left the hospital 
against medical advice.215,265 Other studies excluded hospitals with low stroke numbers 227,298 or 
patients for whom diagnosis and treatment codes suggested an alternative primary diagnosis to 
stroke.276 
4.6.5.3. Summary of key factors 
The following exhibit (Table 20) summarises how different studies have controlled for, or examined, 
some potential determinants of variation in quality and safety. This incorporates details about the 
key dependent variables, case-mix adjustment and exclusions from the indicator denominators. 
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Table 20. Summary of key factors used in studies 
Level  Key covariate Risk-adjusted Participant 
exclusions 
Regional Regional networks Camilo (2005)
250
 e.g. transferred case in 
Mitchell (1996)
217
 
 
 Resources Carinci (2007)
252
 Tung (2009)
268
  
 Competition e.g. Volpp 
(2005)
38,39
 
Tung (2009)
268
  
Hospital Location  e.g. Cross (2003)
239,262
 
260,261,263,268,277,287,288,290
 
 
 Size (volume) e.g. Bardach 
(2002)
35,54-58
 
e.g. Gillum (2008)
269,291
 
211,276,286-288,290
 
e.g. Votruba 
(2006)
227,298
 
 Size (beds) e.g. Andaluz 
(2008)
44,52,53
 
e.g. Polanczyk 
(2002)
47,53,71,93
 
 
 Teaching status e.g. Andaluz 
(2008)
211,217,235,2
53-258
 
e.g. Saposnik 
(2007)
227,260,263,268,275,276
 
 
 Comparison/clusteri
ng 
e.g. NHS 
Information 
Centre 
(2011)
32,43
 
e.g. Volpp (2005)
38,39,51
 
 
 Ownership  e.g. Polanczyk (2002)
211
 
268 
 
 Specialist centre    
Clinician Specialty e.g. Mitchell 
(1996)
217,229,269-
271
 
e.g. Saposnik (2008)
56,58,78
 
 
Stroke Type e.g. Borzecki 
(2010)
209,218,258,2
64
 
e.g. Carinci 
(2007)
42,58,73,83,90,92,115,117
 
 
 Year  e.g. Bardach (2002)
247
 
216,264,274,283
 
 
 Day of stroke 
(weekend) 
e.g. Bell 
(2001)
253
 
268
 
289
 
244,290
 
Howrey (2011)
271
  
Stroke 
outcome 
Length of stay  e.g. Kind (2007)
272
 
238,273,277,281
 
Johansen (2006)
220
 
 Discharge 
destination 
 Reed (2001)
275
  
 ICU  e.g. Lee (2007)
277
 
261,275
  
Patient 
characteristi
cs 
Socio-economic 
status 
e.g. Gregory 
(2009)
239,286
 
e.g. Bell (2001)
45,93,94
 
 
Ethnicity e.g. Lee 
(1998)
278,279
 
220,232,280-284
 
e.g. Mitchell (2000)
300
 
232,283
 
284
 
 
 Distance to hospital Votruba 
(2006)
227
 
Votruba (2006)
227
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 Insurance/payer Shen (2007)
287
 e.g. Bardach 
(2002)
35,57,58,60,61,66,72,74,86,89,90
,95-98
 
 
 Age Gregory 
(2009)
239,286
 
e.g. Kaprai (2002)
222,286
 e.g. Westert 
(2002)
224,238,276,286,299,
303 
Note: The list gives references as examples and should not be considered as comprehensive 
4.6.7. Details from indicators 
4.6.7.1. Range of indicators 
Across the 99 papers, 166 (not necessarily distinct) indicators were described – an average of 1.7 
indicators per paper – with no study having more than 5 indicators. Across the publications there 
were 20 categories of indicators, which cover: urgent acute care; acute treatment; complications; 
mortality; discharge; review; post-discharge (Table 21, with a full list given in Appendix D, p304). 
Through conducting the review, I also identified potential indicators which had yet to be applied to 
administrative data, such as ‘readmission for incontinence’,160 and ‘newly institutionalised within 2 
weeks of admission’.304  Mortality, readmission and thrombolysis rates were all often described 
across the published literature. In line with the inclusion criteria, ‘hospital charges’ was not 
regarding as a quality indicator, even though this was common within the included studies 
211,227,237,247,273,275,288,290. Some studies reported compound measures such as: ‘complications’ which 
covered either pneumonia, UTI and DVT 243 or pneumonia, PE, DVT 219; or ‘adverse outcome’ which 
combined in-hospital death with discharge destination other than home 284.  
4.6.7.2. Indicator validation 
Approaches used to take assurance on the validity of the indicator results were both sparse and 
varied. One of the studies compared performance across different indicators constructed from the 
same dataset; however, in this instance, few pairs had significant correlation.223 A more common 
approach was to compare the results from administrative data to another data set, with the majority 
looking at mortality rates 240,248,283,285,303 with the other data sets ranging from death registers, to 
other administrative database 274 and case note reviews at one of the hospitals.228 One study used a 
present-on-admission (POA) flag within the administrative data to see the effect on the sensitivity 
and specificity of the resulting indicator.298  
The most common form of validation described in the reviewed publications was on the risk-
adjustment, with 16 studies using different sets of variables to create the various models for case-
mix adjustment within their studies 163,166,209,212,216,227,233,239,242,249,257,272,273,282-284 and another study 
using competing analytical techniques for modelling risk.269 Apart from these studies evaluating risk-
adjustment, few of the remaining studies explicitly reported the model fit.226,233,242,244,268,289 One 
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study investigated the impact of missing data and patient identifiers 130 and two repeating the 
analysis on a different stroke extract (derived from different sets of stroke codes).265,290  
Table 21. Categories of measures 
Pathway Outcome measures Indicator 
type 
Example paper 
Urgent acute 
care 
Thrombolysis Process Adeoye (2011)234 
Urgent brain scan within 24 hours Process Lazzarino (2011)222 
 Emergency hospital transfers Structure Kind (2007)272 
Acute 
treatment 
Depression and other mental 
health problems following stroke 
Outcome Williams (2004)228 
 Inpatient rehabilitation services Process Kapral (2002)286 
 Warfarin use Process Smith (2005)264 
 Length of stay Outcome Tu (2003)230 
Complications Urinary Tract Infections (UTIs) Outcome Censullo (2008)243 
 Pneumonia due to swallowing 
problems  
Outcome Field (2004)219 
 Lower respiratory tract infection 
(LRTI) 
Outcome Laudicella (2008)221 
 Deep Vein Thrombosis Outcome Censullo (2008)243 
 Pulmonary Embolism Outcome Field (2004)219 
 Clostridium difficile Outcome Laudicella (2008)221 
 Adverse outcome Compound Zacharia (2010)284 
Mortality Craniotomy: mortality rate Outcome Borzecki (2010)218 
 In-patient death within 30 days of 
admission 
Outcome Ostbye (1997)208 
 All-location deaths within 30 days 
of admission 
Outcome Tirschwell (1999)216 
Discharge Return to normal place of 
residence 
Outcome Votruba (2006)227 
Post-discharge Emergency readmission to 
hospital following treatment from 
a stroke (all cause) 
Outcome Kamalesh (2007)305 
 Recurrent stroke within 28 days Outcome Tu (2003)230 
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4.7. Discussion 
4.7.1. Principle findings  
The literature review identified 99 studies that discussed the use of administrative data to measure 
the quality or safety of hospital stroke care and found 166 indicators, with the most prevalent 
relating to mortality, readmissions and thrombolysis rates. There has been a general increase in the 
application of these indicators, with over two-thirds of the studies using data since 2000.  
4.7.2. Source of data 
Three-quarters of the studies were from North America (USA or Canada) who use ICD-9 and a 
combination of ICD-9 and ICD-10 diagnosis codes, respectively. As such, only a small minority of 
studies, equating to 12%, use ICD-10 diagnosis codes. There is no one-to-one mapping between the 
two frameworks although many of the codes have equivalents. This, however, highlights that 
application of the measures and findings cannot be generalised everywhere. The reason for the 
prominence of research within North America may be an artefact of a greater use of established 
administrative datasets in these countries and, also, a lack of national audit data in USA (to act as an 
alternative data source). 
4.7.3. Stroke case ascertainment strategies 
4.7.3.1. Diagnosis fields 
The review identified studies that used all diagnoses fields, and one 240 that used first to fifth 
diagnosis positions, with these strategies likely to increase the sensitivity but reduce specificity of 
the algorithm for identifying strokes within the administrative database. However, among those 
studies that did describe which diagnosis fields were interrogated, the majority used only the 
primary/principle diagnosis, which is in keeping with previous findings on the use of administrative 
databases for quality research.306 Within Australian administrative health data, the primary 
diagnoses are rarely missing and stroke diagnoses appearing in administrative data sets are accurate 
93% of the time.237 Similar results have been found with ICD-9 databases.307 Moreover, other studies 
have added that using the first diagnosis field only increases the probability that the patient had 
suffered a stroke on the date of admission.219,308 This is also consistent with coding guidance in the 
UK which advises that acute stroke should be coded in the primary diagnosis field.309 
4.7.3.2. Stroke diagnosis codes 
From reviewing the literature, it was also evident that there was no consensus over what diagnosis 
codes were used in the studies on administrative data. As an example, looking just at the research 
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based on ICD-10 databases, the comprehensiveness of the strategy for identifying stroke admissions 
range from using just one 3-digit group of diagnosis code (I61) to using ten (I60 – I69). This is 
significant since certain stroke types have distinct care pathways. For instance, ischaemic strokes can 
potentially be treated using thrombolytic drug treatment; however, this would result in an adverse 
outcome if administered in treating a haemorrhagic stroke. Similarly, subarachnoid haemorrhagic 
strokes will likely receive substantially different urgent care to the other emergency stroke types.  
A 2005 study found that stroke coding was equally good for both ICD-9 and ICD-10 and while there 
were some differences in coding of the different types of stroke, these variations were not 
statistically significant and the most atypical coding performance was not for actual stroke (rather 
for TIAs). 310 However, not all strokes will be either accurately diagnosed or, even where they are, 
coded correctly or specifically enough. As a result, there is variable use of the unspecified or ill-
defined stroke codes (e.g. I64 in ICD-10 and 436 Acute, but ill-defined, cerebrovascular disease in 
ICD-9).  Therefore, a decision has to be made whether to use more limited codes to identify strokes, 
e.g. excluding those recorded as subarachnoid haemorrhages, which will increase the specificity of 
the denominator but might increase bias resulting from variable use of the unspecified stroke codes. 
One study specifically looked at the effect of using two different case ascertainment strategies on an 
outcome indicator (mortality). The risk-adjusted models for cohorts produced from the highly 
specific and, separate, highly sensitive sampling strategies were both robust and had some impact 
on respective rankings of the regional networks against the outcome measure, and whereas two 
outliers were identified in one cohort, none were identified in the other.163 
4.7.4. Indicator validity 
4.7.4.1. Risk-adjustment 
The importance of adjusting for case-mix in research on stroke care using administrative data is 
longstanding.209 However, continuing the theme of the findings of this review, there was 
unexplained variations in the approaches to adjusting for stroke type and both patient- and hospital- 
characteristics. Studies have found that adjusting for socio-economic status is inadequate without 
more comprehensive measures being included; however, even this level of risk-adjustment is more 
sophisticated than that applied in many of the studies.311 Likewise many studies did not adjust for 
comorbidities despite research showing that it is useful for predicting risk-adjusted in-hospital case-
fatality in stroke outcome studies.233  
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4.7.4.2. Coding of covariates, activity and outcomes 
Accurate coding – including of patient and hospital characteristics, treatment activity and outcomes 
– is inherently important if the data are to be used to identify true variations in the quality and 
safety of care. A number of studies evaluating the accuracy of coding for stroke patients – looking at 
variables such as coding of comorbidities310,312,313 and nonmedical and socio-demographic data 
elements269,314 – were identified through the initial search of citations and subsequent review of 
bibliographies and, in general they showed that the coding was of reasonable accuracy. 310  
However, the results are neither appropriate for synthesising – since heterogeneity between the 
studies mean that it is not possible to undertake any meta-analysis of the results – nor generalisable 
– since there are likely differences between the coding practice in different countries and changes 
since these non-contemporaneous studies were published.  
One commonly utilised indicator that directly relies on coding completeness is thrombolysis rate. A 
number of studies on this topic that were referenced in the reviewed studies with, in general, high 
specificity and mixed results on sensitivity, although again these are not necessarily generalisable 
due to the heterogeneity of databases, differing national incentives to complete them correctly and 
limited coverage of some of these studies.225,295,296 
4.7.4.3. Indicator validation 
As well as the ‘upstream’ validation of the case ascertainment strategies and robustness of the risk-
adjustment model, the literature review revealed some examples of ‘downstream’ explicit validation 
of the indicator results, for instance by comparing the results with indicators derived from other 
sources. Despite the existence for various frameworks of taking assurance on the validity of such 
indicators,130,315 none of the studies described a comprehensive validation strategy, certainly not in 
comparison to this study’s analytical framework (Table 8, p67). 
4.7.5. Strengths and limitations 
4.7.5.1. Strengths 
This study represents the most comprehensive review of measures of the quality and safety of 
stroke care using administrative data. An obvious strength of this literature review process which 
focused on a particular specialty is that it seems to be a sensitive strategy for identifying relevant 
research and, as such, provides more assurance that the resultant citations are comprehensive. For 
instance, the literature review followed a similar process to a review of all patient safety measure 
based on routinely-collected hospital data which identified only a similar magnitude of studies (n = 
124) despite its far broader scope.67  
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4.7.5.2. Limitations of the review process 
The limitations of this review process include the potential bias introduced from the use of a single 
reviewer and exclusion on non-English language articles. The exclusion of non-English articles was 
consistent with a previous review of patient safety measures 67 which found that such citations were 
limited in number. No formal meta-analysis could be undertaken because of the heterogeneity in 
study methodologies and underlying data frameworks. I did not use a template to assess the quality 
of the papers since there was a very diverse range of purposes across the studies and, as already 
discussed, validity needs to be proportionate to the purpose. Given the strong evidence on the 
existence of publication bias,316  studies using indicators which did not identify significant results 
when assessing the quality and safety of stroke care may have been missed by the search strategy in 
this study.  
4.7.5.3. Limitation of review protocol 
The literature review again reiterated the differences in extant administrative data and how they are 
used, such as in data-linkage studies. This makes the formulation and application of strict 
inclusion/exclusion criteria for such literature review difficult. In keeping with the review criteria for 
this research as described earlier, a study 317 based on Uniform Data System for Medical 
Rehabilitation (UDSMR) was excluded, since the indicators in the study used this specific 
rehabilitation data collection only and were not readily reproducible with other administrative data 
sources, whereas a study which linked this to the Medicare Provider and Analysis and Review files 
(MedPAR) administrative database was included, since the measure described could be recreated.318 
Similarly, a study with measures using linked data with variables including physical activity (not 
commonly included in administrative datasets) 319 was excluded; however, a study which 
supplemented the hospital administrative data with clinical register data 255 was included since the 
measures could still be replicated - albeit with some minor amendments - using purely 
administrative data.  
4.7.6. Conclusion 
4.7.6.1. Contribution to knowledge of indicators 
Looking at a specialty in detail, had advantages over a broader scope; not least, to better identify 
existing indicators. The study has highlighted a paucity of use of such indicators and a lack of 
transparency and consensus on key assumptions. 
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4.7.6.2. Recommended uses 
The studies in the review have been used for a range of purposes, from comparing performance 
across countries to evaluating the impact of the implementation of a specialist stroke unit within a 
single hospital. Administrative data do not include all the process measures collected in bespoke 
registers, such as provision of anti-thrombolytics, however they cover  the main outcomes – such as 
including all three key outcomes (length of stay, mortality and discharge destination) from one 
register.320 And indeed, in some cases, registers had to be linked to administrative data to get details 
of areas such as clinician experience.255  However, continued monitoring of stroke mortality has been 
described as “essential” 321 322 and, more generally, surveillance of stroke care is necessary to 
understand and meet the demand for stroke care 323 with the current lack of measures having been 
cited as partly attributable to the limitations on the adoption of best practice. 324 
As a result, administrative data has been recommended as a tool for identifying potential quality 
problem deserving further review.310,323,325 Moreover, there is some evidence to suggest that such 
measures can bring meaningful change with, for instance, a decline in stroke mortality rates 
associated with the introduction of an initiative to measure hospital performance, although this was 
not statistically significant (p=0.17).326 While the literature suggests there is a role for stroke-specific 
indicators based on administrative data, there is scope for the current raft of measures to be 
improved in their construction and application. Table 22  sets out six key recommendations for 
future stroke research based on the findings of the review, which are enacted in the following three 
chapters. 
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Table 22. Summary of implications for study design 
Finding Implication Recommendation 
Despite the recommendation of using 
indicators in passive surveillance of stroke 
services, the majority of research has been 
restricted to North America, and using ICD-9 
databases. 
Barriers to generalising findings 
across borders mean that little 
is known about the use of such 
indicators in other countries, 
especially those using ICD-10. 
Key study designs should be replicated 
using data from outside USA or Canada to 
identify any potential outliers. 
Two-thirds of studies applied only one 
indicator. 
Overall level of quality of care 
at a provider-level cannot be 
deduced from the results of 
only a small set of indicators.
223
 
To use the depth of information within the 
administrative data to construct more 
comprehensive set of indicators. 
There is a lack of consensus and 
transparency about the assumptions used in 
applying the indicators to administrative 
data 
Barrier to generalising, 
validating or benchmarking 
results. 
To explicitly set out the assumptions used 
in studies, such as the choice of diagnosis 
codes and fields.  
While concerns remain over bias due to 
differences in coding practice, none of the 
literature reviewed explicitly applied 
sensitivity analyses on effect of variations in 
coding. 
The effect of variation in coding 
practice is unknown. 
To analyse the potential effect of coding 
variation.  
To consider areas known to be potentially 
important and where comparisons are 
less affected by coding practice (e.g. 
weekend care) 
Less than a third of studies looked at trends 
in performance over time. 
Potential shortcomings in 
quality and safety are not being 
identified. 
Research into the potential opportunities 
for monitoring quality and safety using 
longitudinal designs. 
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Overview 
Context 
The review of stroke literature described in the previous chapter revealed a paucity of studies evaluating 
stroke services using administrative data outside Northern America, despite suggestions that this would 
be a useful surveillance tool. Across the research, there was a lack of transparency of the assumptions 
used with little use of the potential richness of indicators available or opportunities to validate results. In 
this chapter I aim to address these limitations by examining the feasibility of evaluating stroke care in 
England using routinely collected administrative data.  
Methods 
Six indicators, spanning the hospital care pathway, were applied to English data in 2009/10. Logistic 
regression analyses were used to adjust for case-mix, and funnel plots to look at potential outliers. I 
investigated the effect of variations in hospitals’ data coding practice. 
Findings 
The indicators were sufficiently sensitive to identify significant variations in performance as recorded in 
the data, with 181 occurrences of hospitals performing statistically differently than expected at the 99.8% 
significance level across the six indicators. Differences in coding practice appeared to only partially 
explain the variation. The work showed that administrative data can be used to indicate potential 
concerns around quality and safety, in specific areas, across the whole stroke care pathway. The chapter 
discusses work – on demographic differences – based on one of the indicators which emphasises the 
impact of stroke care and suggests that there is scope to improve.  
What this chapter adds  
Most comprehensive assessment of stroke services using administrative data in any country 
The most sophisticated evaluation of validity of any stroke assessment using administrative data 
Acknowledgements and related papers 
Advice was provided by: Sue Eve-Jones (UK Professional Association of Clinical Coders) on clinical coding; 
and Charlie Davie provided advice on clinical implications. Antonio Lazzarino undertook the data 
extraction and analysis for the ethnographic study (reported in the discussion). 
Palmer WL, Bottle A, Davie C, Vincent CA, Aylin P. Meeting the ambition of measuring the quality of 
hospitals’ stroke care using routinely collected administrative data: a feasibility study. International 
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Lazzarino AI, Palmer WL, Bottle A, Aylin P (2011) Inequalities in Stroke Patients' Management in English 
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5.1. Background 
5.1.1. Stroke care in England 
5.1.1.1. Priority of stroke care measurement 
Stroke costs the National Health Service (NHS) in England £3 billion a year in direct care costs, and is 
the largest cause of adult disability.151  In July 2010 the Government set out its policy intentions for 
the NHS including to measure performance “against results that really matter”, exemplifying this 
with stroke survival rates and emergency readmissions to hospital within 28 days of discharge for 
stroke.191 The proposals also reiterated that, compared with other countries, the NHS has achieved 
relatively poor outcomes in some measures of stroke and, as such, stroke was earmarked as one of 
the two areas with the most scope for improvement.192 More recently, the NHS’s operating 
framework for 2011/12 highlighted the scope for improving stroke outcomes, in particular through 
access to timely scanning and, if clinically indicated, thrombolysis.327 In recent years, the Department 
of Health in England have also introduced payments for patients receiving thrombolysis,328 early 
scans, and being admitted directly onto stroke units.329  
A national report also recently highlighted both the enduring variations in hospital care and that 
some levels of care remain unacceptably low.151 This phenomenon is not restricted to England,188 
and as a result research has also called for indicators to measure stroke care performance.193,194 
5.1.1.2. Existing measurement of stroke in England 
To date, the most comprehensive and high-profile study to benchmark stroke care in English 
hospitals has been the National Stroke Sentinel Audit (NSSA). The NSSA, which was first run in 1998, 
benchmarks hospitals’ stroke care over both organisational and clinical domains, based on a survey 
of hospital stroke teams and medical record review of around 60 consecutive patients. A further 
bespoke data collection was required after the introduction of mandatory measures regarding 
stroke care in the NHS operating framework for 2008-09 to 2010-11.330 Since 2000, the National 
Centre for Health Outcomes Development (NCHOD) has published a compendium of some 300 
indicators, including three indicators based on administrative data specific to hospital stroke care 
(number of admissions, readmissions and mortality), with a further six measures relating to stroke 
prevention.331  
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5.1.2. Revisiting limitations in existing literature 
The review of literature of stroke measures suggested that, to address the shortcomings of existing 
research, future efforts should focus on (excluding the recommendations relating to temporal study 
designs which are covered in the following chapter): 
1. applying key study designs for surveillance outside the USA or Canada to identify potential 
quality issues; 
2. using a more comprehensive set of indicators than has been done to date; 
3. being explicit about the assumptions used; and 
4. understanding the potential bias from variation in coding practice. 
5.2. Objectives 
In this chapter I investigate the feasibility of using HES data to evaluate the quality and safety of 
stroke care at a hospital level focusing on the ability of measures to identify important effects in a 
robust fashion.  
5.3. Methods  
5.3.1. Selecting indicators 
5.3.1.1. Selection criteria revisited 
Recall the criteria listed earlier (paragraph 3.5.1.2, p76) for the selection of indicators. For this set of 
studies on the stroke specialty, the experts involved in getting a consensus on the indicators are 
listed in paragraph 5.3.2.1, p119. 
5.3.1.2. Selection of indicators 
The literature review described in the previous chapter identified 20 broad categories of indicators 
with the potential to be applied to administrative data in England. Following the selection criteria, a 
subset of six indicators was chosen for application here. The indicators were chosen to cover the 
hospital stroke medical care pathway and include: process measures (e.g. scanning rates); outcome 
measures that are proxies for certain aspects of care (e.g. pneumonia rates, with higher rates 
indicating fewer patients receive swallow assessments); and outcome measures (e.g. emergency 
readmission rates) (Figure 9).  
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Figure 9. Positioning of the stroke indicators across the care pathway 
 
 
 
5.3.2. Developing indicator definitions 
5.3.2.1. Development process 
The selected indicators were then refined using a multi-faceted approach.  
1. I derived draft definitions using details from algorithms applied in existing literature, 
identified through the systematic review outlined in the previous chapter. 
2. I used an iterative consensual approach to ascertain feedback from a multidisciplinary panel 
of expert, consisting of a senior stroke physician (who was also involved in the indicator 
selection), a public health doctor, a clinical coding specialist (who had previously worked on 
developing indicator definitions) and administrative data experts (from Dr Foster Intelligence 
and Imperial’s Dr Foster Unit). 
3. The revised definitions were published online – through the Health Service Journal website – 
as part of an open consultation on clinical indicators.332 
4. Where necessary the panel of experts were consulted on addressing comments raised on 
the definitions from the open consultation.  
5.3.2.2. Final definitions 
The finalised indicator definitions are included below in Figure 10.  
a. Same day (and by-
next-day) scanning 
c. Aspiration 
pneumonia 
e. Discharge to usual place of 
residence within 56 days 
f. 30-day emergency 
readmissions (all cause) 
d. 30-day in-
hospital mortality 
b. Thrombolysis 
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Figure 10: Details of stroke indicators used in analysis 
 Indicator Rationale Numerator (discharges meeting the 
inclusion/exclusion criteria for the 
denominator with...) 
Exclusions 
a Same day and by-
next-day scanning 
Brain scanning should be performed 
immediately (when indicated) or as soon as 
possible (NICE 2008). Hospitals receive 
incentive payment for immediate scanning. 
OCPS codes for CT or MRI brain scan 
(U05.1/2 or U21.1/2 with Z01.9) 
Patients who die on day of 
admission (same day scan) 
or within day (by-next-day 
scan) 
b Thrombolysis Measure of provision of thrombolysis. Hospitals 
receive payment for providing thrombolysis. 
OPCS codes for thrombolysis 
(fibronolytic drugs, X83.3) 
Patients outside 
thrombolysis licence age 
range of 18 – 80 
c Aspiration 
pneumonia 
Aspiration pneumonia is an indicator of no 
swallow assessment or related care 
ICD-10 codes for aspiration 
pneumonia: J69.0 (due to food and 
vomit) and J69.8 (other solids and 
liquids) 
Pneumonia codes recorded 
in episodes that end before 
the first episode with a 
stroke diagnosis 
d 30-day in-hospital 
mortality 
Some mortality following stroke is potentially 
avoidable 
Flag for death at discharge and length 
of stay  after stroke <30 
None 
e Discharge to usual 
place of residence 
within 56 days 
Proxy measure for successful outcome of 
rehabilitation and availability of on-going care 
Length of stay after stroke <56 days, 
and admission source and discharge 
destination suggesting return to usual 
place of residence 
Admissions which end in 
death 
f 30-day emergency 
readmissions (all 
cause) 
Some readmissions are potentially avoidable Emergency admissions within 0-29 
days of discharge 
Admissions which end in 
death 
 
5.4. Application and validation of indicators 
5.4.1. Assumptions 
The next stage was to extract records of stroke admissions from 1 April 2009 to 31 March 2010. The 
assumptions used in the algorithm for identifying strokes in this study - based on previous studies, 
consultation with clinical coders and review of coding guidance - are listed in Figure 11.309,333 The 
assumptions include: diagnosis codes, fields and type; identification of the date of the stroke; 
treatment of transfers, including linkage into superspell admissions and assigning a responsibility to 
the hospital; and treatment of in-hospital strokes.  
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Figure 11: Assumptions for identifying stroke using Hospital Episode Statistics  
Issue Assumption Rationale Alternatives Implication 
Diagnosis 
codes 
ICD-10 codes I60 – I64 Review of literature/ 
clinical coding advice  
ICD-10 codes G08.X, G45 – 46, 
H34, I65 – 69, Q25.8, Q28, R47 
have also been used to identify 
patients in stroke studies 
Incorrect stroke numbers: the 
chosen criteria are quite strict, in 
comparison with most studies  
Diagnosis 
field 
HES primary diagnosis 
field only 
Review of literature/ 
clinical coding advice and 
guidance 
Some or all of the secondary 
diagnosis codes 
Underestimate total number of 
strokes: those incorrectly coded in 
the secondary fields are excluded 
Defining 
stroke type  
Strokes categorised by 
4-digits of first stroke 
diagnosis code meeting 
inclusion criteria 
(above) 
Subsequent stroke codes 
could refer to secondary 
strokes 
[1] Final stroke diagnosis; 
[2] Supersede coding of I64.X 
(not specified) if another stroke 
code is listed;  
[3] Three-digit codes 
Incorrect classification of stroke: 
where stroke is subsequently re-
diagnosed, strokes labelled under 
the initial, provisional diagnosis. 
This will affect case mix 
adjustments 
Date of 
stroke 
Start date of first spell 
with stroke diagnosis 
Coding guidance  [1] Start date of episode with 
first stroke diagnosis; 
[2] Start date of admission 
Incorrect stroke date: In-hospital 
strokes not recorded as a new spell 
may have early stroke date. Strokes 
not diagnosed in the first spell of 
admission may have late stroke 
date 
Linking spells Episodes of care linked 
to same superspell 
Reduce double-counting Analyse by spell rather than 
superspell 
Incorrect stroke numbers: 
Superspells with >1 spell are not 
counted more than once 
Responsible 
hospital 
First hospital of 
admission 
First hospital are 
responsible for onward 
transfers 
Hospital providing majority of 
(e.g. most bed days) or key 
aspects of care  
Performance assigned to wrong 
hospital: if local pathways involve 
hospital transfers, the performance 
of the initial hospital will be 
influenced by the care of 
subsequent hospital 
Type of 
admission 
Emergency and elective To not exclude in-hospital 
strokes 
Emergency admissions only Include non-acute stroke 
admissions as some episodes with 
primary diagnosis of stroke might 
relate to treatment for a previous 
stroke 
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5.4.2. Risk-adjustment 
5.4.2.1. Overview of case-mix adjustment 
Once an extract had been obtained using the above criteria, the first step was to identify outliers, 
which involved applying the indicator definitions to obtain denominators and numerators for each 
hospital. A logistic regression was used to calculate an expected number of numerator events based 
on the case mix for each hospital to account for: age, sex, socio-economic deprivation quintile, 
number of previous admissions, co-morbidities (Charlson index), month of discharge, ethnic group, 
source of admission (including whether admitted as an emergency or elective patient), and stroke 
type (4-digit ICD-10 diagnosis code). Charlson index was fitted as a continuous variable, with all 
others fitted as categorical variables. The risk model would not converge for some specifications 
and, for these, admission source was omitted from the case-mix adjustment. The methods used are 
described in more detail in paragraphs 3.6.2 to 3.6.6.  
5.4.2.2. Reporting of process measures 
For most process indicators, risk adjustment plays a smaller role than it does for outcome 
measures.144 Process measures (scanning and thrombolysis) are reported here as unadjusted (crude) 
rates, although adjusted rates were also calculated to check the validity of this approach.  
5.4.3. Statistical testing and validation 
Crude and standardised rates were plotted using funnel plots with 95% and 99.8% control limits and 
identified outliers (paragraph 3.6.8, p81). Hospitals’ performance across the different indicators was 
compared to evaluate our hypothesis that certain indicators would be correlated. This involved 21 
pairwise comparisons (the scanning measure was considered as two separate measures – same day 
and by next day scans), with further detail on this method included in the discussion below. Since 
these were hypothesised as being correlated and not a un-hypothesised statistical trawling exercise, 
Bonferroni correction or other adjustment to p-values for multiple comparisons was not used; 
however, I do report which correlations are significant at the 99.8% level.  
5.4.4. Sensitivity analysis for coding practice 
There is a risk that hospitals’ performance for these indicators might be largely affected by variation 
in the way they code their data rather than due to differences in quality and safety. As such, the final 
stage of analysis was to investigate, at a hospital level, the consistency of coding practice and 
evaluate the relationship between any coding bias and hospital performance. The three coding 
practices investigated, by comparing to performance in a relevant indicator, were:  
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[1] ‘coding depth’, with the coding practice in some hospitals increasing the likelihood that they 
record secondary diagnoses and, therefore, identify complications and comorbidities; 
[2] use of the ICD-10 diagnosis code I64 - Stroke, not specified, since it may bias the risk adjustment 
for the outcome measures; and  
[3] date of stroke, since some hospitals may be more likely to assign a stroke code to the episode 
when the stroke was formally diagnosed whilst others would assign a stroke code to the date of 
admission. 
For the latter practice, I calculated the average time-lags, by hospital, between the date used to 
signify the stroke in this study (start date of the first spell with a stroke diagnosis) and both the start 
date of the first episode with a stroke diagnosis and the start date for the superspell. 
The effect on the sensitivity of the measures when including a hospital-level variable to account for 
variations in coding practice was investigated by fitting generalised linear models and again plotting 
on a funnel chart to identify outliers.  
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5.4.5. Alignment with analytical framework 
Table 23. Analytical framework 
  Domain Study design Method 
described 
Results 
described 
Im
p
o
rt
a
n
c
e
 
1. Impact Descriptive, national rates  - 5.5.1.1 
2. Amenable Descriptive, range 
Demographic-level variation 
- 5.5.1.2 
5.6.2 
S
c
ie
n
ti
fi
c
 s
o
u
n
d
n
e
s
s
 o
f 
in
d
ic
a
to
rs
 3. Face and content 
validity 
Consultation 5.3.2.1 5.3.1 
4. Precision  Hospital results displayed on 
funnel plots 
5.4.3 5.5.2 
5. Construct validity Correlations between the set of 
indicators, including outcome v. 
process indicators 
5.4.3 5.5.3 
6. Minimum bias Risk-adjustment model 
Sensitivity analyses of influence 
of coding error and practice. 
5.4.2 
5.4.4 
5.5.5 
5.5.4 
A
p
p
li
c
a
b
il
it
y
 7. Data availability Application of indicators to show 
ICD-10 based data is sufficient. 
By implication 
8. Reporting burden Application of indicators. By implication 
9.  External and 
ecological validity 
Explicit statement of 
assumptions used. 
5.4.1 
5.4.6. Analytical packages 
All regression analyses were conducted using SAS version 9.2 using either the PROC LOGISTIC or 
PROC GLIMMIX procedures.   
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5.5. Results  
5.5.1. Importance 
5.5.1.1. National-level results 
Across 147 acute English NHS hospitals, 91 936 stroke admissions were identified in the period April 
2009 to March 2010. Of these, 2 522 (2.7%) died on the same day as admission, 15 846 (17.2%) died 
within 30 days of admission and 19 721 (21.5%) died before discharge. Of those patients meeting the 
inclusion criteria (discussed in Figure 11), 69.7% were scanned within one day of admission, 2.6% 
received thrombolysis, 5.3% had aspiration pneumonia, 72.8% were discharged to their normal place 
of residence, and 11.0% were readmitted as an emergency within 30 days of discharge. 
5.5.1.2. Amenable  
The wide range in performance suggests scope for improvement. For instance, the rate of scanning 
by-next-day ranged from 41.5% to 86.9% and for 30-day in-hospital mortality from 10.1% to 23.1%. 
Similar work I conducted as part of a team using the scanning indicators is reported in the discussion 
(paragraph 5.6.2). 
5.5.2. Precision  
Displaying the hospital-level data on funnel plots highlighted the variation in performance (Figure 
12). With the exception of the measure for emergency readmissions, all the indicators identified at 
least one hospital as having performance outside the 99.8% control limits (Table 24). The number of 
stroke admissions per hospital ranged from 171 to 1532. 
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Figure 12: Funnel plots of hospital-level performance across six indicators spanning the hospital 
stroke care pathway for 2009-10 
  
  
 
 
Note: Each dot represents a hospital. The horizontal line refers to national average; short-gauge dotted line refers to 
p<0.025 significance level; long-gauge dotted line refers to p<0.001 significance level. 
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Table 24: Number of trusts identified as having statistically significant above or below average 
performance 
Label Indicator National 
rate 
Range  Number of hospitals 
higher than average2 
Number of hospitals 
lower than average2 
  147 hospitals [min, max] p<0.001 p<0.025 p<0.001 p<0.025 
a Same day scan 47.1% [20.4% – 
79.3%] 
38 47 38 50 
a.1 By-next-day 
scan 
69.7% [41.5% - 
86.9%] 
13 32 13 28 
a.2 Combined scan1 n/a n/a 9 23 10 24 
b Thrombolysis 2.6% [0% - 16.8%] 13 24 63 75 
c Aspiration 
pneumonia 
5.3% [1.6% - 12.5%] 10 21 14 27 
d 30-day in-
hospital 
mortality 
17.2% [10.1% - 
23.1%] 
0 8 3 10 
e Discharge to 
usual place of 
residence within 
56 days 
72.8% [54.9% - 
85.4%] 
0 7 2 9 
f 30-day 
emergency 
readmissions 
(all cause) 
11.0% [6.1% - 17.3%] 0 4 0 9 
Note 1: Combined scan (a.2) was calculated as p<0.001 if both scan indicators had this value, and p<0.025 if both indicators 
at least p<0.025. 
Note 2: Better care is indicated by higher than average performance for measures a, b, and e, and lower than average 
performance in measures c, d and f.  
5.5.3. Construct validity 
Across the indicators, there were six pairs of indicators which had a statistically significant 
correlation at the 95% level, of which two were significant at the 99.8% level (Table 25).  
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Table 25: Coefficient of correlation between pairs of indicators 
 
By-next-
day scan 
Thrombolysis Aspiration 
pneumonia 
30-day in-
hospital 
mortality 
Discharge to 
usual place of 
residence 
within 56 days 
30-day 
emergency 
readmissions 
(all cause) 
Same day scan 0.570** 0.040* 0.035* -0.040* -0.023 0.004 
By-next-day 
scan 
 0.050 0.014 -0.045* 0.002 -0.021 
Thrombolysis   -0.078 -0.048 0.228 -0.084 
Aspiration 
pneumonia 
   -0.067 -0.720** 0.075 
30-day in-
hospital 
mortality 
    -0.355 -0.042 
Discharge to 
usual place of 
residence within 
56 days 
     0.001 
Note: Correlation significant at the 95% level marked with ‘*’; those at 99.8% level with ‘**’. Coefficient is Pearson’s r. 
5.5.4. Minimum bias: coding practice 
5.5.4.1. Coding depth 
At a hospital level, the average number of distinct diagnosis codes used per admission ranges from 
5.0 to 10.7. There was a statistically significant but weak correlation (p = 0.002, R2 = 0.067) between 
coding depth (measured as average number of unique diagnosis codes in an admission) and 
performance against the aspiration pneumonia measure. Of the 25 hospitals identified at the 99.8% 
level in the original regression, 20 (80.0%) were again flagged as outliers at this significance level 
when coding practice was included in the regression, with no hospitals flagged as having statistically 
different performance highlighted in the reverse performance category. 
5.5.4.2. Case ascertainment: episodes 
Secondly, across hospitals the proportion of strokes diagnosed as ICD-10 code I64 – Stroke 
Unspecified varied from 0.2 to 42.6%; however, there is only a weak correlation (p = 0.125, R2 = 
0.016) between use of this code and performance in the outcome measure of in-hospital mortality 
within 30 days. There was a statistically significant but weak correlation (p = 0.04, R2 = 0.028) 
between the proportion of patients without a specific stroke diagnosis and the hospital’s one-day 
scanning rates; this association was expected as a scan is required to determine whether a stroke is 
ischaemic or haemorrhagic.  
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5.5.4.3. Case ascertainment: date 
Nationally, the date-of-stroke calculations (start date of spell with stroke diagnosed, as described in 
Figure 11 and in the methodology above) were the same for 97.4% (and within one day for 97.9%) of 
patients, as compared with using the superspell start date. In comparison, when using the date of 
the first stroke episode as the alternative, the corresponding figures were 88.7% (93.5%). At a 
hospital level, there was a statistically significant but weak linear correlation (p = 0.006, R2 = 0.051) 
between the proportion of patients identified as having uncertain stroke date and performance in 
this measure. Of the 76 hospitals identified at the 99.8% level in the original regression, 50 (65.8%) 
were again flagged as outliers at this significance level when coding practice was included in the 
regression, with one further hospital (1.3%) flagged as having statistically high rather than low scan 
rates. 
5.5.5. Risk model 
The case-mix models were better at predicting 30-day in-hospital mortality (c = 0.735, r2 = 0.158) 
than readmissions (c = 0.622, r2 = 0.039). 
Table 26: Model fit statistics 
  Model fit statistics 
Label Indicator c r
2
 
a Same day scan 0.616 0.062 
a.1 By-next-day scan 0.645 0.100 
b Thrombolysis 0.771 0.108 
c Aspiration pneumonia 0.661 0.049 
d 30-day in-hospital mortality 0.735 0.158 
e Discharge to usual place of 
residence within 56 days 
0.664 0.095 
f 30-day emergency readmissions 
(all cause) 
0.622 0.039 
Note:  r2: the max-rescaled r-square score reported from PROC LOGISTIC 
 
5.6. Discussion 
5.6.1. Summary of findings 
The results show the potential for using hospital administrative data, meeting the Government’s 
intention to measure stroke care and, moreover, to highlight potentially significant variations in the 
quality and safety across the care pathway. Six measures of quality and safety, covering the acute 
stroke care pathway, were applied to English hospital administrative data identifying 91 936 strokes. 
Five of the six indicators identified hospitals with statistically outlying performance at the 99.8% 
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level.  In particular, the analysis reiterated the high impact of the subject matter, with large numbers 
of potential adverse events. 
5.6.2. Amenable: scope for improvement 
For most of the measures there is no clinical consensus or guidelines for what actual levels are 
acceptable and, in these cases, hospitals should strive to operate at the level of the best performers. 
Indeed, regulators and guideline-setters could use this analysis to suggest levels of performance that 
are attainable. The exception to this rule is in access to a scan, for which extant guidelines 
recommend that all stroke patients  should receive brain imaging “within a maximum of 24 hours 
after onset of symptoms” and, as such, the actual performance of 69.7% of patients receiving a scan 
within one day of admissions is unacceptable.334 While some of this shortfall in performance against 
the measure could be due to incomplete coding of the procedure, audit data in England suggest a 
similar figure.335 The level of performance also falls short of the Danish NIP proposed a benchmark 
that providers should give at least Proportion of patients who have a CT/MR scan on the day of 
admission.336 This project also suggested a standard of a maximum of 15% of stroke patients dying 
within 30 days which, again, was not met in England where 17.2% died within this timeframe.336 
Work I conducted as part of a team during the development of the indicator set and investigated the 
inequalities on this scanning indicator further since being a process measure and with only limited 
and explicit contraindications for the procedure, the expectation is for limited variation in a good 
performance health service.  This analysis, again on English HES data but using a different time 
period (2008/09) showed that young patients were more likely to be scanned quickly than old 
patients (Adjusted OR for 10 year increase of age = 0.90; P<0.001; 95% CI = 0.89–0.91); the relations 
for comorbidity were also similar.222 These findings again support the case that improvements can 
be made. 
5.6.3. Precision 
By using funnel plots and this control limit, I was able to account for random variation. This 
technique was more appropriate than one stroke study which identified outliers as being those 10% 
from expected and, therefore, not accounting for the scale of random variation being linked to the 
number of cases.243 If the deviation were entirely due to random variation, you would only expect to 
identify one outlier for every 3 to 4 measures (given there are 147 hospitals in the sample). Further 
to chance, differences in performance may be due to case mix, how the data were collected, or 
quality of care.337 Given the ambition was to compare hospitals on the basis of the last of these 
factors, the previous two also need to be accounted for.  
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5.6.4. Minimum bias 
5.6.4.1. Adjusting for case-mix 
Previous work has highlighted the importance of adjusting for case mix when comparing 
performance in stroke care.338 I accounted for case mix using patient-level logistic regression to 
calculate expected number of events for the outcome measures. However, at a patient level, some 
significant case-mix factors for stroke, such as severity of stroke and pre-stroke function,339 are not 
directly recorded within the data and therefore some of the variation may still be caused by 
differences in case-mix. If we hypothesis that there are small areas of extreme case-mix but, at a 
larger geographical level, case-mix is more homogenous coupled with units and trusts 
predominantly treating patients from their local area then it holds that any bias from this potential 
‘categorisation error’ will be further diminished by the large number of stroke patients admitted at 
each hospital, ranging from 171 to 1532. 
I report some model fit statistics which suggest that the case-mix models were better at predicting 
mortality (r2 = 0.158) than readmissions (r2 = 0.039) or pneumonia (r2 = 0.049). This information is 
not for making conclusion on the appropriateness of the case-mix adjustment – since it is not 
possible to disaggregated the effect of unmeasured differences in case-mix to differences in quality 
of care provided – but should be considered when interpreting the results. 
One specific issue relating to case mix originates from stroke care being increasingly delivered in 
regional networks, whereby certain hospitals are responsible for the urgent care of patients, whilst 
the other hospitals may take responsibility for rehabilitation. In these cases, the ambulance service 
has bypass protocols so that patients requiring urgent treatment are taken directly to the designated 
hospital. Therefore, the hospital designated to provide urgent care is more likely to receive a higher 
percentage of patients eligible for thrombolysis and, as such, their thrombolysis rates will be higher. 
In contrast, hospitals that are not designated to provide urgent care receive fewer eligible patients 
and, as a result, their performance against the measures of urgent stroke care are likely to be worse. 
5.6.4.2. Accounting for variation in coding practice 
The variation in performance due to how data were collected is harder to disaggregate; some of the 
possible variations in coding practice, for example, would mimic recognised alternative hospital 
pathways. However, I showed that three coding issues that were central to the assumptions for 
extracting the data explained only a small proportion of the differences in performance against the 
measures.  
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5.6.5. Errors in underlying data 
There are few recent studies specifically investigating the accuracy of coding stroke care in 
healthcare systems using the ICD-10 framework; however, one article on coding in England found 
that coding of stroke diagnoses was excellent and elsewhere administrative data have been 
recommended for use in tracking progress and identifying problems for further review.340,325 
Previous studies have suggested coding is improving and, specifically in the instance of stroke care, 
the fact that some of the codes are new - for example the scanning procedure codes were only 
introduced in 2006 - means that it can be expected that there will initially be under-use (and so 
under-reporting) against these codes and that recording will improve over time.341  
The analysis of coding practice highlighted variations in the data recording practice of hospitals, even 
where guidance exists. For example, the current ICD-10 Clinical Coding Instruction Manual “directs 
the coder that on emergency admissions for strokes it is of paramount importance that the coder 
assigns the code for stroke in the primary position”. 333  However, variations in the number of stroke 
codes recorded in secondary diagnosis fields above what would be expected from different 
prevalence of stroke as a co-morbidity suggest there are, from hospital to hospital, differing 
proportions of stroke recorded in secondary diagnosis fields.  
An English study evaluating the accuracy of the coding of stroke diagnosis found that the cause of 
errors was predictable, with confusion in coding of different types of strokes. This implies that 
further guidance and training may be needed to ensure consistency in coding.340 One recent 
suggestion to facilitate an improvement is to develop better relationships between coders and 
clinicians.306 This paper explicitly outlines the assumptions used for identifying strokes in HES data 
and, therefore, can form the basis of a debate within the medical and coding practitioner community 
about how to further develop these indicators and the dataset itself. 
5.6.6. Face and content validity  
Whilst previous studies have used hospital administrative data to measure the performance of 
aspects of stroke care, none have brought together the multiple facets of the care pathway and 
instead mostly focused on one area, such as mortality, and on national trends rather than hospital 
comparisons. A combination of process and outcome measures was used in this study, so benefiting 
from the advantages of process measures (which tend to be more sensitive to differences in the 
quality of care and offer a clear action for improvement) and outcome measures (greater intrinsic 
interest, high face validity, and can reflect all aspects of care, including those that are otherwise 
difficult to measure such as technical expertise and operator skill). 337,342  Face validity can be derived 
from the fact that the indicators appeared in existing literature or clinical guidelines. 
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As described in the previous chapter, overall level of quality of care at a provider-level cannot be 
deduced from the results of only a small set of indicators;223 however, two-thirds of studies within 
the literature review applied only one indicator. This study included six indicators covering the acute 
care pathway and, therefore, is likely to have better content validity (extent to which a measure 
represents all facets of the subject being investigated) over these previous more limited evaluations.  
5.6.7. Construct validity 
In the absence of a gold standard dataset to compare results, some assurance on validity can be 
taken by comparison with other indicators of performance. I investigated whether there were 
associations between hospitals’ performance across the different measures. In the existing 
literature, one study compared performance across different indicators constructed from the same 
dataset; however, in this instance, few pairs had significant correlation.223 One would expect some 
correlation between good performance across all the indicators with, for example, good 
management of a stroke unit likely to affect all the quality and safety indicators to some extent. I 
also predicted that there were two specific clinical explanations, with correlations expected if either: 
1. two indicators measure different events on a defined clinical pathway; or 
2. an outcome indicator measures the results of a process indicators. 
Indeed these two categories could explain the significant correlations that I identified between: 
same day scanning and next day scanning (positive correlation); same day scanning and thrombolysis 
(positive); scanning rates and mortality (negative); and pneumonia and discharge to usual place of 
residence within 56 days (negative). However, the causation in this latter correlation, between a 
proxy outcome measure for swallow assessments and discharge destination, is unclear as developing 
pneumonia is likely to increase length of stay (and so decrease likelihood of discharge within 56 
days) whilst a delayed discharge would inherently increase the chance of developing pneumonia in 
hospital. Further analysis reveals that at least a third (32.1%) of these pneumonia were diagnosed 
within 4 days of stroke; however, since the date of diagnosis is not specifically recorded in HES data 
this figure represents an absolute minimum and, as such, I cannot infer any causal trends between 
length of stay and pneumonia rates. 
The one unexpected, statistically significant result was the positive correlation between same day 
scanning and aspiration pneumonia rates. I expected that hospitals with high scanning rates would 
also be likely to have good processes to ensure urgent swallow assessments and, therefore, have 
lower rates of aspiration pneumonia (so a negative correlation). A plausible explanation for this 
unexpected result is that a hospital with more comprehensive coding practices is more likely to 
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record both the scanning procedure code and pneumonia diagnosis code compared to a hospital 
with less rigorous coding.  
5.6.8. Strengths of this study to other stroke measurement 
efforts 
In the NSSA, there is already a comprehensive tool for measuring hospital performance in stroke 
care. However, the underlying data are self-reported, and the NSSA’s two-year reporting cycle 
coupled with time-lag before publication prohibits its use as a real-time monitoring tool. A recent 
positive development has been the introduction of the Stroke Improvement National Audit 
Programme (SINAP) which collects real-time data on stroke patients albeit this only covers the first 
three days of care and does not include all hospitals. The relative advantages of using administrative 
data were established earlier (paragraph 2.2, p42), but recall that HES has the advantage of being: 
longitudinal; timely; covering all hospital admissions; and being relatively cheap, costing £1 per 
record to collect compared with around £10 - £60 per record for clinical registers.89 Whilst NCHOD 
have made use of some of the potential advantages of administrative data, in assessing a limited 
number of aspects of stroke care, their indicators are only updated annually and at the time of 
writing, hospital mortality from stroke was two years out of date.  
5.6.9. Criterion validity 
As well as these considerations on whether the indicators’ algorithms are functioning as intended, 
further assurance needs to be taken about whether the results of the indicators reflect actual 
performance. The most common process for validating the results is to compare against a gold 
standard. The most applied and comprehensive method for assessing hospital stroke care in England 
is the NSSA, which suggests it would be the most appropriate dataset to compare results based on 
administrative data. However, direct comparison with the published NSSA results is not easily 
achieved due to differences in definitions. In addition there is more statistical uncertainty associated 
with the NSSA clinical data, given that it is based on a small sample of around 60 patients per 
hospital.  
5.6.10. Conclusion 
This study shows that hospital administrative data have the potential for benchmarking the standard 
of hospitals performance over the acute stroke care pathway, in a timely way and without increasing 
the bureaucratic burden on hospitals. The additional analysis described in the discussion - on how 
scanning levels were dependent on patient characteristics - also support the argument that things 
could be improved.  
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Whilst neither the lack of credible gold standard nor evidence of bias from coding practice render 
the indicators redundant, it does temper the extent to which they could be used, such as for 
regulating hospitals. This study shows that HES provides the facility to record some key process and 
outcome measures across the care pathways in a cheap and timely manner. The chapter gives a 
comprehensive overview of feasibility and this should determine future application of these 
indicators. On the more sophisticated end of the scale, these results could be linked to structural 
measures, such as existence of specialist stroke units or a 24-hours service, to investigate their 
effectiveness (and also further evaluate the extent to which performance is amenable). With 
suitable modification and further development, these data could also be used routinely as part of 
the National Stroke Sentinel Audit and replace some aspects of the self-assessment. 
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Overview 
Context 
The literature review revealed that less than a third of studies on stroke care had used the 
longitudinal nature of administrative data. This chapter investigates potential longitudinal 
applications of indicators to address both the gaps in the literature and also to provide evidence on 
the whether performance is amenable to how services are structured.  
Methods 
Application of indicators covering the acute stroke care pathway to investigate changes in 
performance over time, at both a national and regional level. Where appropriate, results were 
adjusted for case-mix using logistic regression and significant changes in performance were 
identified using control charts. Specifically, interrupted time series analysis with a concurrent 
control group study design was used in the regional analysis to assess the impact of the Hyper 
Acute Stroke Units (HASUs) in London. 
Finding 
The longitudinal analyses highlighted improvements in performance and a seasonal effect for some 
measures. Compared with areas outside London, 7 day in-hospital deaths rate reduced significantly 
following the restructuring of services, as did aspiration pneumonia. However, same day brain 
scans showed a small but significant reduction following the intervention, as well as a slowing down 
in the rate of increase. 
What this chapter adds  
The first discussion of how using temporal analyses can overcome commonly cited concerns on the 
application of administrative data and can be used to evaluate the impact of healthcare initiatives. 
Acknowledgements and related papers 
I undertook the national longitudinal analysis. The regional study was led by Roxanna Alexandra 
with all authors (listed below) involved in the study design, analysis and manuscript revision of the 
regional analysis. 
Alexandrescu R, Lee JT, Bottle A, Palmer W, Aylin P. Effect of stroke services reorganisation in 
London: a controlled interrupted time-series analysis (submitted for publication).  
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6.1. Background 
6.1.1. National trends 
The review of stroke literature (Chapter 4) highlighted the unmet potential to use the longitudinal 
nature of administrative data to highlight potential quality and safety issues within stroke care. 
Measuring performance over time – rather than a snapshot cross-sectional analysis – might also 
mitigate against some of the hospital-level variations in unmeasured case-mix and coding practice. 
This was underlined by the hospital-level cross-sectional analysis (Chapter 5) which was found to be, 
at least in part, biased by variations in hospital-level coding practice. In England, previous studies 
have suggested that stroke care has improved but the trend in many aspects of stroke treatment 
and outcomes remains unclear.151,343   
6.1.2. Regional analysis 
Such trend analysis is particularly useful when evaluating any change in structure or process of a 
particular provider unit, such as the implementation of regional stroke units, and this is investigated 
by presenting results of the evaluation of a regional reconfiguration. Prior to 2010, provision of 
stroke care in London was complex, with only 53% of patients treated on a dedicated stroke ward 
and care spread across a number of units.344 To improve the quality of service, eight Hyper Acute 
Stroke Units (HASUs) were established in London from February 2010. The units, which are 
dedicated to treating stroke patients, are open 24 hours, seven days a week to offer immediate 
access to stroke investigations and imaging, including CT brain scan and clot-busting thrombolysis 
drugs. These units replaced the previous disparate services for acute stroke care. 
6.2. Objectives 
In this chapter I investigate the potential to use the longitudinal nature of administrative data to 
identify important shortcomings in quality and safety in a way that overcomes some of the known 
limitations to such indicators. The regional analysis was conducted as a case example to show that 
the indicators can be used to assess the impact of interventions, in this case the HASU policy in 
London, and in doing so show that quality and safety can be influenced by the way services are 
provided. This part of the study is not intended as a full evaluation of the HASU policy but to 
demonstrate the potential of the indicator set I developed. 
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6.3. Methods 
6.3.1. Indicators 
The indicators used for this part of the study are similar to those used in the previous chapter 
(paragraph 5.3.1.2, p118) and were identified in the literature review (Chapter 4). The only 
amendment made to these indicators, for the purpose of this weekend part of the study, was to use 
7-day rather than 30-day mortality. The indicators include both process and outcome measures: 
a) Receiving a brain scan on the day of admission; 
b) Receiving thrombolysis treatment; 
c) Diagnosed with aspiration pneumonia (complication) in hospital; 
d) 7-day in-hospital mortality; 
e) Discharge to usual place of residence within 56 days; and 
f) 30-day emergency readmission (all cause). 
6.3.2. Analysis 
6.3.2.1. Data extract 
For the national trends, the details of stroke admissions from 1 April 2007 to 31 December 2009 
were extracted from the Hospital Episode Statistics (HES) database. The indicator definitions were 
applied to the extract to obtain denominators and numerators, categorised for month of admission 
for stroke. For the regional analysis, data from 1 April 2006 to 31 March 2012 were extracted, to 
account for the differing demands on this analysis and the availability of additional data at the point 
that this analysis was conducted. 
6.3.2.2. Risk-adjustment 
Variables expected to influence the outcome of the association between the quality and safety 
indicators and day of admission were extracted: age; sex; socio-economic deprivation quintile; 
number of previous admissions; co-morbidities - Charlson index with weights derived from all 
England admissions;345 ethnic group; source of admission; and stroke type. The method for risk-
adjustment is covered in paragraph 3.6.2, p79. 
6.3.2.3. National data analysis 
National performance across the six measures was produced, disaggregated by month and, where 
appropriate, multiple linear regressions were used to adjust to the effect of the covariates.  Results 
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were also displayed by plotting – using April 2007 as a reference – odds ratios and 95% confidence 
intervals, by month of admission for stroke.  
6.3.2.4. Regional data analysis 
For the regional analysis, the quarterly unadjusted rates for the process and outcome indicator 
before and after the implementation of HASU policy were plotted. Using an interrupted time series 
(ITS) negative binomial regression model, the impact of HASU policy was assessed. While taking the 
underlying trend into account, this model estimates both the level and slope changes of the time 
trend after the policy change. A dummy variable (coded as 0 for the period before and 1 after 
implementation of the policy) and a continuous variable (set to 0 prior HASU policy, then equal to 
the length of time since HASU policy was implemented) were included. As we use quarterly data, the 
beginning of the reorganisation period is modelled as January instead of February (and ending in 
June). 
To remove potential effect of other national wide policies on our outcomes, a comparison group was 
included in the ITS model using data from rest of England. To do so, a dummy variable representing 
region (coded as 1 for London and 0 for other areas in England) was included, and the model was 
fitted with interaction terms between the dummy variable for region and post-intervention 
step/slope terms.346,347 As the model estimates the effect of HASU after adjusting for a concurrent 
comparison group, a negative/positive change in the step (or slope) will indicate a larger 
decrease/increase in the rates in the intervention group (London) compared with the control group 
(the rest of England). 
6.3.2.5. Software 
Statistical analyses were conducted using SAS version 9.2 software’s PROC GENMOD and PROC 
LOGISTIC procedure for regression analysis. 
6.4. Results 
6.4.1. National 
6.4.1.1. Overview of results 
The number of stroke admissions rose by 9.8% from 85,287 in 2007/08 to 93,621 in 2009/10 (Table 
27). Between these two years, there were reported improvements in scanning (from 29.2% in 
2007/08 to 46.5% in 2009/10), thrombolysis (0.3 to 2.6%), 30-day in-hospital mortality (20.1 to 
17.1%), and discharge to usual place of residence (68.7 to 72.6%). Conversely, reported performance 
Chapter 6: Stroke temporal trends 
141 
 
got worse for aspiration pneumonia (4.8 to 5.2%) and 30-day all-cause emergency readmissions (9.2 
to 11.05).  
Table 27: Annual trend in performance 
Label Indicator 2007/08 2008/09 2009/10 ^ 
  n = 85,287 n = 89,712 n =93,621 
a Same day scan 29.2 37.4 46.5 
a.1 By-next-day scan 50.4 60.0 68.7 
b Thrombolysis 0.3 1.1 2.6 
c Aspiration pneumonia 4.8 5.0 5.2 
d 30-day in-hospital mortality 20.1 18.8 17.1 
e Discharge to usual place of 
residence within 56 days 
68.7 70.2 72.6 
f 30-day emergency 
readmissions (all cause) 
9.2 10.6 11.0 
Note:  ^ Proportions for 2009/10 may differ slightly from those reported in the previous chapter, 
where the results were limited to only those patients admitted to recognised acute trusts. 
6.4.1.2. National longitudinal trends 
Disaggregating national performance by month suggests there are different types of longitudinal 
trends (Figure 13): 
1. Steady increases. There has been a steady, statistically significant increase in scanning rates 
(panel a) over time, which can be closely approximated by a linear regression (R-squared 
0.96, β = +0.06, p < 0.001). Similarly, thrombolysis rates have increased gradually over time 
(panel b).  
2. Overall trend with seasonal effect. Mortality rates have also improved over time (R-squared 
0.28, β = -0.006, p=0.002) but there is also evidence of a substantial seasonal effect (panel d) 
with rates highest around December. The pattern is similar for the rate of patients being 
discharged to usual place of residence (panel e) where there has been a general 
improvement with a seasonal increase around July. 
3. No clear trend. Figures for pneumonia (panel c) and readmission (panel f) rates showed only 
minimal seasonal or overall longitudinal trend. 
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Figure 13. Performance by month1 
 
a. Immediate scan (unadjusted) 
 
 b. Thrombolysis (unadjusted)2 
 
c. Pneumonia (adjusted) 
 
 d. Death within 30 days (adjusted) 
 
e. Discharge to usual place of residence (adjusted) 
 
 f. Readmission (adjusted)3 
 
Note:  1. Data points represent odds ratios, with April 2007 used as a reference (1.00); vertical ranges, 95% confidence intervals. 
 2. The low number/rate for the reference day on the Thrombolysis chart results in large OR for later months; this is discussed later  
 3. For the indicator of 30-day emergency readmissions, data for Jan-08 to Mar-08 has been removed due to data issues  
  
   
0
0.5
1
1.5
2
2.5
3
3.5
O
d
d
s 
ra
ti
o
 (
v.
 A
p
r-
0
7
 =
 1
)
0
10
20
30
40
50
60
70
80
90
100
O
d
d
s 
ra
ti
o
 (
v.
 A
p
r-
0
7
 =
 1
)
0
0.2
0.4
0.6
0.8
1
1.2
1.4
O
d
d
s 
ra
ti
o
 (
v.
 A
p
r-
0
7
 =
 1
)
0
0.2
0.4
0.6
0.8
1
1.2
1.4
O
d
d
s 
ra
ti
o
 (
v.
 A
p
r-
0
7
 =
 1
)
0
0.5
1
1.5
2
2.5
O
d
d
s
 r
a
ti
o
 (
v
. 
A
p
r-
0
7
 =
 1
)
0
0.2
0.4
0.6
0.8
1
1.2
1.4
O
d
d
s
 r
a
ti
o
 (
v.
 A
p
r-
0
7
 =
 1
)
Chapter 6: Stroke temporal trends 
143 
 
6.4.2. Regional trends 
The regional analysis included 536,034 stroke admissions in England over the 6-year period to March 
2012. Around one-in-nine (11.5%) of these admissions occurred in London. The average annual 
admission rate in London was 42,375 per year prior to the intervention. This admission rate 
increased slightly (by 4%) post intervention in London but remained static in the rest of England. The 
national rates are given in Table 28. Over the entire study period, London performed better than the 
rest of England on scanning, thrombolysis, and mortality rates, with the inverse true for pneumonia, 
discharge of usual place of residence, and emergency readmission rates.  
Table 28. Summary of differences in performance  
Indicator National London 
Rest of 
England 
Same day scanning 41.6% 49.3% 40.6% 
Thrombolysis 2.7% 3.6% 2.5% 
Aspiration pneumonia 5.2% 6.1% 5.1% 
7-day in-hospital 
mortality 
9.8% 8.0% 10.0% 
Discharge to usual place 
of residence within 56 
days 
71.9% 71.3% 72.0% 
30-day emergency 
readmissions 
10.7% 11.7% 10.5% 
 
Table 29 sets out the crude rates before and after the intervention for both London and the rest of 
England. In the these regions, there were improvements in scanning rates, thrombolysis, mortality 
and discharge destination. Conversely, readmission rates increased in both London and the rest of 
England. While crude rates of aspiration pneumonia decreased in London (6.3% to 5.6%) they 
increased elsewhere (4.9% to 5.4%). 
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Table 29. Crude rates before and after intervention 
 London, rate (number) Rest of England, rate (number) 
Indicator Before  After Before After 
 n = 37 051 n = 19 270 n = 289 491 n = 143 952 
Same day scanning 38.3% (14 194)  62.5% (12 047)  30.2% (87 533)  55.3% (79 644)  
Thrombolysis 0.7% (265)  4.9% (947)  0.5% (1 541)  3.3% (4 688)  
Aspiration pneumonia 6.3% (2 326)  5.6% (1 088)  4.9% (14 087)  5.4% (7 721)  
7-day in-hospital mortality 8.7% (3 235)  6.8% (1 311)  10.6% (30 792)  8.8% (12 702)  
Discharge to usual place of 
residence within 56 days 
55.9% (20 707)  59.9% (11 540)  53.3% (154 259)  60.2% (86 645)  
30-day emergency 
readmissions 
8.9% (3 282)  10.4% (2 006)  7.7% (22 176)  8.9% (12 827)  
Notes: ‘Before’ denotes April 2006 to December and ‘After’ denotes July 2010 to March 2012 
Table 30 shows the results of the interrupted time series analysis for London, relative to the rest of 
England. There was a significant step change fall in aspiration pneumonia (OR 0.81) and 7 day in-
hospital death (0.93). Same day brain scans appeared to decrease relative to England (0.91). There 
was a decrease in slope relative to the rest of England (0.95), however there was also a reduction in 
slope for same-day brain scans (0.98) and discharge to usual place of residence within 56 day (0.99). 
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Table 30. Time-Series regression analysis of stroke indicators in London relative to the rest of 
England  
 Step – change at time of 
intervention in London vs England 
excl. London 
 Slope – change for post 
intervention trend in London vs 
England excl.  London 
Indicator OR 95% CI p-value  OR 95% CI p-value 
Same day 
scanning  
0.91 (0.88-0.94) < 0.0001 
 
0.98 (0.97-0.99) < 0.0001 
Thrombolysis  1.11 (0.95-1.29) 0.182  0.98 (0.96-1.00) 0.091 
Aspiration 
pneumonia 
0.81 (0.74-0.87) < 0.0001 
 
0.95 (0.93-0.96) < 0.0001 
7-day in-hospital 
mortality 
0.93 (0.86-0.99) 0.035 
 
0.99 (0.97-1.00) 0.109 
Discharge to 
usual place of 
residence within 
56 days 
0.96 (0.93-0.99) 0.002 
 
0.99 (0.98-0.99) 0.001 
30-day 
emergency 
readmissions  
1.02 (0.96-1.09) 0.457 
 
1.01 (0.99-1.02) 0.157 
Note: Selected time periods based on pre-intervention trend linearity: Same-day brain scan (July2007-March 2012); 
Thrombolysis (October 2007-March 2012); Aspiration pneumonia (April 2007-March 2012); 7 day in-hospital death (April 
2007-March 2012); Discharge to usual place of residence 56 day (April 2008-March 2012); 30 day emergency readmissions 
(April 2007-March 2012). Transition period (January to June 2010) removed. 
6.5. Discussion 
6.5.1. Longitudinal  
The longitudinal analysis showed that administrative data could be used to identify potentially 
important trends in stroke care quality and safety. In particular, the analysis showed significant 
improvements over four of the six indicators. Interestingly, the analysis also showed a strong 
seasonal trend in stroke outcomes of death rates and proportion of stroke patients discharged to 
their usual place of residence. This is an area which, to date, has been poorly researched.  
A key strength of this on-going and longitudinal application of administrative data is that it is not be 
possible with the prominent existing tools for monitoring stroke care in England; the NSSA is 
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collected over a short period of time and the Stroke Improvement National Audit Programme 
(SINAP) only covers the urgent part of the care pathway. 
6.5.1. Regional analysis 
The results of the interrupted time series analysis are consistent with the expected effect if the 
reorganisation of stroke services had improved the quality of care in London. Importantly 7 day in-
hospital deaths showed a significant step reduction following the restructuring of services, as did 
aspiration pneumonia when compared to trends in the rest of England. Interestingly, same day brain 
scans showed a small but significant reduction compared with the rest of England following the 
intervention, as well as a slowing down in the rate of increase. This may be due to a possible ceiling 
effect, i.e., a limit beyond which any improvement is less likely to continue. In any case, London scan 
rates are consistently higher than the rest of England.  
The analysis supports the previously (paragraph 5.6.2, p130) made argument that performance 
against the stroke indicator set is amenable. A wider evaluation and discussion about the value of 
HASUs is beyond the scope of this project and, rather, this analysis was presented to support the 
evidence against the analytical framework item of ‘impact’. 
6.5.2. Limitations 
6.5.2.1. Changes in coding practice 
This application mitigates against the bias from variations in coding practice between hospitals, as 
even if there is evidence of a change in distribution of patients between hospitals over time then this 
clustering can be accounted for in such regression analyses. As discussed earlier, the level of 
thrombolysis coding might be expected to increase due to financial incentives attached with the 
recording of this treatment and, also, due to the low stating point because thrombolysis has only 
recently been licensed in England. 
6.5.2.2. Interpreting comparison over time 
The analysis also highlighted the potential issues with making comparisons over time. In particular, 
the choice of using the first month as the reference was unhelpful when interpreting the change in 
thrombolysis performance since this first month was an extreme performance and likely to be a 
consequence of a lack of incentive at the time to code thrombolysis correctly and the treatment not 
being formally approved. Indeed, the odds ratio are substantially different depending on what 
reference month is chosen; for example, with reference to April 2007 (month 1) the odds ratios for 
month 2 (May 2007) and month 33 (December 2009) are 2.109 (95% confidence interval 0.680 – 
6.539)  and 33.670 (12.458 – 91.004), whereas if April 2008 (month 13) is used as reference then the 
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estimated odds ratios are more precise: 0.114 (0.049 – 0.268) and 2.846 (2.027 – 3.994), 
respectively. 
The issues are not isolated to just thrombolysis nor national-level analysis. Statistical control charts 
are common techniques for monitoring performance in healthcare.348 Figure 14 shows performance 
for three anonymised hospitals (labelled Hospital A, B, C which are based on actual data from the 
study) against the same day scanning code. Taking the rule that a trend of six of more consecutive 
increases (or decreases) signifies unexpected variation349, then  Hospital A would be the only 
hospital identified as a potential ‘good performing’ outlier although would not necessarily be the 
obvious interpretation when comparing the trends and overall performance levels. The issue 
described is particularly problematic when changes in coding practice could mimic actual 
improvements (i.e. a hospital which is aiming to improve the recording of scans will automatically 
appear to be performing better).  
Figure 14. Example of hospital trends 
 
6.5.3. Conclusion 
This chapter show that it is possible to address some of the potential bias from case-mix and coding 
practice using longitudinal analyses; however, given the changes in coding practice over time which 
coincides with potential changes in service provision (and therefore hard to detect) this application 
is still susceptible to bias. The regional analysis had the advantage of providing evidence that some 
of the shortcomings in care are amenable to health care organisation.  
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Overview 
Context 
The literature review revealed that no study had comprehensively assessed weekend care. This 
chapter investigates potential temporal applications of indicators to address both the gaps in the 
literature and also overcome the shortcomings in validity relating to cross-sectional application of 
these indicators as identified in the previous chapter.  
Methods 
Application of indicators covering the acute stroke care pathway to investigate the association 
between day of admission and adverse events. Where appropriate, results were adjusted for case-
mix using logistic regression and significant changes in performance were identified using control 
charts.  
Finding 
The day-of-the-week analysis showed performance across five of the six measures was significantly 
lower at weekends at the 99.8% level. In particular, the rate of 7-day in-hospital mortality for 
Sunday admissions was 11.0% (adjusted odds ratio 1.26; 95% Confidence Interval 1.16 – 1.37 with 
Monday as reference) compared to an average of 8.9% for weekday admissions.  
What this chapter adds  
This chapter provides the most comprehensive evaluation of the “weekend effect” in stroke care. 
Acknowledgements and related papers 
Advice was provided by: Alex Bottle on statistical methods; and Charlie Davie on clinical implications. 
Palmer WL, Bottle A, Davie C, Vincent CA, Aylin P (2012) Dying for the weekend: the association 
between day of hospital presentation and the quality and safety of stroke care. Archives of 
Neurology. 69(10):1296-1302 
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7.1. Background 
7.1.1. Measuring the ‘weekend effect’ 
Further to using the longitudinal nature of administrative data, an alternative temporal approach 
which could mitigate some of the known coding issues is to evaluate the association between quality 
of care and day of admission. Previous studies, across a range of countries, have identified higher 
mortality in patients admitted on weekends across a range of medical conditions; a phenomenon 
termed the ‘weekend effect’.253,350-353 This calls into question the idea that quality of care is equal 
irrespective of when you present at hospital. Similarly, there have also been a limited number of 
international studies investigating the effect specifically in stroke care that have suggested poorer 
access to treatments and worse outcomes at weekends, including increased mortality and fewer 
patients returning to their usual place of residence.244,354-358 However, other studies have not 
identified a significant association between day of admission and stroke mortality rates.253,289,359,360 
Therefore, debate remains over the existence and extent of the weekend effect in stroke care. The 
studies on out-of-hours stroke care are limited in number and most of these fail to stand up to the 
criticism of primarily focusing on short-term mortality and therefore not capturing wider aspects of 
the quality and safety of care.361  
This chapter is unique in providing a comprehensive and current assessment of the degree to which 
quality and safety of stroke care is affected by whether a patient is admitted at the weekends, 
highlighting the potential for identifying clinically important issues using this readily available 
resource.  
7.2. Objectives 
In this chapter I investigate the potential to use the longitudinal nature of administrative data to 
identify important shortcomings in quality and safety in a way that overcomes some of the known 
limitations to such indicators.  
7.3. Methods 
7.3.1. Indicators 
The indicators used for this part of the study are similar to those used in the previous chapter 
(paragraph 5.3.1.2, p118) and were identified in the literature review (Chapter 4). The only 
amendment made to these indicators, for the purpose of this weekend part of the study, was to use 
7-day rather than 30-day mortality in keeping with the suggestion that it is a more appropriate 
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timeframe to evaluate the association between day of admission and mortality.354 The indicators 
include both process and outcome measures: 
a) Receiving a brain scan on the day of admission; 
b) Receiving thrombolysis treatment; 
c) Diagnosed with aspiration pneumonia (complication) in hospital; 
d) 30 (or 7)-day in-hospital mortality; 
e) Discharge to usual place of residence within 56 days; and 
f) 30-day emergency readmission (all cause). 
7.3.2. Weekend analysis 
7.3.2.1. Data extract 
For the weekend study, stroke admissions from 1 April 2009 to 31 March 2010 only were used. The 
indicator definitions were applied to the extract to obtain denominators and numerators, 
categorised for day of admission for stroke. The weekend was defined as the period from midnight 
on Friday to midnight on Sunday, with all other times defined as weekdays (the time of admission is 
not captured in HES).  
7.3.2.2. Data analysis 
Variables expected to influence the outcome of the association between the quality and safety 
indicators and day of admission were extracted: age; sex; socio-economic deprivation quintile; 
number of previous admissions; co-morbidities - Charlson index with weights derived from all 
England admissions;345 ethnic group; source of admission; and stroke type. Where only one figure is 
given, process measures were reported as unadjusted rates (paragraph 5.4.2.2, p122). The method 
for risk-adjustment is covered in paragraph 3.6.2, p79. 
Descriptive analysis of the patients, categorised by weekday or weekend admission for stroke were 
produced. Initially unadjusted (crude) rates for each of the six indicators were calculated for 
weekday and weekend admissions (these are plotted for the process measures: access to a scan and 
thrombolysis). Multiple logistic regression analyses were used to account for the covariates and 
estimate adjusted odds, across each indicator, for weekend compared with weekday admissions. 
Results were also displayed by plotting – using Monday as a reference – odds ratios and 95% 
confidence intervals, by day of the week of admission for stroke.  
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Analyses were carried out using SAS Version 9.2, using the PROC LOGISTIC procedure for regression 
analyses. I did not adjust for the clustering of patients within hospital as the hospital-level effects 
were found to be small. 
7.3.2.3. Estimating impact 
Using regression analysis on just weekday admissions, probabilities of in-hospital death and 
discharge to usual place of residence for different patient characteristics were derived. By matching 
these probabilities for each weekday admission, based on the patient’s characteristics, indirectly 
standardised estimates for the outcomes as if those weekend patients had had similar rates as their 
weekday counterparts were calculated, with these particular results reported in the discussion.  
7.3.2.4. Consultant specialty 
To investigate one of the possible organisational factors that could cause variations in the 
performance against the process and outcome measures, an additional indicator – specialty of 
responsible consultant – as a proxy for whether a patient is admitted to a designated stroke unit was 
calculated.  
7.4. Results 
7.4.1.1. Descriptive overview 
Across English NHS hospitals, I identified 93 621 stroke admissions in the period April 2009 to March 
2010. Of these, 8 722 (9.3%) died in-hospital within 7 days of admission and 16 013 (17.1%) died 
within 30 days. Of those patients meeting the inclusion criteria for each indicator, 46.5% were 
scanned on the day of admission, 2.6% received thrombolysis, 5.2% had aspiration pneumonia, 
72.6% were discharged to their normal place of residence, and 11.0% were readmitted within 30 
days of discharge. 
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Of the stroke admissions, 24.9% (23 297) were admitted at weekends. The number of stroke 
patients admitted declined throughout the week from 15.6% on Monday to 12.4% on Sunday (Figure 
15).  
Figure 15. Number of stroke admissions, by day of presentation 
 
 
Table 31 gives a description of the characteristics of the patients included in the study.  
Table 31. Characteristics of the study population 
 Weekday Weekend  
Characteristic % of admissions (number of cases) p-value 
Age of admission in years (s.d) 73.8 (14.8) 74.5 (14.6) 0.048 
Sex < 0.001 
Male 48.5 (34 096) 47.2 (10 990)  
Female 51.5 (36 228) 52.8 (12 307)  
Index of multiple deprivation quintile 0.983 
1 least deprived 16.8 (11 836) 16.9 (3 947)  
2 20.6 (14 507) 20.7 (4 817)  
3 21.4 (15 048) 21.3 (4 958)  
4 20.9 (14 706) 21.1 (4 903)  
5 most deprived 19.4 (13 668) 19.3 (4 491)  
6 unclassified 0.8 (559) 0.8 (181)  
Charlson index of comorbidity 0.100 
0 no comorbidity 45.6 (32 034) 45.4 (10 573)  
1-4* 13.8 (9 715) 14.0 (3 256)  
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5-9* 8.6 (6 050) 8.6 (1 991)  
10-14* 18.7 (13 138) 18.8 (4 385)  
15-24* 9.4 (6 629) 9.3 (2 168)  
25-50 highest comorbidity* 3.9 (2 758) 3.9 (924)  
Number of admissions in previous 12 months 0.157 
0 69.6 (48 960) 70.1 (16 327)  
1 19.3 (13 586) 19.3 (4 484)  
2 6.6 (4 650) 6.2 (1 444)  
3 4.5 (3 128) 4.5 (1 042)  
Source of admission < 0.001 
Admitted from home* 89.2 (62 755) 89.9 (20 939)  
Hospital Transfer* 9.7 (6 799) 9.1 (2 115)  
Other or Unknown* 1.1 (770) 1.0 (243)  
Emergency  0.001 
non-emergency admission 5.6 (3 925) 2.77 (645)  
emergency admission 94.4 (66 399) 97.2 (22 652)  
Stroke Diagnosis   0.038 
I60 5.1 (3 570) 5.0 (1 175)  
I61 11.2 (7 864) 11.8 (2 738)  
I62 6.2 (4 376) 5.8 (1 352)  
I63 58.6 (41 188) 58.5 (13 628)  
I64 19.0 (13 326) 18.9 (4 404)  
Total 75.1 (70324) 24.9 (23297)  
Notes:  χ2 test for association, p<0.001  
* grouped for purposes of this table 
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7.4.1.2. Association between admission at weekends and performance 
 
Table 32 shows the results of the association between weekday/weekend admission and 
performance in the six measures of quality and safety. There were statistically significant 
associations in five of the indicators (the exception being readmissions), all of which were consistent 
with a lower standard of care at weekends. The largest effects were seen in the lower rates of same-
day scanning (unadjusted odds ratio [OR] 0.83; 95% Confidence Interval 0.81 – 0.86), thrombolysis 
(unadjusted OR 0.82; 0.73 – 0.92) and higher rates of in-hospital mortality (adjusted OR 1.18; 1.12 – 
1.24) for weekend strokes.  
Table 32. Association between weekday/weekend admission and indicators of quality and safety 
of care 
Notes:  
^ For Unadjusted rates. The p-value and OR for the other measures are for adjusted rates 
CI denotes conﬁdence interval.  
 Weekday admission Weekend admission   
Indicator Unadjusted   
% (number) 
Adjusted 
rate, % 
Unadjusted % 
(number) 
Adjusted 
rate, % 
p-value OR (95% CI) (weekday 
as reference) 
Same day scanning  47.6 (32521) 47.8 43.1 (9778) 42.6 <0.0001^ 0.833 (0.808 – 0.858)^ 
Thrombolysis  2.69 (1152) 2.70 2.27 (313) 2.23 0.001^ 0.819 (0.730 – 0.919)^ 
Aspiration pneumonia 5.04 (3545) 5.08 5.70 (1329) 5.57 0.003 1.105 (1.035 – 1.180) 
7-day in-hospital 
mortality 
8.89 (6250) 8.98 10.61 (2472) 10.30 <0.0001 1.178 (1.120 – 1.240) 
Discharge to usual 
place of residence 
within 56 days 
73.0 (40692) 72.9 71.3 (12746) 71.3 <0.0001 0.918 (0.883 – 0.954) 
30-day emergency 
readmissions within  
11.1 (6165) 11.1 11.0 (1971) 11.0 0.801 0.993 (0.940 – 1.049) 
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7.4.1.3. Association between day of admission and performance 
Figure 16 shows the odds ratios by day of admission, with Monday as a reference, for the six 
indicators. For the measure of same-day scanning, the highest performing day was Friday with 49.8% 
of patients accessing a scan (unadjusted OR 1.16; 1.11 – 1.22 with Monday as the reference) 
whereas Sunday had the lowest rate at 42.0% (unadjusted OR 0.80; 0.88 – 0.97). For thrombolysis, 
the best performing day was Wednesday when 2.9% of stroke patients received the treatment 
(unadjusted OR 1.16; 0.98 – 1.37) with Sunday the worst at 2.2% (unadjusted OR 0.82; 0.68 – 0.99), 
however this latter result is no longer statistically significant when adjusting for case mix (adjusted 
OR 0.84; 0.70 – 1.02).  
Rates of aspiration pneumonia were higher on Saturdays and Sundays (both 5.7%) than the Monday 
reference (5.0%); however this was not significant at the 5% level with p-values of 0.12 and 0.05 
respectively.  The highest rate of 7-day in-hospital mortality was for patients admitted for stroke on 
Sundays (adjusted OR 1.26; 1.16 – 1.37) at 11.0% compared with an average for weekday admissions 
of 8.9%. Both Saturday (adjusted OR 0.93; 0.87 – 0.99) and Sunday (adjusted OR 0.93; 0.87 – 0.99) 
had lower rates of discharge to usual place of residence within 56 days at 71.4% and 71.2% 
respectively, with an average for weekday admission of 73.0%. The association between day of 
admission and emergency readmission rates were not significant (p-value 0.60). 
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Figure 16. Performance by day of admission 
a. Immediate scan (unadjusted) 
 
 b. Thrombolysis (unadjusted) 
 
c. Pneumonia (adjusted) 
 
 d. Death within 7 days (adjusted) 
 
e. Discharge to usual place (adjusted) 
 
 f. Readmission (adjusted) 
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7.4.1.4. Age stratified results 
There was also some evidence that the weekend effect might be more pronounced for certain 
patient groups, with a more prominent effect on 7-day in-hospital mortality for patients aged 0 to 44 
(adjusted OR 1.61; 1.23 – 2.12) than for patients aged 85 and over (1.13; 1.03 – 1.23) (Table 33).  
Table 33. The variation in ‘weekend effect’ across different age groups, for 7-day in-hospital 
mortality 
 Weekday  Weekend  Odds ratio v. weekday rate, 
adjusted (95% CI) Age group unadjusted rate, % (admissions) 
0 to 44 5.40 (3 221) 8.82 (986) 1.612 (1.225 – 2.123) 
45 to 54 6.17 (4 523) 9.26 (1 414) 1.463 (1.170 – 1.829) 
55 to 64 6.47 (8 344) 7.36 (2 527) 1.097 (0.918 – 1.311) 
65 to 74 7.25 (14 075) 8.30 (4 565) 1.111 (0.978 – 1.261) 
75 to 84 9.25 (22 809) 10.89 (7 660) 1.209 (1.108 – 1.320) 
Over 85 12.26 (17 352) 13.91 (6 145) 1.128 (1.033 – 1.232) 
Notes: CI denotes conﬁdence interval. 
7.4.1.5. Association between consultant specialty and performance 
The most common specialty of consultants responsible for the first episode of care in hospital 
following a patient’s stroke was ‘general medicine’ (48.1%) followed by ‘geriatric medicine’ (26.3%). 
Table 34 sets out the difference in specialty of responsible consultants between weekday and 
weekend strokes, with the latter slightly more likely to be under the responsibility of a general medic 
or neurosurgeon, and less likely under geriatric medics. Aggregating the specialties into two groups 
showed that weekend strokes are less likely to be initially under the responsibility of neuro- or 
geriatric specialists (33.0% with general medics, A&E medics and other specialties accounting to 
67.0%) compared to weekday admissions (33.6%), although this was not statistically significant at 
the 95% confidence level (p-value 0.06). 
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Table 34. The specialty of the first responsible consultant after onset of stroke 
Specialty Weekday, % 
(admissions) 
Weekend, % 
(admissions) 
Total, % 
(admissions) 
Neurology 2.89 (2 034) 2.70 (629) 2.84 (2 663) 
Neurosurgery 4.31 (3 029) 4.42 (1 029) 4.33 (4 058) 
Geriatric medicine 26.42 (18 583) 25.85 (6 022) 26.28 (24 605) 
Accident and Emergency 3.06 (2 151) 3.36 (782) 3.13 (2 933) 
General medicine 47.99 (33 749) 48.41 (11 277) 48.09 (45 026) 
Other 15.33 (10 778) 15.27 (3 558) 15.31 (14 336) 
 
7.5. Discussion 
7.5.1.1. Summary of findings 
We examined more than 90 000 patients admitted for stroke in England across a one-year period. 
The study demonstrated that patients admitted for stroke at the weekend have an increased risk of 
dying in hospital within the first 7 days. Moreover, the study also suggests that weekend care was 
different in terms of both access to treatments – with lower rates of urgent brain scans and 
thrombolysis – and wider outcome measures. Even after adjusting for various measures of case mix, 
weekend stroke admissions had higher rates of in-hospital complications (aspiration pneumonia) 
and a lower proportion of patients being discharged to their usual place of residence within 56 days. 
7.5.1.2. Impact: magnitude of weekend effect 
I calculated, as described in the methods section, that there are some 350 potentially avoidable in-
hospital deaths within 7 days and an additional 650 people could be discharged to their usual place 
of residence within 56 days if the performance seen at weekdays was replicated at weekends.  
There are also reasons to suggest that the inequality of care is more pronounced than identified in 
this study. If the effect is indeed caused by a staff deficiency and a lack of resources, then you would 
expect poorer quality and safety at all out-of-hours periods during the week, including bank holidays 
and weekday evenings and nights. A Dutch study, for instance, found stroke mortality rates were 
higher, in comparison with the Monday day shift, during Sunday and Monday evening shifts and 
during all night shifts.354 If this is the case, then the out-of-hours periods during weekdays are 
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masking some of effect. Our analysis was limited to out-of-hours days, since there is not a time 
stamp within the data.  
7.5.1.3. Amenable: association with resource levels 
There are several possible explanations for these findings, including: fewer clinical staff working in 
hospitals on weekends, with those who do work often having less experience and lower familiarity 
with the patients;253,244 and less accessibility of resources,351 such as radiologists to operate the 
scanners. This study provided some evidence to support the theory that one of the contributing 
factors to the ‘weekend effect’ might be a decreased proportion of stroke patients being admitted 
under the responsibility of stroke specialists at weekends. However, as ‘stroke’ is not a category of 
consultant specialty under the coding framework, the study had to define stroke-specialists as 
geriatricians, neurologists and neurosurgeons, as opposed to general medics, A&E consultants and 
other specialties.  The association between consultant specialty and day of admission also provides 
some evidence that the ‘weekend effect’ is amenable to the provision of healthcare. To some extent, 
this finding is support by previous suggesting that stroke patients cared for by neurologists have 
better outcomes than those treated by other specialties.217   
7.5.1.1. Amenable: experience of addressing the weekend effect 
More work is required to identify the cause of this ‘weekend effect’. However, looking at 
international experience provides evidence for optimism. Stroke care in Sweden in 1990-95 had 
similar levels of disparity to the current situation England with adjusted weekend/weekday odds 
ratios of 7-day in-hospital mortality of 1.14 (95% Confidence Interval 1.09 – 1.20) yet they managed 
to decrease the variation to 1.07 (1.01 – 1.14).358 The study also identified increases over this period 
in the proportion of patients discharged to their usual place of residence within 56 days.358 
7.5.1.1. Amenable: reorganising stroke services 
Furthermore, solutions have been proposed to address the ‘weekend effect’. For instance, 
maintaining a more consistent level of activity – even if this requires hospital staff to be paid at 
higher levels during weekends – is sometimes economical.351 Previous studies have also 
demonstrated that it is possible to provide equal access to thrombolysis at weekends and that the 
use of comprehensive stroke centres and participation in stroke clinical improvement programmes 
can ameliorate the problem.356,359,360 In particular, regional reconfigurations represent a promising 
strategy for providing consistent levels of access to stroke care.  
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7.5.1.2. Precision 
The indicators identified a wide range of performance, by day of admission, with statistically 
significant differences in five of the six indicators. 
7.5.1.3. Minimum bias 
HES data do not include information on the time of admission and therefore I was not able to 
investigate the wider issue of the quality of out-of-hours care in this study. Other limitations should 
also be noted. Firstly, the administrative database used gives only limited information on the 
severity of stroke, which has been suggested to be conceivably higher at weekends.362,363 Whilst I 
used a number of variables, such as Charlson index and number of previous admissions, to mitigate 
for any bias in case mix between admissions on different days of the week, there is no information 
on, for example, patients’ level of consciousness. A further limitation is that the administrative data 
can contain errors; however, you would not expect this to be different in the coding of weekday or 
weekend admissions.  
I stratified one of the key results – in-hospital mortality – by age group to further investigate 
potential bias. Chances of death were higher for each of the six age groups for weekend admissions, 
which again provides some assurance that the results are not an artefact of bias. However, as 
outlined at the start of the results section, there are differing numbers of stroke patients on each 
day of the week which could suggest differences in average case-mix; if differences in severity are 
not recorded in the data then there is a risk of bias. 
7.5.1.4. Construct validity 
Five of the six indicators identified evidence of the weekend effect, and further analyses revealed 
lower level of specialist staffing at weekends, which provides evidence of construct validity. 
However, in lieu of having multiple comparable units – as with the cross-sectional analysis in the 
previous chapter – I have provided some assurance on validity by comparing consistency with 
previous literature. 
The results are consistent with previous findings on the limited availability of stroke services at 
weekends in England, and that this is indeed reflected in lower levels of access. An audit of hospital 
care in 2010 highlighted that nursing practice was presumably leaving many patients in bed over a 
weekend which may be highly undesirable, including increasing the risk of venous thrombosis (blood 
clots). Furthermore, the same audit found that 43% of sites that provided thrombolysis services, 
either on or off site, were not able to provide the service 24/7.343 Similarly, a national study reported 
that despite improvements in access to urgent brain scanning, rates at weekends and evenings 
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remains significantly more limited.151 A study by Rudd and colleagues also found that patients were 
less likely to be admitted directly to a stroke unit (OR 0.77; 95% Confidence Interval 0.69-0.86) at 
weekends.364 Further to these findings on urgent stroke treatments, a recent report found that 
pathways allowing fast track transfer out of hospital covered only 59% of areas at weekends, 
compared to 75% at other times.365  
The findings are also consistent with some studies from other countries, including the surprising 
difference in the number of stroke admissions falling from Monday to Sunday, which in fact tallies 
with the results from a population based register of stroke incidence in Finland.366 A Swedish report 
also highlighted a lower proportion of patients admitted at weekends being discharged to their usual 
place of residence within 56 days (OR 0.96; 0.93 -  0.99).358 Similarly the rate of ischaemic stroke 
patients in a US study receiving screening for dysphagia (which could prevent aspiration pneumonia) 
falling from 6.1% on weekdays to 5.5% at weekends.356 The ‘weekend effect’ for 7-day in-hospital 
mortality (adjusted OR 1.18; 1.12 – 1.24) is also not dissimilar to studies from other countries, such 
as Sweden (1.07; 1.01 to 1.14), USA (1.14; 1.05 – 1.25), and Canada (1.14; 1.02 – 1.26).244,355,358 
7.5.1. Conclusion 
Further work is needed to understand what organisational factors might influence the ‘weekend 
effect’ and to investigate centres that have reduced the disparities in access and outcome in out-of-
hours care. A starting point for this is to allow hospitals to compare the extent of the ‘weekend 
effect’ in their organisation to that in their peers, as exemplified in Figure 17.  
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Figure 17. Hospital-level standardised mortality ratio, for deaths within 7 days of admission on a 
weekend in 2009/10 
 
Note: Each dot represents a hospital. The horizontal line refers to national average; short-gauge dotted line refers to 
p<0.025 significance level; long-gauge dotted line refers to p<0.001 significance level. 
There is also scope to extend this analysis to other specialties, with similar results having also been 
found in a limited number of other clinical areas, such as pulmonary embolism, hip fractures and 
upper gastro-intestinal haemorrhage.354 A greater understanding of the issue will also require better 
data, and the inclusion of an out-of-hours admission flag for hospital administrative data should be 
considered. 
The analysis by day of week addresses most of the coding and risk-adjustment issues raised in the 
previous chapters and, therefore, permits more robust conclusions in what is, coincidentally, a very 
high impact area. 
 
0
50
100
150
200
250
300
0 5 10 15 20 25 30 35 40 45 50
Expected number of deaths
S
ta
n
d
a
rd
is
e
d
 m
o
rt
a
li
ty
 r
a
ti
o
 164 
 
Part Three:  
Obstetrics care 
 
Chapter 8: Obstetrics literature review 
165 
 
Chapter 8.  
Obstetrics literature 
review 
 
 
 
 
 
 
 
 
 
 
 
  
 
Current 
measurement 
Case for 
specialty-
specific use 
Stroke 
 
Review of 
current 
indicators 
 
Obstetrics 
Stroke 
 
Application: 
validating 
common uses 
 
Obstetrics 
Stroke 
 
Application: 
temporal 
analyses 
 
Obstetrics 
Discussion 
PART III: Obstetrics Care 
166 
 
Overview 
Context 
The previous three chapters have shown that there is the potential to improve the application of 
stroke care indicators and, in doing so, to make meaningful inferences about quality and safety. This 
chapter – the first of three to focus on acute obstetric care – looks at how administrative data have 
been used to evaluate perinatal care – a very distinct area of hospital care to stroke treatment – and 
sets out how the indicators have been applied and validated to date.  
Methods 
A systematic review of original studies that applied, evaluated or validated obstetric-specific 
indicators based on administrative data. Indicator and study details were collated. 
Findings 
The initial search identified 1,670 unique citations of which 80 studies had used administrative data 
to evaluate perinatal care. There has been a steady growth in the use of such indicators; however, 
few studies have described the strategy used for identifying perinatal episodes from the data and 
there is a lack of consistency in the use of risk-adjustment of validation techniques. Many countries 
have used obstetrics-specific indicators although each study has only focused on a very small subset 
of measures. There is potential to make more meaningful inferences about the quality and safety of 
acute obstetric care by applying a more comprehensive set of indicators and being more explicit 
about the assumptions used. 
What this chapter adds  
The first review on obstetrics care focusing on: the use of administrative data; how these indicators 
have been used; and, importantly, how they have been applied and validated. 
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8.1. Background 
8.1.1. Background on obstetrics 
8.1.1.1. About obstetrics 
Obstetrics, from obstare the Latin word for “to stand by”, is the specialty dealing with care of all 
women and their children during pregnancy, child birth and postnatal period. The delivery of 
obstetric care varies considerably from one nation to another; however, Figure 18 outlines key 
stages. Obstetrics care is delivered by a range of different healthcare professionals from country-to-
country and may include hospital physicians and surgeons, community/family doctors, nurses, 
healthcare assistants or midwives.  
Figure 18. Overview of the obstetric care pathway 
 
8.1.2. Importance 
8.1.2.1. Impact: global burden 
Globally, there has been a general trend in improvement in obstetric outcomes with an average 
annual decline of maternal mortality (3.1%) and neonatal mortality (1.6%) in the 20 years from 
1990.1 However, annual mortality rates remain at colossal levels, with at least: 3 million stillborn 
babies, 4 million neonatal deaths and half a million maternal deaths. Moreover, it has been 
suggested that the majority of these deaths are avoidable. 367 Whilst poor outcomes are more 
prevalent in developing countries, it is far from limited to these nations. A study from the USA, 
published in 1992, found that 8% of the mothers or infants had serious complications in pregnancy, 
with twice this number being transferred for a higher-level of care either during or after delivery.368  
8.1.2.2. Impact: increasing risk 
In these developed countries, in particular, there have been changes in the burden of obstetrics care 
with increasing numbers and complexity of deliveries. For instance, in England and Wales, overall 
fertility rates (which account for changes in over population numbers) increased by 21.5% in the 
decade to 2011 and by around 50% for women aged over 30.369  
Antenatal 
- regular medical care during 
pregnancy, e.g. maternal health 
checks 
Perinatal 
- management and 
delivery of care to 
women in labour 
Postnatal  
- care women and babies 
receive in the first 6 - 8 
weeks after birth 
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8.1.2.3. Amenable to healthcare 
There is good evidence to suggest that obstetrics outcomes can be improved through delivering 
better healthcare. For instance, one study found that problems of quality of care are the main cause 
of obstetric readmissions,370 while another study showed that continuous improvement efforts have 
shown to be effective for obstetric care in the UK. 64 
8.1.3. Obstetrics measurement 
8.1.3.1. Demand for indicators 
A Cochrane review on maternal mortality and morbidity, which did not identify any RCTs on critical 
incident audit in any of the forty years preceding its publication, concluded that there is an essential 
need for feedback, directed to the relevant person.371 In England, a national audit report recently 
concluded that the Department has only limited assurance on the performance of maternity services 
due to a lack of comprehensive data on key outcomes and activity. The report recommended that a 
framework for gaining assurance should be developed.152  
8.1.3.2. Existing measures 
The measurement of maternity outcomes is not new. For instance, in the UK, the current 
Confidential Enquiry into Maternal and Child Health can be traced to 1952, just four years after the 
inception of the NHS.372 A number of different methods have been introduced and, in 2006, Simpson 
and colleagues wrote a review of current methods for measuring perinatal patient safety. While 
flawed – for instance, there was no indication of how these current methods were identified – the 
paper does usefully set out the range of measurement techniques used to date, such as: safety 
attitude and climate surveys, focus groups, storytelling, executive walk rounds, and external 
review.373  
Indeed there are many existing quality measures of obstetrics. A recent review of guidance from the 
RCOG found 290 quality indicators covering 96 clinical categories, with a range of different 
definitions for each category.374 This exercise yielded a large number than a rapid literature review 
of the indicators on processes and outcomes of maternity services in Europe, Australia, New Zealand 
and the USA which identified 194 different indicators from 30 sources.375 
8.1.3.3. Using administrative data 
In their review, Simpson et al suggest that the use of inexpensive, readily available administrative 
data to identify shortcomings in safety may provide a useful tool for identifying issues and 
monitoring trends in perinatal care and, went further by saying, “an on-going quality improvement 
program based on analysis of data from selected PSIs is essential”. 373 Yet, in the UK, there seems to 
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be little use of such indicators; of the 50 indicators relating to childbirth5 identified from the NHS 
indicator portal,245 none appear to use routinely collected hospital data as source.  Results have 
been presented on a range using, for instance, radar plots and CUSUM charts to monitor 
obstetrician’s performance. 376-378 
8.2. Objectives 
To produce a comprehensive list of indicators of the quality and safety of perinatal care that can be 
based on administrative hospital data, and provide a critical assessment of how these have been 
applied previously. This latter objective is designed to inform the quantitative analyses presented in 
the following two chapters. 
8.3. Methods 
8.3.1. Search resources and validation 
An outline of the systematic methodology was given in a previous chapter (paragraphs 3.4.2 - 3.4.3, 
p72). The method used to search for peer-reviewed journal articles and other research is described 
earlier (paragraph 3.4.4, p74). An initial search of the databases – designed to identify peer-
reviewed journal articles – was performed in June and July 2012, with a further search in February 
2013. 
8.3.2. Definitions 
8.3.2.1. Definition for administrative data 
Recall from paragraph 2.1.1.1 that ‘administrative data’ are defined, for the purpose of this review 
and to meet the ambition of the study, using the inclusion criteria: routinely collected data covering 
more than one hospital; used for administrative purposes (e.g. for reimbursement); and can be 
replicated using the internationally-recognised ICD9 or ICD10 diagnoses coding framework. 
As a principle, where a study was based on administrative data linked to another supplementary 
source, the individual measures described in the paper were reviewed to assess whether they could 
be replicated with administrative data alone. This ensured that no potentially beneficial indicator 
was excluded and that validation studies where results from administrative data are compared to an 
augmented or different dataset were included.  
                                                          
5
 Searched using the string: neonatal OR birth OR matern* 
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Studies based on registers of births and/or deaths without linkage to hospital episode data (such as 
diagnoses and procedures) were excluded.  
8.3.2.1. Definition of quality and safety  
As discussed earlier (paragraph 1.1.4), providing an exact definition of quality and safety is also 
difficult and its application for the purpose of this review on obstetric care is again best defined by 
the treatment of contentious indicators: 
 Length of stay is included. There is an argument that length of stay is a poor measure of 
quality and safety: one study used length of stay instead as a measure of efficiency 379, 
another found that it is not be statistically correlated with satisfaction380 and Oberer and 
Auckerman found that it is not inversely correlated with readmission rates.381 However, 
some variations – such as a dichotomous indicator of long length of stay – are more likely to 
be considered a proxy for aspects of quality.  
 Emergency caesarean section rates are included, although they could be considered either a 
process measure (as caesarean section is an intervention initiated by a clinician) or an 
outcome of the care received earlier in labour (for example, emergency caesarean section 
following induced labour). 375 
 Hospital charges is not considered as a quality indicator since this is a compound measure of 
patient characteristics, length of stay, and treatments provided – which can be picked up as 
separate indicators and risk adjustments – and is probably more obviously interpreted as a 
measure of hospital efficiency. 
 Clinically associated complications of childbirth that are not amenable to healthcare – such 
as congenital malformations – are not included. 
 Elective caesarean section (CS) rates are excluded as this is not related to a decision or 
intervention during the delivery admission. 382 
8.3.2.2. Limitation to delivery admission 
During the research it became evident that clinical care for the antenatal and postnatal aspects of 
the pathway have few agreed indicators of quality that can be applied to administrative data – due 
to limitations in the coding frameworks and relative lack of clinical guidelines – and clinical care 
provided is poorly recorded within English HES data. As a result, the obstetrics chapters focus on the 
delivery admission (or equivalent for home births) within the perinatal (intra-partum) stage. 
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Restricting the research to this aspect of the pathway does not affect the ability to meet the 
objectives of the project and, as well as being pragmatic, is grounded in evidence on:  
- the influence of this aspect of the pathway on outcomes – an Italian review of neonatal 
deaths found that the great majority of deaths (87%) were due to perinatal causes;383 and 
- activity and outcomes in perinatal care are less likely to be influenced by culturally-driven 
differences in decision making, which are likely to be more significant in ante- and post-natal 
care such as access to antenatal care. 
8.3.3. Search strategy 
8.3.3.1. Electronic databases 
The literature review was primarily based on searching the following databases: 
- Ovid MEDLINE(R) In-Process & Other Non-Indexed Citations and Ovid MEDLINE(R) 1946 to 
Present 
- Ovid Embase Classic+Embase 1947 to 2013 February 15 
- Web of Science (to present) 
8.3.4. Search terms 
The search strategy was informed by previous literature reviews relating to obstetric indicators. 384-
386 The first stage was to identify text words, synonyms and index terms for the studies on obstetrics 
care that applied, evaluated or validated quality and safety indicators based on routinely-collected 
administrative data. The synonyms were identified using the existing literature and MESH entry 
terms, a process suggested by the Cochrane review organisation (Table 35).387 
Table 35. Search terms 
Key text words Obstetrics 
 
Quality Indicators 
Medline index terms 
(MESH) 
Delivery, Obstetric/ 
Parturition/ 
Quality Indicators, Health Care/ 
Embase index terms 
(EMTREE) 
Birth/ 
Delivery / 
Health care quality/ 
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Key text words Obstetrics 
 
Quality Indicators 
Synonyms for the text 
words (from MESH 
entry terms) 
 
Parturition* 
Birth* 
Childbirth* 
Obstetric* 
Deliver* 
 
Quality indicator* 
Other synonyms Labour 
 
Quality: quality; safe*; performance; medical 
error*; iatrogenic*; nosocomial*; adverse event*; 
sentinel event*; harm* 
Indicators: administrative data; routine data; 
routinely collected data; claims data; 
international classification of diseases; 
international statistical classification of diseases; 
ICD* 
Other spelling Labor International Classification of Diseases 
 
The databases were interrogated using a two-dimensional search string using the ‘AND’ conjunction 
to identify papers relating to obstetric care which mention either a quality indicator or routine data. 
Medline, Embase and Web of Science were interrogated using the search string outlined in Figure 19 
which was customised to the specific requirements of the search engines, searching the title, 
keywords, and abstract. Embase and Medline were also searched using indexing terms (EMTREE and 
MESH). For completeness non-English articles were included in the review.  
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Figure 19. Search strategy  
Birth terms:  
parturition* OR birth* OR childbirth* OR obstetric* 
OR [  (deliver* OR labo?r*) AND (bab* OR mother* OR matern* OR neonat*)  ] 
Quality indicators: 
[ (quality OR safe* OR performance OR medical error* OR iatrogenic* OR nosocomial* OR 
adverse event* OR sentinel event* OR harm*) AND (administrative data OR routine data OR 
routinely collected data OR claims data OR international classification of diseases OR 
international statistical classification of diseases OR ICD-6* or ICD6* or ICD-7* or ICD7* or 
ICD-8* or ICD8* or ICD-9* or ICD9* or ICD-10* or ICD10*) ] 
OR [ quality indicator* OR safety indicator* ] 
8.3.4.1. Duplicates 
Duplicates citations were identified using Endnote reference management software by identifying 
entries with identical authors, date, journal, and title. 
8.3.5. Review process 
8.3.5.1. First stage: Inclusion and exclusion criteria for review of indicator 
use 
Recall that literature on quality and safety measures were collated if both: (1) based on routinely 
collected hospital administrative data; and (2) applied, evaluated or validated a potential or actual 
indicator of the quality or safety of hospital obstetric care. To meet this latter criterion, an included 
study had to provide numerical results on performance against the indicator. 
Specifically, as a first stage, abstracts were reviewed and candidate papers were excluded if:  
 None of the described indicators related to an perinatal care; 
 None of the described indicators explicitly relate to the quality and safety of health care 
provided, such as measures of cost. As a result, readmission following birth is included but 
neither number of birth episodes nor those complications of births not associated with 
quality are included; 
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 The study was not based on routinely-collected hospital administrative data (as defined 
above); and 
 The assessment of face validity of indicators which did not involve applying the algorithms to 
actual data did not meet the inclusion criteria.388   
Where there was insufficient detail in the abstracts to ascertain whether the criteria above were 
met, the study was included in the second stage (full text) review. 
8.3.5.2. First stage: Inclusion of additional papers describing indicators 
I also separately collated studies which described indicators that could be applied to administrative 
data but no actual database was used (and so failing the first stage criteria to provide numerical 
results) to ensure a well-defined comprehensive list of indicators. A key example of this is Dr Foster 
Intelligence’s consultation on obstetric measures (blood transfusion post-delivery rate; elective, 
emergency and total caesarean section rate; instrumental deliveries rate; maternal length of stay of 
2 or 4 nights following normal or instrumental delivery) which described the indicators but did not 
give results on their application.389 
8.3.5.3. Second stage review criteria 
For the second stage, the remaining articles had the same exclusion criteria applied to the full texts. 
This stage provided a form of quality assurance by double-reviewing many of the studies whilst also 
giving the opportunity to collate a range of additional information from the papers. As well as the 
details of the publication (such as author, title, year of publication) a standard template was used to 
extract additional information (Table 36). Information on validation techniques applied and any key 
limitations were also recorded where available. Information about the key results was also 
extracted. For the limited number of foreign language studies, these were translated by skilled 
colleagues. 
Table 36. Information extracted 
Study section Data field 
Design Country 
 Details of cohort 
 Longitudinal, including months of data 
Data Database(s) 
 Year(s) of data 
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 Diagnosis/procedure coding framework 
Variables Quality and safety indicator(s) 
 Key covariate(s) 
Case ascertainment Diagnosis field(s) 
Diagnosis codes 
Statistical methods Risk adjustment 
 Validation technique(s) 
8.3.5.4. Data extraction and review: analytical tools 
I catalogued and reviewed the extracted abstracts using Endnote version X6 (EndNote Carlsbad, CA) 
reference management software.  Statistical analyses of study details, such as trends in number of 
publications over time, were performed using Microsoft Office Excel 2010 (Microsoft Corp., USA). 
8.3.5.5. Data extraction and review: Comparative analyses 
In discussing the descriptive statistics on the papers identified, I use comparisons to previous 
literature reviews on patient safety indicators, predominantly that of Tsang et al 66,67, to provide a 
benchmark to judge whether the specialty-specific nature of the review, and the specialty in 
question (obstetrics), have revealed atypical results. A comparison to the stroke literature review 
(Chapter 4) is included in the discussion (Chapter 11).  
The information from the studies was compared as a whole and in subsets since certain purposes, 
for instance, would require specific risk-adjustment models and strategies for identifying obstetric 
episodes. For example, where the purpose of the study is to validate the identification of safety 
issues against medical notes, it is unlikely that you would want to adjustment for case-mix where, for 
comparisons between providers, such a risk-adjustment would be important.  
8.4. Results 
8.4.1. Identification of studies that applied administrative data 
8.4.1.1. Studies on application of obstetrics QIs 
The initial search identified 1,670 articles of which 395 duplicates were removed. Of the remaining 
1,275 articles screened, the full text was retrieved for 176 studies with the most common reason for 
exclusion being: non-relevant (n=283); the study describes an indicator using a non-administrative 
dataset (n=472); and evaluated only number of births (n=236). During the second review stage, a 
further 33 potential abstracts were added from the search of grey literature and review of the 
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bibliographies of key articles. Following the review of full texts, 129 citations were excluded resulting 
in 80 studies (Figure 20). A summary of the key characteristics is included in Figure 21. The details of 
a subset of papers are given in Table 37 on page 180. 
Figure 20. Inclusion and exclusion of articles in the literature review 
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Figure 21. Characteristics of literature 
 Number of 
studies 
Proportion of 
all studies 
Example study 
 
Publication year    
Pre-1995 0 -  
1995-1999 1 1.3% Kotagal (1999)
390
 
2000-2004 17 21.3% Oleske (2000)
391
 
2005-2009 31 38.8% Romano (2005)
392
 
Post-2009 30 37.5% Srinivas (2010)
393
 
Not stated / not applicable 1 1.3% BirthChoiceUK
394
 
Country of study    
USA 40 50.0% Simonson (2007)
395
 
Australia 9 11.3% Baghurst (2012)
396
 
England 8 10.0% Bragg (2010)
397
 
France 4 5.0% Bahrami (2008)
398
 
Taiwan 3 3.8% Tseng (2010)
399
 
Other nations with n<3 
studies 
15 18.8% e.g. Canada in Thompson 
(2003)
400
 
Multi-national 1 1.3% Drosler (2009)
401
 
Trend analysis    
Longitudinal 19 23.8% Linton (2004)
402
 
Non-longitudinal 60 75.0% Fantani (2006)
403
 
Detail not available/not 
applicable 
1 1.3% BirthChoiceUK
394
 
Months of data, mean (IQR) 40.7 (12-68) -  
Diagnosis coding    
ICD-9 40 50.0% Romano (2005)
392
 
ICD-10 16 20.0% Bottle (2009)
404
 
ICD-9 and -10 2 2.5% Lutomski (2012)
405
 
Not described 18 22.5% Keino (2012)
406
 
Number of indicators    
1 38 47.5 Baghurst (2012)
396
 
>1 42 52.5 Reilly (2004)
407
 
TOTAL 80 -  
  
8.4.2. Details from studies applying administrative data 
8.4.2.1. Country 
Half of studies (n=40; 50.0%) were from the USA, with only four other nations (Australia, England, 
France and Taiwan) identified as having 3 or more studies included. There was one international 
study, which covered seven countries,401 although a further study compared the results from the 
authors’ country (England) to that of previously published results the USA.408 The USA predominantly 
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use ICD-9 diagnosis coding frameworks and, as a result, the majority of studies included used this 
coding framework, within only 16 explicitly using the ICD-10 framework. 
8.4.2.2. Year of study 
I did not identify any studies applying administrative data meeting the criteria that were published 
from 1998 or earlier, even though the databases were searched from their inception to present. 
There has been a strong approximately linear trend (Figure 22, β = 0.7) in annual publications, rising 
from one in 1999 to thirteen in 2012. 
Figure 22. Trend in annual publication numbers 
 
8.4.2.3. Study types 
The majority of studies were cross-sectional in design, with a limited number of other designs, such 
as: case-control studies (n = 4) to, for instance, understand the burden of safety incidents;407-410 and 
quasi-experimental studies (n=4) designed to evaluate the effect of the implementation of a 
policy.411-414 One of these studies showed that the reporting of performance data may have a 
positive impact on quality improvement.414 The papers also included studies that could be described 
as having cohort designs, with hospital type415 or day of admission as the exposure.416  
8.4.2.4. Purpose 
The studies covered a wide range of uses. Some compared performance between different delivery 
units, whether: physician;417 hospitals;394,397,403,404,418-422 regions;397,423,424 and countries.401,408 Other 
studies, however, used sub-group analysis to evaluate differences in performance, with key variables 
of:  
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- hospital characteristics – including location, size, teaching status and ownership83,406,415,425-429 
– and including performance against other measures, such as blood supply at the facility,430 
level of obstetrical specialist support,431 anaesthetist staffing level,395 and caesarean section 
rate432; 
- patient characteristics83,396,399,400,402,433-437 including type of insurance391; 
- delivery risks, such as gestational age438, type of delivery 405,439, and length of stay390,398; 
- temporal aspects, such as year-on-year changes411,440-443, evaluation of the “July” 
phenomena,444 and day of admission445; 
Nine studies looked at the overall incident rate 81,370,446-449 and their burden 407-409, with sixteen 
focusing on validation.392,393,410,439,449-460 Four studies evaluated change in performance from pre- to 
post- implementation of a new policy,412-414 including the impact of IT.461 
8.4.3. Details from datasets 
8.4.3.1. Data source 
The studies reviewed used a range of different administrative databases, with the most frequent 
single dataset (n= 9) being the Nationwide Inpatient Sample in USA, which includes all patients from 
a stratified random sample of non-federal hospitals in 19-28 states.  The State Inpatient Databases 
(SID), which are also from the AHRQ-sponsored Health Cost and Utilization Project (HCUP), were also 
used widely.  
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Table 37. Example papers 
Article 
author (year) 
Country, 
data 
year 
Study design Sample Measures Results Covariates Key subject Related 
articles 
Zhan et al 
(2003) 
USA, 
2000 
Case-control 720,021 
(neonates) 
Birth trauma 
Obstetric trauma (VBwI) 
Obstetric trauma (VBwoI) 
Obstetric trauma (CS) 
0.7% 
22.4% 
8.6% 
0.7% 
Age, sex, case-mix (DRG), SES, 
insurance, comorbidities, hospital 
characteristics 
Burden of 
incidence 
AHRQ PSIs  
Cameron et al 
(2007) 
Australia, 
1993-
2002 
Cross-
sectional 
775,073 PPH 
PPH readmissions 
5.6% 
1.1% 
Age, mode of delivery Year  
Chantry et al 
(2011) 
France, 
2006-07 
Cross-
sectional 
30,614 Severe Maternal Morbid Events 1.5% Age, parity, delivery type, delivery 
risk (stratified as high- and low-
risk) 
Prevalence 
study 
 
Gould et al 
(2003) 
USA 
(1995-
97) 
Cohort 1,615,041 CS rates 
Neonatal deaths 
20.7% 
0.3% 
Birth-weight, case-mix Day of 
admission 
 
Meara et al 
(2004) 
USA 
(1991-
98) 
Quasi-
experimental 
155,352 
(full-term, 
VB, short-
stay 
neonates) 
Include: 
Readmissions within 10 days 
Emergency department visits 
within 21 days 
 
8.0% 
10.4% 
Age, marital status, parity, 
ethnicity, education, Gestational 
age, birth-weight, location Day of 
admission, Prenatal care visits 
Policy 
evaluation 
 
Bottle et al 
(2009) 
England 
(2005-
06) 
Cross-
sectional 
15,298 Obstetric trauma (VBwI) 
Obstetric trauma (VBwoI) 
Obstetric trauma (CS) 
60.5% 
27.9% 
2.9% 
Age Hospital 
comparison 
AHRQ PSIs 
Vincent 
(2008)
462
 
Lutomski et al 
(2011) 
Ireland Cross-
sectional 
649,019 PPH 
Blood transfusion rate 
2.6% 
1.3% 
Age, marital status, medical card 
status, SES, comorbidities, delivery 
complications, mode of delivery 
Delivery 
type; Year 
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8.4.3.2. Case ascertainment 
Only a minority of studies (26.1%) described the strategy for identifying birth/delivery episodes from 
the administrative data. Of these, a range of methods were used, such as: specific ICD diagnosis 
codes;
405,459
 diagnosis-related group (DRG);
455
 procedure codes;
397,411
 or a mixture of these 
strategies.
454
 
414,424,446
 Across just those studies which used the less commonly applied ICD-10 data, the 
following identifiers were used: procedure codes (OPCS) R17-R25; DRG and diagnosis codes; OPCS 
R17 (elective CS only); and presence of ICD-10 Z37 (outcome of delivery) flag. 
8.4.3.1. Extract validation 
A small number of studies evaluated or explicitly discussed coding accuracy, including: purposefully 
identifying coding errors;434 accounting for variations in how comprehensively the data is entered 
(coding depth);401,455 and making more general descriptive discussion on changes in coding practice. 
442 One study explicitly evaluated the influence of the strategy for identifying birth episodes within 
the administrative data identification strategy.454 
8.4.4. Risk models 
8.4.4.1. Case mix adjustment 
When evaluating whether an algorithm based on administrative data is accurate in identifying actual 
events one might expect that non-risk-adjusted rates would be used but, even when excluding these 
validation studies, there were still many which did not use risk 
adjustment.394,401,407,411,420,422,430,434,442,446  
Where risk-adjustment was used, the maternal factors that were included as covariates ranged from 
a single factor (age)404 to applying numerous maternal factors (such as age, ethnicity, proxy for socio-
economic status, parity, comorbidities and prior CS397). Other studies applied infant risk factors (e.g. 
birth-weight390,391,396,403,405,417,418,426,431,438,439,445,460 and congenital malformation393,403), delivery risks 
(e.g. mode of delivery390,391,405,433,436,440,443,461 and complications during delivery 395,403,425,436,454,461) and 
other proxies for complexity (e.g. day of admission433 or hospital 
characteristics391,395,399,401,409,425,436,441,443,444,450,454,461). 
Even for the same indicators, there was little consistency in the use of risk-adjustment models. For 
instance: 
- CS rates – ranged from no adjustment 422 to age, citizenship, insurance, comorbidities, 
pregnancy risks, birth-weight, congenital malformations, delivery complications 403 
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- Obstetric trauma rates – ranged from no adjustment401 or just age 404 to a combination of 
age, case-mix (DRG), proxy for socio-economic status, insurer, and comorbidities 409 
8.4.4.2. Participant exclusions 
Again there was little consensus in the exclusion of patients from the denominator, even when the 
same potential bias was being mitigated against. For instance, in trying to exclude high-risk 
deliveries, some studies used gestational age as a cut off but, even in these instances, they ranged in 
the cut off mark (from 24 weeks to 37 weeks).411,415,438 Other approaches included setting a 
minimum birth-weight420, excluding deliveries after transfer429, or excluding non-cephalic 
deliveries375. Some studies also excluded deliveries to hospitals with fewer than a certain threshold 
of annual cases. 425,430 Many studies excluded certain modes of delivery, such as vaginal or 
caesarean, with some of these limitations reflecting the scope of the study rather than purposeful 
efforts to reduce bias. 
8.4.5. Details from indicators 
8.4.5.1. Range of indicators 
The literature review also identified studies, that whilst not applying actual data so not meeting the 
inclusion criteria of the primary review, described an indicators which is proposed for application to 
administrative data. As set out in the methods, these studies were retained separately to ensure 
that the resulting list of indicators was comprehensive and well described. Such studies included the 
papers recommending the use of AHRQ indicators,40 SimPatIE,104 and OECD HCQIs.85 
A large number of studies were based on AHRQ’s indicators – consisting either just AHRQ indicators 
(using either all or a subset of obstetrics measures)81,83,401,404,407-409,416,437,439,441,451,455 or using explicitly 
AHRQ indicators alongside other measures 393,436. A full list of indicators is included at Appendix E, 
p306 with some key measures included in Table 38. 
Table 38. Key obstetrics indicators 
Pathway Outcome measures Example study 
Maternal Emergency readmissions Thompson (2003)400 
Puerperal sepsis Lu (2005)427 
Obstetric trauma Downey (2012)441 
 Episiotomy Webb (2002)418 
 Mortality Magalhaes (2012)446 
Chapter 8: Obstetrics literature review 
183 
 
 Post-partum haemorrhage Goff (2012)452 
 Severe maternal morbidity (composite) Callaghan (2012)442 
Delivery Unsuccessful vaginal birth after caesarean (VBAC) Knight (2013)375 
 Emergency caesarean section Roberts (2009)456 
 Failed vacuum or forceps delivery Knight (2013)375 
 Late caesarean section Knight (2013)375 
Neonate Emergency readmissions Meara (2004)412 
 Infections Korst (2005)415 
 Birth trauma – injury to neonate Downey (2012)441 
 Adverse outcome indicators Walker (2010)453 
8.4.5.2. Indicator validation 
The majority of studies (n=42) studies for which full-text was available did not evaluate 
the validity of the indicators applied. Where used, the most common techniques were: 
1. construct validation, which is based on the hypothesis that measures of similar 
aspects should be statistically, positively associated; and 
2. validation of the risk adjustment model (minimum bias). 
The construct validation – which also inherently assesses data accuracy – took the form of 
comparison to either a “gold standard”, such as case notes 392,410,452,453,456-459, or another dataset 
449,451. A similar method involved comparing results derived from the same administrative dataset by 
applying different algorithms for the same adverse outcome (e.g. trauma439). Forms of validation of 
the risk adjustment model were similarly diverse and included simply reporting model fit 
performance,393,421 comparison of different model specifications,396,397,403,417,425,429,433 or evaluating 
reliability of the model by applying additional data.450 For one study, the main focus of the research 
was to develop a valid model for predicting an adverse outcome.460 
Less common strategies for validation were to assess reliability by evaluating performance for 
different cohorts (e.g. including or excluding breech presentations in the denominator 411) and to 
follow a multi-faceted validation process (e.g. following the procedure set out by AHRQ for their 
indicators415). In one study, the hospital-level results were sent to the organisations for qualitative 
feedback, with hospital trusts “generally positive”.404 
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8.4.5.3. Indicator interpretation 
“An example of a commonly used maternity indicator that is difficult to interpret is the overall 
caesarean section rate. Lower caesarean section rates are often assumed to reflect better care. 
However, there is also a threshold below which the caesarean section rate is too low and babies may 
be harmed. One problem is that there are no established guidelines for determining this threshold. A 
second problem is that as elective caesarean sections become increasingly popular,” (p1) 375 which 
may increase rates – irrespective of the intervention of the health services – where there is a policy 
of maternal choice. 
8.5. Discussion 
8.5.1. Principle findings  
8.5.1.1. Descriptive data on studies 
I identified 80 studies that described the application, evaluation or validation of indicators of 
obstetrics care using routinely collected hospital data. While there were no studies meeting the 
inclusion criteria published prior to 1999, there has been an approximately linear increase since 
then. The majority of studies were based on data from the USA and only a third (n=21, from 61 
where diagnosis framework stated) used the ICD-10 coding framework. Approximately a quarter of 
studies used the longitudinal nature of the administrative data to make inferences about quality and 
safety of care. Around half of studies (38 of 80) used only one indicator. The studies took many 
forms, from descriptive cross-sectional studies of differences in performance for various hospital and 
patient characteristics to quasi-experimental designs to evaluate the effect of the implementation of 
an initiative to improve care.  
Some studies have used composite indicators, such as the Maternity Unit Performance Index that 
include both mother and child outcomes as used by Anastasakis.463 There are some potential 
advantages in bringing together different facets of quality into a concise quantified measure; 
however, within the literature I found little explanation over whether these indicators are instead 
heavily influenced by the sub-measure with the largest range in performance. 
8.5.1.2. Case ascertainment strategies for births 
The review of studies identified a lack of consistency – both in terms of which fields, and codes 
within the chosen fields, are used – in the identification of birth episodes within the administrative 
data. These studies are also not necessarily consistent with other purposes with, for instance:  
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- a study led by York University on obstetrics efficiency - using length of stay as a proxy – that 
used a combination (ICD10: any code beginning "Z37"; OPCS4.5: any code beginning "R17", 
"R18", "R19", "R20", "R21", "R22", "R23", "R24", "R25");379 and   
- a recent publication on coding accuracy used admission classification: admimeth 82 (other: 
babies born in healthcare provider) and 83 (other: babies born outside the healthcare 
providers, except when born at home as intended).464  
This could represent an issue if the episodes that are not consistent to two different strategies are 
not wholly representative of the shared cases within the cohort. Taking the latter example,464 which 
used admission method as a flag, the strategy excludes ‘other birth events’ which captures NHS-
funded home births and all other birth events which are not NHS funded, either directly or under an 
NHS service agreement. Previous research465 has shown that results for patient characteristics and 
outcomes are not necessarily the same for home births and, therefore, differing treatment (in terms 
of inclusion/exclusion in study population) of this group would potentially introduce bias. Some 
excluded transfers as proxy for high-risk; however increases in midwifery-led care, which have high 
transfer rates, may invalidate this assumption.429 
8.5.2. Indicator validity 
8.5.2.1. Risk-adjustment 
Achieving good outcomes for the increasingly complex caseload is problematic and sometimes will 
not be amenable to the quality of healthcare provided. For instance, in the UK between 1985 and 
1993, 55% of maternal deaths occurred despite being judged to have received high quality medical 
care.466 Given this evolving complexity in obstetrics care, adjusting performance measures for case-
mix is increasingly important. Yet the literature review revealed a lack of transparency and 
consistency. Disaggregating the results further highlights this problem. In the 2007 indicator set 
described by the SimPatIE project, there were four obstetrics indicators, with no stratification of 
results, and yet different depth of risk adjustment, from none to accounting for age and 
comorbidities (Table 39). No rationale for the differences in sophistication between the different risk 
models was presented.  
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Table 39. Risk adjustment in the SimPatIE obstetrics measures 
Indicator Risk adjustment 
Obstetric trauma - Vaginal Delivery without instrument Age and comorbidities 
Obstetric trauma - Vaginal Delivery with instrument Age 
Obstetric trauma – Caesarean section None 
Problems with Child Birth None 
Source: SimPatIE. Catalogue of Patient Safety Indicators. Work Package 4. March 2007. 
Other studies have mentioned the importance and current issues with risk models but then fail to 
address these. For instance, Janakiraman and Ecker467 mention that risk adjustment of birth trauma 
is not well established; however, the authors do not take the next logical step to recommend that 
this should be empirically tested – as is possible using the administrative data. Indeed such analysis 
has been done elsewhere with one study – although using a neonatal specific data source – 
evaluating the risk adjustment explicitly using a systematic review of literature to identify potential 
risk factors.468 Whilst having a good predictive risk model is important for the purpose of evaluating 
quality and safety, it is also has wider importance such as to ensure that activity-based payment 
schemes are fair. 469 
8.5.2.2. Indicator validation 
Whilst some indicators have been accepted for over a decade – such as the AHRQ PSIs, including 
obstetrics measures, that were accepted in 200282 – the validation is embryonic. As discussed earlier 
there is also a lack of consistency in the techniques and comprehensiveness in the validation of the 
obstetrics indicators presented here. The European-wide SimPatIE project only applied an 
assessment of face validity, involving reaching a consensus amongst a small group of clinicians, 
before recommending their implementation.388 Despite the relative ease with which it can be done 
using administrative data, few studies evaluated construct validity (by comparing results from similar 
measures). Indeed, one study evaluated the AHRQ PSIs by comparing performance (using 
Spearman’s rank) across different indicators but did not include the obstetrics measures. 470 
There are also examples of recommendations being made with only limited knowledge of the validity 
of the indicators. In recommending indicators for future use, the SimPatIE project repeated a 
conclusion that “the AHRQ PSIs are a broad screen for potential safety events that point to needed 
improvement in the quality of care for specific population”; however, this was based on a study that 
looked only at patient characteristics rather than, say, hospital or temporal covariates.104 
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While this reliance on using clinical consensus over definitions goes some way to meeting two of the 
three aspects in Freidman’s model on what makes a good indicator – proxy power (meaningful to 
health) and communication power (transparent) – it fails to address data power (ensuring high 
quality and available data). 471 Moreover, as discussed earlier, in reality the application of the data 
often lacks the required transparency to be judged as having reasonable communication power.  
8.5.2.3. Performance 
The heterogeneity of the studies – for instance in their use of risk-adjustment and strategy to 
identifying birth episodes – means that formal meta-analyses of results were not possible. As well as 
synthesising results and comparing against peers it is also possible to compare indicators 
performance to a predetermined benchmark and, whilst not an a priori aim of this part of the study, 
reviewing the literature revealed that some acceptable standards for these indicators have been 
stated (Table 40). This adds to the evidence that perinatal care is amenable (as certain performance 
can/should be achieved). 
Table 40. Selected benchmarks for performance 
Measure Acceptable 
range 
Cohort Organisation 
Caesarean section 
rates 
5 – 15% All births in the population UNICEF 1997472 
Post-Partum 
Haemorrhage 
≤4% Numerator: post-partum 
haemorrhage ≥1000ml within 
2 hours post-partum 
Danish National 
Indicator Project 473 
Maternal mortality ≤1% Proportion of women with 
obstetric  complications 
admitted to a facility who die 
UNICEF 1997472 
Third or fourth degree 
lacerations 
≤6% All ﬁrst time vaginal deliveries Danish National 
Indicator Project 473 
 
8.5.3. Strengths and limitations 
8.5.3.1. Strengths 
Previous studies – including one in 2013 – had brought together clinically recommended indicators 
from medical associations, such as the Nordic obstetric and gynaecological association (NOGA)  and 
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American College for Obstetricians and Gynaecologists (ACOG), RCOG (UK), Royal Australian & New 
Zealand College Obstetrics and Gynaecology (RANZCOG), Society for Obstetricians and 
Gynaecologists of Canada (SOGC).374,474,475 However, this current review represents the most 
comprehensive assessment of how indicators have been applied using administrative data and adds 
important transparency to the issues over their applications, such as on risk-adjustment models. The 
comprehensive nature from this study stems from its scope and also the process followed such as 
the inclusion of extracts from all languages. 
As with the stroke review, the specialty-specific literature review process was found to be a sensitive 
strategy for identifying relevant research and, as such, provides more assurance that the resultant 
citations are comprehensive. For instance, a literature review of all patient safety measure based on 
routinely collected hospital data, which followed a similar process, identified a similar magnitude of 
studies (n = 124) despite its far broader scope.67  
8.5.3.2. Limitations of the review process 
No formal meta-analysis could be undertaken because of the heterogeneity in study methodologies 
and underlying data frameworks. I did not use a template to assess the quality of the papers since 
there was a very diverse range of purposes across the studies and, as already discussed, validity 
needs to be proportionate to the purpose. Given the strong evidence on the existence of publication 
bias,316  studies using indicators which did not identify significant results when assessing the quality 
and safety of perinatal care may have been missed by the search strategy in this study. However, the 
design of the study – to retain articles which described indicator sets, but did not apply those to 
administrative data – mitigates against this bias to some extent.  
The inclusion criteria that the indicators should measure performance of perinatal care excluded 
studies that looked at general obstetric performance, such as measures of obstetric nosocomial 
infections457 and obstetric readmissions370. However, these indicators were applied to perinatal care 
elsewhere so are included in the list of potential indicators. 
8.5.3.3. Limitations of results 
Maternity care differs from other areas of health care in a number of ways – such as by 
predominantly dealing with healthy people – and, therefore, the findings might not be directly 
generalisable to other specialties. Also maternity services deal with the culturally and emotionally 
sensitive area of childbirth and so non-biomedical outcomes, which are not captured in the 
administrative datasets used in the studies presented here, would also need to be considered to 
have a full understanding of the overall performance of obstetric care.  
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The results do not give a comprehensive set of indicators of obstetric care nor results on this. The 
scope of the review, which was necessitated by a number of factors described above (paragraph 
8.3.2.2, p170), also meant that the measures were focused on the perinatal aspect of the obstetrics 
care pathway and, as such, the indicators described could not give a holistic picture on the overall 
performance of obstetric services. For instance, neonatal indicators (which in many health services 
will be the responsibility of a separate specialty: neonatalogy) including nosocomial infections from 
neonatal units 476 and ambulatory care sensitive conditions  477 which are inherently important 
aspects of quality and safety are not included. A specific reason for the potential incompleteness of 
the list of indicators is that some sets of measures are not based on routinely collected data475,478-482 
such as the commonly applied trigger tools based on chart reviews. 483  
8.5.4. Conclusions 
8.5.4.1. Contribution to knowledge of indicators 
As with the literature review of stroke indicators (Chapter 4) looking at a specialty in detail, had 
advantages over a broader scope; not least, to better identify existing indicators. The study has 
highlighted a paucity of use of such indicators and a lack of transparency and consensus on key 
assumptions. The importance of the transparency added by this review was reiterated by previous 
calls for consistent definition and reporting practices for hospital complications across countries. 66 
8.5.4.2. Purpose 
A set of quality and safety measures would be valuable in improving obstetrics care. 373 However, 
such an indicator set should be meaningful, actionable, timely, feasible and presented data to 
caregivers; 373 which are all plausible requirements within the constraints of routinely-collected 
hospital data. Recommendations on exactly how these indicators should be used vary. Many 
applications have been suggested for use by organisations such as AHRQ, JACHO, OECD, Australian 
Council for Safety and Quality in Health Care (ACSQ) and Canadian Institute for Health Information 
(CIHI); however, these recommendations have not necessarily been echoed by the academic 
community who have conducted much of the research to date. For instance, Kristensen and 
colleagues recommended the use of obstetric trauma-vaginal delivery without instrument (AHRQ, 
JCAHO), with instrument  (AHRQ, CIHI, OECD) and birth trauma-injury to neonate (AHRQ, CIHI, 
OECD) for use, whereas the same study suggested that obstetric trauma following caesarean 
delivery (AHRQ, OECD) and problems with childbirth (ACSQ, OECD) should not be used. 388  
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Whilst administrative data have been used in published literature to identify nosocomial infections, 
there is not universal agreement that this is an appropriately sensitive surveillance tool.457 Table 41 
sets out key recommendations for future obstetrics research based on the findings of the review. 
Table 41. Summary of implications of study design 
Finding Implication Recommendation 
1. Obstetrics indicators based on 
administrative data have been used 
infrequently outside the USA and with 
ICD-10 coding framework  
Barriers to generalising 
findings across borders mean 
that little is known about the 
use of such indicators. 
Key study designs should be replicated using 
data from outside USA or Canada to identify 
any potential outliers. 
2. There is a lack of consensus and 
transparency about the assumptions 
used in applying the indicators to 
administrative data 
Barrier to generalising, 
validating or benchmarking 
results. 
To explicitly set out the assumptions used in 
studies, such as the choice of diagnosis codes 
and fields.  
3. Around half of studies used only one 
indicator 
Content validity of many 
existing studies questionable 
Apply bundle of indicators 
4. Only two studies evaluated the effect of 
coding practice or accuracy on 
performance and these focused solely 
on coding depth 
Concerns remain over the 
validity of results given the 
potential influence of coding 
bias. 
To analyse the potential effect of coding 
variation. 
5. Only one study – USA-based with limited 
scope – evaluated the effect of day of 
admission on performance.  
Potentially important 
quality/safety issue is being 
ignored. 
A non-USA study on day of admission should 
be conducted to identify whether there is a 
potential issue. 
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Overview 
Context 
The previous chapter reviewed the current use of administrative data to evaluate the quality and 
safety of obstetric care in hospitals. This chapter sets out how a subset of the indicators identified 
can be applied, using data from hospitals in England. As well as evaluating whether outliers can be 
identified (precision), and to address the gap in the literature identified in the previous chapter, the 
following study will also measure the effect of differences in coding and investigate other aspects of 
validity.  
Methods 
Eight indicators, spanning process and outcomes measures for both the mother and neonate, were 
applied to English data in 2011/12. Logistic regression analyses were used to adjust for case-mix, and 
funnel plots to look at potential outliers. I also investigated the effect of variation in hospitals’ coding 
practice using a range of proxies and multi-level regression models. 
Findings 
The indicators were sufficiently sensitive to identify variations in performance as recorded in the 
data, with 441 occurrences of hospital trusts – or 550 outliers at the site-level – performing 
statistically differently than expected at the 99.8% significant level across the eight indicators. 
Differences in coding practice appeared to only partially explain the variation in performance. The 
work showed that administrative data can be used to indicate potential concerns around 
performance across some of the different aspects of quality and safety of obstetric care.  
What this chapter adds  
This chapter represents the most comprehensive review of obstetric care in England using 
administrative data. This study is also the first to evaluate the effect of variation in hospital- and site-
level coding of such measures.  
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9.1. Background 
9.1.1. Obstetrics care in England 
9.1.1.1. Policy development in maternity care 
In England, having a baby is the most common reason for admission to hospital,152 with some 
700,000 births currently each year.484 In total, maternity care costs around £2.6 billion annually 
which accounts for nearly 3% of the NHS budget.152 Maternity services are relatively unique in that 
they are focused on supporting predominantly healthy people through a natural life event. 
Maternity care has changed dramatically over time. In the 1950s, around a third of births took place 
at home; however, following a trend of increased hospitalisation during the 1960s and 1970s, this 
proportion currently stands at around 2% nationally.485 There have been improvements in outcomes 
with, for example, the number of babies dying within 28 days of births falling from 6.7 to 2.9 per 
1,000 live births in the 30 years from 1981.486 However, there is evidence to suggest that outcomes 
in obstetrics in England can be improved further, including:  
- that some outcomes are consistently worse than in the other UK nations and wider 
international comparisons; and  
- the failure to fully address the common causes for litigation claims, such as errors during 
caesarean section, with the cost to cover against maternity claims totalling for around a fifth 
of the total cost of maternity services.152 
9.1.1.2. Existing measures of obstetrics care 
The policy for the commissioning and delivery of maternity services was defined by the Department 
of Health in Maternity Matters (2007),487 which recommended the development of a range of 
indicators, that will enable users, trusts and commissioners to compare performance against others. 
However, as recently as 2013, a publication from the Royal College of Obstetricians and 
Gynaecologists highlighted that “there has been an astonishing lack of robust information on even 
simple clinical outcomes on a national basis.” (p.viii)375  
9.1.2. Revisiting existing literature 
9.1.2.1. Previous hospital-level comparisons 
To date, there have been few studies394,397,403,404,418-422 that have used administrative data to compare 
obstetric performance at a hospital level, with the existing studies focusing on caesarean section or 
obstetric trauma rates (Figure 23). These studies do cover a range of countries’ health services, 
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including developed and developing countries. However, there have also been comparative studies 
focusing on a different delivery unit, whether physicians,417 regions,397,423,424 or countries.401,408 Other 
studies have also used sub-group analysis to focus on specific hospital characteristics, such as:  
- location, size, teaching status and ownership,83,406,415,425-429 including performance against 
other measures, such as bloody supply at the facility;430  
- level of obstetrical specialist support;431  
- anaesthetist staffing level;395 and  
- caesarean section rate.432 
A recent report by the Royal College of Obstetricians and Gynaecologists introduced a number of 
indicators of maternity indicators for English providers. However, the work did not look at neonatal 
outcomes – rather focusing solely on data from the maternal patient record – and did not 
empirically test the validity of the measures. 375 
9.1.2.2. Data and indicator validation revisited 
As discussed in the previous chapter, there have been a small number of studies investigating coding 
accuracy. For instance, on identifying coding errors by reviewing medical records and coding 
depth,434 with Drosler et al using the mean number of secondary codes (although not presenting the 
data on the obstetrics measures) as a proxy for coding practice,401 and Grobman et al using quartile 
of ICD-9 coding intensity (although this is metric is poorly defined in the paper).455 Other studies on 
data validation include a more descriptive discussion on changes in coding practice 442 and an 
investigation into the strategy for identifying birth episodes within the administrative data 
identification strategy.454 
Few studies have explicitly validated the indicator algorithms, with the techniques used being 
primarily comparison to other measures of performance and validation of the risk adjustment 
model. The former primarily took the form of criterion validation; namely comparison to a validated 
measure, such as medical records.392,410,449,451-453,456-459 Forms of validation of the risk adjustment 
model included simply reporting model fit performance,393,421 comparison of different model 
specifications,396,397,403,417,425,429,433 or evaluating reliability of the model by applying to additional 
data.450 For one study, the main focus of the research was to develop a valid model for predicting an 
adverse outcome.460 
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Figure 23. Studies comparing hospital performance using obstetric QIs 
 Cohort Country Measures Risk-adjustment Main results 
Caesarean section rates     
Turner (2011)
420
 19 hospitals  
(72,400 births, 2009) 
Irish CS rates (elective and emergency) None Overall CS rates ranged from 18.7 – 
35.6% 
Bragg et al (2010) 
397
 
146 hospital trusts  
(620 604 births, 2008) 
England CS rate (elective and emergency) Age, ethnicity, SES, and clinical risk 
factors for CS 
Adjusted CS rates ranged from 13.6 – 
31.9% 
Fantini et al (2006) 
403
 
29 hospitals  
(62,836 births, 2003-04) 
Italy CS rates (primary) 24 risk factors in the full model; 7 
(marital status, maternal age, infant 
weight, and clinical risk factors) in the 
parsimonious model. 
Correlation between hospital rankings 
of two models was 0.92 
Hsu (2006) 
421
 6 hospitals  
(27,693 births, 1999-
2001) 
Taiwan CS rates Maternal and paternal age and 
education, gestational age, multiple 
births, parity, infant gender, clinical risk 
factors 
33.7% rate. Substantial change in 
rankings for crude vs risk adjusted 
models. 
Gichangi (2001) 
422
 39 hospital districts 
(86,105 births, 1983-97) 
Kenya CS rates None Hospital-based rates of 6.3% (range 
0.3 – 37.7%) 
Obstetric trauma     
Baghurst (2013) 
419
 18 hospitals  
(65,598 births, 2002-08) 
Australia Third and fourth degree lacerations Maternal age, parity, ethnicity, 
assistance with instruments and 
episiotomy, shoulder dystocia, infant 
birth-weight 
8 hospitals with systematically 
more/fewer tears 
Bottle et al (2009) 
404
 
170 hospital trusts  
(572,180 births, 2005-
06) 
England Third and fourth degree lacerations 
(for deliveries with instrument; 
without instruments; and CS) 
Age 60.5% (with instrument), 29.7% 
(without instrument), 2.9% (CS). Part 
of wider study using AHRQ PSIs. 
Webb et al (2002) 
418
 
18 hospitals  
(49,692 births, 1994-98) 
USA Episiotomy rates 
Third and fourth degree lacerations 
“Case mix” factors including maternal 
age, race/ethnicity, education and infant 
birth-weight 
Hospital episiotomy rates ranged from 
20 to 73%, and lacerations from 4 to 
13%. Rates of two indicators 
correlated (p<0.01) 
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9.1.2.3. Revisiting limitations in existing literature 
The review of literature described in the previous chapter suggested that future research should 
focus on: 
1. applying key study designs for identifying any potential outliers outside the USA or Canada; 
2. using a more comprehensive set of indicators; 
3. being explicit about the assumptions used in studies, such as the choice of codes and fields 
for identifying delivery episodes; 
4. analysing the potential effect of coding variation; and 
5. investigating the association between quality and day/month of delivery outside the USA to 
identify whether there is a potential issue. 
The latter area is covered in the next chapter while the other areas are covered in this section. 
9.2. Objectives 
In this chapter I investigate the feasibility of using HES data to evaluate the quality and safety of 
obstetric care at a provider level, focusing on the ability of measures to identify important effects in 
a robust fashion. 
9.3. Methods 
9.3.1. Data 
There are some noteworthy differences in the data collected for maternity care in comparison to the 
other areas of healthcare contained in the HES dataset, which are outlined here and discussed in 
further detail at the end of the chapter. HES contains data for all births in England, including those at 
home and in non-NHS hospitals, irrespective of whether a consultant or midwifery-led episode. 
Pregnant women are admitted as general admissions and only once they have given birth does their 
record become a maternity record.   
There are two types of maternity record – (1) a delivery record for the mother, and (2) the birth 
record(s) for the baby (or babies in the case of multiple deliveries) – with each containing an 
additional 19 fields covering, for instance, parity of mother, method of onset of labour, place of 
delivery, gestational age and birth-weight. The data in these records comes from birth notification 
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records and requires only a limited dataset to be completed; however, these additional fields are not 
as complete as the rest of the HES data.488,489  Despite including both maternal and baby records, the 
HES dataset do not link the baby’s record to that of the mothers, or vice versa. 
9.3.2. Selection of indicators 
9.3.2.1. Selection criteria revisited 
Recall the criteria listed earlier (paragraph 3.5.1.2, p76) for the selection of indicators. For this 
obstetric element to the project, the experts involved in getting a consensus on the indicators are 
listed in paragraph 9.3.3.1 below. 
9.3.2.2. Selection of indicators 
The literature review described in the previous chapter identified 24 maternal, 9 delivery, 11 
neonatal categories of indicators with the potential to be applied to administrative data in England. 
Following the selection criteria, a subset of eight indicators was chosen for application here (Figure 
24). The indicators were chosen to cover both process (e.g. early caesarean section rates) and 
outcome (e.g. infection rates). These two examples also demonstrate that the chosen indicators 
span care given during the delivery admission, from decision on type of delivery through to 
postpartum care.  
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Figure 24. Obstetric indicators across the care pathway 
 
 
 
 
Note: the positioning of the complications is for indicative purposes only 
9.3.3. Developing indicator definitions 
9.3.3.1. Development process 
As with the stroke measures, the selected indicators were then refined using a multi-faceted 
approach. In the first instance, the indicator definitions were implied from any previous studies that 
applied these measures:  
1. I derived draft definitions using details from algorithms applied in existing literature, 
identified through the systematic review outlined in the previous chapter. 
2. I used an iterative consensual approach to ascertain feedback from a multidisciplinary panel 
of experts, consisting of a senior obstetrician, a public health doctor, and administrative data 
experts (from Imperial’s Dr Foster Unit). 
3. The definitions were also reviewed by a multi-disciplinary team, including people 
experienced in the management of health services and clinicians, as part of the review of the 
process of publishing a national report on maternity services.152  
9.3.3.2. Final definitions 
The finalised indicator definitions are included below in Table 42.  
Table 42. Details of obstetric indicators used in analysis 
Mode of delivery Delivery episode 
Admitted 
postpartum care 
Discharge and 
community care 
a. Delivery: Early (pre-
39 week) caesarean 
section 
b. Maternal: Perineal 
tear (3
rd
 or 4
th
 degree)  
c. Maternal: Puerperal 
sepsis  
d. Maternal: 30 day 
emergency 
readmission  
e. Neonatal: Perinatal 
mortality  
f. Neonatal: Injury to 
neonate  
g. Neonatal: Selected 
infections  
h. Neonatal: 28-day 
emergency 
readmission  
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 Indicator Rationale Definition (discharges meeting 
the inclusion/exclusion criteria 
for the denominator with...) 
Exclusions 
Delivery    
a Early (pre-39 
week) caesarean 
section 
NICE recommends
1
 that planned 
caesarean section should not routinely 
be carried out before 39 weeks due to 
increased risk of respiratory morbidity. 
Elective caesarean sections (OPCS 
code: R17) where gestational age 
< 39 weeks 
Diagnoses possibly justifying early 
caesarean section (ICD-10 codes: O100-9, 
O11, O140-9, O16, O244/9, O266/8, 
O356, O360/1/5, O410/1, O421, O430, 
O440, O694, O991/4/8, Z352)
2
  
Missing gestational age 
Maternal    
b Perineal tear Third and fourth degree tears during 
vaginal delivery are not all preventable, 
but the risk can be reduced through 
appropriate labour management and 
care standards. 
Admission includes both 
diagnosis (ICD-10: O702-3) and 
procedure code (OPCS: R322, 
R325) 
Caesarean sections 
c Puerperal 
infection 
Puerperal sepsis is associated with poor 
care (especially hygiene) at the time of 
birth  
Admission includes diagnosis 
code for puerperal sepsis (ICD-10: 
O85-6) within 42 days of birth 
None 
 
d 30-day 
emergency 
readmission (all 
cause) 
Readmission rates have previously been 
shown to be associated with the quality 
of hospital care 
Emergency inpatient admission 
within 30 days, where ‘admission 
source’ field  does not suggest 
transfer from other provider 
Births where the discharge date is in final 
month of year covered in data year 
(March) 
Neonatal    
e In-hospital 
perinatal 
mortality 
Still births plus in-hospital deaths within 
7 days 
Value suggesting still born in 
birth status (2, 3, 4) or discharge 
fields (5) fields, and discharged 
within 7 days with discharge 
method (4) suggesting death  
None 
f Injury to neonate Although rare, birth trauma to the 
neonate is often preventable
3
 
Injury diagnosis code within 
admission (ICD-10: P102-4, P108-
12, P114-5, P119, P122, P130-1, 
P138-9, P142, P148-9, P15) 
Premature births, as identified through 
diagnosis code (ICD-10: P070-3), 
gestational age (<28 weeks) or birth-
weight (< 2.5kg). 
Injury of skeleton (Osteogenesis 
imperfecta diagnosis, ICD-10: Q780)  
Stillborn babies 
g Selected neonatal 
infections 
Neonatal infection is associated with 
poor care (especially hygiene) at the time 
of birth 
Diagnosis procedure code (ICD-
10: P36, P372/5/8-9, O753, O85-
6, A41, A32, A49) 
Premature births, as identified through 
diagnosis code (ICD-10: P070-3), 
gestational age (<28 weeks) or birth-
weight (< 2.5kg). 
Stillborn babies 
h 28-day 
emergency 
readmissions (all 
cause) 
Readmission rates have previously been 
shown to be associated with the quality 
of hospital care 
Emergency inpatient admission 
within 28 days, where ‘admission 
source’ field  does not suggest 
transfer from other provider 
Births where the discharge date is in final 
month of year covered in data year 
(March) 
Missing birth discharge date (c. 1% of 
births) 
Death during birth admission 
Notes:  
1. NICE guidelines on caesarean sections: http://www.nice.org.uk/nicemedia/live/13620/57163/57163.pdf 
2. Specifications Manual for Joint Commission National Quality Measures (v2013 A1). Appendix A Table 11.07, available at: 
https://manual.jointcommission.org/releases/TJC2013A/  
3. AHRQ, details available at: http://www.innovations.ahrq.gov/content.aspx?id=2081  
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9.4. Application and validation of indicators 
9.4.1. Assumptions 
9.4.1.1. Case ascertainment considerations 
The next stage was to extract both baby and maternal records from 1 April 2011 to 31 March 2012. 
There are many potential fields and codes within HES to identify records relating to the delivery 
admission (Figure 25). 
Figure 25. Key diagnosis fields and codes for identifying delivery episode 
Admission 
methods  
(admimeth) 
Episode type  
(Epitype) 
Diagnosis codes  
(ICD-10) 
Procedure codes  
(OPCS-4) 
Delivery method 
31 Maternity: 
where the baby 
was delivered after 
the mother's 
admission 
32 Maternity: 
where the baby 
was delivered 
before the 
mother's 
admission 
82 Other: babies 
born in health care 
provider 
83 Other: babies 
born outside the 
healthcare 
provider, except 
when born at 
home as intended 
98 Not applicable 
(eg other maternity 
event) 
2 Delivery 
episode 
3 Birth 
episode 
5 Other 
delivery event 
6 Other birth 
event 
Z37 Outcome of 
delivery  
Z38 Liveborn infants 
according to place of 
birth  
O80 Single 
spontaneous 
delivery  
O81 Single delivery 
by forceps and 
vacuum extractor  
O82 Single delivery 
by CS  
O83 Other assisted 
single delivery  
O84 Multiple 
delivery 
R17 Elective 
caesarean delivery  
R18 Other 
caesarean delivery  
R19 Breech 
extraction delivery  
R20 Other breech 
delivery  
R21 Forceps 
cephalic delivery  
R22 Vacuum 
delivery  
R23 Cephalic vaginal 
delivery with 
abnormal 
presentation of 
head at delivery 
without instrument  
R24 Normal delivery  
R25 Other methods 
of delivery 
0 Spontaneous vertex 
(OPCS R24)  
1 Spontaneous other 
cephalic (R23)  
2 Low forceps, not 
breech (R21.5,8-9)  
3 Other forceps, not 
breech (R21.1 -4)  
4 Ventouse, vacuum 
extraction (R22)  
5 Breech (R20)  
6 Breech extraction 
(R19)  
7 Elective caesarean 
section (R17)  
8 Emergency caesarean 
section (R18)  
9 Other than those 
specified above (R25) 
  
To evaluate the importance of the case ascertainment algorithm, I checked the consistency of coding 
across the different fields. Some of these are governed by coding rules, with examples given in 
Figure 26 and whilst these rules were adhered to in 100% of cases in 2010-11 (used for exploratory 
purposes), across both birth are delivery records, I identified there were potential issues for using 
the ‘epitype’ field for case ascertainment. 
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Figure 26. Coding rule examples 
Rule Detail Example issue 
Rule 150 Where date of birth and start of 
episode are not missing, and date of 
birth equals epistart, then the first 
episode in the spell (epiorder = 1) with 
admission method 82 (Other: babies 
born in health care provider) is set as 
epitype = 3 (birth episode) 
Does not apply for admimeth = 83 (Other: 
babies born outside the healthcare 
provider, except when born at home as 
intended) which were coded as: epitype = 3 
(birth episode) for 57.7% (2709) of 
episodes; with 0.0% (2) as epitype = 2 
(delivery episode) and 42.2% (1982) as 
epitype = 1 (general episode). 
Rule 160 Where certain treatment codes (first 3 
chars of oper_01 = R17 - R25) are 
recorded then episode set as epitype = 
2 (delivery episode) 
Does not cover secondary diagnoses (fields 
oper_02 to oper_20). 
Source: HES Data Dictionary 
9.4.1.2. Case ascertainment algorithm 
I decided that a more detailed algorithm would be required than using the ‘epitype’ as a flag for a 
delivery or birth episode. After comparing the potential sensitivity and specificity of the possible 
case ascertainment algorithms and reviewing similar algorithms used in the existing literature, such 
as Knight et al (2013) and Murray et al (2012),375,464 I proceeded with the codes outlined below. I did 
not use an algorithm based on procedure codes for identifying birth episodes since this strategy 
lacked sensitivity as the completeness of coding of these fields has been questionable, particularly 
historically. 
Delivery episodes:  Valid delivery method in either procedure (oper_01 to oper_20 = R17 to 
R25) OR maternity tail (delmeth = 0 to 9). 
Birth episode:  epitype = 3, 6 OR admimeth = 82, 83. 
As with the stroke analysis, episodes were grouped into superspells – representing the continuous 
period that a patient receives care and includes transfers between hospitals. Where analyses were 
undertaken at the hospital/unit level, performance against the quality and safety measure was 
attributed to the first provider of care.  
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9.4.1.1. Unit of analysis: trust- and unit-level 
To investigate the variation in performance across England, an appropriate level of analysis is 
required. In 2007, the Department of Health reiterated the policy that women should have a choice 
of where to give birth487 and, as a result, providers are expected to offer multiple different maternity 
units. For instance, many NHS trusts have both a hospital-based consultant-led obstetric unit and a 
separate midwifery-led unit on a different site. Taking this example of an organisational set up, 
analysis at the unit-level will be better able to investigate the effect of organisational and structural 
decisions at this unit-level, whereas it is more likely to be affected by bias due unmeasured 
differences in case-mix resulting from different in the admission criteria to different units (a 
freestanding midwifery unit is typically intended for low risk mothers only). As such, I compared the 
two provider fields (‘procode5’ and ‘sitetret’) to an existing list of providers from a national audit of 
maternity services.152 To validate the matching, I checked that the annual number of births recorded 
in the two datasets were similar. I report the analyses at both the trust and unit-levels. 
9.4.2. Risk adjustment 
9.4.2.1. Overview of case-mix adjustment 
Once an extract had been obtained using the above criteria, the first step was to identify outliers, 
which involved applying the indicator definitions to obtain denominators and numerators for each 
hospital. A logistic regression was used to calculate an expected number of numerator events based 
on the case-mix for each trust/unit to account for case mix factors.f In addition, some of the 
measures have specific case-mix factor considerations as outlined in Table 42. The methods used are 
described in more detail in paragraphs 3.6.2 to 3.6.6. 
9.4.3. Validation 
9.4.3.1. Statistical testing and testing construct validity 
Crude and standardised rates were plotted using funnel plots with 95% and 99.8% control limits and 
identified outliers (see paragraph 3.6.8, p81). Hospitals’ performance across the different indicators 
was compared – at both trust and unit-levels – to evaluate the hypothesis that certain indicators 
would be correlated. This involved 28 pairwise comparisons for each of the institutional levels, with 
further detail on this method included in the discussion below. Given the lack of process measures, I 
supported the evaluation of construct validity by also exploring the association between 
                                                          
f
 Age of mother, sex of baby, parity (maternal indicators only), multiple deliveries, socio-economic deprivation 
(carstairs quintile), previous caesarean section (maternal only), ethnic group, gestational age, birthweight, 
delivery method and other maternal conditions (Pre-existing diabetes, gestational diabetes, pre-existing 
hypertension, pre-eclampsia or eclampsia, placenta praevia or abruption, polyhdramnios, oligohydramios.) 
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performance and intervention rates (using standardised instrumental rates). Since these were 
hypothesised as being correlated and not an un-hypothesised statistical trawling exercise, 
Bonferroni correction or other adjustment to p-values for multiple comparisons was not used, 
although I highlight where relationships are significant at the 99.8%, as well as 95%, levels.  
9.4.3.2. Sensitivity analysis for coding practice 
There is a risk that hospitals’ performance for these indicators might be largely affected by variation 
in the way they code their data rather than due to differences in quality and safety. As such, the final 
stage of analysis was to investigate, at a site level, the consistency of coding practice and evaluate 
the relationship between any coding bias and hospital performance. Coding completeness was 
investigated, by comparing to performance in a relevant indicator, through: 
[1] Including a measure of ‘coding depth’, with the coding practice in some sites increasing 
the likelihood that they record secondary diagnoses and, therefore, identify complications 
and comorbidities. 
[2] Excluding sites with poor coding practice (defined as those sites with fewer than 90% of 
cases with both birth-weight and gestational age fields completed), and evaluating whether 
a similar proportion are still identified as outliers. 
 The effect of the first of these variations in the modelling [1], involved evaluating the effect of 
hospital-level variable to account for coding completeness, and so I fitted multi-level generalised 
linear models and again plotting on a funnel chart to identify outliers.  
9.4.4. Amenable: associations between organisational factors 
and performance 
9.4.4.1. Amenable: size and performance 
To test whether the quality of care being measured by the indicators is amenable to how care is 
delivered, I undertook some exploratory analysis to investigate whether organisational factors were 
associated with variations in performance. In the first instance, I compared unit size (number of 
births) with performance against the indicators. This should be interpreted with caution as tertiary 
or midwifery-led units are likely to be different sizes to general maternity units and will treat a 
different case-mix.  
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9.4.4.2. Amenable: midwifery staffing levels 
I also used data requested from the Health and Social Care Information Centre (HSCIC) on midwifery 
staffing levels, by trust and month. The number of births and maternities each month were 
calculated and a trust-level indicator of relative staffing levels, ‘S’, was defined as: 
      
    
    
  ∑
    
     
∑
    
     
 
where   i = trust i;   t = month ϵ {April 2011,…, March 2012};  
D = number of deliveries (births or maternities);  M = number of midwives 
I used this approach rather than comparing birth-to-midwife ratios between providers, since the 
latter is likely to reflect differences in type of provider (indeed staff-to-bed ratio have previously 
been used as a proxy to differentiate between major teaching, minor teaching, and nonteaching 
hospitals257). 
9.4.5. Alignment with analytical framework 
The table below summarises how this chapter aligns with the overall analytical framework (Table 
43). 
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Table 43. Analytical framework 
  Domain Study design Method 
described 
Results 
described 
Im
p
o
rt
a
n
c
e
 
1. Impact Descriptive, national rates  - 9.5.1.1 
2. Amenable Descriptive, range 
Staffing levels 
- 
9.4.4.2 
9.5.3 
9.5.2.1 
S
c
ie
n
ti
fi
c
 s
o
u
n
d
n
e
s
s
 o
f 
in
d
ic
a
to
rs
 3. Face and content 
validity 
Consultation 9.3.3.1 - 
4. Precision  Hospital results displayed on 
funnel plots 
9.4.3.1 9.5.3 
5. Construct validity Correlations between the set of 
indicators, including outcome v. 
process indicators 
9.4.3.1 9.5.4 
6. Minimum bias Risk-adjustment model 
Sensitivity analyses of influence 
of coding error and practice. 
9.4.2 
9.4.3.2 
9.5.5.1  
9.5.5.2, 9.5.5.3 
A
p
p
li
c
a
b
il
it
y
 7. Data availability Application of indicators to show 
ICD-10 based data is sufficient. 
By implication 
8. Reporting burden Application of indicators. By implication 
9.  External and 
ecological validity 
Explicit statement of 
assumptions used. 
9.4.1 
 
9.4.6. Analytical packages 
All regression analyses were conducted using SAS version 9.2 using either the PROC LOGISTIC or 
PROC GLIMMIX procedures. Funnel plots were created using the template provided by the 
Association of Public Health Observatories (APHO, http://www.apho.org.uk). 
9.5. Results 
9.5.1. Importance 
9.5.1.1. Maternal characteristics 
I identified 669,617 maternities and 678,785 live and still births in the period April 2011 to March 
2012. Some 61.5% of maternities were delivered by spontaneous vertex, with the characteristics of 
the study population in Table 44. The table also includes details of the cohort when excluding sites 
with poor coding, as described in the methods section (paragraph 9.4.3.2, p203). In addition other 
maternal complications included: pre-existing hypertension (0.5% of women), pre-existing diabetes 
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(0.6%), gestational diabetes (3.2%), pre-eclampsia/eclampsia (1.9%), placenta praevia/abruption 
(1.0%), polyhdramnios (1.0%), oligohydramnios (0.9%). 
Table 44. Characteristics of mothers in the study population 
Characteristic Categories Maternities, 
% 
Restricted 
cohort  
p-value 
(restricted vs 
excluded cohort) 
  n = 669,616 n = 516,919  
Delivery method   p < 0.0001 
 Spontaneous vertex  61.5 61.7  
 Spontaneous, other cephalic 0.5 0.5  
 Low forceps, non-breach 4.2 4.4  
 Other forceps, non-breach 2.2 2.0  
 Ventouse, vacuum extraction 6.3 6.2  
 Breech 0.4 0.5  
 Breech extraction not otherwise 
specified 
0.1 0.1  
 Elective caesarean 10.1 9.9  
 Emergency caesarean 14.7 14.8  
 Other than those specified above 0.1 0.1  
Maternal age   p < 0.0001 
 <19 5.0 5.1  
 20-24 18.5 18.8  
 25-29 27.8 27.9  
 30-34 28.9 28.7  
 35-39 15.8 15.5  
 40 and over 4.0 4.0  
Ethnicity    p < 0.0001 
 White 72.1 72.4  
 Asian 10.5 10.5  
 Black (inc. Black British)Afro-
Caribbean 
5.0 5.2  
 Mixed 1.5 1.5  
 Other (inc. Chinese) 3.3 3.4  
 Unknown / not stated 7.6 7.0  
Level of deprivation   p < 0.0001 
 1 14.9 14.2  
 2 16.1 15.9  
 3 18.9 18.8  
 4 22.1 22.2  
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 5 26.6 27.6  
 ‘6’ (unknown) 1.3 1.4  
Parity    p < 0.0001 
 Primiparous 43.2 42.3  
 Multiparous 56.8 57.7  
Gestational age   p < 0.0001 
 < 37 7.5 8.6  
 37-39 34.9 38.7  
 40-41 42.0 46.7  
 >=42 3.7 4.0  
 Unknown 11.9 1.9  
Birth-weight    p < 0.0001 
 <2500g 5.8 6.4  
 2500-4000g 74.3 80.1  
 >4000g 10.2 11.0  
 Unknown 9.7 1.7  
Multip    p = 0.164 
 Yes 1.5 1.5  
 No 91.7 97.1  
 Unknown 6.9 1.4  
Notes:   χ2 test for association, excluding ‘unknown’ categories 
9.5.1.1. National level results 
Of those women meeting the inclusion criteria for the maternal complications: 3.1% had a perineal 
tear, 0.9% had an infection, and 1.0% were readmitted within 30 days of discharge. Of those 
neonates meeting the inclusion criteria for the relevant complications, 0.7% were stillborn or died 
in-hospital within 7 days, 1.5% were injured, 2.1% had an infection, and 6.1% were readmitted 
within 28 days of discharge. Around a third (33.9%) of the 67,370 elective caesarean sections were 
recorded as being conducted prior to 39 weeks gestation; after excluding deliveries for which there 
was no recorded gestational age (15.4%) and/or a recorded indication for early caesarean section 
(20.7%) this equates to 35.2% of cases. 
9.5.2. Amenable 
9.5.2.1. Association with organisational factors 
The range in performance is shown in Table 46, p211. The association between staffing level and 
complication rates suggested that lower staffing levels were associated with higher perinatal 
mortality (p = 0.05) while there were not significant correlations with the other measures (Table 45). 
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Table 45: Association between birth-to-midwife ratio and performance measures 
Label Indicator Effect p-value 
    
B Perineal tear -0.109 0.336 
C Puerperal infection 0.083 0.603 
E In-hospital perinatal mortality 0.397 0.054 
F Injury to neonate 0.228 0.107 
G Selected neonatal infections 0.134 0.277 
Notes  Readmission rates were not calculated as the performance could be affected by staffing levels in subsequent 
month. Early caesarean section was not calculated as this was not assumed to be affected by midwifery staffing levels. 
9.5.3. Precision 
Displaying the performance at the provider level on funnel plots, across either the 149 trusts or 229 
units, highlighted the variation in performance (Figure 27 and Figure 28). All the indicators identified 
at least trusts/sites with performance outside the 99.8% control limits (Table 46). The number of 
births per trust ranged from 1,291 to 10,782, and for sites from 10 to 8,516.  
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Figure 27: Funnel plots of trust-level performance across the obstetric indicators, 2011-12 
  
  
  
  
Note: Each dot represents a trust. The horizontal line refers to national average; short-gauge dotted line refers to p<0.025 
significance level; long-gauge dotted line refers to p<0.001 significance level. 
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Figure 28: Funnel plots of site-level performance across the obstetric indicators, 2011-12 
 
 
  
  
  
Note: Each dot represents a site. The horizontal line refers to national average; short-gauge dotted line refers to p<0.025 
significance level; long-gauge dotted line refers to p<0.001 significance level. 
Chapter 9: Obstetrics variation and validation 
211 
 
 
Table 46: Number of trusts identified as having statistically significant above or below average 
performance 
Label Indicator National 
rate 
Variation  Outliers: number of providers with different 
performance to average (p<0.001)1 
   Range, by 
trust2 
Trust-level (n = 149) Site-level (n = 229) 
   [min, max] Higher3 Lower3 Higher3 Lower3 
a Early caesarean 
section 
35.2% [1.1% – 60.7%] 12 21 11 21 
b Perineal tear 3.1% [1.0% – 5.3%] 13 17 17 21 
c Puerperal 
infection 
0.9% [0.2% – 1.9%] 22 25 26 70 
d 30-day maternal 
emergency 
readmissions 
1.0% [0.2% – 3.0%] 15 21 15 23 
e In-hospital 
perinatal 
mortality 
0.7% [0.3% – 1.0%] 5 15 3 17 
f Injury to 
neonate 
1.5% [0.1% – 6.9%] 37 63 41 73 
g Selected 
neonatal 
infections 
2.1% [0.2% – 11.1%] 34 63 36 77 
h 28-day neonatal 
emergency 
readmissions 
6.1% [1.6% – 14.1%] 31 47 42 57 
Note  1: Some trusts/sites were removed for specific indicators (the total number given represents the maximum) 
 2: Range represents minimum and maximum performance for providers, for unadjusted rates 
3: Better care is indicated by lower than average performance for these measures.  
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9.5.4. Construct validity 
Across the trust-level indicator results, there were five pairs of indicators which had a statistically 
significant correlation at the 95% level, of which one was significant at the 99.8% level (Table 47).  
Table 47: Trust-level Coefficient of correlation between pairs of indicators 
 
Perineal 
tear 
Puerperal 
infection 
30-day 
maternal 
emergency 
readmissions 
In-
hospital 
perinatal 
mortality 
Injury 
to 
neonate 
Selected 
neonatal 
infections 
28-day 
neonatal 
emergency 
readmissions  
Early caesarean 
section 
-0.122 -0.076 -0.049 0.005 -0.189* -0.077 -0.135 
Perineal tear  0.121 0.198** -0.119 -0.107 -0.174* -0.227* 
Puerperal infection   -0.067 0.014 0.218* 0.190* -0.121 
30-day maternal 
readmissions 
   0.002 0.080 -0.022 0.048 
In-hospital 
perinatal mortality 
    0.038 0.008 -0.069 
Injury to neonate      -0.062 0.074 
Selected neonatal 
infections 
      -0.012 
Note 1: Correlation significant at the 95% level marked with ‘*’; those at 99.8% level with ‘**’  
In further exploratory analysis, I found that higher standardised instrumental rates are associated 
with higher rates of: emergency caesarean section (0.451, p < 0.0001); maternal infection rates 
(0.225, p = 0.007); and tears (0.38, p< 0.0001). Across the site-level indicator results, there were 
seven pairs of indicators which had a statistically significant correlation at the 95% level, of which 
three were significant at the 99.8% level (Table 48).  
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Table 48: Site-level coefficient of correlation between pairs of indicators 
 
Perineal 
tear 
Puerperal 
infection 
30-day 
maternal 
emergency 
readmissions 
In-
hospital 
perinatal 
mortality 
Injury 
to 
neonate 
Selected 
neonatal 
infections 
28-day 
neonatal 
emergency 
readmissions  
Early caesarean 
section 
-0.107 -0.014 -0.030 0.006 -0.076 0.030 -0.004 
Perineal tear  0.036 0.012 0.081 0.153* -0.045 -0.202* 
Puerperal infection   -0.036 0.129 0.067 0.259** -0.051 
30-day maternal 
readmissions 
   0.218** -0.024 0.179* 0.074 
In-hospital 
perinatal mortality 
    0.047 0.355** 0.153* 
Injury to neonate      0.017 -0.064 
Selected neonatal 
infections 
      0.097 
Note 1: Correlation significant at the 95% level marked with ‘*’; those at 99.8% level with ‘**’  
9.5.5. Minimum bias: coding practice 
9.5.5.1. Effect of case-mix adjustment 
The analysis of the association between adjusted and unadjusted rates, suggested that the case-mix 
adjustment had the least effect on the measure of maternal readmissions (Pearson correlation 
coefficient, r = 0.969) and greatest effect on perinatal mortality (r = 0.540) (Table 49). These results 
tally with the model fit statistics, which show that the case-mix factors are better at predicting 
perinatal mortality (c = 0.853, r2 = 0.268) than maternal readmissions (c = 0.605, r2 = 0.014). 
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Table 49: Correlation between adjusted and unadjusted rates, and model fit statistics 
Label Indicator Correlation coefficient  Model fit statistics 
  Pearson Spearman’s 
rank 
c r2 
a Early caesarean section 0.849** 0.935** 0.688 0.235 
b Perineal tear 0.903** 0.851** 0.721 0.077 
c Puerperal infection 0.868** 0.971** 0.714 0.057 
d 30-day maternal emergency 
readmissions 
0.969** 0.972** 0.605 0.014 
e In-hospital perinatal mortality 0.540** 0.576** 0.853 0.278 
f Injury to neonate 0.948** 0.965** 0.727 0.097 
g Selected neonatal infections 0.923** 0.913** 0.765 0.134 
h 28-day neonatal emergency 
readmissions 
0.936** 0.945** 0.586 0.016 
Notes  ** p < 0.0001;  
r
2
: the max-rescaled r-square score reported from PROC LOGISTIC 
9.5.5.2. Coding depth (diagnoses) 
Between sites the average number of distinct diagnosis codes used (excluding those relating to 
perineal tear) per admission ranges from 2.8 to 6.6. Similarly, between sites the average number of 
distinct diagnosis codes used (excluding those relating to injury to neonate) per admission ranges 
from 1.1 to 4.4. Compared to the standard logistic model, including a multi-level model with a 
variable to account for coding practice made little difference to trusts performance in the perineal 
tear measure (Pearson correlation coefficient, r = 0.986) although there was a more substantial 
effect for the injury to neonate measure (r = 0.794) (Table 50). 
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Table 50: Effect of including coding practice in case-mix model 
Indicator Correlation coefficient  
 Pearson Spearman’s rank 
Perineal tear (v. adjusted rates ‘standard’ model) 
Multi-level model (including site identifier) 0.991** 0.997** 
Multi-level model, including site coding variable 0.986** 0.983** 
Injury to neonate (v. adjusted rates ‘standard’ model) 
Multi-level model (including site identifier) 0.992** 0.989** 
Multi-level model, including site coding variable 0.794** 0.809** 
Note  ** p < 0.0001 
 
For the perineal tear measure, at this site-level there was no correlation (r = -0.029, p = 0.666) 
between coding depth (measured as average number of unique diagnosis codes in an admission) 
and performance. Of the 38 sites identified at the 99.8% level in the original regression, all (100.0%) 
were again flagged as outliers (and in the same direction) at this significance level when coding 
practice was included in the regression. 
For the injury to neonate measure, at this site-level there was a significant correlation (r = 0.260, p = 
0.0002) between coding depth (measured as average number of unique diagnosis codes in an 
admission) and performance. Of the 114 sites identified at the 99.8% level in the original regression, 
77 (67.5%) were again flagged as outliers (and in the same direction) at this significance level when 
coding practice was included in the regression. In addition, three of the original outliers (2.6%) were 
flagged as outliers in the opposite direction.  
9.5.5.3. Coding depth (characteristics) 
As shown above (Table 44, p206), the maternal characteristics of the cohort treated by sites with 
good coding depth on birth-weight and gestational age, were statistically different to those at poor 
coding sites, although the actual differences are small. 
Across poor coders, 44 of 71 sites were outliers at the 99.8% level for the injury measure whereas 70 
of the 121 good coders were. The distribution of performance (Higher 0.001, High 0.025, Within 
control, Low 0.025, Low 0.001) was not statistically different between good and bad coders (p = 
0.438). 
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Across poor coders, 8 of 55 were outliers for perineal tear measure whereas 30 of 161 of good 
coders were. The distribution of performance (‘Higher 0.001’, ‘High 0.025’, ‘Within control’, ’Low 
0.025’, ‘Low 0.001’) was not statistically different between good and bad coders (p = 0.485). 
9.6. Discussion 
9.6.1. Summary of findings 
The results show the potential for using hospital administrative data, meeting the Government’s call 
to develop measures of performance and, moreover, to highlight potentially significant variations in 
the quality and safety across the delivery admission. Eight measures of quality and safety, covering 
the perinatal care pathway, were applied to English hospital administrative data identifying almost 
700,000 births. All eight indicators identified trusts and units with statistically outlying performance 
at the 99.8% level. Further analysis suggested that differences in coding practice appeared to only 
partially explain the variation. The analysis reiterated the high impact of maternity care with large 
numbers of potential adverse events. 
9.6.2. Amenable: scope for improvement 
For most of the measures, there is no clinical consensus or guidelines for what actual levels are 
acceptable. In these cases, hospitals should strive to operate at the level of the best performers, 
after accounting for random variation and variation in case-mix. Indeed, regulators and guideline-
setters could use this analysis to suggest levels of performance that are attainable. The exception to 
this rule is on caesarean sections prior to 39 weeks, for which the extant guidelines state that “the 
risk of respiratory morbidity is increased in babies born by CS before labour, but this risk decreases 
significantly after 39 weeks [and] therefore planned CS should not routinely be carried out before 39 
weeks” (p18). 490 As such, the current rate of around a third of elective caesarean sections being in 
contravention to these guidelines seems unacceptable. 
9.6.3. Precision 
By using funnel plots and control limits, I was able to account for random variation; if the deviation 
were entirely due to random variation, you would only expect to identify around one outlying 
maternity unit every 2 measures (given there are 229 units, with an even lower likelihood for across 
the lower number of trusts). Further to chance, differences in performance may be due to case mix, 
how the data were collected, or quality of care. 337 Given the ambition was to compare providers on 
the basis of the last of these factors, the previous two also need to be accounted for and are, 
therefore, discussed below.  
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The panels of funnel plots above look like there is less over-dispersion when analysed at a site level. 
Indeed, there seems to be a smaller proportion of sites than trusts identified as outliers with, for 
instance, 33 trusts highlighted as outliers at the 99.8% confident level and only 32 sites. However, 
this may be explained to some extent by the large number of very small units (those clustered on the 
left of the funnel plots) where numbers are insufficient to give appropriate power to identify 
variations in performance.  
9.6.4. Minimum bias 
9.6.4.1. Adjusting for case-mix  
The influence of maternal and foetal risk factors on outcomes is well-recognised. 491 I accounted for 
case-mix using mother- or neonate-level logistic regression to calculate the expected number of 
events for outcome measures. However at an individual-level some significant case-mix factors, such 
as maternal obesity and smoking,491 are not recorded within the data and, therefore, some of the 
variation may still be caused by differences in case-mix. If we hypothesise that there are small areas 
of extreme case-mix but, at a larger geographical level, case-mix is more homogenous coupled with 
units and trusts predominantly treating patients from their local area then it holds that any bias from 
this potential ‘categorisation error’ is less likely to have a substantial effect within the trust-level 
analysis given that at least 1,000 deliveries occurred at each provider, in comparison to the unit-level 
results whereby one unit only had 10 deliveries. 
I report, in detail, the model fit statistics and effect of the case-mix adjustment of hospitals’ 
performance. This showed that the case-mix models were better at explaining performance in the 
perinatal mortality score to the readmission measures. This information is not for making conclusion 
on the appropriateness of the case-mix adjustment – since it is not possible to disaggregated the 
effect of unmeasured differences in case-mix to differences in quality of care provided – but should 
be considered when interpreting the results. One specific issues relating to case-mix originates from 
the difference between obstetrician-led and midwifery-led care. Midwifery-led units are 
recommended only for low-risk mothers and, therefore, obstetric units are more likely to a higher 
proportion of high-risk cases. 
9.6.4.2. Accounting for variation in coding practice 
The variation in performance due to how data were collected is harder to disaggregate since some of 
the possible variation in coding practice, such as depth of diagnosis coding, might mimic differences 
in case-mix.  However, I showed that two key coding issues that were central to the assumptions for 
identifying complications and adjusting for case-mix explained only a minority of the differences in 
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performance against the measures. Previous research has raised questions about differences in 
performance between hospitals with good and poor data recording – for instance, a higher 
postoperative mortality rate following resection of colorectal cancer was found in trusts that do not 
voluntarily report data to a national audit492 –the findings here suggest that outliers were in both 
good and bad recording trusts. 
9.6.5. Errors in underlying data 
Records of births outside of NHS hospitals are significantly affected by data quality issues and do not 
contain information for fields such as admission/discharge date (admidate/disdate) or patient 
classification (classpat). Historically there has been poorer coverage of home deliveries, and for this 
reason, only records for births in an NHS setting are included in the HES Annual Maternity 
publication.493 Yet there are wide geographical and demographic variations in the proportion of 
home births,152 which could cause bias if creating performance indicators without these home births. 
Moreover, some of this missing data can be estimated from the date of birth and, as such, the 
research presented here did not actively exclude births outside hospitals.  
The additional fields have their own data quality issues and the coverage is not as complete as for 
the rest of HES data. For instance, a research project suggested that key data items were missing in 
over 20% of records overall, with some NHS trusts not submitting usable maternity tail data for any 
deliveries. 375 However, I investigated these issues by disaggregating the analysis between good and 
poor coding hospitals, as reported above.  
9.6.5.1. Case-ascertainment strategy 
If the total number of cases attained from the algorithm applied to the HES extract was either 
substantially higher or lower than that derived from the national birth register then this would 
suggest either poor sensitivity or specificity of the case-ascertainment strategy. Reassuringly, 
however, the number of maternities and births from the extract were similar to the register. The 
numbers of maternities and births from the HES data closely matches the register data – differing by 
only 0.3 and 0.2%, respectively, in 2011 – and has improved over time (Table 51). 
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Table 51. Comparison of numbers of maternities and births from the HES extract and ONS births 
register 
 Maternities  Live and still births 
 Register HES Extract Variation  Register HES Extract Variation 
2008 665,779 643,658 -3.3%  676,236 649,741 -3.9% 
2009 645,802 640,957 -0.8%  656,880 651,824 -0.8% 
2010 662,752 661,162 -0.2%  673,641 670,565 -0.5% 
2011 664,468 666,352 +0.3%  675,646 673,961 -0.2% 
Notes: ONS data from Characteristics of Birth 1 
9.6.6. Face and content validity 
Whilst previous studies have used hospital administrative data to measure the performance of 
aspects of obstetric care, none have brought together such a broad range of measures covering both 
maternal and neonatal care and, instead, have tended to focus on a single area such as perineal 
tears. A combination of process and outcome measures (both short- and longer-term) was used in 
this study, so benefiting from the advantages of process measures (which tend to be more sensitive 
to differences in the quality of care and offer a clear action for improvement) and outcome 
measures (greater intrinsic interest, high face validity, and can reflect all aspects of care, including 
those that are otherwise difficult to measure such as technical expertise and operator skill).337,342  
Face validity can be derived from the fact that the indicators appeared in existing literature or, for 
one of the measures, clinical guidelines. 
The overall level of quality of care at a provider-level cannot be deduced from the results of only a 
small set of indicators; however almost half of studies within the literature review applied only one 
indicator. This study included eight indicators covering many aspects of the care provided during the 
delivery admission and, therefore, is likely to have better content validity (extent to which a measure 
represents all facets of the subject being investigated) over these previous more limited evaluations. 
9.6.7. Criterion validity 
As well as these considerations on whether the indicators’ algorithms are functioning as intended, 
further assurance needs to be taken about whether the results of the indicators reflect actual 
performance. The most common process for validating the results is to compare against a gold 
standard. Previous research has focused on the perineal tear (obstetric trauma) indicator, including: 
the California Obstetric Validity Study which found that the indicator had sensitivity of 90% (95% CI, 
82-96%) and PPV of 90-95%;392 a study using a clinical research dataset as comparison which 
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suggested sensitivity of 77% (72-81%) and PPV of approximately 93%;494 and, within England, 
research suggested a PPV of 85% based a review of 995 case notes.112 
9.6.8. Construct validity 
In the absence of a gold standard dataset to compare results, some assurance on validity can be 
derived by comparing with other indicators of performance. I investigated whether there were 
associations between trusts’ and units’ performance across the different measures. One might 
hypothesise there would be correlation between good performance across all the indicators with, 
for example, good management of maternity care likely to affect all the quality and safety measures 
to some extent. More specifically, you would expect a hospital with good hygiene levels to have 
good performance against both the maternal and neonatal infection measure. Ideally there would 
be a range of outcomes and process measures focusing on the same event within the delivery to 
support this validation; however, the literature review revealed only limited process measures and 
these were not directly linked to the outcome measures. 
There were 6 statistically significant correlations at the 95% confidence level at the trust-level, and 7 
at the unit-level. However, only 2 of these were common to both trust- and unit-level, which could 
suggest that there are different unit and trust-level effects that affect performance.  
At the trust-level, the only correlation significant at the 99.8% level was a positive correlation (r = 
0.198) in the direction of good performance in both maternal readmissions and perineal tears, which 
might be expected as poor care during the delivery, as indicated by obstetric trauma, is likely to 
result in readmissions after discharge.  
As hypothesised, at the unit-level there is a strong positive association between neonatal and 
maternal infections (r = 0.259, p < 0.002). Across the units and at the 99.8% confidence level, there 
was also positive statistically significant correlations between perinatal mortality and both neonatal 
infections (r = 0.355) and maternal readmissions (0.218). 
There were further statistically significant correlations at the 95% confidence level. Some of these 
(such as injury to neonate and puerperal infection at both trust and unit levels) showed a positive 
association between complication rates, as expected. However, at this significance level, there were 
also unexpected negative associations (neonatal readmissions with perineal tear at the site and trust 
levels; and at a trust-level only for early caesarean sections and injury to neonate and between 
neonatal infections and perineal tear). It is unclear why these correlations are found; however, 
across the 56 comparisons we might expect around 3 significant correlations by chance alone at this 
level which might provide the explanation. 
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9.6.9. Unit of analysis 
9.6.9.1. Provider identification 
While I was able to identify the trust-level ‘NHS code’ for every birth and maternity, the attribution 
to specific maternity unit was more complex. The matching of fields for identifying the unit of 
provider identified, for 2011-12, 224 distinct geographic locations – either obstetric unit, obstetric 
unit and alongside freestanding midwifery unit, or freestanding midwifery unit – and 5 providers 
where I was unable to disaggregate the distinct locations, although for 2 of these providersg the 
separate units were of the same type. In comparison a national audit of maternity surveys identified 
229 distinct geographical locations, as at June 2013. The closeness of these numbers suggests that 
the HES fields can be used to identify the vast majority of maternity units. 
Performance might be affected by both trust-level factors – e.g. overall staffing levels given that 
midwives are often used flexibly between units – and unit factors – e.g. suitability of the estate. As 
discussed above, analysis at the trust level will better control for unmeasured differences in case-
mix. However this more aggregated level might not be sensitive to some of the local differences in 
quality. As such, there seems to be value to analyse the results at both levels. 
Whereas the report by the Royal College of Obstetricians and Gynaecologists was limited to those 
units with greater than 1000 deliveries, I included the full set here. This inclusion criterion by the 
Royal College seems unnecessary as they too apply a statistical approach that accounts for the 
random variation which is likely to have a greater effect on smaller units. 
9.6.10. Strengths of this study to other measurement efforts 
The Confidential Inquiry into maternal mortality has been commonly cited and linked to many of the 
national standards that had been used in the scheme for providing litigation cover from trusts in 
England (Clinical Negligence Scheme for Trusts). However, the old confidential inquiry was also 
widely criticised for being “anecdotal”, expensive and without evidence of benefit.495,496 The RCOG 
have made advances in measuring performance;375 however, the set of indicators used considered 
only maternal process and outcomes of care, and did not compare sites performance across the 
different indicators. Indeed, the RCOG recommended that “there is also a need to better understand 
the relationships between different process and outcome indicators. Priority areas should be 
neonatal outcomes and measures of user experience.” 375 
                                                          
g
 County Durham and Darlington (RXP) includes two obstetric units (RXP00 and RXPBA). Doncaster and 
Bassetlaw (RP5) includes two obstetric units. 
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HES has the advantage of being: longitudinal; timely; covering all hospital admissions; and being 
relatively cheap, costing £1 per record to collect compared with around £10 - £60 per record for 
clinical registers.89 The introduction of a National Maternity Dataset for England, mandated from 
April 2014, should provide a rich and accurate source of information on the care of pregnant 
women.375 
9.6.11. Conclusion 
This study shows that hospital administrative data have the potential for benchmarking the standard 
of hospitals performance over the care provided in the delivery admission, in a timely way and 
without increasing the bureaucratic burden on hospitals. While the study benefits from drawing 
together both neonatal and maternal indicators being able to link mother and baby records – for 
instance to create a compound measure of ‘no complication form delivery’ – would give a more 
complete picture of performance 375 
As has been previously noted above and reiterated by others, “the data on which our analyses are 
based are not as accurate as we would have liked; however, until these data are used to provide 
information to allow for meaningful benchmarking, encouraging clinicians to take ownership of their 
own hospital data and attempts to drive up quality will be difficult.” (p. viii) 375 There are a number of 
reasons for the coverage and data quality issues, such as different capabilities of local systems to 
record the additional birth details.497 Indeed, a recent audit found that nearly a fifth of maternity 
units’ information systems were either heavily reliant on paper-based notes or not linked to the 
patient administration system, which will negatively affect the ability to provide accurate, timely 
data. 152 However, the government recently stated that they were ensuring that all maternity units 
would be required to have appropriate IT.498 
Whilst neither the lack of credible gold standard nor evidence of bias from coding practice render 
the indicators redundant, it does temper the extent to which they could be used, such as for 
regulating hospitals. This study shows that HES provides the facility to record some key process and 
outcome measures across key aspects of maternity care in a cheap and timely manner. These results 
could be linked to structural measures, such as unit-level data on staffing levels, to investigate their 
effectiveness. 375 With suitable modification and further development, these data could also be used 
routinely as currently measurement efforts. 
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Overview 
Context 
The previous chapter showed how obstetric indicators can be used to highlight variations in the quality 
and safety of care and demonstrated that, while the findings are relatively robust to differences in coding 
practice, this does represent a limitation. This chapter shows how these limitations can be overcome 
through different application of the indicators. The literature review revealed that less than a quarter of 
studies on obstetric care had used the longitudinal nature of administrative data, and none had 
comprehensively assessed weekend care.  
Methods 
Application of indicators covering key aspects of the delivery admission to investigate changes in 
performance over time and association between day of delivery and adverse events. Results were 
adjusted for case-mix using logistic regression. 
Findings 
The longitudinal analysis highlighted both seasonal and longitudinal trends. The day of the week analysis 
showed performance across four of the seven measures was significantly lower at weekends. In 
particularly, the perinatal mortality rate was 7.3 per 1,000 at weekends , some 0.9 per 1,000 higher than 
at weekdays (adjusted odds ratio 1.071; 95% Confidence Interval 1.019 – 1.126).  
What this chapter adds  
This chapter presents the most comprehensive evaluation of the “weekend effect” in obstetric care. 
The study design mitigates for common limitations cited on the use of such indicators and so is able 
to produce robust results about the extent of this important issue.  
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10.1. Background 
10.1.1. Existing obstetric studies on administrative data 
10.1.1.1. Topics, designs and results 
The literature review (Chapter 8) revealed that few studies have taken advantage of the longitudinal 
nature of administrative data to evaluate temporal trends in the quality and safety of obstetrics 
care. Where studies have existed, the temporal trends investigated have included longitudinal 
annual trends, seasonal trends (a so called “July” effect) and association with day of admission 
(Table 52).  
Only one of these studies was based on English data, and this evaluation included only timing of 
caesarean sections as a measure.411 The treatment of changes in case-mix and patient characteristics 
varied amongst this small set of studies with, for instance, Callaghan and colleagues (2012) not 
making any risk-adjustment to the evaluation in changes in maternal mortality and severe 
morbidity.442 Most of these studies fail to stand up to the criticism of primarily focusing on a single 
outcome and therefore not capturing wider aspects of the quality and safety of care. 
The study designs and aims were heterogeneous and so a formal meta-analysis is not possible but, in 
summary, they present a mixed picture on longitudinal trends with some countries showing 
improvement in certain indicators and worsening performance in others. Neither the study of the 
“July” effect 444 nor “weekend effect” 445 showed statistically significant variations in quality and 
safety.  
10.1.2. Other literature  
10.1.2.1. Longitudinal and temporal trends 
A recent national audit suggested that there had been improvement across some key aspects of 
maternity care over time, such as early access and consultant presence.152  
10.1.2.2. Association between performance and day of the week 
Previous studies, across a range of countries, have identified higher mortality in patients admitted 
on weekends across a range of medical conditions; a phenomenon termed the ‘weekend 
effect’.253,350-353,499 This calls into question the idea that quality of care is equal irrespective of when 
you present at hospital. However, not all studies have identified an association between poor 
outcomes and out-of-hours periods.500-502 
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In 1978, Alison MacFarlane published a paper showing a seven-day cycle in birth numbers across 
England (and Wales) and that perinatal mortality was higher among babies born at weekends.503 
Similar studies in the 1970s and 1980s found this phenomenon in other developed countries.504-506 
The delivery of obstetrics care has changed dramatically since this time; however, where the 
“weekend effect” has been evaluated it has predominantly been based on mortality as the sole 
indicator. Indeed, in setting out key challenges to address in obstetrics care, a paper by the World 
Health Organisation (WHO) highlighted ineffective referral to and inadequate availability of 24-hour 
quality services to emergency obstetric care services.367  
10.2. Objectives 
In this chapter I investigate the potential to use the longitudinal nature of administrative data to 
identify important shortcomings in quality and safety in a way that overcomes some of the known 
limitations to such indicators. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter 10: Obstetrics temporal trends 
227 
 
Table 52. Studies using obstetric indicators to investigate temporal issues 
Study Cohort Country Variable Measures Risk-adjustment Main results 
Cameron et al 
(2006)
440
 
52,151 women 
with PPH  
(1994 – 2002) 
Australia Year Primary measures:  
perinatal PPH and readmissions 
from PPH 
Age and mode of delivery 
Adjusted for under-reporting 
From 1994-2002, PPH increased from 8.3 to 
10.7% of deliveries. Hospital readmission 
for PPH declined from 1.2% to 0.9%. 
Gurol-Urgancil 
et al (2011)
411
 
507,410 low risk 
singletons  
(2000 – 09) 
England  Year Elective CS after 39 weeks None – excluded women who had elective 
CS before 24 weeks or contra-indication 
for delaying an elective CS 
Elective CS deliveries after 39 weeks 
steadily increased from 39% in 2000/01 to 
63% in 2008/09.  
Downey et al 
(2012)
441
 
Not stated 
(1998 – 2007) 
USA Year Obstetric trauma – vaginal with 
and without instrument 
Birth trauma – injury to neonate 
Age Average annual decrease in events: birth 
trauma -17.8%; obstetric trauma without -
5.7%; obstetric trauma with -4.1%. 
Callaghan et al 
(2012)
442
 
49,346,974 
deliveries 
(1998 – 2009) 
USA Two-year 
periods 
Severe maternal morbidity and 
related in-hospital mortality 
None Severe maternal morbidity increased by 
75% (and 114% for delivery and postpartum 
hospitalisation) from 1998/99 to 2008/99. 
Roberts et al 
(2012)
443
 
500,603 women 
(1999 – 2004) 
Australia Year Maternal morbidity outcome 
indicator (MMOI) 
PPH 
Age, parity, mode of delivery, smoking, 
delivery hospital, multiple pregnancy, 
previous CS, and other clinical factors 
MMOI increased annually by an average 
3.8% (95% CI: 2.3-5.3%). 
Ford et al 
(2007)
444
 
299,130 
singleton births 
(1998 – 2002) 
USA Month 
(July vs 
non-July) 
Include: third and fourth degree 
laceration; PPH; transfusion; 
anaesthesia related 
complication; birth asphyxia 
Age, ethnicity, socio-economic status, 
hospital size and location 
No increased rate of operator-dependent 
complications of delivery at teaching 
hospitals nationwide in the month of July. 
Gould et al 
(2003)
445
 
1,615,041 live 
births  
(1995 – 97) 
USA Day of 
birth 
Neonatal mortality rates Method of delivery, birth weight and 
excluding congenital anomalies 
Weekend neonatal mortality OR 1.12 (95% 
CI 1.05-1.19) compared to weekdays. 
Difference no longer significant after 
adjusting for birth weight. 
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10.3. Methods 
10.3.1. General methodological considerations 
10.3.1.1. Indicators 
The indicators used for this part of the study are similar to those used in the previous chapter 
(paragraph 9.3.3.2, p198) and were identified in the literature review (Chapter 8). In summary, the 
indicators used in this chapter are set out in the below (Table 53), although some amendments were 
used in the weekend analysis, with the rationale for this discussed below.  
Table 53. Obstetric indicators 
Delivery Maternal Neonatal 
a. Early (pre-39 week) 
caesarean section) 
b. Perineal tear e. In-hospital perinatal 
mortality 
 c. Puerperal infection f. injury to neonate 
 d. 30-day emergency 
readmission rates 
g. selected neonatal 
infections 
  h. 28-day emergency 
readmission rates 
10.3.1.2. Data extract 
The details of deliveries from 1 April 2009 to 31 March 2012 were extracted from the HES database. 
The indicator definitions were applied to the extract to obtain denominator and numerators, 
categorised by either month or day of admission (for maternal indicators) or birth (for neonatal 
records). The weekend analysis was restricted to 1 April 2010 to 31 March 2012 to reduce any bias 
from poorer coding in the preceding year.  
10.3.1.3. Case-mix adjustment 
Variables expected to influence the outcome of the association between the quality and safety 
indicators and day of admission/birth were extracted, including gestational age, birth-weight, and 
maternal age. A full set of case-mix factors and the method for risk-adjustment is covered in 
paragraph 9.4.2, p202.   
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10.3.1.4. Data analysis and software 
National performance across the measures was calculated, disaggregated by either month or day of 
admission/birth. Multiple logistic regressions were used to adjust to the effect of the covariates. I 
did not adjust for the clustering of patients within hospital as the hospital-level effects were found to 
be small (as shown in Chapter 9) except when including site level data (such as hours of consultant 
presence) as described explicitly below. Results were also displayed by plotting – using either April 
2009 (or Tuesday) as a reference – odds ratios and 95% confidence intervals, by month (or day) of 
delivery. 
 Analyses were carried out using SAS Version 9.2, using the PROC LOGISTIC and PROC GLIMMIX 
procedure for regression analyses.  
10.3.2. Additional ‘day of the week’ methodological 
considerations 
10.3.2.1. Defining ‘weekend’ 
Where results are presented as weekend versus weekday performance, the former was defined as 
the period from midnight on Friday to midnight on Sunday, with all other times defined as weekdays 
(the time of admission is not captured in HES). 
10.3.2.2. Estimating impact 
Using regression analysis on just Tuesdays, probabilities of in-hospital perinatal death and puerperal 
infections (maternal) were derived. By matching these probabilities for each Tuesday admission, 
based on the mother’s or neonate’s characteristics, indirectly standardised estimates for the 
outcomes as if those non-Tuesday cases had had similar rates as their Tuesday counterparts were 
calculated, with these particular results reported in the discussion. I used Tuesday (rather than 
Monday, as for the stroke analysis) as the reference since the neonatal indicators use date of birth to 
assign the day even through the outcome might be affected by the standard of care given to the 
mother during labour and, as such, Monday’s performance might be affected by quality of care over 
the weekend for non-same-day births.  
10.3.2.3. Amendments to indicators 
The amendments made to these indicators, for the purpose of this day-of-the-week study, were to:  
- use 3-day readmission rates for both maternal and neonatal indicators in keeping with the 
suggestion that it is a more appropriate timeframe to evaluate the association between 
day of admission and mortality.354,499  
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- drop the indicator for early caesarean sections as such deliveries are not scheduled during 
out-of-hours periods.  
10.3.2.4. Consultant presence 
Data on hours of consultant presence on the labour ward were collected obtained from two 
previous audits, by the National Audit Office152 and Royal College of Obstetricians and 
Gynaecologists (RCOG). 375 Data were linked using unit names with 100% completeness. A binary 
indicator of compliance with was created based on recommendations RCOG as set out in the table 
below (Table 54). The analysis was restricted to obstetric units and sites where data were reported 
for the obstetric and alongside midwifery unit combined. 
Table 54. Recommended levels of consultant presence 
Births per year Recommended minimum 
consultant presence per week 
2,500 – 4,000 60 hours 
4,000 – 5,000 98 hours 
5,000 +  168 hours 
Note: Source table quoted in National Audit Office report.
152
 
10.3.2.5. Association between levels of activity and performance 
The level of activity, A, was defined using the following equation:  
Au,y = {
     
    
∑      
   
     
     
    
∑      
   
     
  
where   u = unit u;  
d = day ϵ {1 April,…, 31 March}; 
y = year ϵ {2011, 2012} 
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10.4. Results 
10.4.1. Longitudinal analysis 
10.4.1.1. Overview of results 
Between April 2009 and March 2012, I identified around 4 million births and maternities. The most 
common adverse event was early caesarean section (37.50%) with the least common being in-
hospital perinatal mortality (0.67%) (Table 55). 
Table 55. Number of births and maternities and complication rates 
 Measure  Total 2009-10 2010-11 2011-12 
  Events, n % % % % 
 Maternities 1,979,360 - n = 646,525 n = 663,218 n = 669,617 
 Births 2,008,144 - n = 658,545 n = 670,814 n = 678,785 
a Early caesarean 
section 
49,074 37.50 39.5 38.0 35.2 
b Perineal tear 43,890 2.94 2.73 3.01 3.07 
c Puerperal 
infection 
15,521 0.78 0.68 0.74 0.93 
d 30-day maternal 
emergency 
readmissions 
18,423 1.02 1.04 1.04 0.99 
e In-hospital 
perinatal 
mortality 
13,402 0.67 0.67 0.66 0.67 
f Injury to 
neonate 
26,005 1.40 1.26 1.41 1.53 
g Selected 
neonatal 
infections 
38,156 1.91 1.74 1.90 2.08 
h 28-day neonatal 
emergency 
readmissions 
106,799 5.85 5.53 5.98 6.04 
Note: Percentage of cases meeting inclusion criteria. Readmission figures exclude final month of data year to allow 
comparability over years 
In the first instance, I plotted the rates per month to better understand what trends might be 
present (Figure 29). Some of the measures, such as early caesarean sections showed a relatively 
consistent trend over time and others, for example neonatal infections, showed a seasonal trend. 
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Figure 29: Trends in obstetric indicators, by month 
 
 
  
  
  
Note: Data points represent odds ratios, with April 2007 used as a reference (1.00); vertical ranges, 95% confidence 
intervals. 
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10.4.1.2. Analysis of longitudinal trends and seasonal effect 
The more detail analysis revealed that all indicators showed a statistically significant (at the 95% 
confidence level) linear longitudinal trend, with six of the eight measures showing a worsening in 
performance.  There were 8 instances of months with statistically different performance to the 
reference (April) at the 99.8% level, covering early caesarean sections, neonatal infections and 
neonatal readmissions (Table 56). 
Table 56. Longitudinal trend and seasonal effect1 
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Longitudinal 
trend 
0.990** 1.004** 1.014** 0.998* 1.003** 1.007** 1.009** 1.003** 2 6 
January 0.975 1.027 1.004 0.953 0.942 1.036 0.899** 1.049** 1 1 
February 1.001 1.032 1.067 0.985 0.927 1.026 0.920* 1.041* 1 1 
March 0.975 1.033 0.977 0.987 0.889* 1.002 0.837** 1.025 2 0 
April 1 1 1 1 1 1 1 1 - - 
May 0.957 1.033 0.978 1.063 1.011 1.076* 1.039 1.006 0 1 
June 0.948 0.957 1.049 0.99 0.968 1.092* 1.002 1.038* 0 2 
July 0.982 0.946* 1.090* 1.039 1.013 1.089* 1.019 1.003 1 2 
August 1.011 0.940* 1.073 1.026 0.957 1.074* 1.064* 0.975 1 2 
September 0.884** 0.955 1.06 1.024 1.049 1.018 0.98 1.023 1 0 
October 1.003 1.019 1.017 0.997 0.948 1.038 1.008 1.062** 0 1 
November 0.982 1.043 1.001 0.932 0.901* 1.047 0.957 1.141** 1 1 
December 1.125** 1.01 1.004 0.914* 0.939 0.99 0.934* 1.123** 2 2 
Note:  1. Longitudinal trend measured as linear, with positive odds ratio suggesting increasing complication rates. 
Seasonal trend measured as performance in month in comparison to April. 
2: Correlation significant at the 95% level marked with ‘*’; those at 99.8% level with ‘**’  
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10.4.2. Association with day of the week 
10.4.2.1. Descriptive overview 
The distribution of births is not even across the days of the week (Figure 30). The most common day 
for giving birth is a Thursday (15% of births and maternities) and the least common is Sunday (12%). 
Much of the difference is explained by number of elective caesarean sections performed during 
weekdays. 
Figure 30. Proportion of births and maternities and breakdown in number of elective caesarean 
sections, by day of week  
  
 
Table 57 gives a description of the characteristics of patients included in the study.  
Table 57. Characteristics of the study population 
Characteristic Categories Weekdays Weekends p-value 
Delivery method Spontaneous vertex  59.7 68.6 <0.001 
 Spontaneous, other cephalic 0.5 0.5  
 Low forceps, non-breach 3.9 4.6  
 Other forceps, non-breach 2.1 2.5  
 Ventouse, vacuum extraction 6.1 6.9  
 Breech 0.4 0.4  
 Breech extraction not otherwise 
specified 
0.1 0.1  
 Elective caesarean 12.7 1.5  
 Emergency caesarean 14.6 14.9  
 Other than those specified above 0.1 0.1  
Maternal age <19 5.1 5.8  
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 20-24 18.4 19.9  
 25-29 27.5 28.2  
 30-34 28.7 28.2  
 35-39 16.2 14.6  
 40 and over 4.1 3.3  
 Unknown    
Ethnicity White 72.3 71.8 <0.001 
 Asian 10.3 10.5  
 Black (inc. Black British)Afro-
Caribbean 
5.1 5.0  
 Mixed 1.5 1.5  
 Other (inc. Chinese) 3.3 3.4  
 Unknown / not stated 7.5 8.0  
Level of 
deprivations 
1 15.2 14.9 <0.001 
 2 16.3 16.0  
 3 19.0 18.9  
 4 22.1 22.3  
 5 26.5 27.0  
 ‘6’ 0.9 0.8  
Parity Primiparous 43.5 46.4 <0.001 
 Multiparous 56.5 53.6  
Gestational age < 37 7.6 7.4 <0.001 
 37-39 35.7 30.3  
 40-41 39.7 45.2  
 >=42 3.6 4.1  
 Unknown 13.5 13.2  
Birth-weight <2500g 5.9 5.4 <0.001 
 2500-4000g 74.1 74.7  
 >4000g 10.1 10.2  
 Unknown 9.9 9.7  
Multip Yes 1.6 0.9 <0.001 
 No 91.0 91.8  
 Unknown 7.4 7.3  
Previous caesarean section 12.8 6.9 <0.001 
Note: Data are for maternities 
10.4.2.1. Association between day of delivery and performance 
Table 58 shows the results of the association between weekday/weekend admission and 
performance in the seven measures of quality and safety. There were statistically significant 
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associations in four of the indicators, all of which were consistent with a lower standard of care at 
weekends. The largest effects were seen in the higher rates perinatal mortality rates (adjusted odds 
ratio [OR] 1.07; 95% Confidence Interval 1.02 – 1.13) and puerperal infections (OR 1.06; 1.01 – 1.11).  
Table 58. Association between weekday/weekend admission (or birth) and indicators of quality 
and safety of care 
Notes: CI denotes conﬁdence interval. 
Over the seven indicators, there were 11 examples of statistically significant differences 
performance of days in comparison to Tuesday. Compared to this reference day, all days bar 
Wednesday had statistically higher rates of perinatal mortality (Figure 31). 
  Weekday admission Weekend admission   
 Indicator Unadjusted   
% (number) 
Adjusted 
rate, % 
Unadjusted % 
(number) 
Adjusted 
rate, % 
p-value OR (95% CI) (weekday 
as reference) 
b Perineal tear 3.03 (22,299) 3.04 3.07 (8,249) 3.05 0.812 1.003 (0.977 – 1.030) 
c Puerperal infection 0.83 (8,358) 0.82 0.86 (2,770) 0.87 0.010 1.059 (1.014 – 1.107) 
d 3-day maternal 
readmissions 
0.20 (1,926) 0.20 0.18 (545) 0.18 0.135 0.929 (0.843 – 1.023) 
e In-hospital 
perinatal mortality 
0.64 (6,481) 0.65 0.73 (2,518) 0.71 0.007 1.071 (1.019 – 1.126) 
f Injury to neonate 1.43 (13,278) 1.45 1.59 (5,038) 1.53 0.002 1.055 (1.020 – 1.091) 
g Selected neonatal 
infections 
1.99 (19,900) 1.99 2.01 (6,852) 2.00 0.542 1.009 (0.980 – 1.038) 
h 3-day neonatal 
readmissions 
1.19 (11,323) 1.18 1.22 (3,976) 1.23 0.044 1.039 (1.001 – 1.078) 
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Figure 31: Association between performance and day of admission/birth 
Indicator ‘a. Early caesarean sections’  
not used in this part of the study 
 
  
  
 
 
Note: Data points represent odds ratios, with Tuesday used as a reference (1.00); vertical ranges, 95% confidence intervals. 
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The weekend effect varied by delivery method (Table 59).  
Table 59 Perinatal rates by delivery rates for common weekend delivery methods  
 Weekday  Weekend   
Delivery method Unadjusted   
% (number) 
Adjusted 
rate, % 
Unadjusted   
% (number) 
Adjusted 
rate, % 
OR (95% CI) (weekday 
as reference) 
Spontaneous 
vertex  
0.57 
(484,998) 
0.76 0.61 
(189,210) 
0.80 1.059 (0.983 – 1.140) 
Unknown 1.12 
(133,424) 
0.64 1.36 
(45,527) 
0.76 1.202 (1.093 – 1.322) 
Emergency 
caesarean 
0.60 
(116,280) 
0.40 0.58 
(42,513) 
0.41 1.035 (0.890 – 1.204) 
Ventouse, 
vacuum 
extraction 
0.16 
(48,887) 
0.34 0.11 
(19,161) 
0.23 0.676 (0.415 – 1.103) 
Spontaneous, 
other cephalic 
0.81 
(36,496) 
0.96 0.79 
(14,094) 
0.92 0.946 (0.746 – 1.199) 
Low forceps, non-
breach 
0.20 
(29,509) 
0.39 0.17 
(11,704) 
0.33 0.836 (0.501 – 1.397) 
Note: Common weekend delivery methods defined as > 5,000 deliveries per year at weekends 
10.4.2.1. Association between activity and performance 
For sites, high activity times accounted for 9.67% of maternities and 10.09% of births. For trusts, the 
corresponding figures were 11.10% and 11.37% respectively. The logistic non-hierarchical regression 
model suggested higher perinatal mortality rates at busy times (Table 60). However, when provider-
level effects are added, this raised mortality is no longer statistically significant at the 95% level. 
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Table 60. Association between business and complication rates, for weekdays April 2010 – March 
2012 
 Trust level1 (busy vs not 
busy) 
Trust level1 with trust 
effects (busy vs not 
busy) 
Unit level with unit level 
effects2 (busy vs not busy) 
Measure OR  
(95% CI)3  
p-
value 
OR  
(95% CI)3  
p-
value 
OR  
(95% CI)3 
p-
value 
Perineal tear 0.986  
(0.943 – 1.031) 
0.55 0.981  
(0.938 - 1.027) 
0.41 0.999  
(0.951 - 1.049) 
0.98 
Puerperal infection 0.999  
(0.930 – 1.073) 
0.98 0.953  
(0.887 - 1.026) 
0.20 0.957  
(0.884 - 1.036) 
0.28 
Maternal 
readmissions 
0.992  
(0.929 – 1.060) 
0.82 1.028  
(0.933 - 1.131) 
0.58 0.998  
(0.902 - 1.105) 
0.97 
In-hospital 
perinatal mortality 
1.101  
(1.014 – 1.195) 
0.02 1.072  
(0.985 - 1.166) 
0.11 1.048  
(0.956 - 1.148) 
0.32 
Injury to neonate 1.022  
(0.965 – 1.082) 
0.46 0.957  
(0.903 - 1.015) 
0.14 0.948  
(0.89 - 1.01) 
0.10 
Selected neonatal 
infections 
1.008  
(0.962 – 1.056) 
0.74 0.977  
(0.93 - 1.025) 
0.33 0.972  
(0.923 - 1.025) 
0.29 
Neonatal 
readmissions 
1.025  
(0.997 – 1.053) 
0.08 1.002  
(0.975 - 1.03) 
0.90 1.004  
(0.975 - 1.034) 
0.79 
Notes: 1. Trusts with > 1000 births per year 
2. Sites with > 100 births per year 
3. OR denotes odds ratio of busy periods (quintile 5) v. other times (quintiles 1 – 4) as 
reference; CI denotes Confidence interval 
4. Accounting for trust/site effects using multi-level model 
 
10.4.2.2. Consultant presence 
Within the maternity extract, 51 of the 128 units (39.8%) with a recommended level of consultant 
presence were compliant. There were statistically significant differences in rates of perineal tears 
between compliant (2.95%) and non-compliant (3.29%) sites (Table 61). There were no statistically 
significant differences across the other measures and, likewise, further analysis against the revised 
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3-day neonatal readmissions (p = 0.83) and 3-day maternal readmissions (p = 0.89) showed no 
significant effects. 
Table 61. Association between compliance with consultant staffing levels and indicators of quality 
and safety of care 
  Unadjusted, % (number) Adjusted 
 Measure Compliant Non-
compliant 
OR (95% CI) (non-
compliant vs compliant)1 
p-value 
b Perineal tear 2.95 (3,916) 3.29 (9,443) 1.205 (1.001 – 1.450) 0.05 
c Puerperal 
infection 
0.76 (1,345) 1.07 (4,149) 0.913 (0.535 – 1.557) 0.73 
d 30-day maternal 
readmissions 
1.10 (1,779) 0.95 (3,336) 1.006 (0.770 – 1.315) 0.97 
e In-hospital 
perinatal 
mortality 
0.60 (1,026) 0.75 (3,076) 1.209 (0.852 – 1.716) 0.29 
f Injury to neonate 1.59 (2,513) 1.46 (5,481) 0.829 (0.460 – 1.494) 0.53 
g Selected neonatal 
infections 
2.04 (3,468) 2.28 (9,342) 1.311 (0.789 – 2.177) 0.30 
h 28-day neonatal 
readmissions 
6.48(10,022) 5.76 (21,400) 0.936 (0.730 – 1.200) 0.27 
Notes: 1. OR denotes odds ratio of compliant v non-compliant performance; CI denotes conﬁdence 
interval.  
 
10.5. Discussion 
10.5.1. Summary of findings on seasonality 
We examined over 2 million deliveries across a three-year period. The longitudinal analysis showed 
that administrative data could be used to identify potentially important trends in obstetric care 
quality and safety. The analysis suggests that there are associations between month of delivery and 
outcomes. Notably, there are raised rates of neonatal readmission during the winter months 
(October to January). Interestingly, there is a substantial increase in early caesarean section rates in 
December, with one possible hypothesis being that NICE guidelines are not followed due to a lack of 
available slots to conduct elective caesareans during holiday season. There is no consistently poorer 
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month but I would suggest aiming for September and March would put the odds in your favour. The 
analysis provided some evidence to suggest there could be some poorer outcomes in July and 
August, a hypothesis that was rejected by a previous study on small preterm infants in USA.507 
10.5.2. Day of week 
10.5.2.1. Summary of findings 
The study demonstrated that babies born at the weekend have an increased risk being still born or 
dying in hospital within the first 7 days. Moreover, the study also suggests that other increased 
complication rates at weekends, with higher rates of puerperal infection, injury to neonate and 3-
day neonatal emergency readmissions.  
10.5.2.2. Impact: magnitude of weekend effect 
I calculated, as described in the methods section, that the study suggests there are some 750 
potentially avoidable perinatal deaths each year and an excess of 450 maternal infections if 
performance seen at the reference day, Tuesday, was replicated on other days.  
There are also reasons to suggest that the inequality of care is more pronounced than identified in 
this study. If the effect is indeed caused by a staff deficiency and a lack of resources, then you would 
expect poorer quality and safety at all out-of-hours periods during the week, including bank holidays 
and weekday evenings and nights. If this is the case, then the out-of-hours periods during weekdays 
are masking some of the effect.  
10.5.2.3. Amenable: resource levels 
There are several possible explanations for these findings, including a lack of consultant obstetrician 
presence. This study provided some evidence to support the theory that one of the contributing 
factors to the ‘weekend effect’ might be failure to meet recommended levels of consultant 
presence.  The association between consultant availability and performance also provides some 
evidence that the ‘weekend effect’ is amenable to the provision of healthcare. 
On the analysis of the effect of activity on performance, there were not statistically significant 
variations, although the raised mortality at busy period might warrant further investigation. While 
based on a similar approach in the existing literature on measuring the association between levels of 
activity and outcomes, which concluded that hospitals that operate at or over capacity may 
experience heightened rates of patient safety events,508 a more sophisticated indicator for relative 
activity could be developed further. 
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10.5.2.4. Precision 
The indicators identified a wide range of performance, by day of admission/birth, with statistically 
significant differences in four of the seven indicators, with further differences identified by 
disaggregating to day of the week. 
10.5.2.5. Minimum bias 
HES data do not include information on the time of admission and therefore I was not able to 
investigate the wider issue of the quality of out-of-hours care in this study. Other limitations should 
also be noted. Firstly, the administrative database used gives only limited information on the 
complexity of the delivery. Whilst I used a number of variables, such as Charlson index and number 
of previous admissions, to mitigate for any bias in case mix between admissions on different days of 
the week, there is no information on, for example, maternal obesity or smoking (as discussed in 
paragraph 9.6.4.1, p217). This may be important since a Canadian study identifying higher rates of 
early neonatal deaths from 1985-99 in weekends (OR 1.11, 95% CI 1.07 – 1.16) found these 
differences were no longer significant after risk-adjustment (0.96, 0.91 – 1.01),509 albeit another 
study found that adjusting for maternal characteristics had no material effect.510 A further limitation 
is that the administrative data can contain errors; however, you would not expect this to be different 
in the coding of weekday or weekend admissions.  
I stratified one of the key results – in-hospital mortality – by mode of delivery to further investigate 
potential bias. For the most common delivery method, spontaneous vertex, the likelihood of 
perinatal mortality was higher at weekends than for weekdays, although this was not significant at 
the 95% confidence level (odds ratio: 1.059, 95% confidence interval: 0.983 – 1.140). 
10.5.2.6. Construct validity 
That many of the indicators identified evidence of an association between performance and day of 
delivery, and further analyses revealing lower level of specialist staffing also being associated a 
poorer outcome, provides evidence of construct validity. However, in lieu of having multiple 
comparable units – as with the cross-sectional analysis in the previous chapter – I have provided 
some assurance on validity by comparing consistency with previous literature. The results from this 
study are consistent with some previous results, including: 
- Elsewhere in the UK, where a study in Scotland found adjusted weekend neonatal death of 
1.3 (1.0 – 1.6, compared to weekday in-hours) which is similar for all out-of-hours 1.3 (1.1 
– 1.6).510 Another study from the same country, while also finding the same effect, 
identified that a primary reason for the out of hours deaths was intrapartum anoxia.510 
Chapter 10: Obstetrics temporal trends 
243 
 
- Further afield, in Australia early neonatal deaths were much higher at weekends (by 29%, p 
<0.001)504, and with a similar affect size (27%) found for neonatal deaths for infants born 
on Sundays.509 However, other studies, including those from Canada and USA rejected the 
hypothesis of greater complications at weekends.507,509 
10.5.2.7. Further work 
Further work is needed to understand what organisational factors might influence the ‘weekend 
effect’ and to investigate centres that have reduced the disparities in access and outcome in out-of-
hours care. A starting point for this is to allow hospitals to compare the extent of the ‘weekend 
effect’ in their organisation to that in their peers.  Other future work to add to this analysis could 
include: 
- Further sensitivity analysis by removing difficult cases and therefore reducing potential bias 
in case-mix. For instance, the analysis could be repeated excluding: cases with gestation 
age either missing or outside 37-43 weeks; and perinatal deaths ascribed to congenital 
abnormality or rhesus isoimmunisation, stillbirths and non-cephalic deliveries.510 
- Analysing the time of onset of the complication as well as the time of delivery. For instance, 
previous work has looked at the date of death as well as the date of birth 505 but there is 
difficulty in interpreting date of death from antepartum and intrapartum still births.509 
- Looking at all out-of-hours periods, with inconsistencies in the existing literature on how to 
account for holiday periods. 445, 503,505 
10.5.3. Conclusion 
There is also scope to extend this analysis to other specialties, with similar results having also been 
found in a limited number of other clinical areas, such as pulmonary embolism, hip fractures and 
upper gastro-intestinal haemorrhage.354 A greater understanding of the issue will also require better 
data, and the inclusion of an out-of-hours admission flag for hospital administrative data should be 
considered. 
This chapter shows that it is possible to address some of the potential bias from case-mix and coding 
practice using longitudinal analyses; however, given the changes in coding practice over time which 
coincides with potential changes in service provision (and therefore hard to detect) this application 
is still susceptible to bias. The analysis by day of the week addresses most of the coding and risk-
adjustment issues raised in the previous chapters and, therefore, permits more robust conclusions in 
what is, coincidentally, as a very high impact area. 
 244 
 
Part IV:  
Discussion, 
recommendations 
and appendices 
 
Chapter 11: Discussion 
245 
 
Chapter 11.  
Discussion 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 Current 
measurement 
Case for 
specialty-
specific use 
Stroke 
 
Review of 
current 
indicators 
 
Obstetrics 
Stroke 
 
Application: 
validating 
common uses 
 
Obstetrics 
Stroke 
 
Application: 
temporal 
analyses 
 
Obstetrics 
Discussion  
Part IV: Discussion, recommendation and appendices 
246 
 
11.1. Summary 
‘While most people are in favour of measurement,  
few are comfortable being measured.’ (Loeb 2004, p i6) 
11.1.1. Overview 
11.1.1.1. Quality measurement revisited 
Using administrative data to measure the quality and safety of hospital care offers many 
opportunities. However, progress has been limited to few countries and predominantly to a small 
subset of broad measures, such as Hospital Standardised Mortality Rates. In this thesis, I investigate 
the potential advantages and feasibility – in terms of validity and applicability – of specialty-specific 
indicators. 
Measurement of hospital outcomes is longstanding; at least dating back to the standardised 
mortality data published by Florence Nightingale in the early 1860s.511 Yet there remain calls for 
further development of indicators. The project described here addressed this, in part, through 
developing two sets of specialty-specific indicators (Chapters 4 and 8). As exemplified in the 
conclusions to a report on the failed Mid-Staffordshire NHS Foundation Trust, a greater consensus 
on how they are applied is needed.512 To address this, I outlined the key implications regarding the 
current use of indicators and summarised important methodological considerations in Chapters 1 to 
3 and, subsequently, I tested and explicitly outlined key assumptions in applying the chosen 
indicators (Chapters 5 and 9). 
11.1.1.2. Structure of this chapter 
Given the shortcomings in quality measurement, coupled with the inexorable rise in the use of 
administrative data, it is important that researchers, practitioners and policy-makers focus on 
making best use of such datasets and related studies. The implications of the studies described here 
for researchers (see section 11.3), the collection of the data (11.4), clinicians (11.5) and policy-
makers (11.6), along with some more general commentary from existing literature, are all covered in 
this discussion. These implications are preceded by a summary of the results in relation to the study 
hypotheses (11.1.2) and an overview of the methodological implications (11.2).  
11.1.2. Summary of findings, by hypothesis 
11.1.2.1. Hypotheses revisited 
The project was designed to test three hypotheses (paragraph 2.7.1, p59) regarding measuring the 
quality and safety of hospital care using specialty-specific indicators based on routinely collected 
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administrative data. Two of these hypotheses focused on the advantages of a specialty-specific 
approach (to create a bundle of indicators and better validate indicators) with the third, more 
generally, on the value of the temporal nature of administrative data.  These propositions (in bold), 
along with a summary on how they were covered in the studies, are given below. 
11.1.2.2. Hypothesis 1: Indicator bundles 
A specialty-specific approach to developing indicators can result in a more useful and valid bundle 
of indicators to identify quality and safety issues. There has been a long-standing recognition that 
most efforts to measure performance have concentrated on mortality rates50 and, consequently, 
there is a need to develop – for the purpose of monitoring hospital performance – additional non-
mortality outcomes or process measures.49 Four particular studies in the thesis supported this 
hypothesis, with the literature reviews (Chapters 4 and 8) showing high level of sensitivity for 
identifying indicators, while the experimental studies applying a sample of the indicators (Chapters 5 
and 9) highlighted benefits in terms of additional validation opportunities. 
The numbers of papers identified in the two literature reviews were also similar to those identified 
from an exercise to identify the broader category of all patient safety indicators (some 124 papers),67 
giving support to the assertion that the specialty-specific approach to identifying literature has good 
sensitivity (ability to identify relevant research). This is important since some of the prominent 
quality and safety initiatives, such as AHRQs patient safety indicators, have been developed using 
general (non-specialty) literature reviews and, as such, have not been based on a full assessment of 
existing evidence on, say, validity of existing measures. 
It is briefly worth noting that as a rudimentary check, it was reassuring that the magnitude of 
abstracts identified through the search of electronic databases (1,999 for stroke; 1,670 for 
obstetrics) and full texts extracted (99 for stroke or 5.0% of abstracts identified; 80 for obstetrics or 
4.8% of abstracts) were similar. This provides some evidence to suggest that the sensitivity and 
specificity of the specialty-specific literature search reviews were reasonable. 
This ability to identify a more comprehensive range of indicators meant that I was able to apply 
broad indicator sets. I identified 20 categories of stroke indicators and 44 for obstetrics, and I 
applied 6 and 8 indicators, respectively, in the experimental studies. The advantage of applying 
bundles of indicators means that this project had higher content validity (the extent to which the 
measurement represents all facets of the area being investigated) than many existing studies 
identified through the literature reviews, which often applied just a single indicator, such as 
mortality rates, capturing only a very small proportion of the total possible complications. As health 
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services continue to improve, the focus on quality and safety is likely to continue to broaden – so 
moving further away from simple mortality – which lends support for the more holistic approach to 
measuring performance that I present here. 
11.1.2.3. Hypothesis 2: Validation 
Hospital-level comparisons could be improved through more robust validation techniques (coding 
practice, indicator comparison and organisational factors). Through the work, I demonstrated that 
investigating correlations between indicators, association with organisational factors, and the effect 
of coding practice, can all provide further assurance on levels of bias, construct validity, and 
amenability of quality and safety measures. The following results, in particular, are noteworthy:  
- I was able to demonstrate that coding depth explained only some of the variation in 
performance, even across measures that are dependent on the recording of secondary 
diagnoses (i.e. aspiration pneumonia within stroke patients, injury to neonate and perineal 
tear) and, therefore, most susceptible to such bias.  
- As well as providing more assurance on content validity (as discussed above), the study 
design – applying a bundle of indicators – had the advantage of allowing the evaluation of 
construct validity by comparing hospitals’ performance across all the measures. The vast 
majority of existing literature has failed to take advantage of this validation method, even 
when more than one indicator is applied. I was able to identify interesting associations; for 
example, trusts with higher scanning rates have lower stroke mortality (p < 0.05) and, for 
obstetrics, sites with higher maternal readmission rates also had higher levels of perinatal 
mortality (p < 0.001).  
- There was some evidence to suggest that staffing is important to quality and safety. In 
particular, I found that lower midwifery staffing levels (i.e. higher birth-to-midwife ratios) 
were associated with higher perinatal mortality, and lower consultant presence within 
delivery wards associated with higher rates of perineal tears (both at p = 0.05).  
While I showed that other applications (i.e. not benchmarking hospitals) hold advantages, as 
discussed in the following paragraphs, the investigatory work on validity of hospital-level 
comparisons is important since this remains a dominant use of these indicators.  
11.1.2.4. Hypothesis 3: Temporal nature 
The temporal nature of administrative data can be used to overcome some of the limitations of 
such indicators and highlight important quality and safety issues. Three studies presented here 
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(Chapters 6, 7, and 10) demonstrated how significant issues in healthcare can be identified using the 
longitudinal nature of the dataset in a robust way. This application of the indicators also has the 
advantage of controlling for the variations in coding practice over time and between hospitals. The 
evaluation of the association between day of admission (or delivery, for obstetric measures) and 
complication rates was the first comprehensive assessments of this issue in England for these two 
specialties by applying multiple indicators so having higher content validity.  
As well as controlling for some of the possible bias, the temporal application also suggested 
significant shortcomings in care. For example, 7-day stroke in-hospital mortality was 10.6% at 
weekends compared to 8.9% at weekdays (adjusted OR 1.178, 95% CI 1.120 – 1.240). Similarly, the 
perinatal mortality rate was 7.3 per 1,000 at weekends, some 0.9 per 1,000 higher than at weekdays 
(1.071, 1.019 – 1.126). By matching cases between out-of-hours and in-hours cases, I was also able 
to estimate the scale of avoidable harm. For instance, in stroke care, the study suggested there are, 
each year, some 250 potentially avoidable in-hospital deaths within 7 days and an additional 650 
people could be discharged to their usual place of residence within 56 days if the performance seen 
at weekdays was replicated at weekends. 
I was also able to use the temporal nature of administrative data to evaluate the existence of 
seasonal trends in obstetric care and the effect of a regional reform of stroke services. In both cases, 
I found potentially important differences in the quality and safety of care with, for example: a 
significant reduction in 7-day stroke mortality within the region that had undergone a service 
restructuring, in comparison to other areas; and raised rates of neonatal readmissions during winter 
months.  
11.2. Methodological issues 
11.2.1.1. Introduction to study limitations 
Methodological issues related to the specific studies were raised in the previous chapters’ 
discussions. However, some general limitations about the approach taken are worth noting when 
considering the implication of the work as a whole.  
11.2.2. Limitations to development of indicator sets 
11.2.2.1. Addressing limitations in review process 
The limitations of this review process include the potential bias introduced from the use of a single 
reviewer. No formal meta-analysis could be undertaken because of the heterogeneity in study 
methodologies and underlying data frameworks and I did not use a template to assess the quality of 
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the papers since there was a very diverse range of purposes across the studies. Despite the 
limitations, the literature reviews shared the features of a systematic, rather than narrative, review 
(paragraph 3.4.2.3, p72). However, there could be benefits to future research in using a more 
resource-intensive review process which, at least, could improve face validity of results. 
11.2.2.2. Selection of indicators  
One limitation of the framework was in the bias towards measuring what has previously been 
measured. Whilst having peer-reviewed articles on particular indicators may support face validity, it 
may bias future work towards such indicators. There would be value in complementing such 
literature reviews with further exercises to develop indicators in areas which are not covered by the 
existing measures. 
The design of the study was, in the first instance, based on a prospective analytical framework, and 
supplemented reactively – formed on the basis of the gaps in the literature. I used a range of 
experts, from coding specialists to medical consultants to help develop the indicator set; however, I 
did not use any formal approach to reach consensus. This could be considered in future research; for 
instance, if there are sufficient resources available an approach such as RAND’s Delphi method could 
be applied.  
11.2.3. Indicator validation 
11.2.3.1. Lack of ‘gold standard’ 
Ensuring that indicators are not just easy to apply, but also have appropriate validity, is important: 
“something that’s measurable may not be worth measuring, and maybe you can’t measure the 
things that are worth measuring. What damage do you do by releasing information just because you 
can measure it?”(GP quote, p 1280) 513 A review, published in 1998, by Fitzpatrick and colleagues 
outlined the key aspects of validity of patient-based outcome measures albeit in the context of use 
in clinical trials.142 The approach used in this study tallies well against this and other such 
frameworks. However, many aspects and tests of validity (e.g. concurrent, convergent and 
discriminative) depend on the existence of a ‘gold standard’ to provide a basis for comparison; if no 
gold standard exists, they represent a form of construct validity in which the relationship to another 
measure is hypothesised. It is, therefore, an inherent weakness that no absolute, incontestable 
statement on validity of indicators can be made here. 
11.2.3.2. Minimum bias 
This study provided the most comprehensive assessment to date on the effect of coding practice. 
While the analysis on both specialties suggested that key issues around variations in coding practice 
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only partially explain variation in performance against the indicators. However this was not 
comprehensive, with other potential variations in coding practice remaining untested.  
The application showed that you can adjust for the measured case-mix factors by building 
converging regression models. However, the extent to whether this is sufficient remains debated 
with some suggesting that good risk adjustment is possible514 whereas others, for instance, 
highlighted that there is bias in the coding of medical records which has implications on the 
administrative data derived from it.106 The lack of some key clinical factors within administrative 
data is an inherent limitation when comparing units with different case-mixes. 
11.2.4. Limitations to findings on shortcomings in care 
11.2.4.1. Reference day 
As highlighted in some of the exploratory work on stroke care trends (paragraph 6.5.2.2, p146), the 
choice of reference period when comparing performance has a significant effect on the derived odds 
ratios. One inconsistency in my approach to the stroke and obstetric out-of-hours analysis should be 
noted. For the latter I used Tuesday (rather than Monday, as for the stroke analysis) as the reference 
day. This decision was made a priori as, on Mondays, large numbers of babies are born to women 
who have received care during the weekend and, as such, this day does not represent a typical in-
hours day. Ideally, the analysis would be able to disaggregate between all in-hours and out-of-hours 
periods but the data used does not include a time field (rather only date) and this is covered later 
(11.4.2.6, p260). 
11.3. Future research 
11.3.1.1. Introduction to future research 
Some specific areas of future research are covered in early chapter discussions. A few notable areas 
are outlined here, covering: the development of indicator sets within other specialties; areas for 
further research within stroke and obstetric specialties; the development of reporting standards for 
similar research; and an outline of which study designs for such indicators might be fruitful.  
11.3.2. Developing indicator sets for other specialties 
11.3.2.1. Introduction 
An obvious area for expanding this project is to transfer the approach for identifying indicators to 
other specialties. This section covers why the specialty-specific approach was worthwhile, then sets 
out a framework for considering what specialties to choose for similar interrogation, and finishes by 
setting out the importance of publishing the resultant indicator set. 
Part IV: Discussion, recommendation and appendices 
252 
 
11.3.2.2. Advantage of the specialty-specific approach 
The specialty-specific reviews proved useful to developing an indicator set. For both specialties, the 
increase in research has been similar (50% per annum for stroke, 60% for obstetrics) with few 
studies prior to 1990 (as expected since few large administrative datasets were available before 
then, as highlighted in paragraph 2.1.1.2, p39. This increase is likely to reflect both the growth in 
agreed indicator sets, which even if not directly relevant to the specialties supports a culture of using 
administrative data to monitor performance, and increasing access to these databases. Both 
specialties yielded a substantial number of indicators (as discussed below), with many of these 
appearing regularly in a range of the literature, including peer-reviewed articles. The implication is 
that future research on developing indicator sets to measure performance should not rely solely on 
generic searches of indicators and instead consider using speciality-specific terms.  
Similarly, I found there are advantages of looking at more than one specialty. For example, I was able 
to learn from different maturation of each specialty’s research, and applied a technique for 
evaluating coding practice that had been used in one of the specialties (stroke) to the other specialty 
(obstetrics).263  I focused on two specialties, both within acute care, and while this scope was shown 
to be appropriate – with proven importance and difference between specialties – not all lessons will 
be generalisable. The implication is that there is value in expanding the application of indicators to 
other specialties. 
11.3.2.3. Choosing other specialties 
Making the assertion that there is value in expanding this approach to other specialties also raises 
the question of which would be the most fertile area to expand into. Table 62 shows that comparing 
the two specialities does not give a clear direction on whether one specialty outperformed the other 
as a subject for such reviews. The high number of obstetrics indicators could suggest high content 
validity by representing more facets of the subject of evaluation. Yet for the obstetrics study, 
indicators are limited to perinatal care whereas the stroke analysis included indicators across the 
pathway. For the former, this suggests reasonable content validity if perinatal care is the subject but 
not necessarily the case if all obstetric care. While not giving a prioritisation for which specialties to 
apply this approach to next, this work does provide a framework to compare facets of specialties 
(Table 9, p69) and shows that relatively disparate specialties can both provide interesting insight 
though the literature-review process.  That said, development should be directed to account for 
both clinical importance (e.g. impact and amenability) and methodological feasibility (e.g. scientific 
soundness and applicability). 
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Table 62. Systematic review findings in relation to analytical framework 
  Domain Both Stroke  Obstetrics 
Im
p
o
rt
a
n
c
e
 1. Impact (+) Clearly articulated policy 
importance and known issue 
  
2. Amenable  (+) Evidence of effect 
of organisational 
differences 
(+) More benchmarks 
of acceptable 
performance 
S
c
ie
n
ti
fi
c
 s
o
u
n
d
n
e
s
s
 o
f 
in
d
ic
a
to
rs
 
3. Face and content 
validity 
(+) Range of (peer-reviewed) 
indicators 
(-) Fewer measures  (-) Indicators focus only 
on perinatal part of the 
pathway 
4. Precision  (+) Known variation   
5. Construct validity (-) No “gold standard” 
(-) Few bundles used 
(+) More process 
indicators to 
supplement outcome 
measures 
(+) More indicators 
focused on the same 
construct (i.e. more 
opportunity for 
convergent validation) 
6. Minimum bias (+) Model fit often described 
(-) No consistency or transparency in 
risk model 
(+) Many indicators applied to 
administrative data 
  
A
p
p
li
c
a
b
il
it
y
 
7. Data availability (+) Examples of administrative data 
being applied 
(-) Few studies on ICD-10 data 
  
8. Reporting burden (+) Many examples of previous 
reporting 
  
9.  External and 
ecological validity 
(-) Predominantly based on USA data 
and ICD-9 coding framework 
(-) Lack of transparency 
  
Notes: The positives (+) for one of the specialties can be interpreted as negatives (-) for the other specialty in this 
comparison. These converse arguments are not presented for brevity. 
11.3.2.4. Publishing indicator sets 
The literature reviews also provide some evidence to suggest that areas with published indicator 
sets have benefited accordingly from increased volume of, consistency across, and evaluation within, 
research. Whilst comparisons between the numbers should be treated with caution, a crude cross-
check of the categories of indicators identifies more within obstetrics (42) than in stroke (20). The 
difference may be merely the natural result of the coding frameworks being more appropriate for 
identifying obstetrics complications and the fact that for this specialty there are two sets of data (the 
mother and baby records). However, this could also reflect the influence of the widely recognised 
indicator sets, with a number of obstetrics indicators appearing, for instance, the AHRQ PSIs. This 
latter hypothesis is supported by the fact that there was more regularity in the use of indicators in 
these sets even outside their country of creation. If true, the implication is that developing and 
publishing indicator sets can create a culture of measurement so proliferating indicator numbers and 
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improve the use of administrative data, increasing the amount and consistency of research and, 
resultantly, allowing better benchmarking of performance (indeed, I found that there were more 
published indicative benchmarks for acceptable performance against the obstetrics indicators than 
for the stroke research). 
11.3.3. Further research within these specialties 
11.3.3.1. Introduction to further research within stroke and obstetrics care 
The stroke and obstetrics studies highlighted some areas for further research within these 
specialties. In particular, within the two specialties, there would be value in: conducting further work 
to improve the indicators; applying the indicator set used here in other countries; and better 
understanding some of the associations between organisational factors and performance. 
11.3.3.2. Improving the stroke and obstetrics indicators 
As stated above, the studies in this thesis suggested need for further research on validity, which is 
echoed in the existing literature. The utilisation of such measures – whether, for example, for 
internal benchmarking by hospitals or for regulation – must be in proportion to the confidence over 
the validity of the individual indicators. So, as well as tempering current reporting to the present 
validity of indicators, efforts should also be made to improve the validity of the indicators. Indeed, in 
addition to developing new indicators (as per section 11.3.2), there have been calls to further 
develop those that already exist. In fact, the WHO stated that “existing measures should be refined 
and further validated.”(p11)515  
In the editorial introduction to the first major set of quality indicators – CSP, Iezzoni et al (1992) – 
the commentator states that they “believe the algorithms will prove difficult to improve 
upon.”(p361)50 History has proved this statement to be wrong with incremental improvements in the 
approaches to using administrative data (as well as some retrograde steps) having been made, and 
this monograph continues the important development. In terms of validating the indicators applied 
to the data, again the existing literature across the two specialties was limited with the most 
common techniques using different risk-adjustment models and comparing results to other sources. 
Further work should continue across all the aspects of validity highlighted in this study. 
11.3.3.3. Application of the two indicator sets to other healthcare services 
For both specialties, the majority of studies were based on data from the USA and using ICD-9 data, 
which is consistent with previous literature on measures derived from routinely-collected 
datasets.137 The geographical coverage of the obstetrics’ studies was greater than in for the stroke 
research; however, this may reflect differences in the search strategies, with the obstetrics review 
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able to include foreign language articles. Some of the indicators and findings presented here might 
be specific to the NHS and its datasets and so further research should focus on less well-researched 
health services.  
11.3.3.4. Addressing specific research gaps  
Across stroke and obstetrics research, many studies have focused on the association between 
performance against the indicators and different hospital characteristics. However, while stroke 
indicators were used to evaluate different service types, such as the use of stroke units, no studies 
based on administrative data had looked explicitly at different modalities for obstetrics delivery. This 
may reflect homogeneity in the organisation of services in some countries, although this explanation 
does not hold everywhere with, for instance, the proliferation in midwifery units – as an alternative 
to hospital obstetrics units – in England. The challenge for such research – as highlighted in 
particular on the discussion on evaluating stroke services in London and effect of size of stroke units 
– is to fully recognise that different modalities might have heterogeneous case-mixes and not all 
such factors might be measurable within the data. 
More generally, the research presented in this thesis found some evidence to suggest performance 
is associated with staffing levels. Further work is required to confirm these relationships, including 
an exploration of the cause. 
11.3.4. Developing reporting standards 
11.3.4.1. Transparency as a methodological strength of this study 
Citing possible bias due to differences in hospital-level coding has become almost a default, generic 
limitation to include when writing up research on the use of administrative data to compare 
between providers performance. However, this project aimed to quantify this potential bias. More 
widely, this study benefited from being explicit about assumptions, methods and model fit.  
In comparison, across the existing literature, there was a similar lack of consistency and 
transparency in the strategies used for case ascertainment for both the obstetrics and stroke 
research. Likewise there were a plethora of strategies used for accounting of potential patient 
confounders, ranging from risk-adjustment models including only age to others combining diagnosis, 
procedure, demographic and case-mix factors.   
11.3.4.2. Recommendation to develop reporting standards 
Given the lack of consistency in the application and reporting of studies using administrative data, a 
natural conclusion would be to introduce a checklist or similar process to standardise the research 
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and, therefore, improve interpretability and generalisability. Indeed, in 2002 a study by the Agency 
for Healthcare Research and Quality called for more work on identifying and resolving quality rating 
issues for observational studies.162 Generic existing scoring system on quality of studies – such as 
Grading of Recommendations, Assessment, Development and Evaluations (GRADE) 512 – lack the 
specific requirements needed to add transparency to studies using administrative data for which 
non-randomness places an importance on risk-adjustment techniques. In fact, even checklists on 
observational studies such as Strengthening the Reporting of Observational Studies in Epidemiology 
(STROBE) guidelines fail in this same respect.516 Such research might start with the most recent 
version of the Cochrane Handbook which contains guidance on dealing with non-randomised studies 
in systematic reviews of interventions, from the protocol to synthesis stages.517 In particular, such 
reporting should include details on: data fields interrogated; diagnosis and procedure codes used in 
the indicator algorithms; the case-mix model fit; and validation techniques applied.  
11.3.5. Study designs 
11.3.5.1. Introduction 
I applied the indicators using a range of different experimental designs to evaluate the specialty-
specific indicators based on routinely-collected hospital administrative data. In all these applications, 
and across both specialties, the studies revealed that the area was important (e.g. through 
estimating potentially avoidable deaths) and that performance could be discriminated (e.g. the high 
numbers of statistical outliers); however, each design has inherent the strengths and weaknesses as 
summarised below (Table 63, with a more comprehensive assessment of performance of each 
approach against the analytical framework given in the respective chapters). A few key study designs 
which could be fruitful areas for further research are described in more detail below. 
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Table 63. Summary of strengths and weaknesses of the hospital and patient-level approaches 
 Hospital-level analysis Longitudinal Regional reform Day of week 
Study design Cross-sectional Cross-sectional Quasi-experimental Cohort 
Key 
strengths 
Discriminates even 
after accounting for 
some coding variations 
Hospital-level trends 
will control for some 
hospital level 
influences on coding 
Ability to compare 
with both historical 
performance and 
that of control 
group 
Unlikely to have 
variation in coding 
by day of the week 
Key 
limitations 
a. Bias from 
unaccounted 
variations in coding by 
hospitals 
b. Bias within regional 
networks with added 
heterogeneity of 
patients between 
hospitals 
a. Evidence that 
coding practice is 
changing over time 
b. Variation in case-
mix over time 
a. Case-mix 
changes due to 
reorganisation 
b. Uncertainty of 
counter-factual 
a. Possibility of 
unmeasured 
variation in case-mix 
by day of the week 
 
11.3.5.2. Epidemiological studies 
There is a longstanding understanding that the patient factors (e.g. co-morbidity and age) and 
hospital factors (e.g. coding and numbers of caesareans performed) associated with adverse events 
are important.47 Yet epidemiological studies are difficult, with challenges to interpret findings when 
there are biological explanations for risk factors affecting outcomes and, specifically on using 
administrative data, there are weaknesses with, for instance, poor recording of some key risk 
factors. 
A literature review conducted in 2003 concluded that analysis of administrative data was not 
relevant to the purpose of understanding the latent causes and contributory factors behind adverse 
events.59 However, since this review a number of patient factors have been analysed using 
administrative data, including significantly higher rates for some adverse events for: children;24 
schizophrenic patients;132 certain races and ethnicities;437 and females.120 Similarly, significant 
associations with hospital factors have been identified, including lower rates of some adverse events 
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for providers with: more sophisticated and mature IT infrastructures performed significantly better 
on the largest number of PSIs;123 access to critical care;124 and holding daily ward rounds.518 For 
better understanding of the risks and to permit future benchmarking, further work should focus on 
gaining better understanding of hospital factors.519  
11.3.5.3. Quasi-experimental 
Such indicators offer the potential for undertaking trend analysis.62 As a result, it is possible to assess 
whether an initiative, such as implementing an IT solution,122,123  has had an effect on patient safety. 
And there are examples which show that rates of adverse events can be influenced by initiatives; 
one project found that improved staffing reduced errors in a 24 hour paediatric critical care satellite 
pharmacy with unit dose drug distribution.14 However, such positive findings might be the result of 
the Hawthorne (observer) effect whereby people modify their behaviour when new initiatives are 
introduced. A weakness of such quasi-experimental approach is that coding changes over time, thus 
making disaggregating underlying effects more difficult. 
Despite limitations in such study designs, researchers should take advantage of the longitudinal and 
comprehensive data which allow for time- and cohort-based comparisons. This thesis has already 
presented examples of evaluating interventions, such as those existing studies on implementing 
stroke unit care and the original work undertaken on investigating London’s regional reorganisation. 
However, there are many other techniques – such as synthetic control matching – and numerous 
other possible foci for further studies. 
11.4. Data implications 
11.4.1. Background 
11.4.1.1. Study implications on data 
While the studies here demonstrated that key coding issues could only explain some of the variation 
in performance, it did highlight the extent of variation in coding practice. For example, providers’ 
average number of distinct diagnoses codes per admission ranged from 5.0 to 10.7 within stroke 
care (by hospital trust) and from 2.8 to 6.6 for maternal admissions (by hospital site). Similarly, the 
use of the ‘stroke unspecified’ diagnosis code ranged from 0.2 to 42.6% of admissions across 
hospital trusts. Some of this variation may be explained by variations in patient case-mix but the 
huge differences suggest that there are also differences in coding practice. 
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11.4.1.2. Framework for improving data 
There is a need to gain understanding of why data errors are created and, to this end, Benin and 
colleagues have provided a useful framework by further disaggregating the potential errors as: 
categorising error (non-recordable differences in case-mix); entry error (improper inputting of the 
data); and query-error (misunderstanding of the data schema).315 Further work is required to ensure 
coding within HES is sufficiently accurate, including improved and more accessible coding guidance, 
and mandatory recording of specific procedures and diagnoses. Where discrepancies are found in 
the recording of data, there is a need for further research for both quality and safety auditors and 
regulators (to ensure performance is known) and hospitals (given the implications on their 
remuneration regarding, for instance, the coding of thrombolysis and scanning).  
11.4.2. Recommended interventions 
11.4.2.1. Peer review of coding 
To improve consistency in application of the coding rules, there should be a degree of peer review 
on practice. Given the changes in the governance arrangements around the quality of data given the 
forthcoming abolishment of the Audit Commission (who previously had a role in auditing this data) 
such a peer review process could be incorporated into any new data validation process. 
11.4.2.2. Adjust the coding framework 
The Government has proposed that the coding framework for administrative data may be 
updated.191 This study suggests that, if administrative data are going to be used for monitoring 
healthcare performance, consideration should be given to ensuring the framework allows for the 
recording of a wider range of quality and safety issues. 
11.4.2.3. Reassess coding rules 
There should be a review of whether some of the coding rules, such as the guidance to not record 
procedures undertaken before the decision to admit has been taken, should be amended. In 
particular, this current rule could introduce some bias where hospitals have differing procedures for 
admitting patients and might also result in an underestimate in, for example, scanning rates. 
11.4.2.4. Present on admission 
A commonly cited issue with using administrative data, is attribution with, for instance, potential 
errors when adverse events are present on admission.520 One solution is to enrich the administrative 
data, such as adjusting for conditions present on admission can be useful.101  The identification of 
diagnoses that are present on admission can be addressed through linking to other datasets, such as 
laboratory results. This endeavour of linking datasets also has the advantage of potentially allowing 
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a greater number and detail of indicators, so improving many aspects of validity. Alternatively, a 
present-on-admission flag could be introduced as used in some systems in the USA and Australia.  
11.4.2.5. Do not resuscitate 
As with ‘present on admission’, there are potential advantages in being able to flag up, within the 
data, patients whose status is Do Not Resuscitate (DNR).520 For instance, a previous publication 
suggested that removing DNR cases from the denominator might improve indicator performance.149 
However, this particular amendment to the coding framework should be done with consideration to 
both the fact that a DNR flag could reflect an adverse outcomes from poor care (and so such cases 
shouldn’t be excluded from quality measures) and the risk of incentivising gaming. 
11.4.2.6. Out-of-hours identifier 
The research I conducted in both specialties produced findings that were consistent with poorer 
standard of care at weekends. However, the true extent of inequality in outcomes by time of 
admission might be masked by a lack of time-, rather than just day-, stamp. Such a flag should be 
considered since it would allow researchers to identify the effect of different access to physical 
resources and staff during out-of-hours periods.  
11.5. Clinical implications 
11.5.1. Clinical guidelines and quality improvement 
For most of the measures applied in this thesis, there is no clinical consensus or guidelines for what 
are acceptable levels. In some instances this may be appropriate but in others this information is 
potentially useful to clinical teams and services because it supports the monitoring of performance. 
The two exceptions (where measures had consensus/guidelines) – with both coincidentally having 
deficiencies in performance – are: 
- access to a scan for people who have had a stroke, for which extant guidelines recommend 
that all such patients  should receive brain imaging “within a maximum of 24 hours after 
onset of symptoms”.334 The actual performance is that 69.7% of patients receiving a scan 
within one day of admission.  
- on caesarean sections prior to 39 weeks, for which the extant guidelines state that “the risk 
of respiratory morbidity is increased in babies born by CS before labour, but this risk 
decreases significantly after 39 weeks [and] therefore planned CS should not routinely be 
carried out before 39 weeks”(p18).490 The current rate is around a third of elective 
caesarean sections being carried out before 39 weeks. While some of this apparent 
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shortcoming may be due to poor coding, the seasonal differences (with particularly high 
rates of elective caesarean sections during December) suggest there are clinical 
shortcomings. 
These two cases, with large proportions of people being treated in contravention to the clinical 
guidelines, seem unacceptable. The implication is that the clinical guidelines need to be revisited, 
checked to ensure they are deliverable and appropriate, then re-communicated. 
11.5.2. Advantages of reporting to a ‘specialty team’ 
11.5.2.1. Introduction 
The studies clearly identified findings of clinical importance and, therefore, the implication is that 
clinicians need to have these findings reported to them. 
Health services should consider how these specialty-specific indicators could be reported routinely 
and directly to the specialty team. This reporting style would represent a hybrid of the 
administrative data identification method and ‘morbidity and mortality conference reporting’ format 
(where the clinical team formally discuss adverse events) and, in doing so, could harness the benefits 
of both. The motivation for reporting to clinicians is implicit in the arguments set out for reporting to 
specialties directly (section 2.6, p54). Further to these, the literature does set out further motivation 
for feeding back the results from indicators directly to specialty teams, as summarised below. Most 
refer to clinicians but hospital managers or even coders in that specialty should not be overlooked 
for risk of entrenching any interdisciplinary divide.  
11.5.2.2. Learning and culture 
Huber’s review of organisational learning research makes a distinction between experiential learning 
and “learning from searching and noticing”.521 The former type of learning is the category under 
which clinicians learn from their mistakes,73,117 whilst the second category would include the use of 
indicators to help clinicians prospectively improve through understanding the risk factors associated 
with patient safety.522  Certainly, there is recognition that reducing adverse events requires in-depth 
involvement of clinicians. Leggat and colleagues (2008), for instance, point out the importance of the 
skill and capacity of healthcare workers in delivering safer patient care.135 Similarly, one of the keys 
to improving patient care is to ensure that the health workforce develops the will to address the 
issues,135 and clinicians are well placed to change cultures.137 
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11.5.2.3. Develop new and existing indicators 
The specialty team members are in a good position to propose indicators. The increased demand for 
indicators that has precipitated from the raised profile of quality and patient safety could be 
addressed, at least in part, by developing and validating more indicators.73,523 Further to meeting the 
need for additional information, developing additional indicators would also:  
- reduce the focus on particular diagnoses and whether they are coded. This would diminish 
any ability and incentive to ‘game’ (as discussed in §11.6.1.2) by not coding accurately or 
comprehensively;  
- would create the opportunity to test correlations and identify factors from among 
indicators. This in turn would enable the indicators to depict quality and safety on a number 
of distinct dimensions;73 and 
- reduce reliance on existing research, which I highlighted earlier as a methodological issue. 
The specialty team can also focus new indicators on areas where they believe there is scope for 
improvement and so meet calls that measurement tools should focus on whether any harm caused 
was preventable.71   
11.6. Policy implications 
11.6.1. Variations in performance 
11.6.1.1. Scale of variation 
There were large variations between providers in their performance across the indicators. For 
example, same-day scanning rates varied from 20.4% to 79.3% between hospital trusts and early 
caesarean section rates varied from 1.1% to 60.7%. Even after accounting for random chance, there 
was a strong indication of substantial underlying differences. There were 181 occurrences of hospital 
trusts performing statistically significantly differently to the average at the 99.8% confidence level 
across the 6 stroke measures. For the 8 obstetrics indicators there were 441 such outliers. 
Moreover, differences in coding practice appeared to only partially explain the variation in 
performance. 
11.6.1.2. Use of benchmarking 
These findings raise questions on how such research should be used. Benchmarking – or comparing 
performance against peers – can be done either confidentially or publicly. There are cases of specific 
indicators being used for public reporting of hospital performance, by benchmarking against similar 
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providers. In the NHS, a number of indicators of quality and safety, derived from administrative data, 
are now used to benchmark providers and commissioners of care and indeed the publication of 
results from this study builds on this. However, a number of problems associated with this possible 
utilisation have been pointed out, including that: 
- if indicators are used to evaluate individual hospitals and in the absence of an effective 
system for auditing the recording of adverse events in the administrative data, there is a 
risk that hospitals may stop coding incidents that could implicate the occurrence of a 
patient safety event;71 and  
- due to the limitations on validity, a report could show an unduly poor rate and, if not 
confidential, a hospital might be pressurised into making a knee-jerk reaction to correct 
this reported problem.119 
Given these unresolved issues, inter-institutional comparisons should be “approached with caution” 
(p788),101 although Marshall and Romano argue that the concept of publicly available data is 
becoming more acceptable to both clinicians and managers.513 A study based in the NHS, which 
involved sending out benchmarking reports to 170 hospital trusts, reported, however, that “trusts 
were generally positive about receiving the reports”(p13).112 The pressure to publish benchmarking 
data to support policies such as choice of provider, which exists in many health services, means that 
benchmarking is likely to remain a common application and, as such, I committed a large proportion 
of my research into investigating some of the issues around this application. As discussed earlier, this 
study suggests that some of the commonly cited limitations of benchmarking – such as coding depth 
– can be addressed to some extent. 
11.6.1.3. Acceptability of variation 
The providers of health services in England are increasing autonomous, although there remains a 
quality regulator (the Care Quality Commission, CQC) with responsibility for registering, monitoring 
and inspecting providers. Some level of variation may be inevitable but it is unclear what level policy 
makers deem acceptable. The scale of the variation is sufficient to suggest that providers and the 
CQC should consider how to address some of the more significant variations. One action could be to 
use such indicators to attempt to reduce such variations and this is covered in the next section. 
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11.6.2. Addressing issue on association between 
complications and day of the week 
11.6.2.1. Scale and causation 
This project identified significant variations in out-of-hours performance, as outlined earlier in the 
discussion. The stroke analysis benefited from reporting both process and outcome measures for 
this weekend analysis which provides greater construct validity and also from certain process 
measures being less susceptible to bias from case-mix. As such, policy makers should ensure that 
further studies on out-of-hours care should endeavour to include process measures. Further 
research should also continue to look at this issue through a specialty-specific lens, with previous 
research suggesting a heterogeneous effect across specialties, which could result in significant 
shortcomings of care being masked by a broader scope.524 
11.6.2.2. Addressing the ‘weekend effect’ 
In England, in response to findings on quality of care at weekends, a number of initiatives have been 
developed to reduce mortality, increase efficiency, ease access, and ensure patients receive the 
same standard of care regardless of the day of the week. Further research suggested that achieving 
a seven day service would: require local solutions; cost up to 2% of total patient care income; and 
unlikely to be cost-neutral.525 In a resource constrained health service, this equation has clear policy 
implications, requiring health service leaders to evaluate how much value they place on providing an 
equal level of care at all times. 
11.6.3. Application of indicators by policy makers 
11.6.3.1. Scope of discussion on application of indicators 
The previous ten chapters have set out the rationale, methods and considerations relating to the 
application of specialty-specific indicators. Coupled with the proliferation of indicator use, it would 
therefore be remiss not to set out some key issues regarding the use of these indicators to improve 
quality and safety. The work represents only a narrative summary of the multitude of considerations 
and views expressed elsewhere by a range of disciplines, including that of Benn and colleagues 
which draw on psychology,126 but aims to give an overview of the considerations for policy-makers 
regarding how such indicators could be applied. The similar discussion for researchers – on 
experimental design (e.g. quasi-experimental or epidemiological) – was covered earlier. 
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11.6.3.2. Revisiting reporting 
The application and interpretation of indicators based on administrative data depends on a 
multitude of often dependent factors, such as the purpose and type of event being identified (Figure 
32). 
Figure 32: Potential uses of patient safety indicators 
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Source: Based on Australian Centre for Economic Research on Health (ACERH) 
Of these broad categories of purposes, the following specific examples of applications have been 
suggested: document the quality of care; make comparisons and benchmarking over time between 
places (e.g. units, hospitals); make judgments and set priorities (e.g. choosing a hospital or surgery 
or organising medical care); support accountability, regulation, and accreditation; support quality 
improvement; and support patients’ choice of providers.65 
The WHO has recommended that reporting systems should be blame-free, concluding that 
successful systems are: non-punitive; confidential; independent; expert analysis; credible; timely; 
systems-orientated; responsive.97 This conclusion was echoed by the team constructing a national 
set of indicators in Denmark which called for reporting systems to be: confidential, sanction-free, 
learning oriented. 117 Both of these recommendations include ‘confidential’ but this may be at odds 
with policies to improve transparency, such as the Freedom of Information act in the UK, which 
highlights the conflict between theoretically-appealing and practical solutions.  
11.6.3.3. Types of application 
The potential application of indicators was covered briefly in the section 2.5 (p51-) to explain the 
context with which the indicators are used. I give greater detail, including some commonly cited 
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strengths and weaknesses (summarised in Table 64), of some of these applications below drawing 
predominantly on the literature on generic (non-specialty-specific) indicators. The limitations and 
strengths of benchmarking between providers were covered earlier (paragraph 11.6.1.2, p262) and 
are not repeated here. 
As a WHO report identified, whilst “they [PSIs] have not yet been validated extensively,… they have 
been found useful in several studies for estimating rates, identifying risk factors and tracking trends 
in inpatient safety events.” 515 More generally, a review of patient safety recommended that 
indicators “can serve as timely indicators for latent problems that the organization is not otherwise 
tracking”(p1644).73 My view would be to use more robust applications for benchmarking adverse 
events and perhaps even accountability, with other less-valid applications for case finding, with any 
use of such indicators within a wider portfolio of measures. I did not identify sufficient evidence 
within the literature that using such indicators for reimbursement or policy-making would 
necessarily be effective.  
Table 64. Key strengths and weakness of common applications of administrative data 
Application  Strength Weakness 
Accountability  11.6.3.4 Indicators can be aggregated 
to whichever level of 
accountability is being 
evaluated 
Majority of commentators 
warn against ‘hard’ 
application due to, for 
instance, gaming 
Benchmarking  11.6.1.2 Administrative data cover 
many providers (or other 
units) and are longstanding 
(so can compare over time) 
Evidence of variation in coding 
practice 
Reimbursement  11.6.3.5 Easy to implement as data 
often forms part of funding 
framework 
Strong incentive to bias coding 
Priorities  11.6.3.6 Linked to activity and cost Lack of comparability between 
specialties due to coding 
framework 
Case finding  11.6.3.7 Promotes openness  
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11.6.3.4. Accountability 
To assess how indicators could be utilised to hold people to account, one has to consider to whom 
the assessment will be made. 73 An advantage of administrative data is that the indicators can be 
aggregated to different levels to meet these difference reporting needs. In England, the levels of 
aggregation have focused on organisations or physicians.526 Such transparency has, for example, 
been called for in reports on adverse care at Bristol Royal Infirmary and Mid-Staffordshire NHS 
Foundation Trust. However, as also suggested earlier, a review of the literature suggested that any 
patient safety measure should be non-punitive,97 so this application remains contentious.  
If health systems start to employ indicators for collecting ‘hard’ evidence to apportion accountability 
and responsibility then there will be a perverse incentive to under-report adverse events and, 
therefore, reduce the validity of the underlying dataset for the indicator. There is a need for a 
reporting culture 527 and, to catalyse a move to such a culture, there will need to be an end to any 
perceived or actual blame culture. This argument leads to the conclusion that indicators should not 
be used to hold people accountable. This is particularly important since many adverse events may be 
blameless. Certainly, “in aviation maintenance – a hands-on activity similar to medical practice in 
many respects – some 90% of quality lapses were judged as blameless” (Marx 1997 cited in 527). 
Given the level of specificity and sensitivity of current indicators, they could only be applicable for 
compensation, professional regulation, or criminal justice if used in conjunction with other methods. 
Certainly, many academics have warned that current indicators should not be used as 
embarrassment, let alone blame or sanction. 73  
11.6.3.5. Reimbursement 
Another potential use for these indicators is to determine levels of reimbursement for healthcare 
providers. In fact, in the USA if the administrative data reveals that one of a specific list of sentinel 
events has occurred during an admission the hospital will not be reimbursed for the costs of the 
healthcare for the index event or for treating the harm relating to the adverse event. However, rate-
based indicators have rarely been used to determine levels of reimbursements. The issues relating to 
benchmarking that were outlined above also hold for this use. Bahl and colleagues have concluded 
that indicators based on administrative data are not appropriate to profile hospital performance or 
determine levels of reimbursement.99 Indeed, Davies, in explaining the refinement of the HCUP 
quality indicators, recommended that indicators should not create incentives to improve measured 
performance without truly improving the quality of care provided, which could be an unintended 
consequence of linking with reimbursement.80 
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11.6.3.6. Make judgements about priorities 
Priority setting – deciding about the areas to invest resources and focus - can be made using a 
myriad of evidence to make informed decisions and, therefore, these indicators can offer 
information relevant to assessing strategies. There is also scope for indicators to be developed and 
analysed further to increase their utility in this respect, for example, by calculating the associated 
costs. One of the advantages offered by analysing hospital administrative data – that it is linked, in 
many countries, to funding frameworks – remains largely unexploited. Further, despite countries 
assessing the value of technology by its cost-effectiveness, such analysis is limited. “There is no full 
economic evaluation of the burden related to the implementation of various methods… Obtaining 
such information is usually a secondary objective of the published studies, and no details are 
available on how the calculations were performed” 59. The WHO noted that the cost-benefit analysis 
of patient safety measures “could provide an impetus and help countries make the necessary 
investments”(p86). 515 
11.6.3.7. Case findings 
The most consistently recommended use of administrative data are for case finding, perhaps 
representing a ‘safe option’ as it does not introduce any significant incentives to game the 
indicators. In a paper outlining how the AHRQ PSIs could be applied to the NHS, Bottle and Aylin 
suggested that the indicators would be a useful tool to assist clinical audit towards potential 
issues.112 Similarly, Miller and Zhan have highlighted the appropriate use of the PSIs as institutional 
case-finding tools aimed at internal quality improvement as opposed to use for directly comparing 
individual institutions, especially in public reports that identify individual hospitals.24 In a paper 
setting out the limitations of hospital mortality rates, Lilford and Pronovost cautioned against the 
use of such indicators as the basis for sanctions or rewards but did concede that there was value in 
using such indicators to flag  where further investigation might be needed.49 
11.6.3.8. As part of measurement portfolio 
A full picture of quality and safety would not be possible from any one data source.528 In particular, 
for many uses, indicators are not detailed enough when used alone 73 and so “caution should be 
exercised when using administrative data, exclusively, to report quality and safety outcomes”.111 As 
well as a plurality of indicators, there are advantages in having a range of types of indicators; recall 
the discussion from earlier that, for instance, process of care measures are more positively 
influenced by feedback than outcome of care measures but the latter more intrinsically interesting 
to most stakeholders (with different data sources being more adept to being used for either 
outcomes or process measures).529 As such, rather than conclude spuriously on which is the best 
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application, I instead recommend that any use of such indicators by policy-makers is, where possible, 
as part of a broader measurement portfolio. This should also involve patient input and experiences, 
perhaps in the form of patient reported outcome measures. 
11.7. Conclusion 
This project showed that specialty-specific standardised mortality rates can reveal significant 
differences in performance both between providers and over time. Moreover, I was able to show 
that routinely-collected hospital administrative data can offer a far broader understanding of quality 
and safety than solely mortality rates. 
While I set out a range of limitations to both this and existing research that has used administrative 
data to evaluate quality and safety of healthcare, researchers in this area should not be too bashful 
about limitations in terms of validity. A paper setting out the limitations of HSMR concluded that 
“quality of care should remain innocent until proved guilty”, although this view has been 
subsequently criticised.512 Indeed there is no perfect measure of quality and so, if this maxim was 
held, then indolence would prevail. 
This project itself has shown that using indicators based on administrative data, albeit in this 
speciality-specific context and applied in a way that overcomes key limitations, can focus 
government, senior doctors and the public alike on areas of likely substandard care.530 To return to 
the similarly-themed fable and idiom introduced at the start of this thesis, if such research continues 
and some of the areas for further work are addressed then the blind men will have a better chance 
of identifying their subject and the issue of patient safety will no longer remain the elephant in the 
room.   
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Appendix B. Details of previous literature reviews of quality and safety indicators 
Review Pub Date  Description / Aims Methods Search terms Resources Inclusion / Exclusion 
criteria 
Research identified Indicator shortlisting Final indicators 
International 
Quality 
Improvement 
Programme 
(IQIP) 
Since 1985 in US 
and 1991 
internationally 
 
http://www.inter
nationalqip.com/
documents/broch
ure.pdf 
Publish topic specific 
indicators that can be 
used for benchmarking 
performance  
The measures were 
reviewed and modified 
following, firstly, feedback 
from subject-matter 
experts and then feedback 
and data from the first 6 
to 12 months of use. 
 
 
 
Tailored to the specific 
topic/procedure8 
PubMed. 
National sites (e.g., 
NPSA, Joint Commission) 
and Departments and 
Ministries of Health in 
the US and other 
countries as well as any 
of the accrediting 
agencies. 
   Nearly 700 indicators, 
covering four care 
settings: acute, 
psychiatric 
(behaviour health) 
care, long term care, 
and home care. 
HCUP QIs 
 
1994 Meet the short-term 
needs for information 
on health care quality 
using standardised, 
user-friendly and 
existing sources of 
data 
 
 
Described in Ball et al 
(1998)531 
 
Not available Not available Not available   HCUP I consisted of 
33 quality measures 
Joint 
Commission’s 
National 
Hospital 
Quality 
Measures. 
 
April 2009 
(Version 2.6b) 
 (based on work 
since 1999) 
To construct quality 
measure set for 
commissioners and 
providers of hospital 
care to publicly report 
their activities. 
 Not stated (and 
unavailable on request) 
-  The ORYX® initiative, 
which became 
operational in March 
1999, has over 8,000 
disparate measures. 
 The Centers for 
Medicare & Medicaid 
Services (CMS) chose 
10 starter set 
measures and 11 
additional measures 
from a consensus-
derived set of 39 
measures. 
                                                          
8
 IQIP information from KarolW@mhaonline.org 
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Review Pub Date  Description / Aims Methods Search terms Resources Inclusion / Exclusion 
criteria 
Research identified Indicator shortlisting Final indicators 
AHRQ QIs 
(refinement of 
HCUP QIs) 
2001 To identify Patient 
Safety Indicators that 
could be used using 
ICD-9. They are based 
on the HCUP QIs. 
Steps: 1. Defined the 
concepts and the 
evaluation framework; 2. 
Search the Literature; 3. 
Develop a Candidate List 
of PSIs; 4. Review PSIs; 5. 
Evaluate the PSIs 
Medical Subject Heading 
(MeSH) terms “hospital, 
statistic, and methods” 
and “quality indicators” 
In addition, electronic 
searches for articles 
published before 
February 2002, followed 
by hand search and 
Author search for 
Iezzoni, given her work 
on CSP 
 
Inclusion criteria: quality 
indicator; novel indicator; 
and based on 
administrative data 
PQI: 2,600 articles 
since 1994 of which 
181 articles provided 
information on 
potential quality 
indicators based on 
administrative data. 27 
met full criteria 
Semi-structured 
interviews, 
evaluation 
framework (7 
aspects: face validity, 
precision, minimum 
bias, construct-
validity, fosters real 
quality improvement, 
application) 
28 provider level and 
4 area level Inpatient 
Quality Indicators 
(IQIs); Patient Safety 
Indicators; Paediatric 
Quality Indicators; 
and Prevention 
Quality Indicators.   
Millar et al 
2004, [OECD 
Health Care 
Quality  
Indicator 
(HCQI) project] 
2004 
 
 
Develop PSIs to cover: 
hospital-acquired 
infections; sentinel 
events; operative and 
postoperative 
complications; 
obstetrics; and other 
care-related AEs. 
Review of existing routine 
data-based PSIs in OECD 
countries. PSIs selected 
according to indicator 
importance, scientific 
soundness and feasibility. 
n/a Previous indicator 
searches 
 7 indicator sets: AHRQ 
PSIs; AHRQ/CIHI PSIs; 
ACSQ; Complication 
Screening Programme 
(BIH, Israel), JCAHO 
Infection Control; 
JCAHO Sentinel Events.  
Expert panel 21 indicators, from 
total of 59 
SIMPATIE 2006 Described in 
Kristensen et al 
(2007)104 
The development of 
indicators was based on 
an adjusted method 
described in Mainz 
(2003)144 
 
The literature search was 
started in the beginning of 
2006, and repeated and 
extended in the process of 
the work, it was finalised 
by the end of 2006. 
 
“Stepwise Assessment 
Framework Approach” 
An extensive literature 
search was initiated using 
the search terms: “Patient 
safety”, “Indicator”, 
“Risk” and “Harm”.  
PubMed and 
http://scholar.google.dk/ 
were searched. 9 
 
 
Search terms: “Test*”, 
“Usage”/”Use”, “Apply” 
and “Valid*” were used to 
assess if indicators 
previously evaluated in 
clinical setting. 
Indicators or indicator 
programmes of the 
organisations 
mentioned in 
‘resources’ were 
reviewed to determine 
whether they were 
suitable for 
characterisation. 
3 aspects: relevance; 
validity and 
reliability; feasibility 
42 indicators with 24 
recommended in all 
or part of Europe 
                                                          
9
 Indicator programmes were reviewed Australian Council for Safety and Quality in Health Care (ACSQHC); Agency for Healthcare Research and Quality (AHRQ); The Good 
Medical Department, Denmark (DGMA); International Compendium of Health Indicators (WHO, OECD, Eurostat and ECHIM; Institute of Healthcare Improvements (IHI); 
Joint Commission on accreditation in Health Care (JCAHO); Nordic Indicators (NI); Performance Assessment Tool for Quality improvement in Hospitals (PATH); The Danish 
National Indicator Project (NIP); Performance Indicators on Patient Safety and effectiveness for Dutch Hospitals. 
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Review Pub Date  Description / Aims Methods Search terms Resources Inclusion / Exclusion 
criteria 
Research identified Indicator shortlisting Final indicators 
NIP (Denmark)   Perform focused literature 
searches concerning the 
existence and experience 
with measurable 
parameters. 
Simultaneously search 
relevant international 
indicator libraries 
^ e.g. the AHRQ, National 
Quality Measures 
Clearinghouse, indicators 
from professional society 
websites (mainly US and 
UK) and indicators from 
international agencies, 
such as OECD, Joint 
Commission etc.) 
  The indicators were 
developed, tailored 
to the chosen disease 
area, based on a 
search of scientific 
evidence or, in its 
absence, the decided 
by expert consensus.  
 
For each disease 
about 6-10 indicators 
were determined. 
National 
Indicators of 
Safety and 
Quality Project 
(Australia) 
The Australian 
Council for Safety 
and Quality in 
Health Care was 
established in 
January 2000 to 
improve the 
safety and quality 
of health care 
provision in 
Australia. 
Report on: suitability 
of OECD indicators for 
Australian data; 
measuring and 
reporting mortality; 
possible primary care 
indicators 
recommending 
indicators to support 
monitoring and 
improvement in safety 
and quality of health 
care. 
General search of patient 
safety literature  
   230 papers from both 
health (152 papers) 
and non-health 
literature (78 papers) 
that are case studies, 
literature reviews, 
research studies or 
guideline documents 
containing data. 
  
Patient safety 
indicators: A 
systematic 
review of the 
literature  
Carmen Tsang, 
Paul Aylin, 
William 
Palmer  
Oct 2008 (11/07 
& 03/08) 
review the literature 
on patient safety 
indicators developed 
from routinely 
collected hospital data 
Systematic Literature 
review 
patient safety OR hospital 
safety OR patient safety 
indicator$ OR safety 
improvement$ 
AND 
adverse event$ OR 
medica$ error$ OR 
sentinel event$ OR 
healthcare associated 
injury OR healthcare 
associated injuries OR 
iatrogenic disease$ OR 
preventable 
complication$ 
Medline (1950 to 
present) and Embase 
(1980 to present).  
Inc. grey literature & 
Government websites 
(Aus, Can, Den, Uk, US) 
Exclusion: 
- Studies outside of 
secondary care; and 
- Studies primarily on 
specific diseases, 
diagnoses or treatments; 
or 
- Studies evaluating 
teaching or research 
tools; and 
- Articles not in English. 
Total 1517 citations 
(1295 databases, 158 
from reference lists, 43 
from websites) 
 
726 non-relevant, 244 
duplications, 75 non-
English, 2 not 
available, 2 non-
human 
 
Of 468 fully 
abstracted, 277 either 
Strategies or 
Background and 91 
articles on PSIs 
  
Notes: ^ The search terms for health related literature were based on the standard medical subject headings (MeSH) and include any or all of the following terms: 
• Manpower, doctors, medical staff, nursing staff, health personnel, staffing, personnel staffing, scheduling, personnel administration, workload# • Nursing staff, hospital/supply, distribution • Quality assurance • 
Hospital safety management • Patient safety, patient incidents, patient adverse health effects, clinical risk, quality management, quality care, risk management, quality of healthcare, quality indicators, outcome 
assessment/methods, hospital/standards, accident prevention, safety management, adverse events, adverse drug reactions • Staff* rostering, staff fatigue, staff supervision, work place harassment, staff 
dissatisfaction, clinical governance, staff competency. # The term ‘out-of-hours’ was not searchable in the majority of databases used for this review. As a general rule, the term ‘of’ is not searchable in a database as 
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it is considered a ‘stop’ word that occurs too frequently to make search results relevant. ‘Out-of-hours’ is found in the searching related to workload, scheduling and working hours. * The term “staff” will include 
doctors, nurses, midwives, managers, surgeons, anaesthetists, physicians, allied health professionals. 
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Appendix C: Additional websites searched 
The list below was adapted from a list used by Tsang and colleagues in their review of general 
patient safety indicators.66 
Organisation URL 
International   
International Compendium of Health Indicators http://www.healthindicators.org/ICHI/general/startme
nu.aspx 
European Commission Health Indicators Monitoring  http://www.echim.org/index.html 
European Observatory on Health Systems and 
Policies  
http://www.euro.who.int/observatory 
Organization for Economic Co-operation and 
Development  
http://www.oecd.org/home/0,2987,en_2649_201185_
1_1_1_1_1,00.html 
Safety Improvement for Patients In Europe Project  http://www.simpatie.org/Main 
The Commonwealth Fund   www.commonwealthfund.org/ 
The Joint Commission International Center for 
Patient Safety  
http://www.jointcommissioninternational.org/ 
WHO Collaborating Centre for Patient Safety 
Solutions 
http://ccforpatientsafety.org/ 
World Health Organization Regional Office for 
Europe   
http://www.euro.who.int/ 
World Health Organization World Alliance on 
Patient Safety 
https://www.who.int/patientsafety/en/ 
Australia  
Australian Commission for Safety and Quality in 
Health Care  
http://www.safetyandquality.gov.au/ 
Australian Council of Healthcare Standards   http://www.achs.org.au/ 
Australian Government   http://www.australia.gov.au/ 
Australian Healthcare Association   http://www.aushealthcare.com.au/ 
Australian Institute of Health & Welfare   http://www.aihw.gov.au/ 
Australian Medical Association   http://www.ama.com.au/ 
Australian Medical Council   http://www.amc.org.au/ 
Australian Patient Safety Foundation   http://www.apsf.net.au/ 
Commonwealth Department of Health and Ageing http://www.health.gov.au/ 
Department of Health and Ageing   http://www.health.gov.au/internet/main/publishing.ns
f/Content/Home 
Queensland Health   http://www.health.qld.gov.au/ 
Royal Australian College of General Practice  http://www.racgp.org.au/ 
Royal Australian College of Physicians   http://www.racp.edu.au/ 
Royal College of Nursing   http://www.rcna.org.au/ 
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Victorian Government Health Information - 
Department of Human Services, Victoria  
http://www.health.vic.gov.au/ 
Canada  
Accreditation Canada   http://www.accreditationcanada.ca/default.aspx 
Canadian Institute for Health Information   http://secure.cihi.ca/cihiweb/dispPage.jsp?cw_page=h
ome_e 
Canadian Patient Safety Institute   http://www.patientsafetyinstitute.ca/index.html 
Institute for Safe Medication Practices   http://www.ismp-canada.org/ 
Denmark  
Ministry of Health and Protection  http://www.sum.dk/sum/site.aspx?p=34 
The Danish Society for Patient Safety   http://www.patientsikkerhed.dk/en/about_the_danish
_society_for_patient_safety/about_the_society/ 
The National Board of Health and Welfare   http://www.socialstyrelsen.se/en/ 
United Kingdom  
Centre for Reviews and Dissemination, University of 
York  
http://www.crd.york.ac.uk/ 
Clinical and Health Outcomes Knowledge Base, 
National Centre for Health Outcomes Development  
http://www.nchod.nhs.uk/ 
Department of Health   http://www.dh.gov.uk/en/index.htm 
National Audit Office   http://www.nao.org.uk/ 
National Patient Safety Agency   http://www.npsa.nhs.uk/  
Patient Safety Research Portfolio,  University of 
Birmingham  
http://www.pcpoh.bham.ac.uk/publichealth/psrp/inde
x.shtml 
Royal College of Obstetricians and Gynaecologists http://www.rcog.org.uk 
Royal College of Midwives http://www.rcm.org.uk 
United States of America  
Agency for Healthcare Research and Quality  http://www.ahrq.gov/ 
American Society for Healthcare Risk Management  http://www.ashrm.org/asp/home/home.asp 
Center on Health Policy/Center on Primary Care and 
Outcomes Research, Stanford University  
http://healthpolicy.stanford.edu/ 
Centers for Disease Control and Prevention   http://www.cdc.gov/ncidod/hip/default.htm 
Healthcare Cost and Utilization Project   http://hcupnet.ahrq.gov/ 
Institute for Healthcare Improvement   http://www.ihi.org/ 
Institute for Safe Medication Practices   http://www.ismp.org/ 
Institute of Medicine   http://www.iom.edu/ 
National Coalition on Health Care   http://www.nchc.org/ 
National Coordinating Council for Medication Error 
Reporting and Prevention 
http://www.nccmerp.org/ 
National Institutes of Health   http://www.nih.gov/ 
National Committee for Quality Assurance http://www.ncqa.org/ 
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National Patient Safety Foundation   http://www.npsf.org/ 
Quality Interagency Coordinating Task Force  http://www.quic.gov/ 
The Joint Commission   http://www.jointcommission.org/ 
National Center for Patient Safety, Department of 
Veterans Affairs 
http://www.patientsafety.gov/ 
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Appendix D: Stroke indicators 
Indicator Definition (example) Reference (example) 
Urgent brain scan for stroke 
patients 
Proportion of stroke patients who have a brain scan 
(CT or MRI) performed on the day of (or by following 
day after) admission 
Queensland 
Government532 
Thrombolysis Proportion of patients receiving thrombolysis 
treatment 
American Academy of 
Neurology (2010)200 
Emergency hospital 
transfers 
All patients with suspected acute stroke are 
immediately transferred by ambulance to a receiving 
hospital providing hyper-acute stroke services 
Kind (2007)272 
Urinary Tract Infections 
(UTIs) 
Proportion of stroke admissions with secondary 
diagnoses of urinary tract infection  
Laudicella (2008)221 
Pneumonia due to 
swallowing problems 
Proportion of stroke admissions with pneumonitis 
due to food or vomiting (a consequence of 
swallowing problems) 
Laudicella (2008)221 
Lower respiratory tract 
infection (LRTI) 
Proportion of stroke admissions with unspecified 
acute lower respiratory tract infection  
Laudicella (2008)221 
Deep Vein Thrombosis Proportion of stroke admissions with secondary 
diagnoses of deep vein thrombosis 
Cnesullo (2008)243 
Pulmonary Embolism Proportion of stroke patients with documented 
pulmonary embolism occurring during admission  
Field (2004)219 
Clostridium difficile Proportion of stroke admissions with Enterocolitis 
due to Clostridium difficile 
Laudicella (2008)221 
Depression and other 
mental health problems 
following stroke 
Diagnosis of depression and other mental health 
diagnosis in the first 3 years post-stroke 
Williams (2004)228 
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Inpatient rehabilitation 
services 
Proportion of stroke admissions with recorded use 
of rehabilitation services, defined as reimbursement 
claims for physical therapy, occupational therapy, 
speech therapy, or a combination of these therapies 
Kapral (2002)286 
Wafarin use Warfarin use as proxied by outpatient claims for 
prothrombin time tests 
Smith (2005)264 
Length of stay Length of hospitalisation Zhu (2009)231 
In-hospital mortality within 
30 days of admission 
The standardised proportion of stroke patients who 
die in-hospital within 30 days of admission 
Queensland 
Government532 
All-location mortality within 
28 days of admission 
Proportion of stroke patients who die within 28 days 
of admission 
Pajunen (2005)294 
Craniotomy: mortality rate Number of deaths per 100 discharges with a code 
for craniotomy, with and without comorbidities and 
complications. 
AHRQ (2013)533 
Return to usual place of 
residence 
Proportion of stroke patients returning to their usual 
place of residence following hospital treatment 
within 56 days 
Qureshi (2005)259 
Emergency readmission (all 
cause) to hospital 
Percentage of patients of all ages with emergency 
readmission to any hospital within 27 days 
(inclusive) of the last, previous discharge from 
hospital after admission with a stroke 
Rosato (2006)534 
Recurrent stroke within 28 
days 
Percentage of patients of all ages with emergency 
readmission for stroke to any hospital within 27 days 
(inclusive) of the last, previous discharge from 
hospital after admission with a stroke 
Johansen (2006)220 
Readmission for 
incontinence 
Percentage of patients readmitted to any hospital 
within 27 days with diagnosis  for incontinence 
Queensland 
Government532 
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Appendix E: Obstetrics indicators 
Indicator Indicator 
type 
Detail Inclusions or 
exclusions 
Alternatives Indicator sets, 
primary (other) 
Key articles Validation 
For mother        
M1. Non-elective 
readmissions 
Outcome Within 42 days of the 
start of a delivery episode 
Excludes 
readmissions of less 
than a day 
1. Different time periods: any post-
natal admission of mother (NCHOD); 
6 months (Jimenez-Puente 2002); 90 
day 
400
; 30 day 
423
(Tseng 2010); 15 
days (Tseng 2010); 7 or 14 days 
(Kotagal 1999) 
2. Readmissions for PPH 
440
 
3. Readmissions within 28 days 
535
 
CQC, NPIC 
390,398-
400,423,536
 
 
M2. Puerperal sepsis 
 
Outcome ICD-10 diagnosis code of 
O85  at any point during 
delivery spell within 42 
days of the start of a 
delivery spell  
Includes 
readmission within 
42 days of the start 
of the delivery spell. 
1. Puerperal sepsis and other 
puerperal infection (ICD-10 O85 and 
O86) or specified puerperal infection 
(excludes O86.4)  
2. Chorioamnionitis (JCAHO) 
3. Uterine infection (Korst 2005)  
4. Wound complications (AHRQ) 
CQC 
427
 
392
 
415,428,435,444,45
2
 
Chorioamnionitis 
and morbidities 
recommended and 
detailed evaluation 
of infections 
indicator exists 
415
 
M3. Obstetric 
Trauma 
Outcome 
/Proxy 
outcome 
(procedures) 
Stratified by delivery type 
(VB with instrument; VB 
without instrument; CS) 
Third or fourth degree 
tear in dx or procedure 
codes 
Includes uterine 
rupture, fracture of 
pelvis, including 
coccyx, laceration 
or haematoma of 
cervix, vagina, 
vulva, perineum 
and anus. 
1. Trauma to perineal (PERISTAT)  
2. Cases of obstetric trauma (third or 
fourth degree lacerations) (JCAHO)  
3. Selected primipara with an intact 
perineum or unsutured perineal tear  
4. Surgical repair of perineum 
(ACHS) 
5. Aggregation of w/ and w/o 
AHRQ, NPCI, 
JCAHO, NOGA, 
RANZCOG/ACHS
, SimPatIE, 
DNBH, RCOG 
83,375,391,393,401
,404,407-
409,416,427,435-
437,441,444,451,45
2,455,456,461
 
 
3
rd
/4
th
 
degree tears 
396,406,418,419
 
Korst et al (2005) 
recommended – 
validation of coding 
needed 
Extensive testing by 
AHRQ 
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Indicator Indicator 
type 
Detail Inclusions or 
exclusions 
Alternatives Indicator sets, 
primary (other) 
Key articles Validation 
instrument (OECD) Other 
392
 
M4. Episiotomy Proxy 
outcome 
  1. Perineal trauma and episiotomy 
rates (NCHOD) 
2. Separated into selected primipara 
undergoing episiotomy AND 
sustaining a perineal tear during VB 
or with NO tear 
JCAHO (future 
measures), 
NOGA 
418
  
M5. Uterine rupture Outcome    NPIC   
M6. Incontinence Outcome Post-natal urinary or 
faecal incontinence 
 1. Faecal incontinence (PERISTAT) NCHOD   
M7. Mortality Outcome Limited to only delivery 
admissions 
Discharges with 
disposition of 
“deceased” 
 AHRQ (death in 
low-mortality 
DRGs), OBCQID, 
NCHOD, OECD, 
PERISTAT 
391,442,446,454
 Core measure in 
PERISTAT 
M8. Long Length of 
stay 
Outcome   1. Average LOS (OECD) 
2. LOS>1 day>local standard (ACOG) 
3. LOS > 2 (or 4) days for normal or 
instrumental delivery (Dr Foster) 
NPIC 
389,390,398,461
  
M9. Complications of 
anaesthesia 
Outcome Discharges with dx code 
for anaesthesia 
complications in any dx 
field 
  AHRQ 
391,395,433,444
  
M10. Foreign body 
left during procedure 
Outcome Discharges with dx code 
for foreign body left in 
during procedure in any 
dx field 
  AHRQ   
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Indicator Indicator 
type 
Detail Inclusions or 
exclusions 
Alternatives Indicator sets, 
primary (other) 
Key articles Validation 
M11. Post-partum 
haemorrhage (PPH) 
Outcome Diagnosis for 
postoperative 
haemorrhage/haematoma 
or related procedures 
Procedure codes for 
control of 
haemorrhage must 
occur within one 
day after birth 
1. Obstetric haemorrhage (ACOG) 
2. PPH or transfusion 
(RANZCOG/ACHS) 
3. Wider measure of PPH morbidity 
440
 
AHRQ 
(postoperative 
haemorrhage or 
hematoma) , 
NCHOD 
391,392,405,427,43
5,440,452
 
Korst et al (2005) 
recommended 
M12. Transfusion Proxy 
outcome 
Women who give birth 
vaginally who receive a 
blood transfusion  during 
the same admission. 
 1. Transfusions (Korst et al 2005) 
PPH or transfusion 
(RANZCOG/ACHS) 
2. Transfusions for CS (ACHS) 
ACHS 
389,405,427,444
  
M13. Transfusion 
reaction 
Outcome    AHRQ-derived   
M14. Episiotomy Proxy 
outcome 
  1. Perineal trauma and episiotomy 
rates (NCHOD) 
2. Separated into selected primipara 
undergoing episiotomy AND 
sustaining a perineal tear during 
VB/NO tear 
JCAHO (future 
measures), 
NOGA 
418,436,452,456
  
M15. Maternal 
transfer to perinatal 
centre 
Outcome   1. Transfer to ICU (NCHOD) JCAHO (future 
measures) 
  
 
M16. Eclampsia Process ICD-10 O15   OBCQID, 
NCHOD, ACOG 
391
  
M17. Severe maternal 
morbidity 
Composite    1. Adverse Outcome Index (Walker 
2010)  
2. Maternal composite (Srinivas 
2010) 
3. Weighted adverse outcome score 
PERISTAT 
393,410,424,429,43
0,442,443,446,449,
453,454,458,459
 
Recommended for 
further 
development 
(PERISTAT) 
Requires extensive 
data collected and 
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Indicator Indicator 
type 
Detail Inclusions or 
exclusions 
Alternatives Indicator sets, 
primary (other) 
Key articles Validation 
(WAOS, Mann 2006) 
4. Problems with Child Birth 
(ACSQ/OECD) 
risk adjustment 
(Janakiraman 2010) 
M18. Selected 
complications 
   1. Other complications (Romano 
2005) 
2. Selected complications (Oleske 
2000)  
3. Preventable complications (Deily 
2012) 
4. Obstetric misadventure [ref!] 
 
81,391,392,461
  
M19. Cardiac arrest     Goff 2000 
391
  
M20. General 
anaesthesia for CS 
Process    RANZCOG/ACHS   
M21. Pharmacological 
thromboprophylaxis & 
CS 
Process Total number of high 
risk women undergoing 
caesarean section who 
receive appropriate 
pharmacological 
thromboprophylaxis 
 1. Thrombosis (Srinivas 2009) RANZCOG/ACHS 
428
  
M22. Timely antenatal 
assessment 
Process Within 10-14 weeks or 
by 12 weeks 
  NHS 
Information 
Centre 
537
  
For delivery method       
D1. Primary 
caesarean birth rate 
Proxy 
outcome 
 Selected primipara 
only 
1. Caesarean section rates (NPIC, 
NOGA, OECD, CIHI). 
ACHS, JCAHO 
(future 
measures), 
ACOG 
389,393,402,403,41
3,414,417,421-
423,425,436,445,46
0
 
Korst et al (2005) 
recommended  
D2. VBAC Outcome vaginal birth after Any dx of abnormal  AHRQ, JCAHO, 
402
 Korst et al (2005) 
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Indicator Indicator 
type 
Detail Inclusions or 
exclusions 
Alternatives Indicator sets, 
primary (other) 
Key articles Validation 
Cesarean (VBAC) delivery 
rate, uncomplicated 
presentation, 
preterm, foetal 
death, multiple 
gestation diagnosis 
code. Breech 
procedures codes. 
NPIC, 
RANZCOG/ACHS
, 
RANZCOG/ACHS  
recommended 
 
D3. Unsuccessful 
VBAC 
Outcome    JCAHO (future 
measures), 
ACOG 
  
D4. Failed vacuum 
or forcep delivery 
Outcome   1. CS after failed instrumental 
delivery (RCOG) 
Roberts 2009 
RCOG 
375,456
  
D5. Emergency 
caesarean section 
Outcome    RCOG 
389,397,420,456
  
D6. Late elective VB 
or CS 
Process At greater or equal to 37 
and less than 39 weeks of 
gestation completed 
 1. Late CS (Gurol-Urganci 2011) 
(Benedetti 2009) 
JCAHO 
411,434
  
D7. Normal births Composite  A normal delivery is one 
without induction, 
without the use of 
instruments, not by 
caesarean section and 
without general, spinal or 
epidural anaesthetic 
before or during delivery. 
Excludes: induction 
of labour; epidural 
or spinal; general 
anaesthetic; forceps 
or ventouse; CS; 
episiotomy 
1. Operative VB rate (NPIC) 
2. Instrumental delivery (OBCQID, Dr 
Foster) 
3. Forceps or ventouse deliveries 
(NOGA) 
4. Births without medical 
intervention (PERISTAT) 
5. Outcome of selected primapara 
(RANZCOG/ACHS) 
6. Indications and/or rate of elective 
labour (JCAHO future measures)  
7. Spontaneous vs instrument VB 
BirthChoiceUK, 
PERISTAT,RCOG 
375,389,394,436
 Further 
development 
recommended 
(PERISTAT) 
Instrumental VB 
recommended by 
Sibanda 2013 
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Indicator Indicator 
type 
Detail Inclusions or 
exclusions 
Alternatives Indicator sets, 
primary (other) 
Key articles Validation 
(ACHS)  
8. Mode of delivery rates (NCHOD) 
Vacuum: forcep rates (RCOG) 
D8. Induction rates Proxy 
outcome 
Deliveries with surgical 
and/or medical induction 
of labour 
Selected primipara 
only 
 ACHS   
D9. Induction of 
labour resulting in 
emergency CS 
Outcome    RCOG 
375
  
For neonate        
N1. Non-elective 
readmissions 
Outcome Within 28 days of birth Excludes 
readmissions of less 
than a day 
1. Readmission for jaundice (Meara 
2004)  
2. Emergency department visits 
(Meara 2004) 
CQC 
412
  
N2. Infections Outcome Live babies of greater 
than or equal to 37 weeks 
gestational age (GA) born 
at the reporting hospital 
who develop a blood 
and/or cerebrospinal fluid 
(CSF) infection within 48 
hours 
 1. Babies admitted to the neonatal 
intensive care unit (NICU) who have 
a significant blood infection 
occurring more than 48 hours after 
birth at any time during their whole 
admission - disaggregated for those 
above or below 1000 grams birth 
weight. (ACHS also) 
2. Chorioamnionitis (JCAHO)  
3. Neonatal sepsis (VON) 
4. Part of wider category of system 
problems (Gould 2004) 
AHRQ (ACHS) 
412,415,432
 Korst et al (2005) 
recommended 
(chorioamnionitis 
and morbidities) 
Detailed evaluation 
of validity and 
feasibility 
415
 
N3. Birth Trauma – Outcome Discharges with code for Preterms with 1. Brachial plexus injury (Ford 2007)  AHRQ, OECD, 
81,83,393,401,407,
Janakiraman et al 
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Indicator Indicator 
type 
Detail Inclusions or 
exclusions 
Alternatives Indicator sets, 
primary (other) 
Key articles Validation 
Injury to Neonate birth trauma in any 
diagnosis field per 1000 
live births 
subdural or cerebral 
haemorrhage; 
infant dx of injury 
to skeleton or 
osteogenesis 
imperfecta 
2. Wider definition of trauma 
(Moczygemba 2010) 
3. Brachial plexus injury excluded 
(SimPatIE) 
CIHI, SimPatIE, 
DNBH 
409,416,437,439,44
1,444
 
(2010) suggest risk 
adjustment not 
well established. 
Generally 
performed well in 
AHRQ validation.
40
 
N4. Neonatal 
mortality 
    Gould 2004 
431,432,445,447
  
N5. Iatrogenic 
pneumothorax 
Outcome dx code for iatrogenic 
pneumothorax in principle 
field; any dx code of chest 
trauma or pleural effusion 
or selected procedures 
Less than 28 days  
and Birth-weight 
<500g;  
    
N6. Term NICU 
admissions 
Proxy 
outcome 
Percentage of inborn term 
babies 
transferred/admitted to a 
neonatal intensive care 
nursery or special care 
nursery facility 
or reasons of 
congenital 
abnormality 
1. Neonatal admission to intensive 
or special care (NCHOD)  
2. Neonatal transfer to perinatal 
centre (JCAHO future measures) 
ACHS (JCAHO)  Korst et al (2005) 
recommended 
Sibanda (2013) 
recommended 
N7. Long length of 
stay 
Proxy 
outcome 
Infant stay over 3 days for 
VB and 5 days for CS 
  Gould et al 2004 
432
  
N8. Conditions related 
to deprivation of 
oxygen to brain 
Outcome   1. Prevalence of hypoxic-ischaemic 
encephalopathy and cerebral palsy 
[ref!] 
2. Birth asphyxia (Ford 2007) 
PERISTAT 
432,444
 Recommended 
further 
development 
(PERISTAT) 
N9. Dehydration Outcome    Meara 2004 
412
  
        
N10. Adverse Outcome Composite Selected dx and 
procedure codes 
 1. Medical errors (Kanter 2004)  Lain et al (2011) 
393,426,430,438
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Indicator Indicator 
type 
Detail Inclusions or 
exclusions 
Alternatives Indicator sets, 
primary (other) 
Key articles Validation 
Indicator indicating adverse 
outcome 
2. Neonatal composite (Srinivas 
2010) 
N11. Selected 
complications 
Composite   1. Complications of labour (Gould 
2004)  
2. Gastrointestinal complications 
(Gould 2004) 
 
432
  
Mother and neonate        
Proportion of births 
with no trauma, 
infection or 
readmissions 
Composite A “combination” of the 
above 
 Include/exclude the individual 
measures (e.g. mortality) to make a 
different composite measure 
1. Ideal delivery (Gregory 2009) 
 
448
  
Notes: 
National Perinatal Information Centre (NPIC); National Centre for Health Outcomes Development (NCHOD), UK; Nordic obstetric and gynaecological association (NOGA) – Knut Dalaker, Einar J 
Berle (Norwegian Society of Obstetrics and Gynecology): Clinical Guidelines in Obstetrics 1999. Norwegian Medical Association, Oslo,1999; OBSQID. European Consensus Conference on 
Quality Indicators for Perinatal Care. Annex II: The 21 Essential Indicators and their Definitions. Nov 1994; OECD measures described in PERISTAT report; American College of Obstetricians and 
Gynecologists (ACOG) as cited in Korst et al (2005)  A Framework for the Development of Maternal Quality of Care Indicators; Vermont Oxford Network (VON) as cited in Korst et al (2005)  A 
Framework for the Development of Maternal Quality of Care Indicators; Danish National Board of Health’s (DNBH) Obstetrics Indicators; Australian Council for Safety and Quality (ACSQ) 
*Selected primipara is defined as: A woman who is 20-34 years of age at the time of giving birth; Giving birth for the first time at greater than 20 weeks of gestation; Singleton pregnancy; 
Cephalic presentation; At 37 weeks to 41 weeks gestation 
Clearing house: http://www.qualitymeasures.ahrq.gov/search/results.aspx?3062=1001%2c1002%2c&term=birth 
